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ABSTRACT
Structure and Dynamics of the HIV-2 TAR RNA-Argininamide
Complex by NMR Spectroscopy
by
Alexander S. Brodsky
Submitted to the Department of Chemistry in Partial Fulfillment of the Requirements for the
Degree of Doctor of Philosophy
ABSTRACT
The Trans Activating Region (TAR) RNA - Tat protein interaction is important for
activation of transcription in the human immunodeficiency virus (HIV). A model complex
for this interaction composed of the two base bulge HIV-2 TAR and the amide derivative of
arginine was studied by multidimensional heteronuclear NMR. Because of the improved
spectral properties of the HIV-2 TAR complex, a larger number of NOEs in the bulge
region were observed than in previous studies of the HIV-1 TAR-argininamide complex.
681 NOE distance restraints were collected and used to determine the solution structure of
the HIV-2 TAR-argininamide complex. As observed in the previously proposed model,
the two A-form stems co-axially stack and the critical U23 and the argininamide are located
in the major groove. Model calculations including non-experimental restraints indicate that
U23 is within hydrogen bonding distance to A27 consistent with the formation of a U-A*U
base triple. Base triple formation helps open the major groove to increase the accessibility
of G26 to hydrogen bond donors from the guanidinium group of argininamide.
Argininamide binding is stabilized by stacking of the guanidinium group between the bases
of A22 and U23, forming an argininamide sandwich. A C-G*C' isomorphic base triple
mutant was designed and demonstrated that base triple formation is required for
argininamide binding. This base triple mutant provides direct NMR evidence for base triple
formation. Relaxation rate measurements and spectral density calculations show that the
base triple nucleotides are not very flexible compared to A-form residues, consistent with
their involvement in a specific interaction. These studies represent some of the first detailed
RNA dynamics measurements on isotopically labeled samples.
Thesis supervisor: James R. Williamson
Title: Associate Professor of Chemistry
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Chapter 1: Introduction
1.1 RNA Structure and RNA Complexes
RNA gets lots of respect. For many, this respect is warranted because RNA plays
a central role in many critical biological processes and RNA has become the focus of
research and life itself. In the NMR community, almost every solution and solid state
NMR spectroscopist, is experiencing RNA envy and wants to study this macromolecule
that is not a protein but unlike DNA also folds into biologically relevant complicated three
dimensional structures. RNA is extensively studied because of its ability to help make
proteins (Moore, 1993; Soll, 1993), to catalyze a wide variety of chemical reactions (Cech,
1993), to bind specifically to small molecules (Gold et al., 1995), to regulate transcription
and translation (Tan et al., 1997), to help maintain telomeres (Blackburn, 1993), to help
splice introns (Moore et al., 1993), to regulate nuclear transport (Ullman et al., 1997), and
to regulate embryonic development (Gavis & Lehmann, 1992), among some of its
fundamental functions (Gesteland & Atkins, 1993). Clearly, RNA is far more than just a
transporter of the genetic message. In all these guises, RNA folds into complicated
structures that enable it to perform its function much like any protein.
1.1.1 RNA structure
For many years, the only RNA structural information, other than from helical
duplexes, was from the tRNA crystal structures. These remarkable structures provided a
wealth of information and a hint of the diverse features available to RNA including base
triples, metal binding, small molecule binding, loop structures, base-phosphate
interactions, modified nucleotides, and base intercalation (Roberts et al., 1974; Rould et
al., 1989; Ruff et al., 1991). In many ways, these form the basic tertiary interactions that
are found in RNA structure.
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Secondary structure predictions have identified a number of basic RNA structural
motifs such as loops, bulges, internal loops, three and four way junctions. These
secondary structure maps often show large regions which are apparently unstructured.
Recently, a number of RNA structures have been solved highlighting how these apparently
unstructured regions often take advantage of non-Watson-Crick base pairing and base
triples to organize into three-dimensional structures. These structures have expanded our
knowledge of the versatility of RNA structure, as almost every new structure has presented
new and exciting surprises. Some recurring motifs have been identified, including the
GNRA tetraloop appearing in a most unexpected place as part of the ATP aptamer
(Dieckmann et al., 1996; Jiang et al., 1996). Recently, larger, more complicated RNA
structures have been solved by X-ray crystallography. The Hammerhead and P4/P5/P6
structures revealed new and recurring motifs of tertiary structure such as the tetraloop
receptor, A-platforms, and anticodon loops (Cate et al., 1996; Pley et al., 1994a). Most
larger RNAs require Mg2 to fold and the P4/P5/P6 structure also showed how a large
RNA specifically binds and folds around a Mg2+ core (Cate & Doudna, 1996; Cate et al.,
1996; Cate et al., 1997).
1.1.2 RNA-protein interactions
RNA protein complexes are found at all levels of gene expression in biology.
However, these complexes are often part of larger ribonucleoprotein complexes, like the
spliceosome and the ribosome, making their dissection into isolated complexes difficult. In
addition to the tRNA-tRNA synthetase structures (Biou et al., 1994; Rould et al., 1989;
Ruff et al., 1991), three RNA-protein complexes have recently been solved: the MS2 coat
protein (Valegard et al., 1994), U1A bound to a hairpin loop (Oubridge et al., 1994), and a
NMR structure of U1A bound to its mRNA regulation site (Allain et al., 1996). These
RNA protein complexes showed how the loop residues are splayed towards the protein
allowing sequence specific recognition with no specific RNA conformation contributing to
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the interaction. The next few years are expected to yield a number of new NMR and X-ray
protein-RNA complex structures as the technology to purify and characterize them
improves. Meanwhile, a number of RNA-protein interactions from retroviruses have been
minimized to peptide-RNA complexes and their structures have been solved by NMR
including the Rev peptide-RRE RNA (Battiste et al., 1996; Ye et al., 1996) and the BIV Tat
- TAR complexes (Puglisi et al., 1995; Ye et al., 1995). These structures further
emphasize themes originally outlined in the TAR-arginine model, that the direct amino acid-
nucleotide specific contacts do not provide all the specificity for the interactions but rather
specific non-canonical base pairing plays a critical role in specific molecular recognition,
often by opening the major groove (Puglisi et al., 1993; Puglisi et al., 1992). In the major
groove, these peptides' arginine guanidium groups form specific hydrogen bonds, often to
guanines for molecular recognition.
1.1.3 RNA-ligand complexes
With the advent of in vitro Systematic Evolution of Ligands by Exponential
enrichment (SELEX), RNAs have been found to bind tightly and specifically to a number
of different small molecules (Gold et al., 1995). Solutions structures of a number of
aptamers has revealed the ability of RNA to organize into specific binding sites. The ATP
aptamer revealed the surprising result that the ATP fit into a binding pocket as the A of a
GNRA tetraloop structure (Dieckmann et al., 1996; Ye et al., 1996). The theophyllin
aptamer explains how the aptamer discriminates between theophyllin and caffeine which
differ by a single methyl group (Jenison et al., 1994; Zimmerman et al., 1997). This
structure also found the new A-platform and S-turn motifs originally identified in the
P4/P5/P6 (Cate et al., 1996) and Rev-RRE structures (Battiste et al., 1996; Battiste et al.,
1995; Ye et al., 1996), respectively. Other recent NMR structures include the arginine
(Yang et al., 1996), FMN (Fan et al., 1996a), and tobramycin aptamers (Jiang et al., 1997)
which highlight RNA's ability to organize purine rich regions into distinct binding pockets.
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1.2 RNA Structure Determination by NMR
1.2.1 General features of RNA NMR
Four important types of information accessible by NMR: 'H-'H NOEs, scalar
couplings, chemical shifts, and dynamics. Of these four major NMR observables, the
nuclear Overhauser effect (NOE) and the scalar coupling constant (J) are the most important
to define a macromolecular structures. The third observable, the chemical shift, has been
successfully applied to help refine protein secondary structure (Wishart & Sykes, 1994;
Wishart et al., 1991), but the database is not yet large enough for RNA NMR to utilize the
chemical shift for structure refinements reliably. Recently, relaxation measurements have
been introduced to measure long range structural restraints, but these difficult experiments
are only in their infancy and have not yet been widely applied to protein structure
determinations (Reif et al., 1997; Tjandra et al., 1997). The more common relaxation
experiments help verify the observed structural data, but their correlations to the structure
are often difficult to determine (Dayie et al., 1996; Kay et al., 1996).
The NOE is proportional to 1/r6 of the distance between any two protons so that
every pair of protons less than 5 A apart should be observable. The goal of NMR structure
determinations is to try to assign as many of these proton-proton distances as possible to
define the structure to the highest possible resolution. A number of studies have shown
that not only the precision but also the accuracy is directly proportional with the number of
distance restraints. The coupling constant, J, is sinusoidally proportional to torsion angles
such that any three or more bond network, with NMR active nuclei at the ends, e.g. a H-C-
C-H or H-C-O-P spin system, will have a J-coupling which is conformationally sensitive,
as described by the Karplus equation (Karplus, 1969).
3J = Acos 20 + BcosE + C (1)
The caveat of the Karplus equation is that the constants A, B, and C must be
empirically parameterized for each three bond network. For nucleic acids this has been
A) Imino protons indicate base-pairing
0%~ .
" O4 H,. ,H
RN N'i H)
C G
B) Sugar pucker determined from JH1'-H2'
5 ' 3' B
HO
C3'-endo
JH1'-H2' -2Hz
H
5' 2' OH
5'-0 5
3'-0
C2'-endo
JH1'-H2' -8Hz
C) Glycosidic conformation from the HI'-H8 distance
N NH 2
HI'
OHOH
anti syn
Figure 1.1: Basic RNA structural features that are easily characterized by NMR.
A) Imino proton resonances, highlighted by the circles, are only observed when
they are in a base pair. B) The two major sugar puckers are determined by
coupling constants. C) The two glycosidic conformations can be differentiated
by the H8-H1' NOE.
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done for the major measurable torsions , but the empirical nature of this equation is another
source of error. This error can be minimized by following a semi-quantitative approach
where if the J is in a certain regime a broad torsion restraint is applied.
A number of excellent reviews are available describing RNA NMR are available
(Pardi, 1995; Varani et al., 1996; Varani & Tinoco, 1991). This discussion will emphasize
some of the more modern multidimensional heteronuclear techniques and only briefly
review the basic assignment procedure that has not changed significantly in years. After a
brief review of homonuclear spectroscopy, a synopsis of some of the recent heteronuclear
multidimensional experiments is presented. The central information accessible from RNA
NMR is summarized in Figure 1.1.
Exchangeable protons. Exchangeable protons are protons that are bonded to oxygen or
nitrogen and are thus labile with water. Typically, the protons attached to oxygen such as
2'OH protons exchange very quickly with water such that most of the time they are part of
a water molecule and are not observed at a hydroxyl chemical shift. In a standard A-form
helix, the 2'OHs are directed towards the solvent allowing fast exchange with water. Only
a few cases of observable 2'OH proton resonances in RNA NMR spectra have been
reported and these are generally involved in a specific interaction (Allain & Varani, 1995;
Dieckmann et al., 1996; Jiang et al., 1996; Jiang et al., 1997). In these cases, the 2'OH is
making specific hydrogen bonds and/or is buried in the structure, protecting the proton
from water exchange.
The imino protons (-11-16 ppm) of guanine and uridine nucleotides resonate far
downfield from most of the other RNA protons when they are involved in a hydrogen bond
(Figure 1.2). These imino protons are generally only observable when they are involved in
Watson-Crick or non-Watson-Crick base pairs and therefore are a good indicator of RNA
secondary structure. Imino-imino NOEs between stacked base pairs help identify helical
regions and make initial assignments. Of the different types of amino protons, the cytidine
2H20 1D spectrum
H2'/H3'/H4'/H5'/H5"
I I
H1'/H5
H8/H6/H2
9 8 7
H20 1D spectrum
aminos
iminos il
4 3 2 1 0
14 12 10 8 6 4 2 0
'H (ppm)
Figure 1.2: 1D spectra in 2H20 and H20 of a TAR mutant show the
typical proton chemical shifts found in RNA. Notice how more than half
the protons are between -3.8 - 5 ppm. The exchangeable H20
spectrum shows how the imino protons are resolved from the rest of
the resonances allowing straightforward monitoring of titrations and
secondary structure from 1D spectra. Because there are no
resonances above 9 ppm in the nonexchangeable spectrum, the
sweep widths differ between the two spectra illustrated.
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aminos are the most easily observed as two distinct peaks, one for each amino proton.
They can be identified in homonuclear spectra by observing strong NOEs to guanine
iminos in a G-C Watson-Crick base pair and by strong NOEs to the nearby cytidine H5
from the same nucleotide. Guanine and adenine aminos are notoriously difficult to observe
and assign because upon base pairing these resonances often fall are in the intermediate
exchange regime where they are unobservable. These protons, especially the guanine
aminos, provide cross-strand NOEs that significantly help define an A-form helix (Mueller
et al., 1995). Furthermore, these resonances are often involved in interesting non-
canonical base pairing, making these NOEs critical to identify.
Sugar pucker and glycosidic torsion One of the hallmarks of A-form helices is the
conformation of the sugar pucker. The pucker can be qualitatively measured by measuring
the 3JH1'-H2' from the Hl'-H2' crosspeak in a 'H-'H COSY experiment. The C3'-endo
sugar pucker found in A-form helices has a small 3JHl'-H2 ' of <3 Hz making these
crosspeaks unobservable for most RNA molecules. However, the 3J H'-H2' is >8 Hz for the
C2'-endo sugar pucker which is often observed in non-helical RNA structure.
The glycosidic torsion angle (x) is generally found in one of two different
conformations, syn and anti. The X torsion is measured by monitoring the H8/H6 to H1'
distance which is -2.5 A the syn conformation and -3.8 A for the anti conformation. This
difference can be effectively determined in short (<50 ms) mixing time NOESY
experiments. Other base to ribose distances are also dependent on the X torsion, but they
generally require multidimensional heteronuclear experiments and/or specifically labeling to
assign.
Helical sequential assignments Along with imino-imino NOEs, the NOE anomeric-
aromatic sequential assignment pathway helps define the RNA secondary structure and
make sequential assignments. Each H8/H6 proton gives a NOE to its own H1' and to the
H1' from its 5' neighbor as illustrated in Figure 1.3. These resonances are particularly
NH2
N
5' H6 N
H5
H5'
Inter-nucleotide
contacts
"NH2
Intra-nucleotide
contacts
3'
Figure 1.3: The standard sequential assignment pathway for RNA
A-form helices between the H8/H6 and H 1'/H2' resonances. Note that
the internucleotide H8/H6-H2' NOEs are very strong (-2.4 A) while the
other inter-and intranucleotide distances illustrated are weaker (>4.0 A).
o
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useful because they generally have well-resolved chemical shifts. Although it is critical to
try to assign as many of these "sequential walk" NOEs as possible to define the A-form
regions, the absence of these NOEs usually suggest that a more interesting non-A-form
structure is present. When beginning a RNA NMR project, it is imperative to try to
maximize the information from the basic 'H-'H NOESY experiment as this will help
identify any unusual connectivities and also make the interpretation of more complicated 3D
and 4D experiments easier. Although unambiguous assignments require heteronuclear
spectroscopy (see below), as larger RNAs are investigated, more dependence on
nonexchangeable homonuclear spectra may be necessary due to broad carbon lines
preventing quality heteronuclear experiments.
Spectral crowding In principle, these basic NMR measurements can quickly and easily
define an A-form helix as the H 1', imino, and aromatic resonances are some of the best
resolved resonances as shown in Figure 1.2. However, to obtain high resolution solution
structures, the other extremely overlapped proton resonances need to be assigned as well.
These protons give a large number of internucleotide NOEs to each other and to aromatic
protons that help define RNA structure as summarized in Table 1.1. Most of the
internucleotide NOEs are sequential in nature as opposed to the very useful cross-strand
NOEs to the adenine H2 and exchangeable protons.
1.2.2 Exchange in NMR spectroscopy
Exchange is a broad term that encompasses many different mechanisms including
lability with water, conformational motions, binding kinetics, etc. The net effect of
exchange is an effect on the observed linewidths. When the different sites are magnetically
distinct, these processes will effect the observed signal. Exchange phenomena are
generally characterized into three broad categories as illustrated in Figure 1.4. Slow
exchange is frequency difference, Av, of the two sites is much larger than the rate constant,
*6-
CO
4-
C
120
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40
20
0
0 50 100 150 200 250 300
Hz
120 -
100 -
c-
Ul)
C
4-(
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60 -
40 -
20 -
-
v
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CI)
C)4,.
c
120
100
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0
250 300
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Hz
Figure 1.4: Exchange for a two-site system. Two peaks are observed in the slow exchange regime.
As the exchange rate between the two sites increases, the two peaks becomes one broad peak until
the rate is significantly greater than A and the system enters the fast exchange regime.
-r- I -I I
Table 1.1: Short interproton distances (A) in an A-form helix.*
Intranucleotide Nonexchangeable
Aromatic-ribose Ribose-ribose C3'-endo
H6 <- H5 2.4 H' -* H2' 2.4
H6/H8 <-4 H' 3.5 H2' <- H3' 2.4
H6/H8 <- H2' 4.0 H3' <- H4' 2.9
H6/H8 <- H3' 2.7-3.0 H4' <-4 H5' 2.4
H6/H8 <- H4' 4.2 H5' <- H5" 1.8
H6/H8 - H5' 3.3 Hi' 4 H3' 3.7
H6/H8 <-4 H5" 4.0 H1' <- H4' 3.3
H2' <- H4' 3.6
H3' - H5' 3.0
Internucleotide Nonexchangeable 3' <- 5'
Aromatic-ribose Ribose-ribose C3'-endo
H6/H8 - HI' 4.5 H2' <- H1' 4.0
H6/H8 <- H2' 2.0 H2' <-4 H3' 4.1
H6/H8 <- H3' 3.0 H4' <-> H2' 4.0-4.6
H6/H8 <-4 H6/H8 4.5 H5' < H2' 3.0-3.4
H5 -4 H2' 3.5 H5" --4 H2' 4.3-4.5
H5 < H3' 3.3 H5' <- H3' 3.8-4.2
H5 - H8/H6 3.75
H5 <- H5 3.7
Hi' <-4 H2 4.0
Internucleotide Exchangeable Stacking 3' <- 5'
G(H3) <-> G(H3) 3.5-3.7 H62 <- H1/H3 3.7-4.2
U(H1) <-4 U(H1) 3.5-3.7 H42 <- H1/H3 3.8-4.1
U(H1) <-4 G(H3) 3.5-3.7 H22/H21 <- H1 4.4-4.6
H5 - H1/H3 4.7-4.9
H42 +- H5 4.1-4.3
* Distances were measured in A-form regions of a tRNA structure (Westhof et al., 1988)
and a duplex (Holbrook et al., 1991).
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k, describing the rate of exchange between the two sites. The other extreme is fast
exchange, when k >> v, and only a single resonance is observed at the population-weighted
average of the frequencies of the two sites. Intermediate exchange describes everything
between the two extremes and is a major problem when the lines broaden to the point
where they are unobservable. The frequency of the spin in each site can only be observed
for a time of approximately l/k before the spin jumps to the other site. In macromolecular
complexes, the affinity is often good indicator of the potential to observe sharp lines.
Assuming a diffusion limiting on rate, a complex with dissociation constant of one
nanomolar will have a very slow off rate of ~ 1 s 1 and a long lifetime allowing observation
of the bound complex. However, if the affinity is one millimolar, the lifetime of the
complex would be approximately one microsecond, which is faster than any typical
frequency difference which is approximately 0.1-3 milliseconds on currently available
spectrometers.
1.2.3 Isotopic labeling of RNA
In order to perform a wide variety of heteronuclear NMR experiments, isotopic
enrichment of RNA samples with NMR active 13C- and 15N-nuclei is required. The
standard method for preparation of isotopically labeled RNA is in vitro transcription from
synthetic DNA oligonucleotide templates using T7 RNA polymerase and isotopically
labeled nucleotide triphosphates (NTPs). Labeled NTPs can be isolated from bacteria
grown on 13C and/or 15N-enriched media (Batey et al., 1995). The advantage of
enzymatic RNA synthesis is that uniform isotopic enrichment is relatively inexpensive and
easy to accomplish. However, the disadvantage is the lack of selectivity in labeling.
Chemical synthesis of RNA, on the other hand, has more potential for applications where
selective labeling is desired. Methods for chemical synthesis of isotopically labeled RNA,
however, are not as straightforward and are relatively expensive. Nevertheless, there has
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been recent progress in chemical synthesis methods, and they may become more utilized in
the near future (Foldesi et al., 1992; Foldesi et al., 1996; Quant et al., 1994; SantaLucia et
al., 1995; Tolbert & Williamson, 1996; Tolbert & Williamson, 1997). Recent work has
demonstrated the cost effectiveness of using metabolic enzymes to make selectively labeled
nucleotides on both the ribose and base from glucose in only a few steps (Tolbert &
Williamson, 1997).
1.2.4 Assignment of RNA resonances
Assignment of RNA resonances has historically been achieved through
identification of sequential base to ribose NOE patterns seen in helical regions of nucleic
acid structure that were originally utilized for DNA studies in the 1980s (Wuthrich, 1986).
With the advent of isotopic labeling for RNA, the basic NOE assignment approach was
initially expanded to include multi-dimensional (3D and 4D) versions of the standard
NOESY, COSY, and TOCSY 2D experiments, which simplified assignment and
identification of NOEs (Nikonowicz & Pardi, 1992b; Nikonowicz & Pardi, 1993; Pardi &
Nikonowicz, 1992). The NOE-based approach, however, is susceptible to errors from
structural bias, and methodology that achieves sequential assignment via through-bond
correlation experiments, as is the case for proteins, would be more ideal. Towards this
aim, there has been a proliferation of experiments in the past two-three years that correlate
RNA proton resonances through the heteronuclear spin-systems of the base and phosphate
backbone. The new NMR experiments for resonance assignment can be conceptually
organized into three classes (Figure 1.5 and Table 1.2). One HCN class correlates the
protons of the bases (both exchangeable and non-exchangeable) to one another via JCC and
JCN couplings (Farmer et al., 1994; Farmer et al., 1993; Sk61lnar et al., 1993a; Sk61nar et
al., 1993b). Another HCN class correlates the base resonances (H8/H6) to the ribose H1'
proton through the intervening carbon (C8/C6/C1') and nitrogen (N9/N1) resonances
(Famner et al., 1994; Farmer et al., 1993;
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Figure 1.5: Schematic of coherence transfer for through-bond
assignment experiments. (A) HCN correlation experiments for
assignment of the base resonances. Closed and open arrows
show HC-TOCSY-CNH and HNC-TOCSY-CH type experiments,
respectively. (B) HCP experiments for sequential ribose-ribose
assignment. (C) HCN experiments for intranucleotide correlation
a)
Table 1.2: Through-Bond Correlation Experiments for Assignment of RNA
Resonances
Experiment Nucleotide Coherence Pathwaya
Base-Base
H(NC)-TOCSY-(C)HC
(H)N(C)-TOCSY-(C)Hd
H(NCCC)H e
HC-TOCSY-(CN)Hb, f
H(C)-TOCSY-(CN)Hb,g
Base-Sugar
Hs(CsNbCb)Hbb,h
HsCsNbb,i
HbCbNbb,i
HsCs(NbCb)HbJ
HsCsNbk
HsCs(Nb)Cbk
HbNbCbk
Sugar-Sugar
HCP I
HCP-CCH-TOCSYm
P(CC)H-TOCSY n
I HT T I
guanosine H1 (tl)--N1 -C6/C2--C8-->H8(t2)
HT HT T I
adenosine H6->N6(tl)--C6--C8/C2->H8/H2(t2)
I HT I I I
uridine H3(tl)-N3C4-C5--C6--H6(t2)
HT HT I I I
cytosine H4(tl)--N4--C4->C5-C6-->H6(t2)
I T I I
purine H8/H2(t1)-4C8/C2(t2)--C6--N6/N1 ->H6/H 1 (t3)
I T HT I
guanosine H8(t1)-->C8-C6-4N1 -->H1 (t2)
I HT I
uridine H6(tl)--C6-4N3H3(t2)
I I I I
all H1 '(t1)->C1'-N9/N1 -C8/C6--H8/H6(t2)
I I I I
H1'->C1'(tl)-N9/N1 (t2)--C1'-->H1'(t3)
I I I I
H8/H6--C8/C6(tl)-->N9/N1 (t2)->C8/C6--H8/H6(t3)
I I I I
H1'(tl)--C1 '(t2)-N9/N1 -- C8/C6-4H8/H6(t3)
I I I I
H1'--C1 '(tl)->N9(t2)-C1 '-4H1 '(t3)
I I I I I I
H1'--C1 '-N9-C8(tl)-N9-4C1 '(t2)-H1 '(t3)
I I I
H8--N9(tl)-C8(t2)-->H8(t3)
I I I I
H4'-C4'-*P(tl)-C4(i+1 )(t2)-H4(i+1)'(t3)
I I I T I
H4'-+C4'-4P(tl)-->C4(i+ )->Cl'(i+1)(t2)--H1 '(i+1)'(t3)
I T HT
P(tl)--C4(i,i+1)--C'(i,i+1)-H1 '(i,i+1)'(t2)
all
all
all
purine
purine
purine
all
all
all
aThe letter above the arrow indicates the type of coherence transfer method used: I - INEPT, T-
TOCSY, HT-Hetero-TOCSY. In () are the dimensions for which chemical shift is detected.
bExperiment titles have been slightly altered in order to be presented in a uniform fashion. ()
indicate a nucleus that coherence is transfered through, but the chemical shift is not detected. c
[Simorre, 1996 #79]; d [Simorre, 1996 #80]; e [Simorre, 1995 #78]; f [Fiala, 1996 #21];
g[Sk61nar, 1996 #325]; h [Sk61nar, 1993 #84]; i [Sk6lnar, 1993 #83; Marino, 1997 #248]; i
[Farmer, 1993 #19]; k [Farmer, 1994 #20]; 1 [Heus, 1994 #114; Marino, 1994 #117]; m [Marino,
1995 #50]; n[Wijmenga, 1995 #90].
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Sk6lnar et al., 1993a; Sk61nar et al., 1993b). Finally, an HCP class of experiments
correlates the sugar resonances of sequential nucleotides through the phosphate backbone
(Heus et al., 1994; Marino et al., 1994; Marino et al., 1995; Varani et al., 1995; Wijmenga
et al., 1995).
Base HCN correlation experiments
A recent set of HNCCH- and HCCNH-TOCSY experiments have been developed
that correlate the exchangeable imino and amino proton resonances with the non-
exchangeable base resonances for the complicated spin systems of all four nucleotides
(Fiala et al., 1996; Simorre et al., 1996a; Simorre et al., 1995; Simorre et al., 1996b;
Sk6lnar et al., 1987). These experiments differ in the exact mechanism of transfer, but
predominantly rely on one-bond heteronuclear coupling constants to transfer magnetization
from protons to the heteronuclei of the ring, and homonuclear 13C-TOCSYs to transfer
magnetization across the ring. There are two important issues which impinge upon the
sensitivity of these experiments. One is the chemical shift differences between the
heteronuclei in the ring. Since the C5 atom of both purines and pyrimidines resonate
around 20-60 ppm upfield from the other carbon resonances in the base, 13 C-DIPSI spin
locks cannot effectively excite all resonances without excessive sample heating. Therefore,
magnetization is usually transferred via smaller two-bond carbon-carbon (2JCC) coupling
constants (C8-C4-C6 for purines and C6-C4 for pyrimidines), which require long spin-
lock mixing times for transfer and loss of sensitivity due to transverse relaxation. There
have been two approaches to circumvent this problem. For pyrimidines, sequential
homonuclear INEPT transfers (C4-C5-C6) can be used rather than a 13C-TOCSY
(H(NCCC)H) (Simorre et al., 1995), since short, high power n pulses excite a wider
bandwidth. For purines, the C5 resonance is only 20-40 ppm away from the other
aromatic carbon resonances (Table 1.3) and a FLOPSY-8 spin locking scheme (Mohebbi &
Shaka, 1991) can be used to increase the efficiency of one-bond carbon-carbon transfer and
Table 1.3: Chemical Shifts and Coupling Constants in Nucleotides
Atom(s) Chemical Shift RangeCarbon
Purine C5 
- 120 ppm
Purine C8 
-~ 140 ppm
Purine C2,C4,C6 
-150-160 ppm
Pyrimidine C5 
~100 ppm
Pyrimidine C6 
- 145 ppm
Pyrimidine C2,C4 
-155-170 ppm
Ribose carbons 
-70-90 ppm
Nitrogen
Purine N9 
- 170 ppm
Purine N3,N7 
-220-240
Guanosine N 
- 145 ppm
Guanosine N2 
-70-80 ppm
Adenosine N1 
-215 ppm
Adenosine N6 
-80-90 ppm
Pyrimidine N1 
-145 ppm
Uridine N3 
-155 ppm
Cytosine N4 
-95 ppm
Atom(s) Coupling Constant
Carbon-Carbon
1J(C,C) -40-60 Hz
2J(C8,C4) (purine) 
-8-11 Hz
2J(C6,C4) (pyrimidine) 
-8-11 Hz? double check
Carbon-Nitrogen
1J(C1',N9/N1) ~11-12 Hz
1J(C8,N9) -4-8 Hz
1J(C6, NI) -13 Hz
1J(C8,N7) -10 Hz
Carbon-Phosphorous (include?)
2J(C3'/C5',P) 
-3-5 Hz
3J(C4',P) 
-8-10 Hz
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decrease mixing times (Simorre et al., 1996a; Simorre et al., 1996b). Another factor which
decreases the sensitivity of some base resonances is rotational exchange broadening of exo-
cyclic amino protons on adenosine, guanosine, or cytosine. It has been shown from
studies on NOE transfer from amino protons that cross-polarization (hetero-TOCSY) or
CPMG-INEPT transfer is more efficient than the standard INEPT procedure when
resonances are broadened by rotational exchange (Mueller et al., 1995). In addition, the
nitrogen linewidths are narrower than protons undergoing chemical exchange, and
detection of nitrogen chemical shift rather than proton is more efficient. Simorre et. al have
utilized nitrogen chemical shift detection and cross-polarization transfer from proton to
nitrogen to optimize sensitivity for the amino protons of adenosine and cytosine (Simorre et
al., 1996a; Simorre et al., 1995). The extra sensitivity gained by optimization is offset by
increased experiment time for acquiring a separate data set for each nucleotide.
Nevertheless, the added sensitivity will probably be essential for assigning the resonances
of many larger RNAs.
Base to ribose correlation experiments
An important application of 13C/ 15N-labeling of RNA is through-bond
intranucleotide correlation of base to ribose resonances, which historically has been
achieved through NOE transfer. There are now many published experiments for achieving
this through bond transfer (Farmer et al., 1994; Farmer et al., 1993; Sk61lnar et al., 1993a;
Sk61nar et al., 1993b) (reviewed in (Dieckmann & Feigon, 1994; Pardi, 1995)). Some of
these experiments transfer magnetization sequentially from ribose to base protons (Farmer
et al., 1993; Sk61nar et al., 1993b), while others use an "out-and-back" approach (Farmer
et al., 1994; Sk61lnar et al., 1993a). A simple sequential INEPT transfer procedure with
non-selective pulses can be used to provide sugar to base correlations. Branching
coherence transfer pathways, however, reduce the sensitivity of the basic approach.
Therefore, selective pulses have been cleverly utilized in the above sequences to direct
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coherence predominantly along the desired pathways. For example, during transfer from
N9/N1 to C8/C6, selective excitation of the C8/C6 resonances refocuses magnetization
proceeding from N9/N1 to C4/C2 resonances in purines and pyrimidines, respectively. A
recent demonstration of multiple-quantum transfer to correlate the C1' and N9/N1
resonances increases the sensitivity of these type of experiments (Marino et al., 1997).
Furthermore, the multiple quantum transfer is predicted to improve as the RNA increases in
size. In principle, any one of the above experiments could provide complete assignment of
all nucleotides (though separate optimized sequences for purines are often required because
of sensitivity problems (Farmer et al., 1994)). In practice, however, spectral overlap will
probably prevent complete assignment from only one experiment. Acquiring several
experiments detecting different heteronuclei (C8/C6, N9/N 1, or Cl') can potentially
resolve overlap problems for larger RNA molecules. The experiments which will provide
the best resolution may vary for different RNA molecules and can be best determined
empirically from 2D 1H- 13C or 1H- 15N HSQCs of the base and C1'/H1' resonances.
ribose to ribose HCP experiments
Sugar proton resonances of 13C-labeled RNA can be correlated via HCCH-type
(Kay et al., 1990) experiments that utilize the large one-bond carbon-carbon coupling
constants to transfer magnetization throughout the ribose ring (Nikonowicz & Pardi, 1993;
Pardi, 1995; Pardi & Nikonowicz, 1992). In order to link the resonances of each ribose
nucleotide sequentially without the use of NOEs, magnetization must be transferred
through the phosphate backbone. A straightforward approach is HCP correlation through
an "out-and-back" procedure via sequential INEPT transfers (1H -> 13C -> 31p -> 13C ->
1H) (Heus et al., 1994; Marino et al., 1994). This approach has two limitations for
complete assignment of RNA molecules over -20 nucleotides. One is that the C4'(i)-P(i)-
C4'(i+1) connectivity is severely overlapped due to poor spectral dispersion of C4' and P
resonances, particularly in A-form helical regions. Second, the better resolved C3'(i)-P(i)-
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C5'(i+1) connectivity requires a separate HCCH-TOCSY experiment to connect the C3'
and C5' resonances on the same nucleotide. Subsequent experiments (HCP-CCH-TOCSY
(Marino et al., 1995) and P(CC)H-TOCSY (Wijmenga et al., 1995)) resolve both problems
by combining the HCP and HCCH-TOCSY experiments. Therefore, sequential
correlations can be observed between C1'/H1' resonances, which are the best resolved
ribose resonances in both carbon and proton. The drawback to this experiment is long
delays and TOCSY mixing times where significant relaxation can occur for larger
molecules. It is not clear whether these experiments will be generally useful for RNA
molecules larger than -30 nucleotides (-10 kDa), particularly with the severe line
broadening of 3 1p resonances at higher molecular weights.
Unlike triple resonance experiments used for proteins, most of the new triple
resonance assignment experiments for RNA have been utilized only in "proof of principle"
situations and have yet to be performed in a published structure determination. The only
exceptions are the use of HCCNH-TOCSY experiments for assignment of base resonances
in a couple of cases where a complete structure determination was achieved (Dieckmann et
al., 1996; Fan et al., 1996b; Jiang et al., 1996; Zimmerman et al., 1997). The experiments
for correlation of the base resonances are the most likely to succeed with medium-size RNA
molecules (30-40 nucleotides, -~ 10-15 kDa) due to less spectral overlap and relatively long
relaxation times of the base resonances. Nevertheless, the standard NOE method for
sequential assignment was used in these structures, and it is not yet clear how generally
useful the through-bond experiments will be for complete non-NOE based sequential
assignment. Complete through-bond assignment will probably not be feasible for many
medium sized RNAs, since the HCP experiments are most susceptible to relaxation
problems. A hybrid approach with HCN and NOESY experiments may be a temporary
substitute. The HCN experiments can unambiguously determine the intranucleotide
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correlations within and between the base and ribose resonances, which will significantly
reduce the ambiguity present in the complete NOESY-based assignment procedure.
Even assuming no problems due to relaxation, it does not appear that there will be a
simple and quick procedure for assignment of RNA molecules. Neglecting the problems
with sensitivity or overlap, complete assignment with only through bond methods still
requires a large number of experiments, if all of the optimized sequences are required (-4
experiments for the bases, -3 experiments to correlate the base resonances to the ribose,
and -2-3 experiments to correlate the ribose resonances). Nevertheless, this is around the
same number of experiments that have been required for many RNA structures solved
recently by the NOE-based method, since multiple samples with different specific labeling
patterns (see below) were required to resolve ambiguities in the sequential NOEs (Battiste
et al., 1995; Cai & Tinoco, 1996; Dieckmann et al., 1996). Despite roughly the same
number of experiments, analysis of the spectra for the through-bond experiments should
hopefully be quicker in addition to lowering the potential for misassignment with the NOE-
method.
1.2.4 NOE measurement
The end goal of NMR analysis is usually a structure determination. Despite the
method used for assignment of resonances, the main source of structural data is obtained
from NOEs, which provide distance restraints for pairs of hydrogen atoms in the RNA
molecule. Identification of NOEs can be aided by resolving the standard NOESY
experiment into 3 and 4 dimensions through detection of the heteronuclear (13C/ 15N)
chemical shifts of the proton-attached nuclei (Nikonowicz & Pardi, 1992a; Nikonowicz &
Pardi, 1992b; Nikonowicz & Pardi, 1993). Even with the extra dimensions in 3D
NOESY-HSQC or 4D HMQC-NOESY-HSQC experiments, overlap can still be severe for
medium size RNAs (-30-40 nucleotides). An approach to aid in the identification of NOEs
that has been very successful is specific isotopic labeling of RNA with either heteronuclei
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(13C/ 15N) or deuterium (2H). 13C/ 15N-labeled nucleotides can be separated and used
individually in vitro transcriptions with other unlabeled nucleotides (e.g. 13C-GTP plus
unlabeled ATP, CTP, and UTP) to produce RNA molecules selectively labeled at only one
nucleotide (Batey et al., 1995; Batey et al., 1992; Nikonowicz et al., 1992). There are two
advantages to selective labeling for identification of NOEs. One is simply reduced overlap
in 3D NOESY experiments, which permits identification of more NOEs. Secondly,
isotopic filtering experiments (Otting & Wuthrich, 1989a; Otting & Wuthrich, 1990) can be
performed to help resolve intra-nucleotide from inter-nucleotide NOEs (Battiste et al.,
1995). This is a particularly powerful approach that can also be utilized for sequential
assignment of RNA where the through-bond methods described above are not successful.
A similar approach has also been used with RNAs containing site-specific labels produced
synthetically at the C8/C6 positions of the base (Cai & Tinoco, 1996; SantaLucia et al.,
1995). In addition to NOE identification, this labeling pattern has application for
measurement of 13C dynamics, since the removal of 13C- 13C interactions simplifies
interpretation. One additional labeling methodology that has been developed is specific
labeling of a short segment of nucleotides within a larger RNA sequence (Xu et al., 1996).
Depending on the RNA being studied and the structural questions addressed, each of these
specific heteronuclear labeling methods will greatly assist in the assignment and structure
determination of medium sized RNA molecules.
Another way to remove or filter proton resonances is to specifically substitute them
with deuterium. An advantage not present with specific 13C/ 15N-labeling is decreased
relaxation of protons not labeled with deuterium. In addition, any 13C atoms attached to
deuterium will have decreased relaxation, and 13C-TOCSY transfer will be more efficient.
Therefore, specific deuterium labeling should greatly aid in the study of larger RNA
molecules. Two protocols have been published for specific deuterium labeling. One uses a
combination chemical/enzymatic synthesis approach (Tolbert & Williamson, 1996), while
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the other uses all chemical synthesis (Foldesi et al., 1992; Foldesi et al., 1996; Glemarec et
al., 1996). In addition to the reduction in overlap, the relaxation times of the non-
deuterated protons were increased about two-fold. The disadvantage to deuterium labeling
is the complete loss of structural information at the deuterated positions. It is possible,
however, to make multiple samples with different deuteration patterns to circumvent this
problem (Tolbert & Williamson, 1996). Alternatively, since many of the NOEs between
the base and sugar protons that define the conformation of the helices are redundant, the
reduced NOE data set from one specific deuteration pattern may still be useful for
determining qualitative structural models of larger RNAs.
An experimental approach to improving the sensitivity of NOEs to amino protons in
RNA has been developed (Mueller et al., 1995). Amino protons are often significantly
broadened due to rotational exchange about the C-N bond. It has been shown that either
hetero-TOCSY or CPMG-INEPT transfer is more efficient than INEPT transfer when there
is conformational exchange broadening (Krishnan & Rance, 1995; Mueller et al., 1995).
As was noted above, this concept has also been utilized to improve the sensitivity of
through-bond experiments for assignment of base amino protons (Simorre et al., 1995;
Simorre et al., 1996b). Easier assignment and identification of amino proton NOEs, which
are often difficult to observe, has the potential to greatly increase the quality of structure
determinations. This is particularly true for RNA-protein interactions, since amino protons
line the grooves where proteins often make specific contacts. RNA structure tends to be
very dynamic and flexible, and it is very common to observe NMR resonances that are
broadened by conformational exchange. Hetero-TOCSY transfer, therefore, might be
generally applicable in 3D NOESY-HSQC experiments to improve the sensitivity of any
conformational exchange broadened resonances.
1.2.5 Measurement of backbone torsions
Many of the interesting RNA structures studied exhibit a wide variety of backbone
H2'
OH NH
N N NH2
O OH
023'
3'
Figure 1.6: The torsion angles which define RNA structures. Notice that
the a and P torsions are not near any protons and are thus not directly
measureable.
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conformations suggesting that torsion restraints will be important to define RNA structure.
RNA conformations are characterized by six backbone torsion angles as illustrated in
Figure 1.6. NMR analysis of the backbone conformation is complicated by the lack of
useful 1H -1H NOE distance restraints available that define the backbone torsions. With
the introduction of isotopic labeling methods, a number of approaches have been
developed that take advantage of both 1H-3 1P and 13 C_3 1P couplings to measure these
backbone torsions.
sugar pucker and the S torsion
A number of 1H- 1H and 1H- 13 C scalar couplings are available to measure the
sugar pucker but the most useful is the H '-H112' coupling constant. This coupling is >8 Hz
for C2'-endo puckers and -1 Hz for the C3'-endo puckers, typically found in A-form
helices. The most direct method to measure the H '-H2' coupling constant is through the
use of 2D 1H- 1H COSY experiments (Varani & Tinoco, 1991). The absence of a Hi'-
H2' COSY cross-peak is often interpreted as the C3'-endo conformation, however, this
approach may be misleading where broad lines lead to the cancellation of the antiphase
crosspeaks. This pitfall can be avoided with the use of the HCCH E. COSY experiment
(Schwalbe et al., 1995), where even small couplings can be measured directly. This
experiment will also be adversely affected by broad lines but because the measurement is
not based on the absence of a peak a more definitive measurement is possible. In the
presence of severe spectral crowding, the HCC- E. COSY CCH TOCSY experiment, a
variant which contains a TOCSY period to transfer magnetization to the well-resolved Cl',
improves the spectral dispersion (Schwalbe et al., 1995). An alternative method involves a
collection of undecoupled HMQC-NOESY and HMQC-TOCSY spectra that permit are
collected such that the sign of a number of 2JCH and 3 JCH couplings to be determined and
used to define the sugar pucker as shown in Table 1.4 (Hines et al., 1994). Often riboses
Table 1.4: Backbone J-Couplings in RNA
Active bond
H5' - P(i)
H5" - P(i)
H4' - P(i)
C4' - P(i)
H5' - P(i)
H5" - P(i)
C4' - P(i)
H5' - P(i)
H5" - P(i)
C4' - P(i)
J (Hz)*
1-4
1-3
8-10
8-10
1-3
<5
<5
>5
1-3
<5
C3'/H3' - P(i+1)
C2' - P(i+1)
C4' - P(i+1)
C3'/H3' - P(i+1)
C2' - P(i+1)
C4' - P(i+1)
C3'/H3'-P(i+ 1)
C2' - P(i+1)
C4' - P(i+1)
8-10
<5
>5
8-10
>5
<5
8-10
<5
<5
H4' - H5'
H4' - H5"
C4' - H5'
C4 - H5"
C5' - H4'
H4' - H5'
H4' - H5"
C4' - H5'
C4 - H5"
C5' - H4'
H4' - H5'
H4' - H5"
C4' - H5'
C4 - H5"
C5' - H4'
H1' - H2'
H3' - H4'
C2' endo HI' - H2'
H3' - H4'
* A + or - indicates that the coupling is positive or negative.
1-3
3
3
9-11
+
9-11
>8
<5
-1
>5
Angle
P
Rotamer
trans
gauche-
gauche+
trans
gauche-
gauche+
gauche+
trans
gauche-
C3' endo
_ _
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are found with coupling constants in the 3-6 Hz range indicative of a conformation in
between the C2'-endo and C3'-endo puckers. This mixed conformation is often left
unrestrained as it is averaging between the two major conformations (Aboul-ela et al.,
1995; Brodsky & Williamson, 1997).
e and p torsions
In a standard A-form helix, P is in the trans conformation for which the 3j PH, and
3 PH are small and the 3J PC4 and 3 JPH4' are large as summarized in Table 1.4. Therefore,
when one of the 3jHS couplings is large, an unusual conformation is present. This analysis
can also easily indicate the presence of conformational averaging as found in the HIV-2
TAR-argininamide complex where one of the nucleotides exhibited large couplings for both
the 3 JPH5' and 3 JPHS [Brodsky, 1997 #10; this thesis]. A similar analysis exists for the e
torsion which can be measured by monitoring the 3JC4'P, 3JC2'P, and 3JH 3 P couplings.
However, the 3 H3 P coupling does not change significantly for the different conformations
and the 3JC4'P and 3 JC2, need to be analyzed. The s torsion is in the trans conformation in a
standard A-form helix where the 3JC2'P coupling is small and the 3J 4 coupling is large as
shown in Table 1.4.
The E and P torsions can be determined by measuring a variety of 13C_31P and IH-
P scalar couplings. Some of these torsions may be measured directly in 2D HP-
HETCOR (Sk61nar et al., 1986) and HSQC if the phosphorus and proton resonances are
sufficiently resolved. Accurate measurements for H5'/H5"-P and H3'-P couplings can be
obtained from spin echo difference experiments as well (Legault et al., 1995). However,
both the proton and phosphorus resonances are generally overlapped for even moderate
size RNAs. A more extensive strategy has been introduced based on the intensity of cross-
peaks in 3D HCP and HPCH experiments (Varani et al., 1995). The intensity of
crosspeaks in these spectra are proportional to the 3JPH5,
,
3JPH5", and 3 JPC4' couplings. This
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approach suffers from the potential drawback that peak intensities may also be affected by
other factors, such as dynamics. However, at this time, this scheme is the most
comprehensive method to gather a large number of loose restraints in crowded spectra.
y torsion
Measurement of the y torsion is difficult due to the need for stereospecific
assignments of the H5' and H5". The C4'-H5'/H5" couplings can be used in conjunction
with the H4'-H5'/H5" couplings to define y (Hines et al., 1994; Schwalbe et al., 1994).
Some couplings may be obtained from a collection of experiments undecoupled 3D 13 C
edited TOCSY and NOESY spectra (Hines et al., 1994; Hines et al., 1993).
Unfortunately, both the C4' and the H4' in A-helical RNA's are extremely crowded
making correlations from these to the crowded C5'/H5' region difficult. Therefore,
experiments similar to the HCC- E. COSY CCH TOCSY, where the overlapped H4'-H5'
crosspeaks to the CI'/H1' are correlated to the CI'/H1', may be particularly useful if
sufficient TOCSY transfer can be achieved (Schwalbe et al., 1994). In A-form helices,
both the 3JH4'H5' and 3JH4'H5" scalar couplings are small in the gauche+ conformation. Table
1.4 indicates that when y changes to an unusual conformation either the 3JH4 'H5' O 3 H4'H5"
coupling becomes larger. However, additional information is required to determine the
stereospecific assignment. The sign of the 2C4'H5S C4H5", and 2C5'H4 couplings are very
useful to help determine not only the stereo specific assignments but also the conformation
as summarized in Table 1.4.
o and torsions
Unfortunately, the a and torsions are not accessible by direct J-coupling
measurements. Some groups have used 3 1P chemical shifts as a guide for loose constraints
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on these torsions, however, the correlation between 3 1p chemical shifts and the
phosphodiester backbone conformation is not well understood in RNA. For example, in
tRNA a wide range of phosphorus chemical shifts are observed that are outside the ranges
expected for variation of the c or torsions, and other factors may be major contributors to
phosphorus chemical shifts (Gorenstein & Luxon, 1979; Gueron & Shulman, 1975;
Salemink et al., 1979). Furthermore, quantum calculations have shown that counterions
also effect the chemical shift, further indicating that 31p chemical shifts may not be a
reliable indicator of the conformation (Giessner-Prettre & Pullman, 1987). Until a more
complete chemical shift data base is created, restraints based on the phosphorus chemical
shift alone should probably be used with caution.
1.3 RNA Structures by NMR
To generate a family of structures consistent with the NMR data, structures are
refined against the distance and torsion restraints along with geometric and non-bonded
terms using restrained molecular dynamics calculations (Brunger & Karplus, 1991; Nilges,
1996). A number of RNA structures have been recently determined utilizing many of the
heteronuclear techniques discussed in this review. Many of the problems in RNA NMR
studies revolve around the difficulty of gathering a large data restraint set due to chemical
shift overlap along with dynamics issues. These issues also need to be considered during
the molecular modeling process and for interpreting the resulting family of structures.
Furthermore, the paucity of protons along the backbone leave few distance restraints to
define the many degrees of freedom of the RNA backbone.
1.3.1 Overall quality of RNA NMR structures
In evaluating the quality of a family of RNA NMR structures, a number of statistics
can be evaluated: rmsd, number of NOE and torsion restraints, residual distance and
torsion violations, and the largest distance and torsion violations. The distance constraints
are further dissected into the number of interresidue, intraresidue, and intermolecular
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NOEs. A listing of the recent RNA NMR structures is shown in Table 1.5 with the rmsd's
shown in the context of the number of NOE and torsion restraints. The local rmsd is given
because the overall global rmsd is usually in the 2.0 - 2.6 A range indicative of poor
convergence. This is because almost every RNA structure studied includes a region which
is poorly defined like a disordered loop, terminal base pair, or a nucleotide without any
internucleotide NOEs. This situation is comparable to protein NMR and X-ray studies
which often neglect the N and C terminal ends of proteins because of the lack of structural
data from these regions. Therefore, the more useful rmsd to consider includes only the
region of interest and is usually a more accurate description of the quality of the structure
than the overall global rmsd. However, for RNA NMR studies, the region that is defined
as the structured "core" can be a subjective decision as the tendency is to find a
combination of nucleotides which will give the lowest possible rmsd. One alternative is to
define the well-ordered region by using an average standard deviation matrix which will
calculate the ordered and disordered regions (Kundrot, 1996).
All the structures listed in Table 1.5 have low rmsd's indicating that a family of
structures converged to a very similar structure, but the crucial question is whether the
structures are accurate. As in all structural biology techniques, correlations with other
biochemical and structural data are used to help determine the accuracy of the structure.
For RNA NMR studies, it is possible to make mutations of the RNA to determine whether
any specific nucleotide alters the structure or complex as has been done in a few cases
(Dieckmann et al., 1996; Puglisi et al., 1995; Ye et al., 1995) to help support the proposed
interactions. In addition, the GNRA tetraloops were first determined by NMR (Heus &
Pardi, 1991) and have now been seen in both the Hammerhead crystal and P4/P5/P6 IVS
crystal structures (Cate et al., 1996; Pley et al., 1994a; Pley et al., 1994b). The GNRA
tetraloops determined by NMR and X-ray crystallography are extremely similar and
Table 1.5: Recent Structures and Structural Statisics
Structure Number local Total Inter- Torsion Total Inter- Initial Reference
of rmsd NOEs per nucleotide restraints Peptide molecular Structures
Structures (A)a nucleotide NOEs per per NOEs NOEs
nucleotide nucleotide per amino
acid
SMALL RNAS
GNRA
tetraloops
GAAA 10 0.96 P 7.1 4.4 1.6
GAGA 10 0.89 P 7.3 5.5 1.3
GAAA 10 0.57 P 7.2 4.6 2.8
CUUG
tetraloop
P1 Helix
P loop
SMALL LIGAN
COMPLEXES
AMP aptamer
FMN aptamer
HIV TAR -
Arg
Paromomycin
-16S RNA
Theophyllin-
aptamer
13 1.3 A 6.8 4.2
20 0.59 A 24 12.5 4.6
33 0.68 A
D
8 1.48 P 11 5.9 0
10 1.52 P 15 .6 b 1 1 .5 6 b 2 .1b
1.24/
1.31 P
12.8 5
20 1.22 A 26.9 8
R.T.
R.T.
R.T.
D.G.
(Jucker et al.,
1996)
(Jucker et al.,
1996)
(Jucker et al.,
1996)
(Jucker & Pardi,
1995)
R. T. (Allain &
Varani, 1995)
R.C. (Puglisi et al.,
1997)
45 D. G. (Jiang et al.,
1996)
40 D. G. (Dieckmann et
al., 1996)
18 D. G. (Fan et al.,
1996)
8 R.T. (Aboul-ela et
al., 1995)
19 R.C. (Brodsky &
Williamson,
1997)
47 R.C. (Fourmy et al.,
1996)
4.8
20 0.84 A 22 9.7 1.9
20 0.61 A 10.7 7.3 5.4
10 1.32 P 7.56 6.65 2.82 41 R.T. (Zimmerman et
al., 1997)
Tobramycin 7
aptamer
PEPTIDE/PROTEIN
COMPLEXES
BIV Tat-TAR 2
1.13 P 15.41 9.89 45 A-form (Jiang et al.,
1997)
.0 1.49 A 10.8 6.9 2.43 15.2 26 R.C. (Puglisi et al.,
1995)
4 1.16 P 24.7 9.8 4.7 4.1 102 D.G. (Ye et al.,
1995)
HIV Rev-RRE
U1A
7 0.91-
1.18 P
19 1.05-
1.39 A
25 1.0-
1.36 A
15 7.8 5.8 8.1 92 D.G. (Ye et al.,
1996)
11.6 5.4 2.8 14.7 61 D.G. (Battiste et al.,
1996)
23.7 12.5 3.5 17.4
a When the reported rmsd is the average pairwise rmsd a P is indicated.
structures
to the average structure.
b Restraints were only given for the 16 nucleotides defining the "core."
96 R.T.
An A indicates the rmsd
(Allain et al.,
1996)
was calculated by comparing the
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incorporate the same essential features. Furthermore, RNA NMR studies have been found
to be very self-consistent as all the general features and many of the specifics were very
similar for the four structures that have been independently solved by two research groups.
1.3.2 Choosing a molecular modeling protocol
The goal of the molecular modeling calculations is to start from a sufficiently
random initial model and then to explore as much conformational space as possible. It is
difficult to assess whether the protocols currently used are sampling all conformational
space consistent with the data and this is an area of much study (Brunger & Karplus,
1991). Three major types of initial models are predominantly used as shown in Table 1.5:
random coordinates, random torsions, and distance geometry. The major difference
between these approaches is the computational expense required to generate a family of
structures. Generally, random torsions offers high convergence rates in the 40-50% range
(Aboul-ela et al., 1995; Allain et al., 1996; Allain & Varani, 1995; Jucker et al., 1996)
while random coordinates requires significant sorting of the atoms and generally generates
lower convergence rates in the 10-20% range (Brodsky & Williamson, 1997; Puglisi et al.,
1995). Distance geometry is an algorithm routinely used to sample conformational space in
protein NMR studies with great success (Vlieg & Gunsteren, 1991). In RNA NMR
studies, distance geometry has been found to be especially useful when many long-range,
global fold type of NOEs are found as in peptide complexes and the highly folded ATP
aptamer (Battiste et al., 1996; Dieckmann et al., 1996; Fan et al., 1996a; Ye et al., 1996).
1.3.3 Determining bounds for the distance restraints
A large difference in the number of NOEs per nucleotide is seen in the structures
summarized in Table 1.5 in part because not all NOEs are always included in the distance
restraint data set for molecular modeling calculations. These apparent discrepancies occur
because although some intranucleotide NOEs are important in defining RNA structure,
there are a number of intraribose and intrabase NOEs that do not contain any useful
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information either because the range of sugar puckers do not change these distances
significantly within the precision that the constraints can be accurately defined or the
covalent structure of the nucleotide itself defines the structure. The HIV-2 TAR
argininamide NMR study did not use intrabase H5-H6 and H5-H4 NOEs (Brodsky &
Williamson, 1997). Also, one of the BIV Tat-TAR and one of the ATP aptamer studies
excluded many "conformationally unimportant" NOEs from the NOE restraint list, thus
accounting for the small difference between the total number of NOEs and internucleotide
NOEs shown in Table 1.5 (Dieckmann et al., 1996; Puglisi et al., 1995).
Deciding what bounds to use for NOE restraints is a critical issue for RNA NMR
structures. Modeling studies of protein structures using both synthetic and real data have
demonstrated a correlation between the precision of a family of structures and the accuracy
to a target structure (Liu et al., 1992). This correlation is critically dependent on the
accuracy of the bounds used and the proper identification of NOEs. However, it is unclear
whether this same correlation between rmsd and accuracy pertains to RNA structures which
have fewer inter-residue NOEs and lack the global fold, long-range NOEs often found in
protein NMR studies. However, as discussed extensively in this review, the dynamic
character of many RNA molecules on the NMR time scale prevents the accurate
determination of tight bounds. For RNA NMR studies, NOE constraints are often
determined semi-quantitatively and placed into four categories strong, medium, weak and
very weak NOEs. Protein NMR studies have shown that with a sufficiently large restraint
data set, a precise and accurate family of structures can be determined even when the loose
bounds are used (Liu et al., 1992). The RNA NMR studies listed in Table 1.5 have used
different upper and lower bounds to define these categories and these differences lead to
slightly different residual distance violation statistics which may or may not reflect the
quality of the structure. Each research group has used a slightly different methodology to
determine the NOE bounds which also changes on a case by case basis depending on the
I Introduction
quality of the spectra. The P1 helix, HIV TAR and U1A studies set all the lower bounds to
1.8 A with upper bounds ranging from 3.0 A for the most intense NOEs to 7.0 A for the
weakest NOEs found in H20 experiments (Aboul-ela et al., 1995; Allain et al., 1996;
Allain & Varani, 1995; Brodsky & Williamson, 1997). One of the reasons for this very
conservative approach is demonstrated by the extreme case of the HIV TAR studies where
a weak binding ligand which caused a variety of conformational exchange issues that
precluded the use of accurate tight bounds such that both groups used very conservative
bounds (Aboul-ela et al., 1995; Allain et al., 1996; Allain & Varani, 1995; Brodsky &
Williamson, 1997). However, this approach may be too conservative in some cases as
much of the information in the NOE data is not being used. An alternative approach, often
used, is to use slightly tighter bounds where the lower bounds are set to 1.8, 2.5, and 3.5
A with upper bounds of 2.5, 3.5, and 5 A for the strong, medium, and weak categories
respectively (Fan et al., 1996a; Fourmy et al., 1996; Jucker et al., 1996; Puglisi et al.,
1995; Ye et al., 1996; Ye et al., 1995). This strategy has been used in a number of cases
with water NOESY spectra treated differently to account for possible spin diffusion effects
of close amino protons. Both these approaches lead to a family of converged structures as
shown in Table 1.5. However, when looser bounds were used, a significant number of
restraints were used and thus presumably overcame the larger conformational space
allowed by each bound as illustrated by the P1 helix, U1A, and HIV TAR studies (Aboul-
ela et al., 1995; Allain et al., 1996; Allain & Varani, 1995; Brodsky & Williamson, 1997).
The danger of using tight bounds is that errors could be made some of which may lead to
the wrong structure or can limit the rate of convergence making the structure calculations
difficult. Some techniques have been developed to help limit the amount of spin diffusion
and therefore increase the accuracy of tight bounds by limiting the effects of spin diffusion
thus increasing the precision and presumably the accuracy of the resulting structures
(Hoogstraten & Markley, 1996), but these have yet to be applied to RNA.
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1.3.4 Hydrogen bonds in RNA NMR structures
Some of the most important interactions are hydrogen bonding interactions which
can be very difficult to determine unambiguously by NMR especially when exploring non-
canonical base pairing interactions which are the most biologically interesting and novel
aspects of RNA structure. Evidence for Watson-Crick base pairing in the A-form helix
usually consists of the observation of upfield shifted imino resonances along with a
network of cross-strand NOEs indicative of a typical base pair. Interestingly, with a
sufficiently large NOE restraint data set, the global fold of an RNA can be determined in the
absence of any explicit hydrogen bonding restraints (Brodsky & Williamson, 1997); this
thesis. In this study, the initial stages of the molecular modeling calculations were
performed in the absence of any hydrogen bonding constraints, but because of the large
number of cross strand NOEs in the base-paired regions, the correct global fold was
obtained, and hydrogen bonding partners could be unambiguously assigned. This
approach explicitly demonstrated that base pair hydrogen bond restraints could be safely
added to the data restraint set for the final refinement stages of the molecular modeling
calculations.
The situation is more complicated for non-canonical base pairing and 2'OH
hydrogen bonding interactions. There is no general consensus describing the rules for
identifying a hydrogen bonding interaction in RNA. However, it makes sense to use the
statistical nature of the structure determination to report the ranges and average distances for
the heavy atoms involved in the proposed hydrogen bonding interaction as has been done
in a few studies (Brodsky & Williamson, 1997; Fourmy et al., 1996; Jiang et al., 1996;
Jucker et al., 1996).
Recently, crystal structures of two different ribozymes have highlighted the
important structural role of 2'OH's (Cate et al., 1996; Pley et al., 1994a; Scott et al.,
1995). Only a handful of 2'OH have been observed by NMR thus making any direct
evidence for hydrogen bonding difficult (Allain & Varani, 1995). However, hydrogen
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bonding interactions have been proposed based on a large number of NOEs in the region
which localize possible hydrogen bond acceptor and donor groups near the 2'OH as in the
GNRA structures (Jucker et al., 1996). One additional consideration is suggested by the
paromomycin-16 S RNA structure where some potential interactions appeared with heavy
atom distances in the 4.0 - 4.5 A range (Fourmy et al., 1996). This distance is generally
considered too long for hydrogen bond, but could possibly be due to a water mediated
hydrogen bond. These type of interactions are very difficult to determine even in protein
NMR where large hydrophobic cores help protect single water molecules from exchanging
with the bulk solvent (Otting et al., 1991; Otting & Wuthrich, 1989b). The structural role
of 2'OH's and water molecules in RNA structure will be an important area of future
investigation.
1.4 NMR Dynamics Measurements
NMR relaxation parameters provide a powerful method to study the internal
dynamics of macromolecules (Palmer et al., 1996). The relaxation properties of protonated
oN r 13C heteronuclei are dominated by dipole-dipole interactions, permitting the
measurements to be correlated with the interspin bond vectors, which in turn are related to
the internal dynamics and the overall molecular tumbling. The relationship between the
internal dynamics of macromolecule and their biological function has been extensively
investigated. To date, the role of dynamics for biological functions has not been
conclusively determined, though some studies have found correlations with elements of
specific binding (Kay et al., 1996). Recent studies have also used dynamics to probe
protein stability and folding (Buck et al., 1995; Farrow et al., 1997). RNA offers a
number of unique possibilities for NMR dynamics measurements because of the isolated
'H-15 N and 'H- 13C spin pairs in the aromatic bases. In proteins, most 'H-13C spin pairs
are next to other carbons and 13C-13C homonuclear scalar relaxation mechanisms complicate
the measurements. Few studies of RNA dynamics have been pursued as isotopically
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labeled samples and high resolution structures have only recently been available (Akke et
al., 1997; King et al., 1995). Previous studies of RNA dynamics have often encountered
conformational exchange dominating the measurements, and transverse relaxation rates are
often used to determine whether the residues are structured (Addess et al., 1997; Legault &
Pardi, 1997). RNA dynamics may be more complicated to study as different motional
models and analysis of the relaxation rates may need to be developed because many RNAs
probably tumble anisotropically. Also, the spin pairs in the heteroaromatic rings of the
bases have large Chemical Shift Anisotropies (CSA) contributing to the relaxation
permitting the measurement of cross-correlation effects to determine the intrinsic dynamics
without adverse effects of conformational exchange (Dayie et al., 1996).
A number of excellent reviews have been written describing dynamics
measurements (Dayie et al., 1996; Peng & Wagner, 1994), therefore, this discussion will
focus on briefly summarizing the measurements and analysis performed in Chapter 5.
Experiments to measure six basic relaxation rate constants with high sensitivity have been
devised (Peng & Wagner, 1994). For a 1H- 15N spin pair, these relaxation rates can be
written in terms of the spectral densities as follows:
RN(Nz) = (3D + C)J( N) + DJ(IoHI+IoNI) + 6DJ(coHl-1oNI) (2)
RN(HZ-+Nz) = D[6J(Iol-lIOl)) - J(IoHl+lc )] (3)
RN(Nx) = (2D + 2C/3)J(O) + (3D/2 +C/2) J(wN) + (D/2)J(I1)HI+01N1) + 3DJ(oH) +3DJ(1OI-
1wNI)+Rex (4)
RHN(2HzNx) = (2D +2C/3)J(O) + (3D/2 + C/2)J(0N) + (D/2)J(1)HI+10)NI) + 3DJ(1)HI-1NI) +
PHH + Rex (5)
RHN(2HzN z) = (3D + C)J(ON) + 3DJ()H) + pHH (6)
RH(Hz) = D[J(oHI+IlwI) + 3J(0H) + 6J(1o)HI-1I)] + pHH (7)
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where RN(Nz) is the SN longitudinal rate constant, RN(Hz<-Nz) is the heteronuclear NOE
(longitudinal cross-relaxation), RN(Nx) is the 'H longitudinal, RHN(2HzNx) is the antiphase
'
5N single quantum coherence, RHN(2HzNz) is the longitudinal heteronuclear two-spin
order, and RH(Hz) is the 1H longitudinal relaxation rate constant. The constant D is
proportional to the mean squared value of the heteronuclear DD interaction and is given by
h p yc
D= 6 (8)
4 rHC
The constant C is proportional to the mean square value of the anisotropic component of the
'
5N-Bo interaction and is defined as
C= (yBo2 )(A2) / 3 (9)
and A is the chemical shift anisotropy for which some values of been reported for both
carbon (Williamson & Boxer, 1989) and nitrogen (Akke et al., 1997). PHH describes the
sum of all proton-proton dipole-dipole interactions for the proton attached to nitrogen. The
Rex term describes any exchange contributions to the relaxation rates and can be measured
by rotating field experiments (Akke & Palmer, 1996; Palmer et al., 1996; Szyperski et al.,
1993).
These relaxation rate constants are sensitive to a range of time scales allowing NMR
spectroscopists to monitor molecular motions from the picosecond to hour time scale as
summarized in Table 1.6. To measure these relaxation rate constants, various pulse
sequences have been designed to isolate just the relaxation process desired.
The spectral density function J(o) describes the contribution of orientational
dynamics of the molecule from motions in a particular frequency range. Once the
frequencies and magnitudes of the different orientational processes are determined,
Table 1.6: NMR explores dynamics on a variety of time-scales
Time Scale (t)
s < T <hrs
ms < < s
ns < T < ms
ps < T < ns
T < ps
NMR Methods
Temp, pH, 2H Exchange HSQC
Line shape analysis, EXSY,
Pulse Labeling
Variable RF field on/off resonance
Spectral Density Mapping at diff B0
R1, R2, Rip
NOE, ROE
Averaging of relaxation rates
Molecular Process
*Protein/RNA Folding
eAmide hydrogen Exchange
*Protein/RNA folding
*Proline Isomerization
*Imino proton exchange
oH-bond formation/breaking
Iesomerization processes
*Change in metal
coordination
*Helix-coil transition
*Tightly bound water
*Overall tumbling
*Local conformational
motion
*Fast atomic motions
*Fast side chain dynamics
oDihedral Angle
Fluctuations
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motional models can be fit to J()) to determine how the behavior of individual spin
systems and the overall tumbling of the molecule. Peng and Wagner introduced the full
spectral density mapping approach in which six relaxation rates are measured at multiple
fields to determine the spectral density values at several frequencies (Peng & Wagner,
1994; Peng & Wagner, 1995). The full mapping approach measures the six rate constants
listed in equations 2-7, and then solves for the five spectral density terms at different
frequencies. However, the full mapping approach suffers from a few practical problems
originating
from experimental difficulties. Because the difference of some of the relaxation rate
constants is required and these rate constants are of the same magnitude, the method
required a high level of precision that is not always possible and thus, it is sensitive to
experimental error. An alternative approach, promoted by several groups, is to use a
reduced spectral density mapping approach (Farrow et al., 1995; Ishima & Nagayama,
1995; Lefevre et al., 1996). Since the high frequency terms are the same magnitude, it can
be assumed that J(oI±o)N)=J(o)i) which then allows the spectral densities to be calculated
from just three relaxation measurements, 15N longitudinal and 15N transverse relaxation
rates, and the heteronuclear NOE. Instead of calculating the spectral densities from the
relaxation rates, a functional form of J(o) is assumed containing a limited number of
parameters that are fit to the data. One of these is the commonly applied Lipari-Szabo
model-free approach which describes the dynamics in terms of internal correlation times
and order parameters which describe the flexibility of the measured spin system (Lipari &
Szabo, 1982a; Lipari & Szabo, 1982b).
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1.5 HIV Tat-TAR Background
1.5.1 HIV life cycle and gene expression
HIV contains - 10-20 viral proteins that are produced from overlapping exons on a
10 kilobase (kB) RNA transcript. Early in the viral life cycle the small regulatory proteins
(Rev, Tat, Vif, Nef, etc.) are translated from mRNAs generated by multiple splicing events
on the full 10 kB mRNA. Tat acts during these early stages of the life cycle to increase the
expression of the viral mRNAs by enhancing the efficiency of transcription elongation and
perhaps also by increasing the rate of transcription initiation. To function, Tat binds to the
Transactivation Response Element (TAR), an RNA hairpin that resides in both the 3' and
5' LTR of the HIV genome as shown in Figure 1.7. However, only the 5' copy is active
and binds Tat. Using both in vivo and in vitro biochemical approaches, the Tat binding site
has been localized to a small RNA element within TAR containing a hexanucleotide loop
and a three base bulge, shown in Figure 1.8 (Cordingly et al., 1990; Dingwall et al., 1989;
Dingwall et al., 1990; Roy et al., 1990b; Weeks et al., 1990). The loop sequence is critical
for transcriptional activation but does not affect Tat binding to TAR, and the residues
critical for Tat binding are localized to the bulge region (Cordingly et al., 1990; Roy et al.,
1990a).
1.5.2 Mechanism of Tat action in vivo
In vivo, Tat requires additional cellular factors to activate transcription. It is clear
that TAR provides the binding site for Tat and is formed on the nascent transcript, but it is
less certain whether the target of activation is the elongating transcription complex or
subsequently initiating complexes. To recognize TAR during transcription, it appears that
at least one additional protein must assist Tat in binding. It is believed that his protein is
encoded on human chromosome 12 and helps tether Tat to TAR by interacting with the
hexanucleotide loop (Alonso et al., 1992; Hart et al., 1995; Newstein et al., 1993). Rodent
TAR yrev
tat
gag I vif vpue
5' LTR vpr 3' LTR
RRE
I I I I I I II II
0 2 4 6 8 10 kb
Figure 1.7: Open reading frames in HIV. The boxes represent the
position of genes on the genomic RNA. Single and multiple splicing
events occur to produce the different mRNAs to express the various
gene products. Tat is expressed in two exons, highlighted in black.
The active TAR is located in the 5'-LTR.
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cells appear to lack the factor, supporting only low levels of Tat activity unless
complemented by chromosome 12. The loop is clearly important for Tat activation as most
nucleotides within the loop are required for transactivation and the sequence is highly
conserved among both HIV-1 and HIV-2 isolates. However, since Tat can also activate
transcription when tethered to a heterologous RNA-binding protein and delivered to a
corresponding RNA-binding site placed at the 5' end of the transcript (Selby & Peterlin,
1990; Southgate et al., 1990), or even when bound to DNA (Southgate & Green, 1991).
Although the identity of the loop-binding protein is not yet clear, several candidates
have emerged from in vitro binding specificities (Jones & Peterlin, 1994). One of the
these, is TRP- 185 (or TRP- 1) binds poorly to loop mutants or to mutants where the
distance between the loop and the bulge has been increased, correlating with decreased Tat
transactivation (Sheline et al., 1991; Wu et al., 1991). A cDNA encoding TRP-185
reveals a protein of 1621 amino acids contains a leucine zipper and may be a novel RNA-
binding motif (Wu-Baer et al., 1995). Three cofactors have been identified which help
stimulate TRP-185 in vitro TAR binding including elongation factor la (EF-la), the
polypyrimidine tract-binding protein (PTB), and a novel protein aptly named the stimulator
of TAR RNA-binding (SRB). Recombinant EF-la, PTB, and SRB have been shown to
stimulate binding to TAR in vitro (Wu-Baer et al., 1996). TRP-185 and RNA polymerase
II bind in a mutually exclusive manner, and it has been proposed that TRP- 185 may
disengage RNA polymerases stalled by binding to TAR. TRP-185 is located on human
chromosome ip and thus is not the factor which resides on chromosome 12. A TAR loop-
binding protein of 83 kDa has been observed in human cells and in rodent cells containing
human chromosome 12, but not in the parental rodent cells.
Recently, some progress has been made towards dissecting the mechanism of Tat
function. Tat can be positioned relatively far from the 5' end (-500 nucleotides) and Tat
remains associated with the elongating RNA polymerase II (Keen et al., 1996). Evidence
A) G GU G
C GA
29 36
G*C
A*U
G*C
U 26 39CuUU
23A 1U
G*C
A.U
C*G
C*G
G*C
G C
HIV-1 TAR
NH 2
B) H2N N H 2
0 NH 2
Figure 1.8: A) The sequence and secondary structure of HIV-2
TAR is identical to HIV-1 TAR except for the deletion of a bulge
nucleotide that is not required for Tat or argininamide binding. The
critical nucleotides required in the bulge region are highlighted in
bold. B) The molecular structure of argininamide.
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has pointed to a role for kinases in Tat function. A Tat stimulatory factor, Tat-SF1, co-
purifies with a cellular kinase and stimulates Tat activity in transfection experiments. Tat-
SF1 us a 754 amino acid protein which contains two RNA recognition motifs and a highly
acidic carboxyl-terminal half. A second kinase, the Tat-associated kinase (TAK), can
specifically bind to the Tat activation domain and phosphorylate the C-terminal domain
(CTD) of RNA polymerase II. A third kinase, the TFIIH-associated kinase which also
phosphorylates the CTD of RNA polymerase II is stimulated by Tat in vitro.
Phosphorylation of the CTD is believed to trigger the transition from initiating to elongating
transcription complexes and also to influence later stages during elongation (O'Brien et al.,
1994). Thus, an intriguing model for Tat function emerges from these kinase studies
which link Tat to regulation of the transcription machinery. However, it remains unclear
which, if any, of these kinases is biologically important for HIV Tat function.
1.5.3 Biochemical analysis of the Tat-TAR complex
Features of RNA recognition Mutational studies have shown that U23 is the only essential
nucleotide in the three nucleotide HIV-1 TAR bulge (Churcher et al., 1993; Weeks &
Crothers, 1991). The other two bulge residues can be freely substituted, acting as spacers
that can even be replaced with a non-nucleotide (Churcher et al., 1993; Sumner-Smith et
al., 1991). The bulge can vary in size from two to four residues without significant loss of
Tat binding affinity (Weeks & Crothers, 1991). Two base pairs, G26-C39 and A27-U38,
in the upper stem have also been shown to be important for specific Tat binding (Churcher
et al., 1993; Weeks & Crothers, 1991). The same nucleotides, U23, G26, and A27, are
also critical for transactivation assays in vivo (Churcher et al., 1993). Modification of G26
and A27 at the N7 position with DMS or DEPC interferes with Tat binding, consistent with
the importance of major groove recognition (Churcher et al., 1993; Hamy et al., 1993;
Weeks & Crothers, 1991). Any change to the base of U23 severely inhibits Tat binding,
although the U23 2'OH is not essential for Tat binding (Hamy et al., 1993; Roy et al.,
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1990a; Weeks & Crothers, 1991). The mutation and modification interference data indicate
that just a few nucleotides in and around the bulge region of TAR are required for specific
Tat protein binding. Except for the G26-C39 and A27-U38 base pairs, the sequence of the
two stems surrounding the bulge region is not critical for Tat binding as long as Watson-
Crick base pairing is maintained (Weeks & Crothers, 1991).
Features of Tat protein required for TAR binding The HIV-1 Tat protein is 86 aminos
acids long and is encoded by two exons, but only the first exon (1-72 aa) is sufficient to
activate the HIV-1 LTR (Kuppuswamy et al., 1989). Tat has a domain-like structure
identified by sequence analysis as shown in Figure 1.9. It can be functionally divided into
an N-terminal activation domain (1-48) and a C-terminal RNA-binding domain (49-72).
The activation domain consists of an acidic and proline-rich amino-terminal region (1-21), a
conserved cysteine-rich region (22-37), and a hydrophobic core region (38-48) found in all
lentiviral Tat proteins (Kuppuswamy et al., 1989). The RNA-binding domain (49-57) is
rich in arginines also acts as a nuclear localization signal (Hauber et al., 1989; Ruben et al.,
1989). A 25 amino acid Tat fragment containing only the core and arginine-rich domains
can weakly activate the HIV-1 LTR promoter (Derse et al., 1991), suggesting that these
regions are sufficient for a minimal TAR response.
Short peptides spanning the arginine rich region of the Tat protein bind specifically
to TAR, recognizing the same U23, A27, and G26 nucleotides important for Tat binding
and transactivation (Churcher et al., 1993; Cordingly et al., 1990; Long & Crothers, 1995;
Weeks et al., 1990; Weeks & Crothers, 1991). The same modification interference
patterns observed for Tat were also observed for these peptides suggesting that TAR binds
to the peptides in a similar manner as Tat protein (Churcher et al., 1993). In addition,
modification of phosphates P22 and P23 with ENU interferes with Tat peptide binding
(Calnan et al., 1991; Churcher et al., 1993; Pritchard et al., 1994; Tao & Frankel, 1992).
Although peptide-TAR complexes have been very useful for performing careful
S -- trans-activation -
CYS-RICH
-- Active in vivo
Figure 1.9: HIV Tat proteins have a domain structure. The C-terminal
region is not required for in vivo activity. The N-terminus is highly acidic
and the core region is hydrophobic. Other than the basic RNA binding
domain, very little is known about the function of these domains.
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biochemical studies, they have not yielded high quality NMR spectra suitable for detailed
NMR structural studies (Aboul-ela et al., 1995; Puglisi et al., 1992).
1.5.4 Previous NMR studies of TAR
Two NMR studies have been performed on the HIV-1 TAR-argininamide complex
(Aboul-ela et al., 1995; Puglisi et al., 1992). The first study by Puglisi et al. showed that
a specific complex forms between the amide derivative of arginine, argininamide, and HIV-
1 TAR forms a complex suitable for study by NMR. Similar binding modes of the peptide
and argininamide were indicated by the very similar spectral characteristics in both the
peptide and argininamide complexes. This similarity of conformations has also been seen
in transient electric birefringence studies (Zacharias & Hagerman, 1995). The NMR data
showed that the argininamide guanidinium group is binding near G26 and that U23 is in the
major groove near A27, suggesting the formation of a U38-A27oU23 base triple upon
argininamide binding. When non-experimental base triple and argininamide hydrogen
bonding restraints were added, the NMR data were found to be consistent with the
resulting model of the bound conformation of TAR. The major strength of the model is
that it provides a structural role for every functional group on the RNA identified as
important by binding studies. However, no direct evidence for the proposed base triple
hydrogen bonds was obtained. To test the base triple proposal, an isomorphic C-G*C+
base triple was designed and found to bind argininamide in a pH dependent manner, further
suggesting that base triple formation is important for argininamide binding (Puglisi et al.,
1993). The Puglisi et al. NMR studies did not address the structure of the hexanucleotide
TAR loop. Two studies focusing on the TAR loop showed how this loop has little ordered
structure defined by relatively few internucleotide (Colvin et al., 1993; Jaeger & Tinoco,
1993).
The second NMR study by Aboul-ela et al. of the HIV-1 TAR-argininamide
complex used heteronuclear multidimensional NMR to assign a much larger number of
I Introduction
NOEs and torsion restraints for the structure determination than the previous NMR studies.
Although the U23 was located in the major groove near the argininamide ligand, the
structure determination by Aboul-ela et al. did not find evidence for the proposed base
triple (Aboul-ela et al., 1995). The global conformation of the TAR bulge was similar to
that of the low resolution structure of Puglisi et al., but the details of the structure differ.
Both studies positioned the U23 and the argininamide in the major groove but Aboul-ela et
al. found that a U38-A27*U23 base triple was inconsistent with their NOE data.
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Chapter 2: HIV-2 TAR-Argininamide NMR
2.1 Formation of the TAR-Argininamide Complex
In previous NMR studies of the HIV-1 TAR-argininamide complex, the U40 imino
proton resonance was not observed despite numerous other NOEs indicating that this base
pair was formed. Since only U23 in the bulge is important for binding, and reasoning that
a shorter bulge might have more favorable dynamic properties, the HIV-2 TAR-
argininamide complex was examined. The improved spectral properties due to the
differences in dynamics of the HIV-2 TAR RNA were immediately evident from the imino
proton spectrum of the argininamide complex, which was very similar to the HIV- 1 TAR-
argininamide complex, except that an additional resonance at 14.06 ppm was observed
from the imino proton of U40. Figure 2.1 shows how the HIV-2 TAR imino spectrum
changes upon the addition of argininamide. The U40 imino resonances appears at 5 mM
argininamide and sharpens significantly at 50 C. The apparent binding constant of the HIV-
2 TAR-argininamide complex is 2-3 mM, which is the same as observed previously for the
HIV-1 complex. The total argininamide concentration in the sample is -6 mM, which
corresponds to 76 - 88% of the TAR molecules bound to argininamide in a rapid
equilibrium. Higher concentrations of argininamide produced no further spectral changes,
and weak NOEs were observed to other non-specific argininamide binding sites.
Therefore, approximately 6 mM argininamide concentrations were used for all structural
studies.
2.2 Materials and Methods
2.2.1 Sample preparation
Three samples were prepared for this study: unlabeled, uniformly 13C-labeled, and
uniformly 15N-labeled RNA, by in vitro transcription using T7 RNA polymerase from
G26 G43G28 G21
0 mM Arg
2 mM Arg
4 mM Arg
6 mM Arg
50C, 750 MHz
14.5 14.0 13.5 13.0 12.5 12.0
'H (ppm)
Figure 2.1: The imino spectrum of HIV-2 TAR changes upon
addition of argininamide. In particular the resonances around
the bulge region, G26, G21, and U38 imino resonances shift
and the U40 imino proton appears when the temperature is
lowered to 50C. The HIV-2 TAR RNA concentration is -2.5
mM.
1 I I _ 1 I
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oligonucleotide templates (Milligan et al., 1987). Isotopically labeled samples were
prepared using the procedure reviewed in (Batey et al., 1995). Slightly different
transcriptions conditions were used for the isotopically labeled nucleotide triphosphates
prepared from cells. For the labeled samples, 20 pl transcription trials were performed to
maximize the molar yield per nucleotide triphosphate. The transcription conditions used for
each sample are summarized in Table 2.1. Each T7 polymerase preparation was optimized
as the activity per milligram varies significantly. Recently, two new tricks were introduced
and found to increase transcription yields significantly. The first addition is to add an extra
G-C base pair in the promoter region which is reported to increase yields by approximately
two to ten-fold. Also, the addition of a methylindole to the 5' end of the template helps
prevent additional nucleotides from being added to the 3' end, e.g. N+1. These two
advances yielded three micromoles of pure dialyzed HIV-2 TAR RNA from a 80 ml
transcription reaction. Without these new additions, 80 ml of transcription typically yielded
only about one micromole. Radioactive small scale trial transcriptions indicated that an
increase of between 3-5 fold in yield is expected.
After transcription, the RNAs were purified by electrophoresis on 20% (w/v)
polyacrylamide gels, electroeluted from the gel slices, and ethanol precipitated. The
samples were dialyzed for >48 hours against NMR buffer (10 mM sodium phosphate, pH
6.4, 50 mM sodium chloride and 0.1 mM EDTA). The final concentrations in 500 pl were
2.5 mM, 1.5 mM, and 1.5 mM for the unlabeled, 13C-labeled and 15N-labeled TAR RNA
samples, respectively.
The labeled RNA's were titrated in the NMR tube to a final total argininamide
(Sigma) concentration of 6 mM, while the unlabeled TAR RNA was titrated to 6.5 mM.
No changes in the spectra are observed above this concentration indicating that the binding
site is nearly saturated. As in the previous NMR studies of HIV 1 TAR, argininamide is in
fast exchange between bound and unbound forms.
Table 2.1: Transcription Conditions for HIV-2 TAR.
Sample
unlabelled
unlabelled with
methyl-indole
and extra G-C
"C TAR
15N TAR
Total NTP
Concentration
(mM)
16
16
8
8
MgC12(mM)
32
32
16
16
Yield
(gmoles)
0.6
3
0.75
0.6
Total
Volume of
Reaction
60
80
120
100
All reactions were performed in 40 mM Tris pH 8.1, 1 mM spermidine, 0.01% (v/v) triton
X-100, and 5 mM dithiothreotol.
HIV-2 DNA Template:
5' - X GGC CAG AGA GCT CCC AGG CTC AAT CTG GCC TAT AGT GAG TCG
TAT TA(G)- 3'
DNA T7 Top Strand:
5' - (C)TA ATA CGA CTC ACT ATA
The nucleotides in parantheses represent the added G-C base pair which increases
transcription yields.
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2.2.2 NMR spectroscopy
Spectra were collected on 500 MHz or 591 MHz spectrometers constructed at the
Francis Bitter Magnet Lab, equipped with Nalorac triple resonance gradient probes. 750
MHz spectra were recorded on a Varian Unity Plus spectrometer equipped with a Varian
triple resonance gradient probe. Some 500 MHz spectra were collected on a Varian VXR-
500 spectrometer with a Varian inverse detection probe. The 4D HMQC-NOESY-HSQC
spectrum was collected on a Bruker DMX 600 MHz spectrometer. All spectra were
processed and analyzed using NMRPipe (Delaglio et al., 1995) and PIPP (Garrett et al.,
1991) on a Silicon Graphics Indy workstation.
Proton NMR spectra in H20 were recorded at a variety of temperatures and mixing
times, including 40, 50, 100, 150, and 200 ms. NOESY spectra used a WATERGATE 3-
9-19 water suppression scheme with a selective E-BURP-1 flip-back pulse (Green &
Freeman, 1991; Lippens et al., 1995; Piotto et al., 1992) . The flip-back pulse significantly
helped the observation of NOEs to the argininamide guanidinium protons. Sweep widths
were 12000, 14000, 16000 Hz at 500, 600, and 750 MHz, respectively, with 4096 x 512
real points collected. Data were zero filled to 4K x 2K real points and apodized using
Gaussian-Lorentzian functions in both dimensions before Fourier transformations.
NOESY, DQF-COSY, and TOCSY experiments were recorded in 99.996% 2H20
at 25°C (Varani & Tinoco, 1991). Data sets with 4096 real points in t2 and 512 real points
in tl were acquired for the NOESY and TOCSY. The DQF-COSY was collected with
1024 points in t2 with WALTZ decoupling of 31P during acquisition. To monitor NOE
buildups, spectra were recorded at 500, 600, and 750 MHz with mixing times of 50, 100,
200, 300, and 400 ms. In addition, a 35 ms NOESY experiment at 500 MHz was also
collected. Sweep widths were 5500 Hz, 6000 and 8000 Hz at 500, 600, and 750 MHz,
respectively.
Acquisition parameters for all the heteronuclear spectra are provided in Table 2.2.
Table 2.2: Data acquisition parameters for heteronuclear NMR experiments.
Molecule Experiment Field 0 4a o3a 2a 1 a JXH (Hz)b Other No. of Ref.
(MHz) scans
Unlabelled HP-HSQC 600 550 Hz 6000 Hz 13 msc 16
TAR RNA 512 pts 4096 pts
31p 1H
HP-COSY 600 5000 Hz 2000 Hz 16 (Sk6lnar
512 pts 4096 pts et al.,
31p 1H 1986)
Uniformly 13C- 3D NOESY- 500,600 5050 Hz 5000 Hz 5000 Hz 160 200 ms
d  16 (Clore
labeled TAR HMQC 32 pts 128 pts 512 pts et al.,
RNA 13C 1H IH 1990)
3D HCCH- 500 5000 Hz 2500 Hz 2500 Hz 142 20 mse 16 (Clore
DIPSI 37 pts 64 pts 512 pts et al.,
13C  'H IH 1990))
3D HCCH- 500 5000 Hz 3000 Hz 3000 Hz 142 16 (Clore
COSY 32 pts 64 pts 512 pts et al.,
13C IH 'H 1990)
4D HMQC- 600 3333 Hz 3333 Hz 3003 Hz 6024 Hz 156 90 msdf 2 (Vuister
NOESY-HSQC 20 pts 20 pts 50 pts 384 pts et al.,
13C  13 C  IH 'H 1993)
HSQC-CT 500,600 5000 Hz 5000 Hz 142 25 ms' 16 (Santor
256 pts 512 pts o &
13C  'H King,
1992)
Table 2.2 (cont): Data acquisition parameters for heteronuclear NMR experiments.
Molecule Experiment Field o 4a a 8la XH (Hz)b  Other No. of Ref.
(MHz) scans
3D-HCP 600 550 Hz 6000 Hz 6000 Hz 165 Hz 16 (Heus et
32 pts 150 pts 512 pts 8 Hz al.,
31p 13C  1H 1994)(Marino
et al.,
1994)
Uniformly '5N- 3D NOESY- 600,750 5000 Hz 7500 Hz 16500 Hz 90 Hz 150 msd 8 (Mori et
labeled TAR
RNA
HSQC
HSQC
2 bond HSQC
31 pts
15 N
600,750
500
128 pts
'H
6800 Hz
64 pts
15N
10000 Hz
128 pts
15N
1024 pts
'H
18000 Hz
2048 pts
'H
6000 Hz
1024 pts
'H
90 Hz
18 Hz
al.,
1995)
(Mori et
al.,
1995)
(Sk6lnar
et al.,
1994)
a The number of real data points acquired, the spectral width, and the nucleus detected are listed for each dimension.
b Given is the value of the of the one-bond X-nucleus-hydrogen coupling constant used for determination of the delay for transfer of
magnetization between the proton and the X-nucleus. For the carbon NOESY experiments, the value used was an average of the
aromatic and ribose coupling constants.
c Although the H-P coupling constant is usually between 8-10 Hz, due to fast 3 1p relaxation, reducing the transfer time from -25 ms to
-13 ms significantly increases the sensitivity.
d The mixing time of the period for NOE transfer.
e The mixing time of the carbon spin- lock pulse for transfer of magnetization through the ribose ring.
f The 13C transmitter in the 4D experiment was at 80.9 ppm.
g Value of the constant-time interval for evolution of the carbon chemical shift in o.
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In all 13C experiments, 13C decoupling was achieved with a GARP (Shaka et al., 1983)
scheme during acquisition and a composite 1800 13C pulse in the middle of the tl proton
evolution times. This composite pulse is required to effectively decouple enough
bandwidth covering both the ribose and aromatic carbon regions. Spectra were apodized
with shifted squared sine bell functions. For some spectra, the o1 and w2 dimensions were
Fourier transformed first. The o3 dimension was linear predicted by a factor of 2 and then
zero-filled to 128 points. The o2 dimension was then inverse Fourier transformed and
linear predicted by a factor of two and zero filled by a factor of two. This processing
strategy did not significantly help resolve peaks compared to the more straightforward and
easier to implement method where the o2 dimension is not linear predicted.
The 15N NOESY-HSQC at 50C used a 3-9-19 WATERGATE sequence for water
suppression at 750 and 600 MHz with the transmitter set to 124.7 ppm (Mori et al., 1995).
GARP was used to decouple 15N during acquisition (Shaka et al., 1983), and a composite
1800 15N pulse in the middle of the tl proton evolution time.
2.3 Assignment of Exchangeable Resonances
2.3.1 Secondary structure of HIV-2 TAR
Imino proton resonances were assigned from NOESY spectra in H20 and
confirmed in a 3D '5N-NOESY-HSQC spectrum (Varani et al., 1996; Varani & Tinoco,
1991). Figure 2.2 shows the imino-imino proton region of a 75 ms mixing time
750 MHz 'H-'H NOESY spectrum in H20 at 50C. The U40 imino peak is sufficiently
sharp that NOEs to the G21 and G26 imino protons are observable, as well as a NOE to
C39(H42) and a strong NOE to A22(H2) (data not shown). These NOEs are consistent
with stacking between the A22(U40) base pair and the G26-C39 base pairs at the junction
G26(H1)
G21(H1)
13.0
1H (ppm)
12.5 12.0
Figure 2.2: The imino-imino region of a 75ms 750 MHz 'H-'H
NOESY in 90% H20/10%2H20 at 50C indicates that the U40 imino
proton is observable and gives stacking NOEs to the G26 and G21
imino protons.
12.0
- 12.5
'13.0
-13.5
14.0
-
14.5 14.0 13.5 11.5
. I I I I
n 0
S#
0- 4.2
S- 4.4
U -4.6
4.8
C45 C29 5
C37 6=s 5.2
C18 ..
-5.6C41 C
5.8
P 6.0
-6.2
- 6.4
8.8 8.6 8.4 8.2 8.0 7.8 7.6 7.4
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Figure 2.3: A 40 ms 750 MHz 50C NOESY in H20 highlights an
alternative connection between the exchangeable and non-
exchangeable spectra. The lines connect cytidine H42 amino proton
resonances with the H5-H6 crosspeaks from the same nucleotide.
Every base paired cytidine is observed and resolved except for the
C19 and the terminal C46. The C19 H42 is highlighted by the box
but the H5-H6 crosspeak is overlapped.
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between the upper and lower stems.
The standard approach to begin correlating the exchangeable and non-exchangeable
spectra is to identify the strong U(H3)-A(H2) NOE crosspeaks. A second pathway is
available by looking for NOEs between the cytidine amino protons to their own H5s and
H6s as illustrated in Figure 2.3. The good spectral dispersion of both the H5 and
downfield amino proton resonances helps the identification of many of these crosspeaks.
Because these NOEs are observable even at really short mix time NOESY experiments,
fewer intervening and deceiving crosspeaks are observed. Each additional assignment
pathway helps solve the puzzle as the different correlations will have different dispersion
and give additional information.
The proposed base triple model of Puglisi et al. predicts that the U23 imino proton
is hydrogen bonded and thus should be observable (Puglisi et al., 1992). However, the
HIV-1 TAR-argininamide NMR studies found no evidence for this resonance. For these
HIV-2 TAR studies, temperatures ranging from 00 C to 350C, NaCl concentrations from 5 -
100 mM, and magnetic field strengths from 11.4 to 17.5 T were tested to try to find this
missing imino resonance without any success. The 50 C 750 MHz "1 N-FHSQC of Figure
2.4 shows only the three Watson-Crick base paired uridine iminos. Thus, no overlapping
hidden uridine imino resonances appear to be present that could not be observed in the 1D
imino spectrum.
Of the four adenines in HIV-2 TAR, a single adenine amino crosspeak is observed
in the 15 N-HSQC even at 750 MHz as shown in Figure 2.5. This adenine amino
resonance is only observable at temperatures less than 10 'C. Assignment of the A27
amino protons was obtained from a 150 ms mixing time 750 MHz 3D NOESY-HSQC
experiment at 50 C, shown in Figure 2.6. A strong NOE to U38(H3) and NOEs consistent
with stacking to the C39(H42/H41) and G26(H1) are observed. However, the two A27
00Guanine-Hls #OP
()
U42
U38
14.5 14.0
U40 Uridine-H3s
13.5 13.0
1H (ppm)
12.5 12.0
144
146
148
150
152
154 "
156
158
160
162
164
, 166
11.5
Figure 2.4: The imino region of a 750 MHz FHSQC at 50C. No
evidence of the U23 imino resonance is observed in the Uridine-H3
region. The nitrogen imino resonances are distinctly resolved by
nucleotide type.
~
0 g I
G43(H22)
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G21(H22)
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Figure 2.5: 15N FHSQC at 50C at 750 MHz of the HIV-2 TAR
argininamide complex. Only one adenine amino nitrogen resonance
is observable and the proton resonances have degenerate chemical
shifts. This is the A27 amino which is part of the proposed base triple.
Three guanine amino resonances have two distinct proton chemical
shifts with the intensity becoming weaker as the difference between
the two proton chemical shifts decreases.
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amino protons are apparently coincident, perhaps because they are in exchange due to
rotation about the C-N bond. The observation of the A27 amino resonances suggests that
the A27 amino group may be involved in additional interactions beyond Watson-Crick base
pairing.
Three guanine amino nitrogen resonances were also observable as shown in Figure
2.5. In the absence of 13C/15N double labeled samples, the only way to assign these
resonances is by NOE analysis in the 750 MHz 3D NOESY-HSQC. Why the G26, G21,
and G43 are the only guanosine amino protons which are exchanging in the right regime to
be observed as distinct proton resonances remains a mystery. Because the argininamide
interacts in the major groove of TAR, it is not expected to interact and possibly effect the
observation of the guanine amino proton resonances. Interestingly, as the difference in
chemical shift between the H22 and H21 amino proton resonances decreases, the intensity
of the peaks is also reduced. This is expected as the two proton peaks move from slow
exchange and enter the intermediate exchange regime. The other eight guanine amino
resonances remain in fast exchange in one large crosspeak at -6.3-6.4 ppm. As discussed
in Chapter 1, guanine amino protons give a number of extremely useful long-range cross-
strand NOEs, similar to adenine H2 protons. These NOEs are used to assign the guanine
amino resonances as shown in the 750 MHz 3D S1 N-NOESY-HSQC in Figure 2.6.
Because a 15N/13C sample was not prepared, the only way to assign these exchangeable 15N
and 'H resonances is by NOESY based assignments. The danger of depending on the
structure as a guide to assign the NOEs was minimized as other information suggested that
the upper and lower stems are A-form. In addition, the observed NOEs made sense with
this structure and as Chapter 3 discusses were consistent with all the other observed NOEs.
2.4 Assignment of Non-Exchangeable Resonances
2.4.1 Homonuclear spectroscopy
G26(N2), o = 71.2 ppm
G26(H1) ' ,
3
Ar (Hy)
-- Arg(H p)
-- G26(H1)
-- Arg(H 8)
Arg(H cca)
- U38(H3)
- H20
C37(H41)
-C39(H41)
-=-A27(H2)
-- C39(H42)
,- C37(H42)
U40(H1')
G26(H1')
A27(H1') -
C39(H42)
32
1H (ppm)
Figure 2.6: Two slices from a 150 ms 15N-NOESY-HSQC at 750 MHz in
90% H20/10% 2H20 at 50C. These purine amino resonances were
assigned by these NOEs. The G26(H22) proton gives a number of useful
cross-strand NOEs.
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Non-exchangeable proton resonances were assigned from 1H-'H 2D NOESY,
COSY, and TOCSY spectra, their 3D 13C-resolved counterparts, and a 4D HMQC-
NOESY-HSQC experiment (Nikonowicz & Pardi, 1992b). These multidimensional
experiments were absolutely necessary to assign all the resonances because of the extreme
overlap that the HIV-2 TAR argininamide complex demonstrated. They also allowed the
identification of a very large distance restraint data set.
The sequential assignment pathway in the aromatic-anomeric regions is highlighted
in the NOESY in 99.996% 2H20 of Figure 2.7. Although some of the A-helical regions
can be assigned in this spectrum, the key resonances in the bulge region cannot be
identified. (Note that this high quality 750 MHz spectra was not even available when this
project began.) In particular, the U23(H1') - G26(H8) NOE, which was a key restraint
observed in the HIV 1 TAR - argininamide complex, cannot be identified in the 'H-1H
NOESY spectrum due to spectral overlap. For additional sequential assignments, the
aromatic-aromatic region displays excellent dispersion over a 1.6 ppm range. Figure 2.8
shows a number of interesting aromatic-aromatic NOEs in the bulge region and in the TAR
loop, including a stacking NOE between the G26(H8) and A22(H2). These types of
crosspeaks are generally observed at longer mixing times and may be influenced by spin
diffusion because of the strong H8/H6-H2' internucleotide NOEs. Thus, even though
these NOEs are expected for A-form RNA (see Table 1.1), careful analysis of shorter
mixing times is required to determine whether any of the NOEs can be converted to
restraints.
'H-'H DQF-COSY and TOCSY experiments provide through bond assignments of
some pyrimidine H5-H6 and H l'-H2' spin systems. These experiments are limited to
riboses with C2'-endo as the couplings are too small for the C3'-endo case. Longer
TOCSY mix times allow 'H- 'H magnetization transfer from the Hl' to the H5'/H5". In
conjunction with the H20 NOESY data, significant progress towards complete assignments
is usually possible with homonuclear data, especially with the excellent resolution and
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Figure 2.7: The aromatic-anomeric region of a 750 MHz NOESY
spectrum (mix=100 ms) of the HIV-2 TAR-argininamide complex in
99.996% 2H20. The sequential assignment pathway is highlighted by
dashed and solid lines for nucleotides G21-C29 and A35-G44
respectively. The numbers indicate intranucleotide H8/H6 to H1' NOEs.
The U23 resonances are overlapped and are not indicated along with the
C17-C18, A22, G26, C30-G34, and C46 resonances. The U25 H6-H5
and H6-H1' crosspeaks are marked by the rectangle.
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Figure 2.8: Aromatic-aromatic NOEs in a 7
NOESY at 250C.
a) A20(H2)-C19(H6) b) G21(H8)-A20(H8)
d) A22(H2)-G26(H8) e) A22(H2)-C41(H6)
g) G44(H8)-C45(H6) h) G36(H8)-A35(H8)
k) G36(H8)-C37(H6) m) G28(H8)-A27(H8)
o) C39(H6)-U38(H6) p) G17(H8)-G16(H8)
'50 MHz 100 ms 2H O
2
c) G21 (H8)-A22(H8)
f) G44(H8)-G43(H8)
i) G36(H8)-G34(H8)
n) C39(H6)-U40(H6)
r) G43(H8)-U432(H6)
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signal to noise available at 750 MHz. This analysis does not preclude the use of 13C
spectroscopy to make unambiguous assignments, but some interesting information about
the RNA structure may be deduced long before the first 13C HSQC is acquired.
2.4.2 13C NMR assignments
To make unambiguous assignments, a 13C isotopically labeled sample proved to be
extremely useful and necessary for HIV-2 TAR. The ribose region of a constant time
HSQC with the constant time interval set to 1/Jcc which differentiates the Cl' and C5'
from the C4', C2', and C3' is shown in Figure 2.9. The J-coupling modulation during the
constant time period causes a sign alteration due to the number of carbon-carbon bonds.
Thus, because the C1' and C5' have only one carbon-carbon bond they will have the
opposite sign of the other ribose carbons which have two carbon-carbon bonds. RNA
carbons usually resonate in very distinct regions allowing for initial assignments to be made
by simply monitoring the carbon chemical shifts, but significantly shifted resonances have
been found in a number of cases, most notably the tetraloop structures (Heus & Pardi,
1991). In HIV-2 TAR, only the G26(C5') and the C46(C3') is significantly shifted as
highlighted in Figure 2.9 and no H1' or Cl' resonances are significantly shifted into any
unusual regions. A similar analysis was performed in the aromatic region by a 13C-CT-
HSQC spectrum to differentiate the pyrimidine C6's from the purine C8's and adenine
C2's. A separate CT-HSQC experiment is usually required to observe the aromatic and
ribose regions because the aromatic carbons are far (>40 ppm) from the ribose region
preventing carbon 180's from exciting both regions and thus limiting the obtainable signal.
The resolution of constant time experiments is limited resolution as points can only
be collected up to the total constant time period. A non-constant HSQC can provide more
resolution in the carbon dimension and the pyrmidine and purine resonances can be
distinguished as only the C5 and C6 are split by a single carbon-carbon coupling. Figure
2.10 shows how almost every C6 and C8 is observable when 512 points are collected.
3D HCCH-COSY and HCCH-TOCSY experiments correlate the usually well-
'CI
Io
g t
G26 (5'/5")
H5'/C5',H5"/C5'
oo
o
0
1 H (ppm)
Figure 2.9: Constant time HSQC of the ribose region of HIV-2
TAR in the argininamide complex at 600 MHz. RNA ribose
carbon resonances are generally in distinct chemical shift
regions. The C4' and C3'/C2' regions are negative in this
experiment because these carbons are attached to two other
carbons. Notice the unusually shifted G26 C5' resonance
marked by the box.
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Figure 2.10: The aromatic region of a '3C-HSQC shows
the good dispersion of the purine resonances and the
generally crowded pyrmidines except for a few non-helical
resonances.
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resolved H1'IC1' resonances with the rest of the ribose spin system (H2'->H5'/H5").
These experiments transfer magnetization by using the large one-bond, conformationally
independent, JHC and Jcc couplings instead of the very small 3 JHH couplings of the ribose
spin system. For HIV-2 TAR, these were the only unambiguous through bond
assignments that were made. A 20 ms, 3000 Hz spin lock time was sufficient to transfer
magnetization from the C1' to the C5' allowing almost all 150 resonances in the 30 riboses
to be unambiguously assigned. The HCCH-COSY identifies the various H1'-C1'-C2'-
H2' and H5-C5-C6-H6 spin systems. The other ribose HCCH spin systems (e.g. H5'-
C5'-C4'-H4') are difficult to resolve because the proton resonances do not have sufficient
spectral dispersion and thus will be severely overlapped. Once the different ribose spin
systems were identified, they can be sequentially linked by NOESY experiments.
2.4.3 13C NOESY experiments
In the HIV-2 TAR-argininamide complex, chemical shift overlap was a particularly
severe problem. NOEs between Hi' protons in the 5.90-5.95 ppm range to H8/H6
protons at 7.70-7.75 ppm were very crowded and unambiguous assignments of all the
observed crosspeaks were not possible in 3D 13C-NOESY-HSQC experiments at either
500 or 591 MHz. Figure 2.1 la shows the crowded HI'/H5 region of the 2D H- H
NOESY where many overlapping NOEs were observed in the 4.0-4.8 and the 7.70-7.75
ppm regions. The corresponding region from the U23 Cl' plane of a 3D NOESY-HMQC
spectrum is shown in Figure 2.1 lb. Although the U23 Cl' resonates at a distinct chemical
shift, resonance overlap still precludes identification of some of the NOEs in the 4.0-4.8
and 7.70-7.75 ppm regions. However, a 4D HMQC-NOESY-HSQC experiment (Vuister
et al., 1993) proved to be extremely valuable for resolving these peaks. One example of a
severe overlap problem is seen for peak a in the 3D plane of Figure 2.1 lb. Although this
may appear to be one NOE, the 4D spectrum showed that this cross peak is actually two
distinct NOEs, including one important long-range internucleotide NOE between U23(H1')
A) 2D NOESY
4.0-
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5.6-
6.0-
6.4-
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b
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Figure 2.11: A. The spectral crowding in the H1' region is shown in a 100 ms
750 MHz 2D NOESYspectrum in 2H20 at 250C. B. At the U23(C1') frequency
in a slice from a 3D NOESY-HMQC shows significant clarification of the NOEs.
C. However, some of these crosspeaks still contain more than one NOE as
shown by a plane of a 600 MHz 90 ms 4D HMQC-NOESY-HSQC at the
U23(H1'/C1') resonance. These are critical NOEs to the U23.
C) 4D HMQC-NOESY-HSQC
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and G26(H8). A second example is illustrated by peak b in Figure 2.1 lb, which is
resolved into three NOEs in the 4D plane. The U23(H4'), U23(H2') and one of the
G26(H5'/H5") protons all have about the same chemical shift, but very distinct carbon
chemical shifts allowing the unambiguous interpretation of these useful NOEs in the 4D
spectrum.
The NOEs highlighted in Figure 2.11 could be not be assigned from the 3D
NOESY-HMQC because of the extreme overlap of the Hi' resonances. This is explicitly
illustrated in Figure 2.12 which shows the G26(C8), G26(C1'), U23(C6), and U23(C1')
13C slices from a 3D NOESY-HMQC. The carbon resonances resolved the overlapped
aromatic proton resonances but not the anomeric proton crowding. Examination of the
U23(C1') and the G26(C1') slices shows the same problem as the crosspeak now suffers
from the aromatic proton resonances overlapping. In none of the slices, can the crosspeak
at approximately 5.90 - 7.73 ppm be unambiguously identified. Without the 4D spectrum,
one may think that theses NOEs are simply the intranucleotide aromatic-anomeric NOEs
and no long range NOEs between G26 and U23 exist. It is even difficult to determine that
these crosspeaks are particularly bigger than other observed peaks which would suggest an
additional resonance is overlapped with the expected intranucleotide NOE. The 3D
spectrum still relies on proton chemical shift dispersion in one of the slices to identify the
crosspeaks. However, we had suspicions from the previous HIV-1 TAR NMR studies
that an NOE between the U23(H1') and the G26(H8) exists and therefore performed the
4D experiment to unambiguously identify this critical intemucleotide NOE. This incredible
overlap presents a serious warning flag for RNA NMR; severe chemical shift overlap can
prevent the identification of key NOEs. This scenario places more emphasis on performing
more selective labeling strategies and/or 4D NMR to assign every possible NOE. In
addition, it may be prudent to build initial models and determine what other NOEs should
be observed and then try to find them in the spectra.
The potential of using a 4D NOESY spectrum for stereospecfic H5'/H5"
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Figure 2.12: The proton spectral crowding in 3D the NOESY-
HMQC prevents assignment of the crosspeak at -7.73 - 5.91
ppm in any of these carbon slices. Looking at either the aromatic
slices or the C1' slices suffers from severe proton chemical shift
overlap problems preventing assignment of these NOEs. Is there
a NOE between G26(H8) and U23(H1') or not?
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Figure 2.13: Two slices from the 4D HMQC-NOESY-HMQC.
A) The G26(H5'/C5') slice. B) The G26(H5"/C5') slice. At 90
ms, a slight difference in intensity between the G26(4') and the
G26(5') and the G26(5") is apparent, suggesting the possiblity
of stereo assignments, especially with shorter mixing times.
The dashed crosspeaks are negative.
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assignments is shown in Figure 2.13. The H4'-H5'/H5" NOEs are resolved and their
intensities in a shorter mixing time experiment should vary with the y torsion. The problem
with this strategy is that by going through two proton - carbon magnetization transfers, the
magnetization could be differentially affected by dynamics. Nonetheless, in this 90 ms
experiment, many additional NOEs to the H5' could be assigned. The 4D NOESY
spectrum permitted the identification of 10 of 19 possible 5'/5"-2' and 9 of 19 3'-2'
internucleotide NOEs in the A-helical regions. A number of additional interesting
internucleotide NOEs were identified in the bulge region, including G26(H4')-U23(H1')
and G26(H8)-U23(H4'). The NOEs in the bulge region observed in previous NMR
studies of the HIV-1 TAR-argininamide complex (Aboul-ela et al., 1995; Puglisi et al.,
1992) were also observed here, indicating that the HIV-1 and HIV-2 TARs are binding in
similar conformations. Table 2.3 lists all the NOEs observed in the bulge region of the
HIV-2 TAR - argininamide complex.
2.4.4 "P NMR spectroscopy
Phosphor is an intriguing nucleus as it is in a prime position to make ribose-ribose
sequential assignments. However, because 31P relaxes very fast in macromolecules along
with the small C-P and H-P J couplings ( <10-11 Hz), acquiring sufficient signal becomes
very difficult for these experiments. In addition, 31P nuclei are very sensitive to motions
such as conformational exchange which is very common in RNA and may cause the signals
to decay even more rapidly than predicted for the size of the RNA. Luckily, the 31p spectra
had fairly strong signal for the HIV-2 TAR - argininamide complex allowing for some
sequential assignments to be verified by reliable through-bond experiments, as shown in
Figure 2.14. The HP-HSQC in Figure 2.15 shows that many of the non-A-form 31p
resonances are resolved but that the A-form crosspeaks are packed together in one big
happy family.
The H5'/H5"-P and H3'-P J-couplings can be measured in a HP-COSY or HP-
Table 2.3: NOEs in the bulge region.
A22 H8 -G21 HI' w G26 H1'
-G21 H2' s
-G21 H3' w
-G21 H8 w G26 H2'/H3'
-A22 HI' w
-A22 H2' w
-A22 H3' m G26 H4'
-A22 H4' w
-A22 H2 w
-U23 H1'
-G26 H1'
-U23 HI' w
-G26 HI' m
-G26 H2'/H3' m
A22 H2 -G21 H1
-G21 H22
-A22 H1'
-A22 H2'
A22 H1' -G21 H2'
U23 H6 -U23 H1'
-U23 H2'
-U23 H3'
-U23 H4'
U23 H5 -U23 H2'
U23 H5'/5" -A22 H2'
U25 H6 -U25 H1'
H2'
H3'
H4'
H5'/5"
U25 H5
U25 H3'
U25 H1'
-U25 H2'
-U23 H4'
-U42 H1'
G26 H8 -A22 H2' w
-A22 H2 w
-U23 HI' w
-U23 H4' w
-G26 HI' w
-G26 H2'/H3' w
-G26 H4' w
-G26 H5'* w
G26 H1 -A22 H2 v.w.
w
v.w.
w
w
G26 H5'/H5" -U23 HI' w
-U23 H4' w
-G26 HI' w
-G26 H2'/H3' w
-G26 H4' s
A27 H8
A27 H2
-G26 HI' w
-G26 H2'/H3' s
-G26 H8 w
-A27 HI' w
-A27 H2' w
-A27 H3' m
-A27 H5'/H5" w
-G26 H1 v.w.
A27 H61/H62 -G26 H1 v.w.
A27 HI' -G26 H2'/H3' v.w.
-G26 H22 v.w.
-G26 H21 v.w.
A27 H2' -A27 HI' s
A27 H3' -G26 H2'/H3' v.w.
-A27 HI' m
-A27 H2' s
A27 H4' -A27 H1'
-A27 H2'
-A27 H3'
A27 H5'/H5" -G26 H2'/H3' v.w.
-A27 H3' w
-A27 H4' m
s = strong NOE, m = medium NOE, w = weak NOE, v.w. = very weak NOE
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Figure 2.14: The first fid from the A) HP-HSQC and B) HCP
experiments shows the signal obtained for the -10 kDa HIV-2
TAR-argininamide complex.
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Figure 2.15: 1H- 31P HSQC of HIV-2 TAR-argininamide complex at 591 MHz
proton frequency at 250C. Notice the two G26(H5'/H5") crosspeaks to the
G26(P) whose appearance is not consistent with a single rotamer suggesting
conformational averaging. Notice the non-helical resonances from U25, G26,
G34, A35, and U40 are resolved.
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HSQC experiment and provide restraints for the P and e torsions, respectively. The HSQC
is a more sensitive experiment and suffers from less overlap because there are only two
antiphase peaks per HP spin system as opposed to four in a HP-COSY spectrum. For
HIV-2 TAR, the HP HSQC displayed evidence of mixed populations of backbone
conformers in the bulge region. For example, the G26 H5' and H5" both gave medium
couplings to the G26 phosphorus indicative of a mixture of gauche- and gauche+
conformations as highlighted in Figure 2.15. As seen in Table 1.4, none of the three major
rotamers of the 3 torsion are consistent with the observation of cross peaks for both the
H5' and the H5" - P. Evidence for mixed conformers was also observed for the backbone
torsions of U23 and U25. Thus, no a, P, y, 8, or E torsion restraints were used in the
structure determination.
The HCP experiment is a series of INEPT transfers from 'H to 13C to 31P and back
to 'H (Heus et al., 1994; Marino et al., 1994). The HCP experiment links sequential
riboses as each C4' has a 8-10 Hz coupling to both its own and neighboring phosphorous
(Heus et al., 1994; Marino et al., 1994). The HCP spectrum's signal was sufficient to see
most of the expected crosspeaks (Figure 2.15). Figure 2.16 shows two representative 31p
slices from the HCP experiment for some of the better resolved resonances. These slices
provide straightforward identification of C5', C3', and the two sequential C4' resonances
for all nucleotide conformations. On the other hand, the observation of the C2' crosspeak
suggests that the e torsion is gauche- for the U25 (Varani et al., 1995). The sequential
assignment pathway from the HCP experiment is illustrated by following the 3C slices as
shown in Figure 2.17. This pathway depends on the poor C4' chemical shift resolution
(see the CT-HSQC of Figure 2.9). By combining the information from both the 31P and
13C slices, through-bond sequential assignments are possible for many residues. A more
powerful assignment experiment, the HCP- CCH TOCSY (Marino et al., 1995),
C39(H4',C4') U40(H4',C4')
4.6 4.5 4.4 4.3 4.2
'H (ppm)
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4.7 4.6 4.5 4.4 4.3 4.2 4.1
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Figure 2.16: 31P slices from the HCP experiment at 250C. A)
U40(P) at -4.92 ppm B) G26(P) at -3.25 ppm. The
G26(H4',C4') crosspeak is weak and overlapped with the water
peak at 4.75 ppm.
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Figure 2.17: 13C slices from the same HCP experiment as in Figure
2.16 showing the sequential assignment pathway linking the C39 and
U40 residues. These resonances are well-resolved unlike most of the
A-form residues.
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which combines the HCP and HCCH TOCSY experiments failed to provide significant
signal for the HIV-2 TAR - argininamide complex, probably because the magnetization
cannot survive the demands of a -20 ms DIPSI delay along with the reliance on the fast
relaxing 31P resonances.
Nearly complete assignments were obtained for the HIV-2 TAR - argininamide
complex as shown in Table 2.4. Of the 13C resonances, only the C19(H5'/H5") and
C37(H5'/H5") protons could not be unambiguously assigned due to spectral overlap.
Because of the limited 31P chemical shift dispersion, only about half of the 3 P resonances
could be assigned. In addition to the fiendish overlap of some of the bulge and loop
resonances, many of the resonances from the upper and lower A-form stems are
overlapped making their assignments difficult as well. Many of the A-form pyrimidines
have degenerate chemical shifts even for all the different types of carbon and proton
resonances, making assignments very difficult. These difficulties highlight the potential
problems for NMR studies of even larger RNAs where chemical shift overlap, especially of
the A-form regions will be poor at best.
2.4.5 Non-exchangeable nitrogen resonances
A number of nitrogens that do not have directly attached protons are also observable
by monitoring their two bond coupling to protons in "SN-HSQC experiments. Figure 2.18
shows the various purine signals accessible from a two bond HSQC. The N7, N1, and N9
regions give the most signal and are well-resolved as all 15 N7's can be counted in the 2D
spectra. However, three N7-H8 crosspeaks could be assigned because of the overlapping
H8 chemical shifts as listed in Table 2.5. A 13C/15N labeled sample could alleviate this
problem by correlating the Cl' and/or C8 resonances to the N7 and N9. For larger '3C/' 5N
labeled RNAs, where chemical shift overlap becomes a major problem, using some of
these other nitrogen resonances to gain dispersion may be useful.
An upfield shift of a nitrogen chemical shift may suggest a hydrogen bonding
interaction at that position (Gaffney et al., 1993). The A27(N7) is of particular interest in
Table 2.4. Proton, Nitrogen, Carbon, and Phosphor chemical shifts (ppm) for HIV-2 TAR
RNA bound to argininamide.
Residue 1/3 2/4
G16
G17
C18
C19
A20
G21
A22
12.99
146.92
13.50
147.92
--
12.61
146.57
U23
U25
G26 12.54
146.92
A27 --
G28 13.69
147.62
C29 --
C30 --
U31
G32
G33
G34
A35 --
G36
C37
U38
C39
13.25
148.32
14.21
161.59
U40 14.05
161.94
C41 --
U42 13.35
161.59
G43 12.05
146.22
G44 13.31
148.32
C45 --
C46 --
7
8.68,6.91
99.41 1
8.44,6.97 7
97.66 1
8
1
7.88,6.0 7
73.90 1
7
1
7
1
-- 7
1
8.13,5.94 7
74.25 1
8.03 7
84.73 1
7
1
8.52,6.98 7
97.31 1
7
1
-- 7
1
7
1
7
1
7
1
8
1
7
1
8.81,6.98 7
98.71 1
7
1
8.40,7.23 7
96.26 1
8
1
8.34,7.12 7
98.36 1
-- 7
1
7.75,5.81 7
73.90 1
7
1
8.67,7.00 7
99.41 1
8.56,7.04 7
1
8/6 2/5 1' 2' 3' 4' 5'/5"
8.12 -- 5.80 4.92 4.74 4.56 4.42,4
139.51 92.52 75.22 75.05 83.65 67.10
7.70 -- 5.93 4.59 4.61 4.55 4.55,4
137.37 75.35 72.97 82.58 66.09
7.72 5.28 5.56 4.43 4.47 4.44 4.57,4
41.25 97.23 93.91 75.53 72.06 81.95 64.42
.69 5.56 5.47 4.58 4.54 4.16
41.25 98.14 93.88 75.30 73.32
.00 6.94 5.92 4.72 4.67 4.51 4.57,4
39.80 152.70 93.39 75.72 72.98 81.95 65.27
.07 -- 5.53 4.43 4.43 4.48 4.45,4
36.01 92.61 75.22 72.70 81.76 65.80
.75 7.16 5.95 4.35 4.63 4.45 4.59,4
39.65 154.24 92.77 75.55 72.90 82.03 64.35
.71 5.60 5.90 4.49 4.79 4.48 4.29,4
44.75 103.85 89.45 73.46 77.12 85.33 67.64
.91 5.97 6.03 4.49 4.69 4.55 4.30,4
44.52 105.60 91.09 75.39 75.74 84.93 67.37
.75 -- 5.90 4.95 4.95 4.75 4.50,4
38.80 94.51 75.57 75.39 84.30 70.39
.82 7.51 6.06 4.86 4.74 4.62 4.63,4
40.32 153.90 93.07 75.70 73.67 82.40 65.55
.49 -- 5.81 4.55 4.51 4.52 4.55,4
36.44 92.58 75.39 72.98 81.79 65.78
.58 5.14 5.52 4.25 4.44 4.40 4.55,4
40.80 97.23 94.06 75.49 72.01 81.98 64.32
.68 5.55 5.88 4.37 4.59 4.38 4.45,4
41.90 98.33 91.94 76.00 75.39 83.68 65.91
.75 5.80 5.75 4.31 4.51 4.25 3.96
43.80 105.40 91.09 75.50 76.43 84.62 67.29
.79 -- 5.48 5.59 4.63 4.13 3.99
40.98 89.69 75.39 77.81 85.11 67.74
.65 -- 5.51 4.53 4.67 4.01 3.88
39.92 90.05 75.63 77.12 84.63 67.77
.91 -- 5.95 4.96 4.98 4.50 4.23,4
38.99 88.93 75.74 75.74 84.68 67.81
.41 8.25 6.09 4.94 4.88 4.63 4.35
42.74 155.66 90.73 75.84 76.37 85.13 68.22
.43 -- 5.49 4.57 4.51 4.47 4.48,4
37.29 93.38 74.90 73.17 82.71 66.06
.84 5.21 5.58 4.43 4.48 4.45 4.09
42.00 96.90 94.03 75.44 72.00 81.98
.95 5.43 5.66 4.80 4.52 4.43 4.58,4
42.37 102.15 93.44 75.59 72.45 81.97 64.47
.55 5.63 5.34 4.50 4.08 4.54 4.37,4
41.20 98.90 95.27 75.39 73.67 82.44 67.53
.02 5.51 5.49 4.38 4.52 4.39 4.52,
42.34 103.25 93.64 74.93 71.74 82.03 64.08
.90 5.69 5.44 4.20 4.47 4.40 4.55,4
42.30 97.35 93.84 75.40 71.95 81.85 64.28
.84 5.33 5.46 4.56 4.52 4.40 4.57,4
42.2 103.5 92.45 75.28 72.39 82.07 64.34
.70 -- 5.77 4.59 4.59 4.49 4.51,4
36.67 93.05 75.45 73.04 82.11 65.75
.34 -- 5.69 4.47 4.52 4.46 4.51,4
36.38 92.76 75.05 72.63 81.76 65.05
.66 5.18 5.53 4.30 5.53 4.39 4.56,4
41.20 97.10 93.98 75.50 71.94 81.80 64.39
.69 5.55 5.77 4.02 4.17 4.20 4.48,4
41.90 98.33 93.01 77.61 69.58 83.31 65.02
4.27
.29
.12
.15
.06
.09
.22
.24
.29
.19
.16
.06
.06
.11
.19
.10
.11
4.11
.09
.08
.14
.08
.09
.03
The errors in chemical are ±0.01 for proton and ±0.1 ppm for the other nuclei. The exchangeable protons and
nitrogen chemical shifts are given for 50C while all the non-exchangeable data were assigned at 250C.
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Figure 2.18: Portions of a 600 MHz 2-bond 'H-1 5N FHSQC of '"N labeled
HIV-2 TAR-argininamide at 150C, showing A) H8-N9, B) AH2-N1,
AH2-N3, and H8-N7 crosspeaks.
A27-H2
A22-H2 A20-H2
46
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Table 2.5: Chemical Shifts of the purine non-exchangeable nitrogens in
the free and bound forms of HIV-2 TAR at 150 C. The G17, A22, and G26
resonances have overlapped proton chemical shifts prohibiting their N7 and
N9 assignment.
Bound N7
231.08
229.93
233.61
228.32
233.38
235.16
234.65
235.80
232
232.98
233.84
232.75
Free N9
167.86
170.16
168.09
166.71
168.55
168.78
168.55
Bound N9
167.80
168.95
170.16
168.49
168.78
169.30
166.83
168.72
168.38
168.78
168.61
Adenine Free N1 Bound N1 Free N3 Bound N3
A20
A22
A27
A35*
212.79
213.13
211.00
212.84
213.02
209.91
219.34
222.16
220.44
219.52
222.39
220.21
* One weak peak at the A35(H8) frequency was observed between the NI and N3 chemical
shift regions as seen in Figure 2.18 but it is unclear which nitrogen this peak represents.
Purine
G16
G17
A20
G21
A22
G26
A27
G28
G32
G33
G34
A35
G36
G43
G44
Free N7
231.42
234.70
229.64
233.44
230.45
228.38
232.98
235.74
232
232.75
232.46
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this complex because of its predicted role in the A27-U38*U23 base triple. Table 2.5 lists
the assignments in the free and bound form of HIV-2 TAR. However, even though the
A27(H8) resonance changes upon addition of argininamide (A6=-0.05 ppm), the N7
chemical shift does not shift significantly (Table 2.5). Since the complex is in fast
exchange, different conformational exchange processes may be occurring that would effect
the 'H and 15N chemical shifts differently because they are effected by motions on slightly
different time scales (see Chapters 1 and 5). An alternative explanation, is that the base
triple may not exist, though the evidence for it is very significant, as this thesis discusses
extensively everywhere.
2.5 Ribose Torsion Measurements
To generate sugar pucker torsion restraints, J-couplings were estimated from H '-
H2' crosspeaks in a DQF-COSY spectrum. Strong crosspeaks were observed for U23 and
U25 with J-coupling -8 Hz, indicative of a C2'-endo conformation. A weak DQF-COSY
crosspeak for A35 suggested a mixed conformation and was left unconstrained. The other
loop nucleotides, C30-G34, were also constrained to C2'-endo while the remaining
nucleotides were constrained to the C3'-endo A-form sugar pucker based on the absence of
a DQF-COSY crosspeak and the presence of NOEs indicative of A-form geometry.
Various other schemes were attempted to try to measure the y torsion including a
variation of the protein backbone HAHB experiment. The problem with this strategy was
that the H4' and the H5'/H5" proton resonances are typically < 0.3 ppm from each other
causing extensive overlap and preventing the measurement of any y torsions. However,
this experiment worked well for the Hl'-H2' couplings where the protons are usually >0.5
ppm apart. Thus, this experiment may be a viable alternative to the DQF-COSY experiment
for larger RNAs when the lines are very broad and limit the observable signal from the
antiphase DQ-COSY crosspeaks.
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2.6 Intermolecular NOEs
1H-IH NOESY spectra in 2H20 and H20 of the HIV-2 TAR-argininamide complex
permitted assignment of a large number of intermolecular NOEs including intermolecular
NOEs to A22, U23, G26, A27 and C39 as listed in Table 2.6. Of particular note is that the
same strong U23(H5) to Arg(HS) and Arg(Hy) that was observed in the HIV-1 TAR-
argininamide and TAR-peptide studies is observed indicating that the HIV-2 TAR is
binding argininamide in a similar manner. Even in a 500 MHz 35 ms 2H20 NOESY
spectrum both the Arg(H6) and Arg(Hy) crosspeaks to the U23(H5) were observed
suggesting that both of these observed crosspeaks are real and not due to spin diffusion.
Because the complex is in fast exchange, the intermolecular crosspeaks were carefully
analyzed to determine which are real NOEs and which may be due to spin diffusion and/or
the conformational mobility of the complex. Only the strongest intermolecular crosspeaks
in a short 40 ms 750 MHz 1H- H H20 and/or a 50 ms 2H20 NOESY spectra were used as
restraints in the structure determination. Figure 2.17 shows traces from the 40 ms 750
MHz 1H- H H20 NOESY spectrum illustrating the crosspeaks observed. The He showed
a number of crosspeaks of which only a few are unambiguous NOEs. The RNA
crosspeaks e and c are near very strong crosspeaks in the 2D spectrum while f could be
spin diffusion through H6. o and q are assigned to A22(H3') and A22(H2') NOEs. H8
and Hy give crosspeaks to these A22 ribose protons only very weakly in a 100ms 750
MHz 2H20 NOESY spectrum. The C39(H42) shows an interesting pattern of NOEs by
giving crosspeaks to the HP and H5 and a weaker crosspeak to the Hy suggesting that the
HP and H8 crosspeaks are real and that the Hy crosspeak may be spin diffusion influenced.
Peak m is a weak peak that could be A22(H 1') but cannot be unambiguously assigned in
the H20. The C37 amino gives a number of crosspeaks but they are all very weak and the
A22
(H3')
H2 0
U23(H5)
Ar
(H E
C37(H42)
C39(H41)
/
A22
(H2')
Arg(He) 7.33 ppm
Arg(H6) 2.97 ppm
Arg(H3) 1.86 ppm
Arg(Hy) 1.56 ppm
8 7 6 5 4
1H ppm
Figure 2.19: Intermolecular NOEs between the HIV-2 TAR and
argininamide are shown in a series of traces from a 40ms 750 MHz 1H-1H
NOESY in 90% H20/2H20 at 50C. Not all of the observed intermolecular
crosspeaks were used as restraints. The HE trace is from the F1
dimension while the other three are from the F2 dimension. The peaks
marked with an x cannot be unambiguously assigned. Peaks that
appear in multiple traces are labeled in only one trace.
Intermolecular NOEs.
Arg(NH2) -U38 H5 v.w.
-C37 H5 v.w.
Arg(HP3) -A27 H61/H62 v.w.
-C39 H42 v.w.
H41 v.w.
Arg(Hy) -A22 H8 w
-U23 H5 s
H6 v.w
Arg(HS) -A22 H8 w
-U23 H5 s
-C39 H42 v.w.
H41 v.w.
Arg(He) -A22 H2' v.w.
H3' w
H8 v.w.
-U23 H5 v.w.
H6 v.w.
Arg(H1j) -A22 H8 w
-G26 H8 w
s = strong NOE, m = medium NOE,
w = weak NOE, v.w. = very weak NOE
Table 2.6.
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C37 amino is far from the majority of the RNA NOEs. The C39 amino has NOEs to the
H5 and HP. In the trace, a crosspeak is observed to He but this peak is next to and may be
a part of the very large H41-H42 crosspeak and the height of the peak may be influenced this
large intraresidue crosspeak. The C39(H41) crosspeak j is included in the restraint set
because the C39(H42) gives strong NOEs to the argininamide and spin diffusion is
formidable for the amino protons. The A27(H61/H62) - HP cross peak is a weak NOE
but was used as a restraint because it was consistent with all the other restraints and no spin
diffusion pathway is available. Peak b is one of two crosspeaks observed from a non-
specific argininamide binding site in the lower stem providing further reasoning for
ignoring many of the weaker intermolecular crosspeaks. The other is a G43(H3') to H8
NOE observed in the 3D 13C NOESY-HSQC spectra. This conservative approach yielded
19 intermolecular NOE which are all observed in short mixing time experiments at a variety
of magnetic fields (Table 2.6).
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Chapter 3: The HIV-2 TAR-Argininamide Structure
3.1 Assignment of Bounds
The improved spectral properties of the HIV-2 TAR-argininamide complex
compared to the three base bulge HIV-1 TAR-argininamide complex are apparent from the
appearance of the U40 imino proton resonance, and NOEs from the U40(H3) to the
G26(H1) and G21(H1). In addition, two internucleotide NOEs to U25 were observed in
the 4D NOESY spectrum suggesting that U25 may have a more unique position in the
HIV-2 TAR-argininamide complex than in the three base bulge TAR complexes where no
internucleotide NOEs to U25 were observed. In the HIV-2 TAR complex, 19
intermolecular NOEs were assigned, suggesting that the argininamide is well-constrained
relative to TAR. Using restrained molecular dynamics calculations, a set of 20 converged
structures of the 30 nucleotide TAR RNA complex with argininamide was obtained.
Although the spectral properties of the bulge region were improved in the two base
bulge TAR, there is still significant evidence for dynamics. In 13 C-CT-HSQC
experiments, the intensities of the peaks were different for various nucleotides indicating
that they were being differentially affected by motions on the NMR time scale. The
linewidths for the A-helical nucleotides were similar, while the loop and bulge residues
gave a variety of broader and sharper lines (See Chapter 5 for more details). J-coupling
data were also indicative of the averaging of multiple conformations. These observations
are not surprising since the complex is in fast exchange with an estimated lifetime of about
5-10 gs. In addition, a number of nucleotides do not give many inter-residue NOEs
indicating that they are unstructured. As a result, the NOEs and J-coupling data are time-
averaged between the bound and free conformations. Therefore, conservative loose
bounds were used in the bulge region to allow for possible effects on NOE intensities due
100
III HIV-2 TAR-Argininamide Structure
to averaging. A more detailed explanation of the dynamics and its implications for the
structure is discussed in Chapter 5.
Many of the NOEs observed in the bulge region may also be affected by dynamics,
but it is difficult to determine the range of conformations that the complex may be
sampling. Because the complex is nearly saturated, the NOEs are expected to be primarily
diagnostic of the bound conformation. However, due to their fast exchange of the
argininamide ligand it is possible that the NOE intensities are affected by sampling other
conformations, especially for the intermolecular NOEs. In particular, the methylene side
chain of the argininamide is very likely sampling multiple conformations in fast exchange,
and few NOEs are observed to the side chain distal to the guanidinium group. Because a
number of NOEs are observed to the He, H6, Hy, and Hrl protons, the position of the
guanidinium group of the argininamide is likely representative of the bound conformation.
3.2 Materials and Methods
3.2.1 NMR-derived restraints
A total of 681 NOEs were obtained that define the RNA structure (See Appendix
B. 1 for a complete list). This restraint set does not include covalently fixed distances such
as pyrimidine H5-H6, cytosine amino H42 to H41, cytosine amino to H5, or adenosine H2
to H8 NOEs. All lower bounds were set to 1.8 A. NOEs to prochiral hydrogens such as
the H5'/H5" and the argininamide backbone protons were accounted for by using 1/r6
averaging option for NOE restraints in X-PLOR. For exchangeable protons, restraints
were generally assigned in two categories with upper bounds of 4.0 or 6.0 A. The
unusually strong NOEs between uridine-H3 and adenine-H2 protons were assigned an
upper bound of 3.0 A.
NOEs observed in D20 NOESY experiments were placed into four categories:
strong, medium, weak, and very weak, with upper bounds of 3.0, 4.0, 5.0 and 6.0 A. A
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6.0 A upper bound was used for weak NOEs to H8/H6/H5 resonances where a strong spin
diffusion pathway is available. Intermolecular NOEs between the U23-H5 and the Arg-Hy
and Arg-H6 were observed at equal intensity in a very short 35 ms mixing time NOESY
experiment. No intramolecular argininamide NOEs were used for distance restraints.
Hydrogen bond restraints were only used for the base pairs where an imino peak
was observed and characteristic internucleotide NOEs were observed such as NOEs
between the base paired nucleotides and other internucleotide NOEs indicating that the two
hydrogen bonded nucleotides are close and that the base pair is stacked. Two restraints
were used to define each hydrogen bond: one between the proton and the hydrogen bond
acceptor and a second between the two heavy atoms centered one angstrom longer than the
proton-heavy atom restraint. The following restraints were used for a G-C base pair, the
G(06)-C(H42) is 1.91 ± 0.2 A, the G(H1)-C(N3) is 1.95 ± 0.2 AO, and the G(H22)-C(02)
is 1.86 ± 0.2 A. For an A-U base pair, A(N1) - U(H3) is 1.70 ± 0.2 A and the A(H62) -
U(04) is 1.95 ± 0.2 A.
The sugar pucker was estimated from analysis of the HI'-H2' coupling constants in
the 31P-decoupled DQF-COSY. Nucleotides with a H1'-H2' coupling constant of >8 Hz in
the COSY spectrum were classified as C2'-endo. Nucleotides with no COSY and TOCSY
cross peaks were classified as C3'-endo. Weak COSY cross-peaks indicative of a mixed
population of conformers were left unconstrained. Since the correlation of 31P chemical
shifts and backbone torsions is poorly understood in RNA structures, no torsion restraints
based on chemical shifts were used (Jucker & Pardi, 1995). This is particularly important
in the bulge region where evidence for conformational averaging of backbone coupling
constants is observed and the 31P chemical shifts are not very far from A-form.
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3.2.2 Structure determination
Structure determination was performed with X-PLOR 3.1 (Brunger, 1992) using a
modified force field. Bonds, angles, impropers, and non-bond parameters were taken
from the updated parameters from the Nucleic Acid database (Berman et al., 1992; Gelbin
et al., 1996). Proton parameters were added adapting those from the standard X-PLOR
forcefield for nucleic acids. Dihedral parameters were adapted from the AMBER force field
(Weiner et al., 1986). Electrostatic terms were not used at any time during the calculations.
The following is a description with explanations for the molecular modeling
protocols. Appendix B contains the particular XPLOR scripts in all their glorious detail.
Initial Dynamics
Random coordinates uniformly distributed in a 20 A cube were used as the starting
structures. Force constant for the NOE terms were scaled to 2% of their final value, and
the bonds and angles were scaled 0.01% at the beginning of the calculations. No hydrogen
bond restraints were used during this first phase. The repulsive quartic potential was used
for the non-bonding terms and was scaled to 10% of its final value. The improper,
dihedral and the torsion restraint terms were set to zero during these initial dynamics
calculations. Dynamics at 1000 K were performed for 100 steps of 40 fs. During this time,
the NOEs were scaled up to their full value. With the NOEs now at their full value, 1000
K dynamics was continued with the bond, angle, non-bond and improper terms scaled to
1% of their final value for 500 steps of 3 fs. The bonds, angles, and impropers were
ramped to their full value during another 500 steps of 3 fs of 1000 K dynamics. A third
round of 500 steps of 3 fs 1000 K dynamics is performed while the quartic non-bonding
term is ramped to its full value. During this third round, the dihedral terms were included
in addition to the torsion restraints which were introduced at 10% of their full value, which
helped the overall convergence rate. At this stage, 41 of 142 structures were chosen for
further refinement. Structures were chosen based on both their total and violation energies.
The rmsd of this initial set to the average is 3.82 A.
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Simulated annealing
A procedure similar to Jucker and Pardi (Jucker & Pardi, 1995) was performed in
the next phase. Hydrogen bond restraints were introduced for the first time for three
rounds of 10000 steps of 1 fs dynamics at 1000 K, 600 K, and 400 K with 700 steps of
energy minimization between the dynamics and 1000 steps at the end. All restraint terms
were now set to their full value: the NOE force constant was 50 kcal/mol A2 and the
torsion restraint force constant was 1000 kcallmolodeg 2. The dihedral force field term was
turned off to avoid being locked into incorrect conformers in these lower temperatures.
Structures were again chosen based on the total energy and violation energies with the
converged structures having 3-11 violations > 0.2 A.
Refinement
At this stage, the dihedral force field term was turned off to lower the barrier to
dihedral conformational changes. Dynamics was performed for 2 ps in 2 fs steps at 500
K, 300 K, 150 K, 50 K and 10 K followed by 1000 steps of energy minimization. At this
stage, each converged structure had only 3-10 NOE violations > 0.2 A. For the last stage,
the Lennard-Jones non-bonding term was used for 2000 one fs steps of dynamics at 300
K, 150 K, 50 K, 10 K. The calculations ended with 1000 steps of energy minimization.
The 20 structures with the lowest total energy and violation energy were chosen. The
average structure was calculated from this set of 20 and refined with 1000 steps of
minimization to arrive at the final minimized average structure.
Modeling calculations
Two aspects of the structure were tested with non-experimental hydrogen bonding
and planarity restraints: the argininamide binding to the major groove face of G26 and the
base triple (U38-A27oU23). The set of 41 structures created from random coordinates was
used as the starting point for all non-experimental restraint calculations. The same
restrained molecular dynamics protocol was performed from this point. The base triple
hydrogen bonds were restrained in the same way as the A-form base pairs: U23(N3)-
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Table 3.1: Restraint and Structure Statistics.
Distance Restraint
Sequential NOEs:
strong
medium
weak
very weak
Long Range NOEs
strong
medium
weak
very weak
Number of
restraints
Restraints
per Nucleotide
3
19
20
58
Total Internucleotide NOEs: 292 9.73
strong 96
medium 96
weak 153
very weak 25
Total Intranucleotide NOEs: 370 12.33
Intermolecular NOEs:
Total Number of NOEs
Hydrogen Bonds
Total distance restraints
Dihedral restraints
C3'-endo
C2'-endo
Superposition statistics
All nucleotides and arg (A)
16-29,36-46,arg (A)
21-28,37-41,arg (A)
19
681
60
741
44
14
over 20 structures
RMSD of experimental restraints
All distance restraints (A)
All torsion restraints (0)
Maximum distance restraint violation (A)
Maximum torsion restraint violation (0)
Average number of distance violations > 0.1 A
Average number of torsion violations > 0.5 (0)
RMSD ofrom idealized geometry
Bonds (A)
Angles (0)
Impropers (0)
0.01 ± 0.001
0.10 ± 0.02
0.15
0.61
1
0.15
0.003 + .0002
0.54 ± 0.02
0.46 ± 0.02
2.63
1.32
0.84
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A27(N7), 2.95 ± 0.2 A, U23(H3)-A27(N7), 1.95 ± 0.2 A and U23(04)-A27(N6), 2.95 ±
0.2 A and U23(04)-A27(H61), 1.95 ± 0.2 A. The U23 and A27 were held planar to each
other by using the planar restraint option of X-PLOR with a force constant of 250.0
kcal/mol*deg 2. For the calculations including torsion restraints, the a, f, y, 8, and A-
form conformers were restrained into ±300 ranges. The 3' side of A22, the 5' side of G26,
the two bulge nucleotides and the hexanucleotide loop were left unrestrained. During the
1000, 600, 400 K 30 ps dynamics phase of the calculations, the torsion restraints were
slowly scaled to full value which helped the structures fit both the large number of distance
and torsion restraints. Good convergence was obtained for each set of calculations: 17 for
the argininamide hydrogen bonds to G26, 10 for the argininamide hydrogen bonds and
planarity, 23 for the base triple hydrogen bonds, 11 for the base triple planarity, and 11
structures were obtained when all hydrogen bonds and planarity were included. 15
structures were obtained for the calculations without sugar pucker restraints in the bulge
and 20 structures were obtained when all the intermolecular NOEs were used. Rmsd's
were measured using X-PLOR and the structures were viewed and displayed in Biosym's
InsightII Release 95.0 software package (Biosym/MSI, San Diego, CA).
3.3 Structure Determination
The NOEs and coupling constant data, summarized in Table 3.1, were converted to
distance and torsion restraints for restrained molecular dynamics calculations. Non-
exchangeable data were placed into one of three categories with upper bounds of 3.0 A, 4.0
A, and 5.0 A while some exchangeable NOEs had upper bounds of 6.0 A for very weak
resonances and when a clear spin diffusion pathway was evident. No non-experimental
restraints were used in the structure calculations, and electrostatic interactions were
neglected. In the first of three phases for the calculations, random coordinates within a 20
A cube were generated and refined against the experimental restraints to obtain the global
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Figure 3.1: Pictorial representation of the structure calculations. I. Random
coordinates II. The NOE restraints have guided the structures before covalent terms
are scaled up. III. Before annealing, the RNA is defined in the absence of hydrogen
bond restraints. IV. The final cooled structure.
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fold of the complex. In the second and third phases, the structures were refined by slowly
increasing the scale factors of the various force field terms and then lowering the
temperature. A pictorial representation of the structure calculations is shown in Figure 3.1.
The 142 random starting structures were refined with 40 ps of initial restrained molecular
dynamics where the NOE restraints dominate, and the covalent and the repulsive non-
bonding terms are greatly reduced. 41 structures with violation energies <600 kcal/mol-
A2 were chosen for further refinement. Surprisingly, the global fold of the complex is
defined at this stage and an RNA A-form helix is clearly recognizable despite the lack of
hydrogen bonding restraints for the base pairs, as seen in Figure 3.1c. During the second
phase of the calculations, refinement was continued with the introduction of hydrogen bond
restraints during 10 ps of restrained molecular dynamics at 1000 K, 600 K, and 400 K.
The last stage of the calculations consisted of cooling from 500 to 10 K in 2 ps steps. The
dihedral force field term was turned off at this stage to allow sampling of all torsion
conformations. The Lennard-Jones potential was introduced for a second annealing
starting from 300 K and cooled in 2 ps steps.
At each stage of the refinement, NOE violations were reduced, indicating that the
calculations were refining against the restraints to define the structure. Using this protocol,
20 converged structures were obtained starting from 142 sets of random coordinates.
Examination of the family of structures revealed that an RNA A-form helix was defined in
the absence of backbone torsion restraints. A complete listing of the rmsd values for the
restraint and idealized geometry violations is given in Table 3.1.
3.4 Structure of the TAR-Argininamide Complex
The superposition of the 20 structures to the average structure is shown in Figure
3.2. The overall structure is well-defined except for the six nucleotide loop which is not
shown. The rmsd to the average for this set of structures is 1.32 A when all residues of the
complex except the loop nucleotides (30-35) are superimposed. The loop region gives few
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Figure 3.2: The best fit superpositions to the average structure of all
20 structures of all residues except for the poorly defined loop. The
U23 is in green and the argininamide is in red. Notice that the
guanidium group of the argininamide is well-positioned especially
compared to the distal amide side of the argininamide which is poorly
positioned.
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internucleotide NOEs leading to very poor definition, consistent with previous work
(Aboul-ela et al., 1995; Colvin et al., 1993; Jaeger & Tinoco, 1993). The bulge region is
well defined with a rmsd of 0.84 A to the average structure (nucleotides 21-28,37-41 and
the argininamide) as shown in Figure 3.3. The position of the argininamide guanidinium
group is well-defined, while the position of the remainder of the side chain is poorly
defined.
A stereo view of the average structure with the phosphate backbone highlighted by
a ribbon representation is shown in Figure 3.4. U23 and the argininamide are in the major
groove while U25 is in the minor groove. The upper and lower stems are continuously
stacked between C39 and U40 opposite the bulge, but there is an over twisting of the two
stems relative to each other, and G26 does not stack directly on A22. The argininamide is
located in a pocket formed by A22, U23, and G26. Figure 3.5 illustrates how well the
structure is defined by the NOEs as all the internucleotide and intermolecular NOEs are
overlayed on the average structure. Only three internucleotide NOEs are in the
hexanucleotide loop preventing any conclusions from being drawn about this part of the
structure. In the lower and upper stems, most of the NOEs are aligned with the helix and
only a few connect the two strands. A much more complex, denser network of NOEs
define the structure of the argininamide binding site which is the best defined region of the
structure. This pattern of NOEs is explicitly tabulated in Table 3.2 where the number of
long range distance restraints to G26 is clearly seen.
The intermolecular NOEs are highlighted on the average structure in Figure 3.6.
Most of the 19 intermolecular NOEs to the argininamide are to protons near the
guanidinium group, while few NOEs were observed to the amide and Hxo protons of the
argininamide. The position of the guanidinium group of the argininamide is defined by
intermolecular NOEs to nucleotides on all sides of the binding pocket in the major groove.
This localization of the intermolecular NOEs explains why the guanidium group is well-
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Figure 3.3: The best fit superpositions to the average of all 20
structures for the argininamide binding site region. The U23 is in green
and the argininamide is in red. Notice the excellent definition of the
U23 and the surrounding base pairs.
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Table 3.2: NOEs by residue. Note that inter-residue NOEs count as one for both
of NOEs will be larger than listed in Table 3.1.
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Figure 3.4: A stereo view of the average structure of the TAR-
argininamide complex is shown with U23 highlighted in green, G26 in
purple, A22 in yellow and the argininamide in red. The ribbon traces
the backbone showing the distortion in the bulge region.
Figure 3.5: All the internucleotide and intermolecular NOEs are
overlayed in green on the average structure. The argininamide is in
red. Most of the NOEs are aligned along the helix axis except in the
bulge region where a much more complex network of NOEs is found.
Also, notice the very few number of NOEs in the loop.
Figure 3.6: The intermolecular NOEs to the argininamide are
highlighted in black with the U23, A27, and U38 in green, A22 in
yellow, G26 in purple and the argininamide in red. Most of the
intermolecular NOEs are to the guanidium group side of the
argininamide.
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defined while the amide side is not. One of the guanidinium group 7q-nitrogens is within
hydrogen bond distance to the G26(N7) and the G26(06) in all 20 structures suggesting
that the argininamide is hydrogen bonding to G26. In addition, the guanidinium group is
making van der Waals contacts to the U23 and the A22 bases, as shown in the two views
of the bulge region in Figure 3.7. Thus, the argininamide guanidinium group is lying
between the planes of the bases, U23 and A22, making contacts analogous to stacking
interactions, to form an argininamide sandwich.
In 17 of the 20 structures the 04 and N3 of U23 are within hydrogen bonding
distance (3.5 A) to the N6 and N7 of A27, respectively, and in all 20 structures the
distances are less than 4.08 A. The average U23(N3) to A27(N7) distance is 2.94 ± 0.15
A and the average U23(04) to A27(N6) distance is 3.56± 0.33 A. The U23 is very close
to the major groove face of the A27 in the orientation of a typical U-A*U base triple as
shown in Figure 3.7. However, the view into the major groove in Figure 3.7a, shows that
the U23 is not in the same plane as the A27-U38 base pair as might be expected for an ideal
base triple. The conformation of this bulge region is well-defined by a large number of
conservatively assigned and loosely constrained distance restraints. Therefore, this
structure represents a static view of the critical features of the dynamic complex between
HIV-2 TAR and argininamide.
3.4.1 The argininamide binding site
The Puglisi et al. model of the bound conformation of the HIV-1 TAR suggested
that the argininamide is hydrogen bonding to the major groove of G26. The high
resolution structure of the HIV-2 TAR reveals that one of the guanidinium group nitrogens
is less than 3.5 A from the G26(N7) in all 20 structures and is less than 3.5 A from
G26(06) in 18 of 20 structures. Arginine guanidinium groups have been frequently
observed in hydrogen bonding interactions with guanines in the major groove in many
DNA-protein and RNA-peptide complexes. The structure of HIV-2 TAR suggests an
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Figure 3.7: Two views of the bulge region of the minimized average
structure are shown. A) Looking into the major groove, the
argininamide, in red, is seen lying next to the G26, in purple. The
argininamide is stacking between the U23, in green, and the A22, in
yellow. The A27 and U38 are also highlighted in green. B) Looking
down the helix axis, the orientation of the U38, A27, and U23,
highlighted in green, in a U-A-U base triple is seen.
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additional mode of interaction with the RNA by stacking of the guanidinium group between
the bases of U23 and A22. A number of NOEs position the guanidinium group between
U23 and A22 including NOEs from the A22(H8) and G26(H8) to guanidinium protons,
NOEs from the A22 ribose, A22(H8) and the U23(H5) to the argininamide He. These
argininamide He NOEs orient the argininamide in the groove by drawing the He proton
towards A22.
The guanidinium group of the argininamide is stacking on A22, lying where G26
would be positioned if it continued the A-form helix by coaxial stacking on A22. On the
opposite strand, the C39 and U40 nucleotides are stacking much like they would in an A-
form helix. G26 is pushed aside by over twisting at the junction of the coaxially stacked
helices to be juxtaposed to the argininamide while the U23 is stacking on top of the
argininamide guanidinium group. This local rearrangement serves to widen the major
groove making the G26 more accessible for hydrogen bond contacts to the argininamide.
The two backbone phosphates, P22 and P23, identified in ethylation interference
studies are near the argininamide in the 20 structures (Calnan et al., 1991; Churcher et al.,
1993; Pritchard et al., 1994; Tao & Frankel, 1992). The two oxygens of these phosphates
were not consistently <4.0 A from the guanidinium group nitrogens in the calculated
structures, and direct hydrogen bonds to these phosphates are not consistent with the NMR
data. However, these phosphates may help the argininamide bind to TAR through
favorable electrostatic interactions.
3.4.2 The base triple
The proposed base triple plays a critical role in forming the argininamide binding
site by opening the major groove to provide access to G26. In the HIV-2 TAR-
argininamide family of structures, all 20 structures show that the U23(04) and U23(N3)
are within hydrogen bonding distance to the A27(N6) and A27(N7), respectively.
Although hydrogen bond formation does not require the U23 and the A27 to be co-planar,
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previously observed base triples have been co-planar. The reason for the non-planarity in
the structure may simply be that there are no extensive geometric constraints as observed in
the triplex and tRNA structures where the base triples are part of a stacking network
(Macaya et al., 1992; Roberts et al., 1974).
Of the three adenine amino protons involved in base pairing, only the A27 amino
resonances were observed in a 15N-HSQC spectrum even at 750 MHz suggesting that the
A27 amino is different than the other adenosine aminos. The A27 amino proton resonances
were sufficiently sharp to allow the observation of a number of NOEs including a weak
NOE to Arg(HP) and along with NOEs to the G26(H1), G28(H1), and C39 amino group.
However, one long (>4.0 A) NOE, A27(H62/H61)-U23(H5), predicted from the base
triple model, is unobserved. We believe that the base triple is formed, but dynamic, and
that some weak NOEs are not observed because of a combination of conformational and
solvent exchange. The base triple may be simply fraying, analogous to a terminal Watson-
Crick base pair in a helix, where imino protons are often rapidly exchanging. Despite the
lack of any direct NOEs between the U23 base and the A27 base which would
unambiguously define a base triple, the U23 base is well-positioned by NOEs to its own
ribose and to the argininamide, which in turn give many NOEs to the surrounding
nucleotides in the binding pocket.
The base triple model has been tested by designing a C-G*C+ isomorphic base triple
mutant (Puglisi et al., 1993). This base triple mutant binds argininamide in a pH dependent
manner as predicted suggesting the importance of base triple formation for argininamide
binding. Chapter 4 discusses studies of a two base bulge C-G*C+ base triple mutant which
found direct NOE and hydrogen bonding evidence for the existence of a base triple.
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3.5 Modeling Calculations
The structures based solely on experimental NMR data are consistent with
hydrogen bonding interactions in the bulge region. However, we did not obtain direct
evidence of hydrogen bonding between the U23 and the A27, or the G26 and the
argininamide. To test various possible hydrogen bonding interactions, modeling
calculations were performed using non-experimental hydrogen bonding restraints in
addition to the NOE experimental restraints. All modeling calculations were performed
beginning with the set of 41 structures resulting from the initial phase of the restrained
molecular dynamic calculations. The second and third phases of the restrained molecular
dynamics refinement protocol was performed for each set of non-experimental restraints
exactly as was done for the structure determination. The distance restraint violations and
the total energy of the sets of structures were monitored to examine the effect of the
inclusion of the non-experimental restraints.
The first calculations examined the potential hydrogen bonds of the U-AoU base
triple between the A27-U38 base pair and U23. Refined structures including two hydrogen
bond restraints between the U23 and the A27 produced a set of structures with the same
range of total and violation energies as the structure determination, as summarized in Table
3.3. Although the hydrogen bond restraints are satisfied, the U23 is not co-planar with the
A27-U38 base pair in the resulting set of structures. A second set of calculations were
performed including a planarity restraint between the A27 and U23. No violations greater
than 0.1 A were induced and the U23(N3) and U23(04) were within hydrogen bonding
distance of the A27(N7) and A27(N6) as expected for base triple formation. These
calculations clearly show that our experimental restraint set is consistent with base triple
formation, but that the experimental constraints alone do not specify the ideal base triple
geometry.
Modeling calculations were also done to test argininamide hydrogen bonding to the
G26. Hydrogen bond restraints between the guanidinium group and the G26 were added
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Table 3.3: Summary of total and distance violation energies.
Structure Determination
Avg. total energy (kcal/mol) -278 ± 18
Avg. distance violation energy (kcal/mol) 4.4 ± 1.0
Calculations with non-experimental restraints
Arg H-bonds to G26
Avg. total energy (kcal/mol) -275 + 21
Avg. distance violation energy (kcal/mol) 4.4 ± 0.5
Arg H-bonds and planarity to G26
Avg. total energy (kcal/mol) -277 ± 19
Avg. distance violation energy (kcal/mol) 4.4 + 0.6
Base triple H-bonds
Avg. total energy (kcal/mol) -277 ± 15
Avg. distance violation energy (kcal/mol) 5.0 + 1.7
Base triple planarity
Avg. total energy (kcal/mol) -279 ± 16
Avg. distance violation energy (kcal/mol) 3.9 ± 0.5
All non-exp. restraints
Avg. total energy (kcal/mol) -268 ± 15
Avg. distance violation energy (kcal/mol) 4.9 ± 0.6
Additional (27) intermolecular restraints
Avg. total energy (kcallmol) -271.91 ± 8.14
Avg. distance violation energy (kcal/mol) 3.95 ± 0.15
Alternative Arg(He) hydrogen bonding restraints
Avg. total energy (kcal/mol) -261.91 ± 19.04
Avg. distance violation energy (kcal/mol) 8.84 ± 1.61
For each value, the mean is given with the standard deviation.
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and found to be consistent with the NMR data as monitored by both the total and violation
energies, although the argininamide guanidinium group was not co-planar with G26. A
planarity restraint between the guanidinium group and the G26 was added, and the
calculations were repeated. The co-planarity of G26 and the argininamide was also found
to be consistent with all the NMR restraints.
An alternative hydrogen bonding between the argininamide He hydrogen hydrogen
bonding to the G26(N7) and one of the guanidium protons hydrogen bonding to the
G26(06) was tested. Although 15 structures with a rmsd of 1.36 A were obtained, these
structures have higher violation energies with an average of 4.47 NOE violations > 0.1 A
per structure as seen in Table 3.3. In addition, some hydrogen bonding restraints were
violated in every structure and the base triple is not as well defined as the average U23(N3)
to A27(N7) distance is 3.69 A ± 0.21 A and the average U23(O04) to A27(N6) distance is
4.15 ± 0.29 A. These results suggest that a non-experimental restraints are able to induce
violations indicating that the NMR restraints sufficiently define a particular argininamide
binding orientation.
The last set of modeling calculations was performed to test if all the hydrogen bond
and planarity restraints for both the argininamide and the base triple could be satisfied
simultaneously. An idealized family of structures was obtained consistent with all the
experimental NMR restraints. The average structure of this idealized TAR-argininamide
complex has an rmsd to the experimental NMR average structure for all the residues, except
the loop, of 0.73 A. This difference is smaller than the precision of the experimental
structure, indicating that the idealized average structure is within the range of the family of
20 experimental structures. A close-up view of the minimized average from this family of
structures is shown in Figure 3.8 illustrating the argininamide stacking between the A22
and the U23. These calculations demonstrate that all the NMR data are consistent with both
base triple formation and argininamide hydrogen bonding to G26. In the family of 20
structures derived solely from experimental restraints, no planar base triple is observed.
122
AB
Figure 3.8: The same two views of Figure 3.7 of the bulge region of
the minimized average structure with non-experimental hydrogen bond
and planarity restraints are shown. A) Looking into the major groove,
the argininamide, in red, is seen lying next to the G26, in purple. The
argininamide is stacking between the U23, in green, and the A22, in
yellow. The A27 and U38 are also highlighted in green. B) Looking
down the helix axis, the U38-A27-U23 base triple is highlighted in
green.
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This may be a sampling problem of the molecular dynamics protocol since all the
calculations with non-experimental restraints are within the same range of both total and
violation energies as shown in Table 3.3.
To test whether the stems are truly A-form, a family of structures was generated
including non-experimental restraints for A-form torsions with a rmsd of 1.22 A. No
significant differences in the structure of the bulge region are induced, and U23 and A27
are still within hydrogen bonding distance. The slightly lower rmsd in this family of
structures is consistent with the expected higher precision that the A-form torsion restraints
induce in the structures. However, a 0.1 A increase in precision is a modest gain,
suggesting that a large number of NOEs, as obtained for this complex, can define the
structure in the absence of backbone torsion restraints.
Effect of additional intermolecular NOEs Some intermolecular NOEs were not used for the
structure determination because they may be influenced by spin diffusion and/or dynamic
motions. Additional modeling calculations were performed to test the range of
intermolecular NOEs that are required to define the interaction. A total of 27 intermolecular
NOEs that include some of the weaker NOEs that were observed in the spectra and not
used for the conservative structure determination were used. These restraints (see
Appendix B) include some restraints between the argininamide He and the C39 amino
protons, seven structures with a rmsd of 1.29 A were obtained. No large violations > 0.1
A were induced by these extra restraints suggesting that these loose constraints are
consistent with all the other experimental restraints.
Effect of no sugar pucker restraints Because of the conformational averaging observed for
some of the backbone torsions, it would not be surprising if some of the sugar puckers
were also sampling multiple conformations. Only the A35 sugar pucker showed evidence
of conformational averaging and was left unconstrained in the original structure
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calculations. Nevertheless, to ensure that the sugar pucker constraints did not unduly
influence the final structure, calculations were performed with no torsion restraints. 15
structures with a 1.39 A rmsd were obtained from the same molecular dynamics protocol
without any sugar pucker or backbone torsion restraints. The average U23(N3) to
A27(N7) distance is 2.95 ± 0.04 A and the average U23(04) to A27(N6) distance is 3.59
S0.10 A. These calculations show that enforcing the sugar puckers does adversely effect
the base triple nor the argininamide binding structures.
No intraribose restraints Although the intraribose NOEs appear to be redundant and
unnecessary for the structure determination, calculations without any intraribose distance
restraints suffered from extremely very poor convergence. This is likely a function of the
molecular dynamics protocol utilized in these studies where the random coordinates require
the restraints to guide the structures, even before the geometric covalent terms are defined.
Other protocols which use other random starting structures such as random torsions which
have intact covalent structure from the beginning may work better when no or very few
intraribose distance restraints are implemented.
HI' and H2' restraints only Calculations were also performed with all the restraints
involving the exchangeable and aromatic protons along with the hydrogen bond restraints
but with only the distance restraints to the H1' and H2' protons from the ribose for a total
of 403 distance restraints. These calculations suffered from poor convergence as only four
structures from 75 different random coordinates were obtained. However, the salient
features of the TAR-argininamide structure remain well-defined as the average U23(N3) to
A27(N7) distance is 2.83 A ± 0.63 A and the average U23(04) to A27(N6) distance is
3.39 ± 0.75 A. Surprisingly, the rmsd of these four structures is a very low 1.17 A. This
low rmsd could be because the influence of the statistics of small numbers as previous
similar calculations found that the rmsd for structures from limited restraint sets is higher
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than with all the restraints (Allain & Varani, 1997). Alternatively, it may reflect the
stringency required to converge with only a limited number of distance restraints. These
structures may be a subset of the structures calculated with all the restraints included.
3.6 Backbone Torsion Analysis
Inclusion of experimental backbone torsion restraints was limited due to the extreme
chemical shift overlap of A-form helix proton and phosphorous resonances in HCP
experiments. Furthermore, conformational averaging of J-couplings provided evidence
that no unique conformer was assignable for the bulge region nucleotides U23, U25, and
the G26 y and P. Despite the lack of backbone torsion restraints, the structures had well-
defined phosphodiester backbones as illustrated in Table 3.4 which shows that many of the
backbone torsions were well-defined by the NMR data.
Table 3.4: Torsion Analysis
Torsion Number in
A-form Rotamer
a 151/368
P 252/368
y 149/368
E354/388
322/388
The backbone torsions, e and P, fall within the expected range 93% and 84%,
respectively, of the time in the A-form helical regions. The y torsion is not as well defined
as it falls into the expected gauche+ conformer only 40% of the time in the A-helical
regions. Because a and cannot be directly measured by NMR, it is interesting to see
how well they are defined in the A-form regions in this high resolution structure. The r
torsion falls into the expected A-form gauche conformer 68% of the expected A-form
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Table 3.5: Average torsions with rms deviations for each residue from the 20 structures.
[ERESIDU
16
17
18
19
20
21
22
23
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
* Except for A35 all
N.M. t
167.06 ± 15.72
180.42 + 23.57
172.80 ± 14.43
254.00 ± 16.83
233.53 + 15.72
176.01 ± 18.28
192.12 + 29.03
181.35 + 3.86
209.14 ± 10.83
161.71 ± 6.97
226.05 ± 15.92
210.72 ± 15.63
211.56 ± 19.19
166.88 ± 22.10
165.53 ± 22.35
134.52 + 19.18
181.26 + 19.75
163.92 ± 18.72
140.94 ± 18.81
193.60 ± 22.21
217.41 ± 15.81
191.52 ± 14.99
187.13 + 13.91
233.71 ± 16.17
177.59 ± 23.40
238.22 ± 13.97
200.56 + 17.94
216.20 ± 16.07
217.31 + 17.23
292
0X P
N.M. 201.30
194.66 ± 4.73 152.84
187.97 ± 1.87 128.80
185.23 ± 9.74 161.69
179.73 ± 4.71 80.47
175.17 ± 5.65 108.62
197.43 ± 3.78 141.71
211.88 ± 13.87 176.86
237.01 ± 6.65 296.64
242.48 ± 15.13 169.64
181.55 ± 2.49 169.53
189.18 ± 4.76 109.09
191.14 ± 8.80 113.68
187.39 ± 5.05 107.42
196.21 ± 10.82 136.72
184.37 ± 12.32 243.76
211.37 ± 9.13 124.46
175.63 ± 14.53 190.30
179.31 ± 17.23 158.75
187.06 ± 8.16 145.46
189.15 ± 3.38 122.81
182.66 ± 2.17 119.36
189.49 ± 5.07 139.83
204.94 ± 7.51 140.37
177.54 ± 7.67 99.72
191.44 ± 2.82 123.80
185.13 ± 1.64 97.25
183.60 ± 5.91 132.35
186.91 ± 2.74 117.73
185.44 ± 9.53 112.02
7
+ 13.26
+ 9.87
+ 15.22
+ 10.27
+ 10.45
+ 13.13
+ 12.45
+ 17.90
+ 15.22
+ 6.36
+ 6.44
+ 10.78
+ 12.21
+ 13.76
+ 13.37
+ 18.28
+ 14.98
+ 22.32
+ 17.10
+ 14.36
± 14.23
+ 13.66
+ 10.37
+ 9.19
+ 10.19
+ 12.51
+ 12.41
+ 13.08
+ 14.04
± 12.10 85.63 ± 0.39 N.M. N.M.
86.37
84.90
84.70
87.24
85.01
83.74
85.06
144.45
139.66
87.12
86.68
85.92
85.73
143.87
144.00
148.20
144.40
144.66
128.88
85.79
85.89
84.75
85.89
85.53
83.96
85.54
84.23
85.63
85.63
t The terminal torsions were not measured as there are no restraints at the termini.
0.43
0.75
0.36
0.62
0.28
0.36
0.67
0.56
0.17
0.11
0.33
0.32
0.43
0.69
0.51
0.88
0.34
0.54
6.48
0.47
0.38
0.49
0.43
0.41
0.57
0.41
0.46
0.45
0.38
46
A- forn 178 60 88* 205 292
the riboses were restrained to be C3'-endo or C2'-endo.
178.80 ± 9.74 275.01
163.25 ± 13.66 232.14
192.23 ± 7.86 255.92
193.56 ± 9.64 276.36
199.95 ± 2.34 277.72
162.08 ± 10.74 233.96
138.73 ± 22.98 202.36
277.06 ± 1.46 68.47
296.54 ± 1.52 200.77
189.62 ± 1.61 301.59
193.95 ± 6.71 276.71
210.63 ± 6.29 266.96
186.42 ± 9.56 230.17
233.47 ± 10.97 209.92
258.16 ± 5.44 183.02
261.34 ± 5.90 159.75
245.21 ± 6.31 211.69
244.58 ± 6.02 223.22
234.52 ± 14.88 151.94
173.65 ± 13.76 242.38
199.10 ± 1.63 295.59
187.20 ± 6.55 278.79
211.80 ± 3.44 279.68
201.92 ± 7.92 263.16
146.45 ± 14.47 208.98
199.13 ± 1.89 296.52
196.83 ± 7.43 278.30
205.23 ± 3.26 290.37
214.21 ± 6.63 259.84
± 12.28
± 22.31
± 19.34
± 14.12
± 13.51
± 21.67
± 16.96
± 5.21
± 37.91
± 1.60
± 10.20
± 12.84
± 24.24
± 25.86
± 23.32
± 11.57
± 21.82
± 12.91
± 21.38
± 20.73
± 1.42
± 10.08
± 1.92
± 15.76
± 22.74
± 1.13
± 10.78
± 1.79
± 12.71
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torsions but a is only in the A-form gauche rotamer 40% of the time. The average
torsions at each position for the 20 structures is shown in Table 3.5. The 8 and 0 torsions
are reasonably well-defined for many of the A-form residues as the standard deviations are
fairly small with the average value close to the expected A-form values. Surprisingly, the
5' side of A27 and 3' side of G26 are fairly well-defined to non-A-form conformations.
When calculations restraining every all the A-form backbone torsions except without the
restrained except the 5' side of A27, nine structures with a very low rmsd of 0.99 A were
obtained. Furthermore, the A27 and G26 backbone torsions were again well-defined in the
same range as in Table 3.5. Thus, these backbone torsions are non-A-form to widen the
major groove and allow the argininamide to bind to G26.
Correlations among the backbone torsions have been observed in polynucleotides
with correlation coefficients ranging from 0.65 - 0.71 (Saenger, 1983). Interestingly, in
the A-form regions, the backbone torsions are found in distinct conformations depending
on the rotamer of the other surrounding backbone torsions. For example, when y is trans 1
is either trans or gauche' and only rarely gauche (Figure 3.9). But when y is in the A-
form gauche , the other backbone torsions are almost always in their correct rotamer. On
the other hand, when a is in the typical A-form gauche the other backbone torsions are
almost always in only a single rotamer (Figure 3.10). These correlations are in sharp
contrast to the non-A-form regions which are sampling many possible torsions, and show
no distinct correlations.
These correlations suggest that restraining either the ( or y torsion may force all the
other backbone torsions into their correct A-form rotamers. Unlike the y torsion, the a
torsion is not directly measurable by NMR and can only be roughly estimated from the 31P
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Table 3.6: Average torsions for each residue with rms deviations for 8 structures with a restrained.
DUE 0X pRESI
16
17
18
19
20
21
22
23
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
N.M.
179.78 ± 15.52
N.M.
287.85 ± 4.68*
288.37 ± 1.35*
282.95 ± 4.08*
288.25 ± 5.17*
282.39 ± 2.23*
188.57 ± 41.43
191.61 ± 42.78
217.71 ± 33.69
229.86 ± 17.77
284.18 ± 4.03*
282.07 ± 2.35*
280.91 ± 3.03*
204.23 ± 36.56
205.97 ± 40.06
197.84 ± 34.03
167.57 ± 34.31
210.93 ± 36.85
152.33 ± 18.64
194.68 ± 35.39
300.09 ± 2.68*
286.46 ± 2.66*
277.19 ± 2.50*
151.15 ± 3.49
290.57 ± 2.88*
287.15 ± 2.69*
279.41 ± 2.49*
282.18 ± 3.71*
281.68 ± 1.62*
178.80
168.79
202.97
185.18
179.11
233.02
160.85
234.55
177.48
202.21
208.19
170.91
210.52
169.86
203.22
215.98
179.66
188.06
155.89
180.95
211.35
223.61
193.36
183.69
219.42
225.51
227.65
46 164.58 ± 37.68 196.37 ± 10.79
A-form 292 178
* These residues have the a torsion
2.70
20.68
18.71
14.69
6.42
14.50
22.74
31.67
2.53
19.56
18.30
18.72
15.82
20.68
15.25
19.14
21.95
15.37
7.21
15.35
23.80
2.50
21.40
14.69
21.13
24.90
18.05
7
237.92 ± 20.68
85.57 ± 14.65
56.89 ± 3.28
92.63 ± 20.83
98.65 ± 22.60
89.80 ± 19.91
133.20 ± 21.64
181.00 ± 32.13
298.76 ± 5.99
181.01 ± 10.36
66.40 ± 4.12
109.97 ± 25.34
100.43 ± 25.85
135.56 ± 17.27
136.78 ± 22.76
249.16 ± 19.62
137.27 ± 28.30
224.97 ± 29.96
131.81 ± 23.43
127.15 ± 22.86
93.79 ± 33.32
91.13 ± 19.37
139.33 ± 26.65
163.59 ± 2.32
105.73 ± 24.83
89.51 ± 19.88
128.28 ± 28.39
147.09 ± 28.26
118.77 ± 30.96
128.26 ± 18.88
60
restrained to t
86.30 ±
83.54 ±
81.69 ±
82.00 ±
83.03 ±
80.62 ±
84.35 ±
145.19 ±
138.79 ±
86.81 ±
83.05 ±
84.21 ±
84.41 ±
144.28 ±
145.15 ±
148.85 ±
145.84 ±
145.41 ±
121.06 ±
86.48 ±
83.06 ±
82.94 ±
84.56 ±
87.20 ±
86.53 ±
85.27 ±
85.29 ±
85.40 ±
84.04 ±
0.71
0.56
0.30
1.29
0.90
1.20
1.14
0.35
0.18
0.29
0.73
0.71
0.90
1.18
0.87
1.33
0.40
0.24
9.59
0.58
0.66
0.62
0.83
0.03
0.23
0.45
0.77
0.78
1.10
186.35 ±
203.47 ±
211.94 ±
181.74 ±
198.58 ±
146.68 ±
194.22 ±
250.08 ±
285.55 ±
205.96 ±
194.02 ±
196.08 ±
187.01 ±
255.71 ±
254.87 ±
251.65 ±
260.37 ±
239.01 ±
257.62 ±
204.24 ±
200.08 ±
190.49 ±
200.31 ±
208.25 ±
204.05 ±
192.24 ±
193.39 ±
190.44 ±
144.30 ±
22.26
1.74
10.57
20.50
3.78
21.13
32.73
10.11
3.64
2.20
4.24
4.85
22.79
8.77
8.47
8.85
7.75
9.03
12.58
21.98
3.76
6.71
1.97
8.62
4.23
6.02
9.89
5.62
25.22
278.16 ±
293.05 ±
256.53 ±
248.74 ±
265.57 ±
214.35 ±
223.58 ±
101.19 ±
104.33 ±
294.41 ±
234.11 ±
238.24 ±
277.29 ±
247.05 ±
195.46 ±
213.64 ±
150.56 ±
233.89 ±
125.03 ±
259.33 ±
258.68 ±
207.12 ±
277.97 ±
232.02 ±
259.32 ±
213.03 ±
178.85 ±
212.70 1
219.38 4
85.82 ± 0.44 N.M. N.M.
88 205 292
he A-form gauche-
14.26
1.04
26.97
28.05
27.68
37.71
24.34
14.88
34.87
2.35
35.80
34.49
16.15
20.56
34.23
14.26
23.74
26.14
25.25
19.24
26.21
38.59
4.49
31.61
- 26.88
39.16
36.57
37.18
30.86
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chemical shifts, which is not a reliable method at this time. To test whether constraining
the a torsion is sufficient to define the entire phosphodiester backbone, a series of
calculations defining the a torsion to its A-form gauche rotamer 292 ± 300 were
performed. Eight structures with a rmsd of 1.14 A were obtained, but the other torsions
did not consistently fall into A-form rotamers as shown in Table 3.6. Careful analysis
revealed that four of the eight structures had well-defined torsions for all the A-form
nucleotides but the other four could not be distinguished from these structures as they all
had about the same total, violation, and angle energies.
On the other hand, when the A-form y torsions were restrained to 60 ± 300, all the
backbone torsions consistently fell into their A-form rotamers for almost all the expected
positions as shown in Table 3.7. The six converged structures had a rmsd of 1.01 A in
the range obtained when all the backbone torsions were restrained. Remarkably, even
though the y torsion is broadly defined to a 600 range, many of the backbone torsions,
including y, are defined very precisely with rmsd's less than one. Furthermore, the
torsions are centered at about their A-form rotamer further suggesting that all the backbone
torsions are correlated and fall into the lowest energy state together. Calculations were
performed to test whether the y torsion in the context of a more limited data set with only
H1' and H2' NOEs from the ribose is sufficient to define an A-form helix. This data set
may be realistic for larger RNAs where the extreme chemical shift overlap along with line
broadening problems may inhibit full assignments of all the ribose protons (see Chapter 1).
The phosphodiester backbone is well defined for most of the constrained residues in the
five structures that converged except for residues 17-20. Although the 1.14 A rmsd is only
slightly lower than without the y torsion restrained, the backbone is significantly better
defined. Thus, restraining the y torsion has profound effects on the phosphodiester
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Table 3.7: Average torsions for each residue with rms deviations for 6 structures with y restrained.
RESIDU
16
17
18
19
20
21
22
23
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
A-form
E 0
N.M.
270.84 ± 13.27
288.05 ± 0.97
285.30 + 1.03
268.36 ± 18.17
283.41 ± 2.44
178.51 ± 20.78
215.00 ± 49.53
227.88 ± 22.01
197.02 + 21.99
163.99 ± 7.95
287.97 ± 1.71
265.95 ± 9.80
228.60 ± 28.96
109.82 ± 36.91
217.16 ± 36.20
212.38 ± 47.89
164.69 ± 26.28
164.49 ± 22.66
179.29 ± 25.49
297.06 ± 2.82
293.59 + 2.32
282.95 ± 2.58
163.25 ± 13.20
294.33 ± 1.93
278.29 ± 10.78
283.86 ± 0.72
287.75 ± 1.09
285.75 ± 0.80
290.42 ± 4.86
292
* These residues have
N.M.
165.67 ± 5.43
173.26 ±
160.33 ±
164.67 ±
180.45 ±
183.91 ±
209.06 ±
205.60 ±
210.43 ±
162.48 ±
159.92 ±
196.45 ±
185.73 ±
232.51 ±
198.15 ±
225.82 ±
216.99 ±
155.19 ±
154.98 ±
178.60 ±
164.68 ±
162.02 ±
185.58 ±
150.27 ±
185.96 ±
175.51 ±
170.43 ±
176.44 ±
1.69
7.47
1.00
4.95
17.70
21.70
20.93
36.08
12.00
6.97
12.37
17.31
11.77
22.64
22.17
20.38
21.95
27.03
4.82
1.95
1.17
24.38
6.11
8.30
0.91
1.69
0.88
177.78
71.08
61.71
67.98
77.61
59.13
160.77
118.87
257.29
164.35
170.59
72.82
60.07
161.12
167.13
280.36
188.65
199.49
104.03
146.74
45.33
64.18
79.90
160.88
67.71
61.42
62.56
62.73
59.18
P 7
+ 38.14
+ 4.23*
+ 2.17*
+ 4.19*
+ 2.59*
+ 2.70*
+ 16.88
+ 32.18
+ 45.37
+ 11.60
+ 5.42
+ 2.67*
+ 5.41*
+ 37.38
+ 21.31
+ 14.88
+ 28.35
+ 36.55
+ 20.52
+ 28.04
+ 3.06*
+ 2.25*
+ 2.48*
+ 5.50
+ 3.98*
+ 5.85*
+ 1.63*
+ 1.18*
+ 1.05*
87.08 ±
82.44 ±
81.11 ±
80.00 ±
83.16 ±
82.99 ±
85.34 ±
143.23 ±
138.78 ±
86.94 ±
87.33 ±
85.18 ±
84.24 ±
143.16 ±
146.29 ±
145.88 ±
145.25 ±
145.50 ±
113.27 ±
87.20 ±
84.57 ±
82.39 ±
82.69 ±
87.38 ±
83.97 ±
82.94 ±
81.42 ±
82.56 ±
82.65 ±
0.03
0.66
0.23
0.90
0.37
0.35
1.08
0.73
0.34
0.33
0.06
0.51
0.66
1.10
0.36
1.69
0.71
0.78
12.37
0.10
0.45
0.28
0.32
0.09
0.58
0.37
0.18
0.20
0.10 219.64 ± 10.34
196.69
200.66
211.06
177.30
202.30
185.31
135.16
227.10
287.32
188.37
214.86
205.99
196.54
220.30
245.65
276.52
263.66
242.02
223.38
222.18
210.09
198.09
204.58
228.99
205.36
201.10
204.25
198.99
271.07 ± 8.64
154.47 ± 9.92 60.89 ± 1.06* 83.99 ± 0.41 N.M. N.M.
178 60 88 205 292
the y torsion restrained to the A-form gauche'
12.93
1.33
7.33
19.51
1.39
2.14
34.42
36.98
4.15
2.88
6.98
8.48
11.18
32.47
11.63
1.95
7.50
11.55
18.95
3.65
3.18
0.90
6.00
4.22
3.86
1.07
1.15
0.90
246.95 +
290.84 +
286.30 +
254.27 +
300.00 +
296.22 +
193.95 +
111.63 +
165.88 +
254.48 +
286.70 +
292.46 +
207.65 +
233.94 +
176.55 +
193.18 +
151.87 +
169.17 +
43.97 +
290.22 +
283.00 ±
292.17 ±
237.60 +
277.85 +
294.60 +
296.75 +
286.01 +
289.64 +
40.07
1.00
4.02
31.48
2.48
10.73
36.67
36.61
56.20
46.21
3.60
4.55
50.38
20.55
43.84
14.21
49.01
34.04
13.56
3.31
2.88
1.22
38.04
2.70
1.86
1.21
2.41
0.69
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backbone and improves the quality of RNA NMR structures. Measuring the y torsion is
difficult because of spectral overlap, but stereospecific selective labeling techniques may
solve this problem. These results suggest that this effort is worthwhile because this
restraint will greatly improve the quality of structures.
The total and violation energies were used to determine which structures converged,
but the importance of the angle energy term became clear when the backbone torsions were
restrained. When the and a torsions around a particular phosphor were not in their A-
form rotamer, the C3'-03'-P and C2'-C3'-03' angles were significantly violated by 4-50,
resulting in angle energy terms a few kcal/mol higher than the lowest energy structures,
even though the total and violation energies were in the same range as the lowest energy
converged structures.
3.7 Does the Structure Make Sense?
All the important nucleotides identified in binding studies play a critical role in
forming the argininamide binding pocket in the HIV-2 TAR-argininamide structure. The
argininamide binds to the major groove side of G26 where a strong N7 modification
interference is observed (Churcher et al., 1993; Hamy et al., 1993; Weeks & Crothers,
1991). The A27 N7, which gives a very strong modification interference with DEPC,
interacts with U23 in the proposed base triple, forming the scaffold for the argininamide
binding site (Churcher et al., 1993; Hamy et al., 1993; Weeks & Crothers, 1991).
Chemical modification of the N6 position of A27 with a methyl group reduces Tat peptide
binding by a factor of five, which represents half of the specific free energy of binding
(Hamy et al., 1993). All the modification interference and mutational binding data of this
interaction are consistent with the structure presented here. Thus, the U23 and A27 are part
of a critical RNA structural element required for argininamide binding while the G26
interacts directly with the argininamide. Furthermore, this structure also explains why the
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binding data are so similar for both the small ligand, argininamide, and Tat protein binding
to TAR. Considerable evidence suggests that the TAR conformation in the argininamide
complex is relevant to Tat binding, and one of the arginines in Tat, most likely R52, should
hydrogen bond directly to G26. Thus, a small ligand is able to interact specifically with
TAR RNA by recognizing a specific conformation with multiple contacts. Undoubtedly,
other contacts to the protein exist, but these bulge nucleotides, which are all involved in
argininamide binding, constitute the most critical determinants for both specific Tat and
argininamide binding.
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Chapter 4: HIV-2 TAR CGC Base Triple Mutant
4.1 Design of an Isomorphic Base Triple Mutant
Chapters 2 and 3 discuss the structure determination of the two base bulge HIV-2
TAR-argininamide complex, which exhibited higher quality spectra than the previously
studied three base bulge HIV-1 TAR, allowing for an even larger NOE data set to be
obtained. Even though the NMR spectra of the two base bulge HIV-2 TAR-argininamide
complex are superior to those of HIV-1 TAR, the effects of dynamics are still present,
limiting the number of weak NOEs observed and preventing the unambiguous identification
of the proposed base triple. The expected U23 imino proton may simply exchange too
rapidly to be observed, as is frequently observed for terminal base pairs.
To determine if the base triple is required for argininamide binding, an isomorphic
C-G*C+ base triple mutant was introduced in the three base bulge HIV-1 TAR and was
found to bind argininamide in the expected pH dependent manner (Puglisi et al., 1993).
Binding only occurred when the pH was lowered to -5.5 where the cytidine is protonated
and thus able to form a base triple. This mutant helped demonstrate that the base triple is
required for specific argininamide binding. However, the proton resonances at the
interface of the base triple were unobservable and no NOEs between the C23 and the G27-
C38 base pair were observed due to the dynamic nature of the complex. Previous studies
showed that an isomorphic base triple mutant TAR can be designed that binds
argininamide.
Chapter 2 describes some of the improved dynamic properties of the TAR -
argininamide complex allowing for a high resolution structure determination of this
complex. Although this work provided significant indirect evidence for base triple
formation upon argininamide binding, no direct NOE evidence indicative of the presence of
a base triple in the HIV-2 TAR argininamide complex was observed. We reasoned that
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Figure 4.1: Sequence and secondary structure of the wild-type HIV-2 TAR and
the HIV-2 TAR CGC triple mutant. The critical nucleotides required for arginine
and Tat binding in the bulge region are highlighted by the rectangles.
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replacement of the U38-A27*U23 base triple with an isomorphic C38-G27oC23 + base triple
in the context of the two base bulge HIV-2 TAR may allow us to observe critical
resonances indicative of base triple formation in the argininamide complex. Typically, the
cytidine amino proton resonances are sharper than uridine imino proton resonances and,
therefore, may be observable upon hydrogen bonding in the base triple of TAR. Also, the
extra G-C base pair in the upper stem may help the overall stability of the complex. Thus,
we constructed the two base bulge HIV-2 TAR CGC triple mutant shown in Figure 4.1.
The same pH dependent argininamide binding was observed for the HIV-2 TAR
CGC as was observed for the HIV-1 TAR base triple mutant. However, additional proton
resonances due to hydrogen bonding at the interface of the proposed base triple were
observed for the first time. These protons exhibit a number of inter-residue NOEs that
position C23 and G27 near each other, consistent with base triple formation. This work
provides direct NMR evidence of the base triple structure in the HIV-2 TAR-argininamide
complex.
4.2 Materials and Methods
Sample Preparation The HIV-2 TAR CGC RNA was synthesized by in vitro
transcription by T7 RNA polymerase and purified by denaturing gel electrophoresis
(Milligan et al., 1987). The DNA template for T7 transcription was: 5' - GGC CAG AGG
GCT CCC AGG CCC AGT CTG GCC TAT AGT GAG TCG TAT TA- 3' and
transcriptions were primed with 10 mM GMP. Samples were dialyzed for >48 hours
against NMR buffer (10 mM sodium phosphate, pH 6.4 at 250C, 50 mM sodium chloride
and 0.1 mM EDTA). The final concentration in 600 gl was approximately 1.5 mM. The
sample was then titrated with argininamide (Sigma) in the NMR tube to a final total
concentration of 6 mM, and the pH was lowered to 5.4 with HC1.
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NMR spectroscopy NMR experiments were recorded on a Varian INOVA 600 MHz
spectrometer, Varian Unity Plus 750 MHz spectrometer or a 500 MHz spectrometer
constructed at the Francis Bitter Magnet Lab. All spectra were processed and analyzed
using NMRPipe and PIPP on a Silicon Graphics Indy workstation (Delaglio et al., 1995;
Garrett et al., 1991). Proton NMR spectra in H20 were recorded at a variety of
temperatures and mixing times including 50, 100, and 200 ms. NOESY spectra used a
WATERGATE 3-9-19 water suppression scheme with a selective E-BURP-1 flip-back
pulse (Green & Freeman, 1991; Lippens et al., 1995; Piotto et al., 1992). Sweep widths
were 12000, 14000, and 16000 Hz at 500, 600, and 750 MHz, respectively, with 4096 x
512 points collected. Some spectra were recorded with sweep widths of 14000 x 8000 Hz
which increased the digital resolution. Data were zero filled to 4K x 2K real points and
apodized using Gaussian-Lorentzian functions in both dimensions before Fourier
transformation.
Standard NOESY, TOWNY, and DQF-COSY spectra in 99.996% 2H20 were
recorded at 250C. To monitor NOE buildups, spectra were recorded at 500, 600, and 750
MHz with mixing times of 50, 100, 200 and 400 ms. Sweep widths were 5500 Hz, 6000
and 8000 Hz at 500, 600, and 750 MHz, respectively. Some spectra were obtained with
4096 x 1024 real points which aided the assignment of some crowded resonances.
4.3 Identification of a Base Triple
As previously observed in the studies of the HIV-1 TAR CGC, argininamide does
not bind significantly at pH 6.4. However, at pH 5.4, the U40 imino proton resonance
significantly sharpens and the G26 and G21 imino resonances shift as is observed for
argininamide binding to wild-type TAR. In addition, a number of new peaks appear in the
imino and amino proton regions, as shown in Figure 4.2. These exchangeable resonances
are generally not observable under these conditions unless they are involved in a hydrogen
bonding interaction. The peak at 15.55 ppm is too broad to be observed in 2D 1H-1H
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Figure 4.2: The imino-amino proton region of HIV-2 TAR CGC shows a
number of new resonances upon addition of argininamide and the lowering
of the pH to 5.4. At pH 6.4, a few changes are observed upon addition of
argininamide. At pH 5.4, the U40(H3) at 14.11 ppm sharpens significantly
and the C23(H3) resonance appears at 15.55 ppm. In addition, the
C23(H42/H41) resonances are also observable at 10.61 and 9.17 ppm.
The chemical shifts of the C23 amino and imino protons are in the range for
protonated cytidines found in C-G-C' base triples.
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NOESY experiments but its chemical shift is in the exact range observed for protonated
cytidine imino protons found in base triple structures in DNA triplex NMR studies (Dongen
et al., 1996; Macaya et al., 1992; Santos et al., 1989). The remaining new resonances are
easily identified as cytidine amino protons in 750 MHz NOESY spectra. The cytidine
amino protons are also observed at chemical shifts typical for a base triple structure
(Dongen et al., 1996; Macaya et al., 1992; Santos et al., 1989).
The NOEs observed to the C23 amino protons in a H20 NOESY are shown in
Figure 4.3. Since the chemical shifts for most of the molecule are very similar to the wild-
type HIV-2 TAR, resonance assignments were straightforward. Most of the exchangeable
imino protons and amino protons that were observed in the high resolution HIV-2 TAR-
argininamide structure were assigned, along with most of the H8/H6/H5 and H1'
resonances, as shown in Table 4.1. Unlike the wild type HIV-2 TAR spectra, the critical
bulge nucleotides could be identified along with most of the upper and lower stems. This
chemical shift dispersion allowed the key resonances in the bulge region to be assigned as
many of the A-form resonances have almost identical chemical shifts to the wild type HIV-
2 TAR-argininamide complex and the anomeric-aromatic sequential walk assignable by
homonuclear spectroscopy as shown in Figure 4.5. Complete assignments were not
possible without isotopic labeling, but the salient features of the structure could be
identified. The C38 and G27 resonances were readily assigned by the observation of
standard A-form sequential NOEs. The C23 amino protons were assigned based on very
strong NOEs to the C23 H5, which in turn gives NOEs to the C23 base and ribose. The
C23 sugar pucker is C2'-endo, as in the wild-type HIV-2 TAR, which allows assignment
via 1H-IH TOCSY and DQF-COSY experiments (data not shown) (Varani & Tinoco,
1991).
Some weaker NOEs that were observed in the HIV-2 TAR-argininamide complex
were not observed in the triple mutant spectra. Most of these differences can be attributed
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Table 4.1: Proton chemical shifts (ppm) for HIV-2 TAR CGC RNA
bound to argininamide.
Residue H1/H3 H42/H41 H8/H6 H5/H2 H1'
G16 --- 8.09 --- 5.78
G17 13.51 --- 7.69 --- 5.93
C18 8.70* 7.72 5.27
C19 8.44,6.95 7.74 5.19 5.55
A20 --- 8.00 6.91 5.92
G21 12.60 --- 7.10 ---- 5.56
A22 --- --- 7.76 7.15 5.99
C23 15.55 10.61,9.17 7.76 5.77 5.85
U25 --- 7.89 5.99 6.05
G26 12.93 --- 7.79 --- 5.94
G27 13.02 --- 7.58 --- 5.95
G28 13.56 --- 7.43 --- 5.87
C29 8.37 7.59 5.17 5.54
C30 7.69 5.55
U31 --- 7.74 5.84
G32
G33 --- ---
G34 --- 7.94 ---
A35 --- 8.42 8.20 5.98
G36 13.25 --- 7.45 --- 5.55
C37 8.88,7.03 7.89 5.23 5.55
C38 8.56,7.01 7.88 5.45 5.63
C39 8.51,7.42 7.41 5.58 5.45
U40 14.11 --- 8.02 5.52 5.57
C41 8.36,7.10* 7.94 5.67 5.50
U42 13.35 --- 7.86 5.34 5.46
G43 12.05 --- 7.86 --- 5.77
G44 13.31 --- 7.35 --- 5.70
C45 8.66,7.00 7.66 5.18
C46
The errors for the chemical shift are ±0.01. The exchangeable proton chemical
shifts were assigned at 20C while all the non-exchangeable data were assigned at
25 0C.
* indicates the chemical shift was assigned at 150C as the peaks were overlapped at
20C.
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Figure 4.3: The internucleotide NOEs to the C23 amino protons are
shown in a 750 MHz H20 NOESY at 20C. A number of NOEs
between the C23 and the G26, G27, and U38 position the C23 near
the G27, consistent with a base triple structure.
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Figure 4.4: Aromatic-anomeric region of a 600 MHz NOESY
(mix=100ms) of the HIV-2 TAR CGC - argininamide complex in
99.996% 2H20. The sequential assignment pathway is highlighted
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to the use of multidimensional heteronuclear NMR for the HIV-2 TAR assignments, which
was not replicated here for the base triple mutant. Intermolecular NOEs to the argininamide
guanidium protons were not detected because these resonances were broader in the HIV-2
TAR CGC spectra. Also, the weak C39(H42/H41)-Arg(HS) intermolecular NOEs were
not observed. Spectral crowding inhibited the unambiguous assignment of intermolecular
NOEs between the A22(H2') and A22(H3') and the Arg(H) even though candidate peaks
are observed.
All the observed NOEs for the triple mutant are consistent with the base triple
structure of the wild type HIV-2 TAR-argininamide complex. In fact, a similar set of
intermolecular and internucleotide NOEs are observed in both the HIV-2 TAR CGC and the
wild-type HIV-2 TAR complexes indicating that argininamide is binding to both molecules
in the same manner. Table 2 lists the critical NOEs in the bulge region that are observed in
the HIV-2 TAR CGC argininamide complex. Important intermolecular NOEs that are
found in the wild-type HIV-2 TAR-argininamide complex including NOEs between the
C23-H5 and the argininamide Hy and H8 are also observed in the triple mutant.
Significantly, NOEs from the C23(H42/H41) to the G27(H1) and C38(H42/H41) are
observed positioning C23 near G27, as shown schematically in Figure 4.5.
Summary We have investigated an isomorphic C38-G27*C23 base triple mutant TAR
which provides direct NMR evidence for base triple formation in the TAR - argininamide
complex. The C23 imino and amino protons were observed upon the addition of
argininamide at pH 5.4, suggesting that these C23 amino and imino protons are involved in
hydrogen bonding interactions. The chemical shifts of the C23 amino and imino are in the
exact range found for base triple structures in numerous nucleic acid triplex studies.
Furthermore, a number of NOEs were identified, positioning the C23 near the G27
consistent with base triple formation. Finally, a similar set of intermolecular and
internucleotide NOEs are observed in both the HIV-2 TAR CGC and the wild type HIV-2
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TAR complexes indicating that argininamide is binding to both molecules in the same
manner.
Additional evidence for a base triple structure has emerged from the Rev aptamer
NMR structure. The Rev aptamer has a TAR bulge on one end that increased the binding
affinity to the Rev peptide compared to the wild type RRE sequence. A TAR-like set of
mutants and chemical modification interference patterns were also observed suggesting that
the TAR bulge may also be recognizing an arginine like the HIV TAT-TAR interaction.
The ensuing solution structure of the Rev aptamer found direct evidence of a U-A*U base
triple that promoted arginine binding to a G-C base pair just like TAR. The studies
presented here along with the building evidence in other systems, strongly suggests that a
base triple is forming in the HIV TAR argininamide complex.
146
A. B.
...5' 3'...
Figure 4.5: Summary of NMR data for the HIV-2 TAR-CGC triple mutant bound to argininamide. A.
Bases are indicated by rectangles and ribose sugars by pentagons. Ribose, base H8/H6, and imino protons
are represented by dots within pentagons or on the outside of the base, respectively. Base-pair hydrogen
bonding is shown by dashed lines between bases. Observed internucleotide NOEs are indicated by thin
dashed lines; NOEs that indicate base-triple formation are shown by thicker dashed lines. The nucleotides
that form the base triple are highlighted. B. The C38-G27*C23 + is shown with the key internucleotide
NOEs that are observed that position the C23 next to the G27 shown by the dashed lines. The C23 imino
proton is highlighted by the box.
Key intermolecular and internucleotide NOEs in the HIV-2
TAR CGC bound to argininamide.
-C39 H42
H41
-A22 H8
-U23 H5
H6
-A22 H8
-U23 H5
-G27 H8
-U23 H5
H6
C23 H42/H41" -G26
G26 H8
G26 H1'
G27 H1
-C37 H42
-C38 H42
H41
-C39 H42
H41
-A22 H1'
H2
-C23 H1'
-A22 H2
-C23 H42
H41
* All these NOEs were also observed for the wild-type HIV 2 TAR-argininamide complex
except those to the C23 H42/H41 protons, which have no counterparts in the wildtype
RNA sequences.
Arg(HP3)
Arg(Hy)
Arg(H8)
Arg(He)
Table 4.2:
V Dynamics
Chapter 5: Dynamics of TAR-Argininamide
5.1 Motivation for Dynamics Studies
In the previous chapters, the improved NMR spectra of the two base bulge HIV-2
TAR were used to solve the high resolution structure. Structures, however, are not static
and it is important to understand how the intrinsic internal dynamics may play a role in the
molecule's function. Furthermore, conformational changes are important parts of many
macromolecular complexes, especially RNA, and local internal motions may play a role in
these changes. Also, recent advances have calculated thermodynamic parameters from
internal dynamics measurements, which likely play a role in the stability of the
macromolecule. In addition, knowledge of how the different spin systems are relaxing
may help design improved pulse sequences for future structure determinations. Only a few
dynamics studies have been performed on isotopically labeled RNA. One study focused on
13C measurements of HIV- 1 TAR in the absence of argininamide and interpreted the data in
term of the Lipari-Szabo model. The other study focused on 15N imino measurements of a
RNA tetraloop where a slightly different behavior for the non-canonical base pair compared
to the A-form Watson-Crick base pair residues was observed.
This study examines both the "'N and 13C dynamics behavior in isotopically labeled
RNA samples of the HIV-2 TAR-argininamide complex. TAR is an excellent model
system because of its structure has been solved and it has a variety of basic RNA structural
elements with a hexanucleotide loop, base triple, internal bulge, and A-form regions. The
excellent proton spectral dispersion of the imino resonances allows collection of one-
dimensional versions of the relaxation measurements to be collected, permitting all the
experiments to be collected in a few hours with a large number of relaxation times.
Unfortunately, the imino resonances do not sample a variety of RNA structure, because
they are generally only observable when they are hydrogen bonding as part of a base pair.
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The amino resonances are not examined because of the more complicated interpretation of
the rotating amino proton. On the other hand, there are proton-carbon spin systems
available on every ribose and base of each nucleotide. The purines are of particular interest
because the H8-C8 and H2-C2 spin systems are not next to any other carbons, presenting a
unique opportunity to study isolated proton-carbon spin systems in macromolecules, in the
absence of 13C-13C dipolar coupling.
Full spectral density mapping allows the spectral densities to be calculated in the
absence of any mechanical motional models or analytical models from the measurement of
six relaxation rate constants (Peng & Wagner, 1992; Peng & Wagner, 1992b; Peng &
Wagner, 1994; Peng & Wagner, 1995). One of the initial motivations for this work was
the observation that adenine H2-C2 spin systems are very isolated as it gives only a few
NOEs in an A-form RNA helix reducing the proton-proton dipole-dipole interactions that
interfere with accurate measurements of the RH(Hz) and RH(2HzXz) relaxation rate
constants. One of the central problems of the full spectral density mapping approach is the
complication introduced by the surrounding proton spins around each H-X spin system,
invalidating the two-spin assumption implicit in all the measurements. An alternative
method to determine the spectral densities is a reduced spectral density approach which
avoids measurements of the spin assumption, where J(oH) is assumed to be equal to
J(0)H±c) (Farrow et al., 1995; Ishima & Nagayama, 1995), which is a reasonable
assumption for nitrogen but may not work as well for carbon as c is 25% of oH compared
to 10% for oN.
The full spectral density method did not work well for the adenine(2), as physically
impossible negative values of J(aH) were calculated. The reduced mapping approach gave
J(0) values that were very similar to the values obtained from full spectral density mapping.
Both the 15N and 13C data reveal that the relaxation rates and spectral densities have about
150
V Dynamics
the same values for all the A-form residues. Surprisingly, only the U40 imino resonance
showed evidence of conformational exchange. Some flexibility is observed in the
hexanucleotide loop and U25 of the bulge. Surprisingly, the bulge nucleotide, U23, is not
experiencing fast internal motions, which the previous NMR studies suggested.
5.2 Materials and Methods
The two isotopically labeled samples used for the structure determination were used
for these measurements and all assignments have been made as discussed in Chapter 2.
15N NMR experiments were performed at a variety of temperatures as discussed in the text
on either a 600 MHz or 750 MHz Varian INOVA spectrometer equipped with a triple
resonance shielded z-gradient probe. Pulse sequences for the measurement of 15N
longitudinal (R,), transverse (R2) relaxation rates and the heteronuclear NOE in NH spin
systems were adopted from Dayie and Wagner (Dayie & Wagner, 1994). Suppression of
the solvent resonance was achieved by 3-9-19 WATERGATE. Both one and two
dimensional versions were performed with a recycle delay of 4.0 seconds for the R1 and
R,P experiments. One dimensional experiments were collected with 1024 real points at a
sweep width of 6000 Hz with the transmitter set to the middle of the imino proton and
nitrogen regions. For the ID experiments, the longitudinal R, experiments used relaxation
delays of 10, 40, 80, 120, 240, 320, 600, and 1200 ms while the R2 experiments used
relaxation delays of 4, 8, 12, 16, 24, 32, 48, 64, 80, 88 ms with a spin lock radio-
frequency field of 3 kHz with the transmitter set to 155.27 ppm, which is between the U
and G nitrogen imino chemical shifts. For the 2D experiments, longitudinal RI
experiments used relaxation delays of 10, 40, 80, 320, 640, 1280 ms and while the R2
experiments used relaxation delays of 2, 5, 10, 20, 40, 60, 80 ms. Heteronuclear cross-
relaxation rates require recording of steady-state NOE intensities. Two pairs of spectra
were recorded for the steady-state NOE intensities. One pair involved proton saturation to
achieve the steady-state intensity for four seconds, while the other pair consisted of the
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control spectra with no saturation to obtain the Zeeman intensity. The rate constants
(Rc(Hz--Nz) were then calculated from the ratio NOE=(yH/yN)[RN(Hz<--Cz)/RN(Nz) ] .
Two dimensional experiments were acquired with 1024 real points and 64 real
points for the 2D experiments. The one-dimensional data was processed and analyzed
using VNMR software while 2D spectra were processed in nmrPipe (Delaglio et al., 1995)
and analyzed in NMRView (Johnson & Blevins, 1994). Data sets were zero filled once
and apodized using a 90 shifted squared sine bell. Rates were fitted by the Levenburg-
Marquardt algorithm assuming a monoexponential decay. Error estimates were obtained
using a Monte Carlo procedure described by Peng and Wagner (Peng & Wagner, 1992b).
All 13C measurements were collected at 25C on a 600 MHz Varian INOVA
spectrometer equipped with a triple resonance shielded z-gradient probe. Six relaxation rate
constants were measured, as outlined by Peng and Wagner (Peng & Wagner, 1992), on the
aromatic the H-C spin systems. Longitudinal 13C relaxation rate, Rc(Cz), used relaxation
delays of 10, 40, 80, 160, 320, 640, and 1280 ms. In-phase 13C transverse relaxation
rate, Rc(Cx), measurements used relaxation delays of 4, 8, 16, 24, 32, and 48 ms.
Measurements of transverse antiphase, RHc(2HzCx), used delays of 8, 16, 24, 32, 48, and
64 ms. Longitudinal two-spin order, RHC(2Hz Cz), used delays of 4, 16, 32, 64, 128, and
400 ms. Measurement of proton longitudinal relaxation rate measurements, RH(Hz), used
delays of 8, 16, 32, 64, 100, 200, and 400 ms. All these spectra were collected with a
recycle delay of 5 seconds. Heteronuclear NOE spectra recorded with proton saturation
utilized a relaxation delay of 3s, followed by a 3 s period of saturation, while spectra
recorded in the absence of saturation employed a recycle delay of 6 s. Constant time data
were collected for the Rc(Cc), Rc(Cx), RHC(2HzCz), and NOE relaxation rate constants.
Representative fits are shown in Figure 5.1.
The spectral densities can be calculated from the longitudinal, transverse, and
heteronuclear cross-relaxation NOE relaxation rate constants by assuming that
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J(0)=J(o H±w). Spectral densities from both 15N and 13C data are calculated as
previously described (Farrow et al., 1995; Ishima & Nagayama, 1995; Lefevre et al.,
1996) with chemical shift anisotropy (CSA) values of 180 ppm for all the carbons
(Williamson & Boxer, 1989) and 100 ppm for uridine and 130 ppm for guanine iminos
(Akke et al., 1997) as previously reported.
5.3 s'N Base Dynamics
5.3.1 Rate constants
The ability to measure relaxation rate constants of the imino H-N spin systems by
one dimensional spectra allows fast collection of spectra at many different temperatures
with a larger number of points than can be reasonably collected by two-dimensional
experiments. The longitudinal and transverse rate constants were measured by fitting peak
intensities at the different relaxation delays to a monoexponential decay.
Figure 5.2 shows the R, and Rp, relaxation rates and heteronuclear NOE values for
the six imino resonances that are observable at all temperatures. Little variation among the
different Watson-Crick base paired imino resonances is observed and the relative
magnitude of the rates do not change at the different temperatures. Uridine and guanine
imino nitrogens have different CSA values which differentially affect the relaxation. Thus,
the U38 has lower R, and RI, rate constants than the guanine iminos but is not necessarily
more mobile. The RI rate constant is approximately proportional to the rotational
correlation time. As expected RP increases with decreasing temperatures as the molecule
tumbles more slowly as shown in Figure 5.2. On the other hand, the Ri rate constant is
inversely proportional to the correlation time for this size molecule and decreases at lower
temperatures. The cross-relaxation rate is sensitive to high frequency motions but the
measurements suffer from poor signal to noise causing larger errors than the other rate
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constant measurements. In particular, the G26 and U38 have very large NOE errors from
the ID data probably because of poor signal to noise. The G26 imino is partially
overlapped with the G21 imino while the intensity of U38 decreases at higher temperatures.
At lower temperatures, both these problems are alleviated and the errors are smaller.
Relaxation rate constants calculated from ID and 2D experiments agree well with
each other as shown in Figure 5.2. With the 2D data at 50C, accurate measurements of the
U40 and U42 imino resonances are possible, as shown in Figure 5.2. At higher magnetic
fields, RP is should increase because of the increasing CSA contribution while the J(Oc)
dependence of R, should cause it to decrease. These trends are observed as shown in
Figure 5.3 suggesting that the experiments are measuring the expected effects. For both
the R, and R,, rate constants, the U40 imino is different than the other two uridine imino
nitrogens. The U40 imino proton resonances is only clearly observable at temperatures
<10 0 C and is part of the argininamide binding site (see Chapters 2 and 3). The relaxation
rates suggest that this residue may be more rigid than the other uridine iminos. As the R, is
not very different than the other two uridines, a more plausible interpretation is that the U40
may be experiencing conformational exchange processes that increase the measured R,
relaxation rates. Additional rotating frame experiments are required to measure directly any
conformational exchange effects (Akke & Palmer, 1996; Palmer et al., 1996; Szyperski et
al., 1993). The different relaxation of the U40 imino correlates with the U40 being part of
the argininamide binding site where argininamide binding and/or stacking of the guanidium
group on U40 might be influencing the rate.
5.3.2 Reduced spectral density mapping
Protein relaxation studies have observed that the J(O), J(0N), and J(o)H) values and
the RI,, R,, and (1-NOE) rate constants, respectively, are correlated (Buck et al., 1995;
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Ishima & Nagayama, 1995; Palmer et al., 1996). For the motionally restricted protein
backbone amides, J(O) makes the most significant contribution to J(o) and the higher
frequency components are almost negligible. When more mobility is observed, the J(oH)
and J(o4) increase while the J(O) decreases. Reflecting the relaxation rates, the imino
resonances do not show significant variation of their spectral densities compared to
sequence as shown in Figure 5.4. As the temperature is lowered, J(0) increases and J(O)N)
decreases as the rotational correlation time increases by approximately a factor of 1.5.
Taking into account the slightly different CSA, uridine J(0) values are slightly smaller than
guanine and the same pattern of correlations between the relaxation rate constants and the
spectral densities is observed for this RNA.
5.4 "C Base Dynamics
5.4.1 Relaxation rate constants
Relaxation measurements were made on the H8-C8, H6-C6, and H2-C2 spin pairs
at 25°C. For RNA, the advantage for carbon relaxation measurements is that the purine H-
C spin systems are not affected by carbon-carbon relaxation mechanisms allowing for a
unique opportunity to measure H-C dynamics. The pyrimidine C6 is next to the C5 carbon
and carbon-carbon relaxation will interfere with the measurements. Measurements were
made with and without a constant time delay that helps the observation of the C6
resonances. However, most of the pyrmidine resonances are severely overlapped,
preventing accurate measurement of intensities. Only the U23, U25, and C39 could be
consistently measured while the U40 and U38 were accessible in the better signal to noise
experiments.
As observed for the '5N dynamics, the A-form helical residues exhibit fairly
uniform dynamics behavior as shown in Figures 5.5 and 5.6. The A-form helical H2-C2
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spin systems are just as rigid as the other A-form aromatic spin systems as seen by the
similar 13C Ri and RI rate constants. However, the isolated nature of the H2-C2 spin
systems is illustrated by the shorter 'H R, rate constants. The non-helical residues, U25(6)
and A35(2), exhibit different 1H R, and 13C R,~ rate constants than the other A-form
pyrmidine(6)'s and adenine(2)'s, respectively. The large R, and NOE suggest that these
resonances have large high frequency motions contributing to their relaxation. As observed
for its imino, the terminal G16(8) has very similar relaxation rate constants as the other A-
form residues, suggesting that even though H20 exchange measurements suggest that
terminal base pairs are fraying, the bases, themselves, are not very mobile.
5.4.2 Full spectral density mapping
The common problem with full mapping is the proton dipole-dipole term affecting
the RH(2HzNz), RH(2HzNx), and RH(Hz) which cannot be easily measured and distorts
these measurements. This term is proportional to molecular weight and also to the nearby
proton density with which the proton of interest can cross-relax. The advantage of full
spectral density mapping is that the spectral densities are calculated from six independent
relaxation measurements in the absence of any motional models or other major
approximations. The H2-C2 spin system presents an excellent candidate for the full
mapping approach since it is a very isolated spin system with only a few NOEs to each H2
proton resonance in a RNA A-form helix when the sample is in 2H20. To test whether full
spectral density mapping is applicable to adenine H2-C2 spin system in medium sized
RNAs, all six relaxation rate constants were measured as shown in Figure 5.6. When the
spectral densities were calculated, some J(o)H)'s had negative values which are physically
impossible, as summarized in Table 5.1. Perhaps by eliminating all the NOEs to the
adenine H2s eliminating almost every proton by fully deuterating the ribose, the full
mapping strategy may be possible.
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Table 5.1: Spectral densities from 13C data: Full vs. Reduced Mapping
Position J(0) J(0) full J(0) J(0) J(oC) J(oC) J(oC) J(cO) J(ZOH) J(OH) J(OH) J(OH)full rmsd reduced reduced full full reduced reduced full full reduced reduced
rmsd rmsd rmsd rmsd rmsd
Adenine(2)
A20(2) 2.11 0.02 2.0213 0.0322 0.0531 0.001 0.0712 0.0010 0.013 0.016 0.0005 0.0005
A22(2) 1.97 0.01 1.8578 0.0176 0.0554 0.003 0.0673 0.0021 -0.016 0.015 0.0009 0.0012
A27(2) 2.00 0.02 1.9821 0.0405 0.0550 0.001 0.0641 0.0019 -0.016 0.017 0.0008 0.0010
A35(2) 0.9920 0.0233 0.0732 0.0022 0.0037 0.0012
Purine(8)
G16(8) 1.94 0.03 1.9103 0.0132 0.0625 0.002 0.0754 0.0020 0.113 0.027 0.0011 0.0013
G17(8) 1.95 0.02 1.9745 0.0152 0.0499 0.003 0.0636 0.0023 0.041 0.026 0.0011 0.0003
A20(8) 2.25 0.03 1.9964 0.0174 0.0581 0.001 0.0611 0.0016 -0.156 0.029 0.0009 0.0014
G21(8) 2.19 0.03 2.3436 0.0118 0.0534 0.001 0.0618 0.0025 -0.109 0.031 0.0007 0.0006
A22(8) 2.07 0.03 1.9030 0.0102 0.0550 0.002 0.0611 0.0016 -0.011 0.029 0.0008 0.0009
G26(8) 1.93 0.02 1.9319 0.0114 0.0527 0.001 0.0665 0.0011 0.125 0.025 0.0009 0.0006
A27(8) 2.02 0.02 1.9677 0.0177 0.0580 0.001 0.0630 0.0010 0.069 0.016 0.0008 0.0007
G28(8) 2.23 0.03 2.1993 0.0224 0.0520 0.003 0.0630 0.0017 -0.084 0.034 0.0010 0.0011
G36(8) 1.98 0.04 2.0143 0.0215 0.0541 0.001 0.0672 0.0007 0.011 0.038 0.0013 0.0004
G43(8) 2.01 0.03 2.1183 0.0233 0.0568 0.001 0.0617 0.0020 -0.063 0.032 0.0009 0.0011
G44(8) 2.04 0.02 2.0436 0.0170 0.0582 0.002 0.0614 0.0016 -0.095 0.019 0.0009 0.0010
Pyrimidine(6)
U23(6) 2.1940 0.0310 0.0835 0.0022 0.0013 0.0010
U25(6) 1.1148 0.0085 0.0956 0.0019 0.0034 0.0010
U38(6) 2.5272 0.0193 0.0841 0.0026 0.0006 0.0012
C39(6) 2.5585 0.0377 0.0819 0.0023 0.0010 0.0007
U40(6) 2.5720 0.0242 0.0824 0.0023 0.0010 0.0005
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5.4.3 Reduced spectral density mapping
Because full spectral mapping did not accurately determine the J(OH) values, the
reduced spectral density approach was applied to calculate the spectral densities. As
discussed above, these calculations use only the longitudinal, transverse, and NOE
relaxation rates to calculate the spectral densities by assuming that J(o ±oc)= J(OH). This
assumption may be suspect because the carbon Larmor frequency is about 25% of the
proton Larmor frequency, which is not as insignificant a difference as for nitrogen. The
high frequency components still suffer from large errors translated from the NOE
experiments as seen in Table 5.1. The two spectral density mapping methods give very
similar J(O) values, but the reduced mapping J(Oc) values are systematically higher than
those from the full mapping calculations. This over-estimation originates from the
J(o3±oc)= J(oH) assumption.
The spectral densities indicate that the A-form residues exhibit uniform dynamics as
they all have very similar J(O) values. The spectral densities indicate that the A35 and U25
residues are very flexible. This increased mobility for the U25 and A35 correlates with the
structure and previous NMR studies, as these residues have very few internucleotide NOEs
and are solvent exposed. Despite not being imbedded in helix, the U23(6) is fairly rigid, as
it has a slightly lower J(0) than the other pyrmidines, but higher than the U25(6) as seen in
Table 5.1.
5.5 Summary
These results present some of the first detailed "'N and 13C relaxation measurements
made on isotopically labeled RNA. All the A-form residues seem to behave similarly,
while the non-helical regions exhibit a variety of dynamic behavior. The U25 and A35 are
very flexible while the U23 is not as rigid as other A-form pyrmidines but also is not as
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flexible as the unstructured residues. The HIV-2 TAR-argininamide structure suggests that
the U23 may behave like a terminal base because it is only stacking on one face similar to a
terminal base pair. The U23 and terminal G16 both have fairly rigid J(O) values that are
very similar to the A-form residues and do not show any signs of conformational
exchange. Thus, the U23 is truly behaving like a terminal base as the imino proton is
difficult to observe, while the aromatic H-C spins system is not very flexible. Although the
G16 imino proton resonance is observable as a very broad peak at 50 C, the U23 is not.
Perhaps the slightly more flexible dynamics of the U23 compared to the terminal G16 are
sufficient to prevent the observation of its imino proton. This dynamics behavior may be
reflecting the partial base stacking and protection from solvent that these residues may be
experiencing.
This work explores how the various residues are behaving in the saturated
argininamide complex of argininamide. To understand the dynamics of the argininamide
binding site and the changes that occur upon binding, measurements of both the free HIV-2
TAR can be collected and at various argininamide concentrations. Because the dissociation
constant of argininamide is - 1-3 mM, the dynamics of TAR can be monitored as it
undergoes the conformational changes required for specific binding. In addition, TAR's
behavior in peptide complexes can also be monitored. It may also be interesting to explore
the differences between the three and two base bulges in the argininamide complexes. The
power of NMR to study weakly binding complexes can be fully applied to the arginine
binding site of TAR permitting the dissection of the role of dynamics in specific binding.
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VI Tat peptides
Chapter 6: Tat Peptide - HIV-2 TAR NMR Studies
6.1 Choosing a Tat Peptide
Chapters 2-4 focused on the HIV-2 TAR-argininamide complex and showed how
TAR specifically recognizes a single arginine. Even though most of the specificity for the
Tat-TAR interaction resides in a single arginine, some minor specificity elements may exist
in other residues of the RNA binding domain. Also, the conformation of the Tat peptide
remains unknown even though some unconvincing evidence has emerged suggesting that
the Tat peptide may be a-helical. The structure of the Tat peptide-TAR complex would be
valuable towards understanding how the arginine is tethered to the rest of the peptide and
how other residues may be specifically recognizing TAR. As discussed in Chapter 1,
previous NMR studies demonstrated that the structure of TAR has a similar conformation
when in complex with either argininamide or Tat peptides (Aboul-ela et al., 1995; Puglisi et
al., 1992). The improved spectral properties of the two base bulge HIV-2 TAR helped
determine a high resolution structure and identify the base triple. This chapter discusses the
Tat peptide complexes in the context of the two base bulge HIV-2 TAR. Although HIV-2
TAR may help improve the RNA spectra, the choice of which peptide to study remains
unclear. A number of different peptides have been tested but the spectral quality of these
complexes with HIV-1 TAR have been very poor and not amenable to high resolution
structural studies (Aboul-ela et al., 1995). Peptides containing a single arginine with 10
lysines, the R52 peptide with the HIV-1 TAR were tested. By having only one arginine
residue instead of the six found in the Tat basic domain, the key arginine residue contacting
the RNA would be assignable in homonuclear spectra. However, the peptide proton
resonances were broad and essentially uninterpretable. These studies were performed
before the technology to produce isotopically labeled peptides became available.
Recently, in vivo peptide expression as a fusion protein making isotopic labeling
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Figure 6.1: A number of different peptides have been tested for specific
TAR binding. However, it is not clear what other Tat residues, if any, in
addition to the critical arginine is required for specific binding. The
arginine-rich RNA binding domain is highlighted by the shaded rectangle.
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possible became available, thus creating an opportunity to revisit Tat peptide-TAR
complexes with some hope of making full assignments. Because of a continuing
controversy on whether there are minor elements of specificity and which residues may be
involved, the choice of which peptide to study remains non-trivial. Figure 6.1 highlights
the major candidates which have been extensively studied (Churcher et al., 1993; Hamy et
al., 1993; Long & Crothers, 1995; Weeks & Crothers, 1991; Weeks & Crothers, 1992).
Besides the key arginine, the other residues only induce very small specificity effects of
factors of two to four, making these measurements difficult. Because another research
group has been studying different ADP peptides with HIV-1 TAR in the NMR (Aboul-ela
et al., 1995), we chose to start with the TFR series of peptides which have been
extensively investigated by Crothers and co-workers (Long & Crothers, 1995; Weeks et
al., 1990; Weeks & Crothers, 1991; Weeks & Crothers, 1992). Also, the ADP peptides
contain a stretch of hydrophobic residues which may explain the slightly steeper binding
curves and may cause aggregation problems at the high concentrations required for NMR
studies. The tfr24 peptide is a good first candidate because of its kinetic stability compared
to shorter peptides and the additional residues of the tfr38 fragment are probably not critical
for specific RNA binding as the last 14 residues are unimportant for in vivo activity.
6.2 Materials and Methods
6.2.1 Peptide expression and preparation
To obtain isotopically labeled Tat peptides, peptide sequences were expressed as a
C-terminal fusion with a modified, His-tagged TrpE leader polypeptide (Figure 6.2)
(Schumacher et al., 1996; Staley & Kim, 1994). This construct allows a straightforward
purification because the trpE readily forms inclusion bodies. The peptide is cleaved from
the fusion protein by cyanogen bromide at the methionine immediately N-terminal to the Tat
peptide.
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5' AGCTTTGCGTAAAAAAAGACGTCAGCGCCGGCGGCCGCCTCAGGGC TCCCAGACTCACCAAGTGAGCTTAAGCAAACAGTGATAAAT
3' ATACGCATTTTTTTCTGCAGTCGCGGCCGCCGGCGGA GTCCCGAGGGTCTGAGTGGTTCACTCGAATTCGTTTGTCACTATTTAGC
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Figure 6.2: Oligo A is annealed with C and B with D before being ligated together
and to the plasmid. The Tat peptide is expressed as a fusion with TrpE and separated
from the fusion by cyanogen bromide cleavage.
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Plasmid construction The genes to express the peptides were constructed by direct three
piece ligation into the pKK223-3-XN expression vector (Pharmacia Biotech), which was
altered by Christopher Cilley for expression of XN peptides (personal communication).
This vector contains the TrpE protein under the control of a strong tac promoter and an
ampicillin resistance gene marker. Four oligos were synthesized, kinased, and annealed
before being ligated between Clal and HindI restriction sites as shown schematically in
Figure 6.2. The plasmids were transformed into E. Coli strain JM109 by the Hannehan
method. Attempts to use frozen competent JM109 cells for the transformation failed
probably because JM109 does not transform with high yields in combination with the low
transformation efficiencies obtained from three piece ligations. SacI was added to linearize
any uncut plasmid and reduce the number of background colonies, since there was an
unique SacI in the original pKK223-3-XN plasmid and none in the desired product.
Transformants were selected by growing on ampicillin LB plates, tested with restriction
digests, and sequenced.
Peptide purification For isotopic labeling, cells were grown on minimal media consisting
of: 21.5 g/L glycerol (17.2 ml), 0.7 g/L "N-(NH 4)2SO 4, 10.01 g/L Na2HPO 4.7 H20, 1.6
g/L KH2PO4, 0.5 g/L sodium citrate, 0.3 g/L MgSO 4, 5 mg/L Vitamin B 1 (thiamine), 50
mg/L ampicillin, and 1.5 ml of a trace elements solution consisting of 20 g/L Na2EDTA,
0.5 g/L CaC12*H20, 16.7 g/L FeC12*6 H20 , 0.18 g/L ZnSO 4 7H 20, 0.16 g/L CuSO 4.5
H20, and 0.18 g/L CoCl2.6 H20. Expression was induced with isopropyl-p-D-
thiogalactopyranoside (IPTG) when the cells reached an optical density between 0.6 and
0.8 at 600 nanometers. Typically the optical density increased by a factor of 2-2.5 during
the 4-8 hours of induction and 2-3 grams of wet cells per liter were obtained.
An inclusion body preparation was performed by initiating lysis with lysozyme and
sonicating the cells for three 20 minutes periods. Per liter, the cells were resuspended in 30
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ml of 50 mM Tris-Acetate, pH 8.0, 10 mM MgCl2, 100 mM NaCi, and 0.1 mM EDTA
(SB 1) with 5 mg lysozyme and -50 gg of DNAse I. After gently agitating the solution at
room temperature for 15 minutes, the solution was cooled on ice before being sonicated for
five 30 second periods with two minutes between the pulses. The pellet was collected by
centrifugation at 6000 g for 30 minutes and resuspended in 45 ml of 20 mM Tris-Acetate,
pH 8.0, 0.5 M NaC1, and 1 mM EDTA (SB2) with 2.25 ml of 20% Triton X-100 before a
second round of sonication. After centrifugation, the pellet was dissolved in 45 ml of H20
and the sonication was repeated for a third and final time. This procedure solubilizes most
of the cellular proteins, except the inclusion bodies containing the fusion protein, resulting
in a simple, large-scale purification. The remaining pellet was dissolved in 30-40 ml of
100 mM HCI or 10 ml of 70% formic acid and incubating with 100 mg cyanogen bromide
was added for one hour at room temperature. Cyanogen bromide cleaves the methionine
immediately N-terminal to the Tat peptide, releasing the peptide from the fusion protein
(Schumacher et al., 1996; Staley & Kim, 1994). A second 100 mg aliquot of cyanogen
bromide was added for an additional hour. After lyophilization to remove the cyanide, the
pellets were dissolved in water and neutralized with sodium hydroxide which caused the
trpE to precipitate. The supernatant, which contained the cleaved peptide, was further
purified by two rounds of reverse phase HPLC with 0.1% TFA in H20/acetonitrile and
concentrated by lyophilization before dialysis for >48 hours into water using a 1000
molecular weight nitrocellulose membrane (Spectrum). To check the peptide composition
and estimate the concentration, amino acid analysis was performed. For concentration
measurements, two amino acid analyses were averaged because no aromatic residues are in
these sequences for UV spectrometric determination of the concentration and the peptide
backbone is not very accurate because many small impurities have large extinction
coefficients in the low UV region. From two liters of minimal media growth,
approximately 830 nanomoles were obtained, which was split into two "1 N tfr24 samples:
one 1.2 mM peptide-TAR complex and one 0.45 mM tfr24 free peptide sample. Synthetic
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tfr24 peptide was synthesized and purified by Andrew Bennett and Rob Tycko of the NIH.
Samples were dialyzed and concentrations determined by amino acid analysis. To assay a
number of different sample conditions, the peptide-TAR complex sample was divided into
thirds. Temperatures from 5-300 C, pHs from 5-7, and NaCl concentrations from 5-100
mM were tested.
6.2.2 NMR spectroscopy
Spectra were collected on either a 600 Varian INOVA spectrometer or 750 MHz
Varian Unity Plus spectrometer equipped with a Varian triple resonance gradient probe. All
spectra were processed and analyzed using NMRPipe (Delaglio et al., 1995) on a Silicon
Graphics Indy workstation.
Proton NMR spectra in H20 were recorded at a variety of temperatures and mixing
times, including 50 and 100 ms. NOESY spectra used a WATERGATE 3-9-19 water
suppression scheme with a selective E-BURP-1 flip-back pulse (Green & Freeman, 1991;
Lippens et al., 1995; Piotto et al., 1992). Sweep widths were 14000 or 16000 Hz at 600
and 750 MHz, respectively, and 4096 x 512 real points collected. Data were zero filled to
4K x 2K real points and apodized using Gaussian-Lorentzian functions in both dimensions
before Fourier transformations.
15N FHSQC spectra were collected at a variety of temperatures and peptide:RNA
concentrations using 3-9-19 WATERGATE for water suppression with the transmitter set
to 98 ppm (Mori et al., 1995; Piotto et al., 1992). Sweep widths were 7000 x 6000 Hz
and 512 x 128 real points collected. The 15N NOESY-HSQC at 250 C used a 3-9-19
WATERGATE sequence for water suppression at 600 MHz with the transmitter set to 90
ppm with a 100ms mixing time (Mori et al., 1995). Sweep widths of 6000 x 13,500 x
4500 were used and 512 x 128 x 32 real points for the )3, (02, and ol dimensions,
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respectively. GARP was used to decouple 15N during acquisition (Shaka et al., 1983), and
a composite 1800 15N pulse decoupled the protons during the tl proton evolution time.
6.3 Formation of the tfr24 Peptide-TAR Complex
The titration of the tfr24 peptide with TAR was carefully monitored as the peptide
concentrations determined from amino acid analysis are susceptible to errors by as much as
a factor of two. We expected to add peptide until the TAR imino spectrum looked like the
argininamide complex which should indicate that most of the TAR was bound. Before
reaching this endpoint, the RNA resonances almost completely broadened significantly
before returning to observable levels as shown in Figure 6.3. The imino lines are
significantly broader than in the TAR-argininamide complex as illustrated in Figure 6.4.
Some broadening is expected because of the larger molecular weight of the peptide
complex. The peptide complex imino spectra look strikingly similar to the argininamide
complex suggesting that the RNA secondary structure is the same in the two complexes.
Further tests verified that the complex is approximately equimolar peptide and RNA. The
titration was performed twice: once with "1 N-labeled tfr24 and once with synthetic tfr24 in
a 2 mM sample. The synthetic tfr24 complex was prepared for solid state NMR studies
where the two labeled 13C carbonyl carbons could be integrated and compared to all the
natural abundance methyl and methylene peaks. This calculation demonstrated that the
complexes were at a 1:1 peptide:RNA stoicheiometry (data not shown). Thus, more
confidence that the observed NMR spectra are 1:1 complexes was obtained.
6.3.1 "SN-NMR spectroscopy of tfr24
To determine whether the peptide spectra were of sufficient quality for high
resolution structural studies, the peptide backbone and arginine sidechains were monitored
by 1SN-FHSQC spectra. In a structured peptide or protein, the amide "1 N/'H and the
arginine NE/HE crosspeaks are sharp and well-resolved as observed for the Rev (Battiste et
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al., 1996) and X peptide RNA complexes (Cilley and Williamson, unpublished results).
Figure 6.5 compares the '5N FHSQC of the tfr24 peptide before and after the addition of
HIV-2 TAR. The amide and He resonances are very poorly resolved and the proton peaks
are broadened in the RNA complex. All five of the critical arginine He/NE crosspeaks are
severely overlapped and only a single backbone amide significantly shifts upon addition of
TAR. The 3D 15N NOESY-HSQC experiment suggest that this amide is an arginine as
shown in Figure 6.6. This result is consistent with all the previous NMR and biochemical
results which suggest that only a single arginine is required for specific TAR binding. The
other residues of the peptide increase the affinity of the complex presumably by making
non-specific phosphate backbone contacts and increasing the contact surface area. The
spectra are certainly not of high enough quality to pursue high resolution structural studies.
It would be very difficult to assign the backbone where only 11 of the 24 amide resonances
can be clearly observed. Furthermore, the critical arginine intermolecular contacts would
be impossible to resolve due to the lack of dispersion of the arginine He resonances, which
proved extremely valuable in solving the Rev-RRE structure. Because of the lack of
dispersion, it is unlikely that the peptide is forming an a-helix. Furthermore, base on the
chemical shift index, the peptide is likely in a random coil or extended strand conformation
and not a a-helix as has been previously proposed (Mujeeb et al., 1994). These results
are consistent with careful difference CD measurements showing that the argininamide
complex CD spectrum is very similar to the wild type peptide TAR complex suggesting that
the peptide does not significantly change conformation upon binding (Long & Crothers,
1995). To try to improve the quality of the spectra, a wide range of pH, salt and sample
concentrations were tested but no significant improvements in the chemical shift dispersion
or linewidths were observed. More peptide was also added to one of the diluted samples
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Figure 6.5: 1 5N-FHSQC spectra of the Tat tfr24 peptide A) in the
absence of TAR and B) in complex with HIV-2 TAR at 250C at 600
MHz. Some chemical shift changes occur but the lines broaden and
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Figure 6.6: Watergate NOESY (mix=100 ms) at 150C at 600 MHz of the
tfr24 peptide-HIV-2 TAR RNA complex. The lines are very broad. However,
the A27 amino proton resonances, highlighted by the rectangle, are split
indicating that the base triple structure is more stable. These resonances
are exchanging more slowly than in the argininamide complex where only a
single proton peak was observed at the average of these two resonances.
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beyond the 1:1 equimolar ratio, but no significant changes in the '5N-HSQC or imino
spectra were observed.
6.3.2 Conformation of TAR in the tfr24 complex
The RNA spectrum is very similar to the TAR - argininamide complex spectra,
suggesting that the RNA conformation is very similar in the two complexes. The 250 C
imino proton chemical shifts of the imino spectrum is almost identical to the 50 C spectra of
the TAR - argininamide spectra. Many of the cytidine aminos and H5 chemical shifts also
are very similar to the TAR-argininamide spectra. One interesting difference is that both
A27 amino protons are observed as distinct peaks, while those in the argininamide complex
are degenerate (Figure 6.7). This observation is consistent with a base triple interaction
where one of the A27 amino protons is hydrogen bonding to the U23. Disappointingly,
the already broad spectra continued to broaden at lower temperatures where the base triple
imino is generally more easily observable as seen in the BIV Tat-TAR and HIV Rev-
aptamer peptide complexes (Ye et al., 1996; Ye et al., 1995). This broadening probably
contributed to obscuring the U23 imino resonance which is not clearly observable in the
homonuclear spectra in any of the conditions surveyed.
6.4 Future Prospects and Research
6.4.1 The TAR arginine binding motif
The arginine binding motif originally identified in the HIV Tat-TAR interaction has
recently been observed in other contexts. A TAR bulge motif was identified in the selection
of high affinity Rev-binding aptamers, which gave the same chemical modification
interference signature as TAR (Giver et al., 1993; Jensen et al., 1994). The ensuing
solution structure of the Rev peptide-aptamer complex provided unambiguous evidence for
a U-A*U base triple forming an arginine binding site (Ye et al., 1996), very similar to the
HIV-2 TAR structure. The rmsd between the Rev-aptamer and the HIV-2 TAR for the
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bases involved in the base triple, U-A*U, the arginine, and the G-C base pair contacting the
arginine is 1.12 A. The architecture of the arginine binding site in these two different
contexts is the same. An U-A*U base triple also forms an arginine binding site in the BIV
Tat-TAR complex (Ye et al., 1995). The TAR bulge motif has also been identified in the
Rex Response Element (RexRE) RNA-Rex peptide interaction by SELEX (Baskerville et
al., 1995). Because of the sequence similarity, we expect this structure to resemble the
HIV TAR-arginine interaction. Finally, small molecules that bind to the HIV TAR bulge
mimic the arginine guanidium group and bind in a very similar manner as arginine-rich
peptides (Hamy et al., 1997). Thus, the base triple in the TAR bulge may prove to be a
common structural motif for arginine guanidium group recognition.
6.4.2 Other Tat-TAR complexes
Because of the many subtle kinetic effects involved in the Tat peptide-TAR RNA
interaction, a wide variety of peptides may have to be tested to find one that would give
high quality spectra for a high resolution structure determination. Perhaps the next best
candidate after tfr24 is the HIV-2 tfr24 equivalent, t2fr27. Comparing the HIV-1 and HIV-
2 Tat protein sequences reveals significant variation of the other amino acids in the basic
RNA binding domain (Figure 6.1). Some subtle specificity differences may exist between
the two and three base bulge TARs, so that it is worth investigating the HIV-2 equivalent of
tfr24 (Chang & Jeang, 1992). Another possibility is to examine the C38-G27*C23 + base
triple mutant, discussed in Chapter 4, as the peptide does not seem to be adversely affected
at lower pHs. Because of the extra G-C base pair in the upper stem, this mutant may be
more stable and help improve the quality of the peptide complex spectra. Chapter 5
presents evidence suggesting that U40 may be experiencing conformational exchange,
thus, mutating the A22-U40 to a G-C base pair may stabilize the peptide complex. A C22-
G40 mutant binds the tfr24 peptide with a factor of two higher affinity than wild type TAR.
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One of these mutants or a combination may help improve the quality of the peptide complex
spectra.
Perhaps the future of structural studies of the Tat-TAR system depends on the
identification of the loop binding protein and the ensuing formation of a tripartite complex.
These three molecules probably bind in a highly cooperative manner providing some hope
that a complex suitable for NMR and/or X-ray studies is possible.
6.4.3 Drug discovery
Extensive efforts over the last decade have focused on finding inhibitors of the HIV
Tat-TAR interaction. A number of different candidates have been found that specifically
bind TAR and inhibit Tat binding in vitro. One of the problems of HIV pharmaceuticals is
HIV's remarkable ability to mutate rapidly and avoid the drug even with the new triple drug
therapy approaches. The Tat-TAR interaction may be an excellent target not only because it
is critical for the viral life cycle but to avoid an inhibitor, a large number of concomitant
mutations would be required compared to mutating a single amino acid in a protein.
Inhibitors that are based on peptide or peptoid chemistry have arginine guanidium groups
that bind to TAR which even has the same conformation when bound to the drug as it does
in arginine complexes (Hamy et al., 1997). This candidate inhibits the Tat-TAR interaction
in both in vivo transactivation and in live virus assays. Perhaps finding a small molecule
that can specifically bind to both the TAR loop and bulge regions would provide more
specificity. One recently introduced method, Structure-Activity Relationships, SAR, to
identify weak binding molecules is to test libraries of small molecules by NMR and then
linking these weak binding molecules together to make a high affinity inhibitor (Shuker et
al., 1996). Perhaps weak binding molecules that specifically bind to different parts of TAR
including the hexanucleotide loop can be linked together to form a highly specific Tat
inhibitor. SAR requires large quantities RNA and more importantly a large and diverse
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library of molecules to screen. However, it offers the ability to find weak binding
molecules which can be used as candidates to start making high affinity inhibitors.
Much effort and many neurons have been applied to the Tat-TAR interaction and we
still do not know how this critical step in the viral life cycle works. These proposed studies
may not lead to the holy grail of a therapeutic agent but they may help discover more about
the Tat-TAR interaction and identify specific inhibitors.
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Appendix A: 2' Hydroxyls in RNA
This appendix discusses the observation of 2'hydroxyl protons in homonuclear
NOESY experiments. These protons are rarely observed in RNA spectra. The few
examples that have been identified are involved in unusual structure like in tetraloops,
tobramycin or ATP binding. In typical A-form helices, the 2'OH is directed out into
solution and does not make any hydrogen bonding contacts with other parts of the
structure. Thus, the 2'OH proton is exchanging rapidly with water making the observation
and assignment of 2'OH protons very difficult. However, at higher fields and lower
temperatures, 2'OH protons were observed in homonuclear watergate NOESY
experiments. They were identified by their unique pattern of NOEs to ribose protons,
summarized in Table A. 1, and through spin-diffusion cross peaks to aromatic H8 and H6
protons. Figure A. 1 shows that some of the 2'OH protons that were observed in the HIV
2 TAR - argininamide complex. Of course NOESY assignments are unreliable, so
numerous attempts were made to devise experiments to make through bond correlations to
the 2'OH protons. These experiments would need to overcome both the fast water
exchange rate and the small two bond coupling constants to either the C2' or >3 bond
coupling to a nearby proton. Neither CPMG type experiments nor direct INEPT and
TOCSY transfers succeeded. Perhaps, higher field and better signal to noise spectrometers
will help make unambiguous assignments of 2'OH protons. Although there does not seem
to be many particularly useful NOEs to 2'OH protons in a standard A-form helix, their
unambiguous through-bond assignment in other RNA structures may be imperative.
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Appendix B: Molecular Modeling Details
This appendix is a compilation of the XPLOR scripts and NMR-derived restraints
used for the structure determination. These files provide all the details of exactly how the
structure was calculated, as described in the materials and methods section of Chapter 3. In
addition the non-experimental files are also included showing how the argininamide and
base triple hydrogen bonds were restrained along with A-form torsions. The first section
contains the three .tbl files which contain all the NMR restraints along with the .tbl files
used to define the various hydrogen bonding and planarity restraints for the modeling
calculations discussed in section 3.6. Appendix B.2 lists the four XPLOR scripts that
constitute the molecular dynamics protocol used for structure determination. Numerous
additional XPLOR and PERL scripts were written to analyze the structures and some of the
more useful and generally applicable ones are compiled in appendix B.3. These scripts
include measuring torsions from XPLOR .pdb files, measuring particular distances, like
the U23-N3 to A27-N7. Also, a PERL script which converts the .tbl files to INSIGHT
.rstrnt files is provided. These scripts were necessary to make the NOE figures of Chapter
3. Note that for many of the PERL scripts, master csh scripts are used to direct
input/output and run logic loops through multiple structures/files. Finally, in section B.4, a
series of csh scripts, a c program, and a PERL script that work together to convert XPLOR
.pdb files to standard .pdb (c.a. 1997) for submission to the Brookhaven PDB are
presented. For further explanations of the XPLOR scripts, consult the XPLOR manual
(Brunger, 1992) or the excellent on-line manual at the XPLOR web page. The final 20
structures have been deposited into the Brookhaven Protein Data Bank.
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Appendix B.1 NMR restraints
NOE Restraints:
These are all the NOE restraints used for the structure determination. Residue number 47 is
the argininamide. The three columns define a distance range in the following order: the
center distance, center - this column, center + this column.
! noes in order residue number order
! for square well potential, the format is: d dminus dplus
! adjusted ARG HH restraints to 4.0 A upper bound and two epsilon noes where
! spin diffusion is unlikely to 5.0 A upper bound
!removed intranuc H5 - H4* and H5-H6 noes
! made H5 noes upper bound 6.0 A except for the strong internuc H5-H3'
set echo = off end
set message = off end
! LOWER STEM
assign (resid 16 and name H2' )(resid 16 and name H1' )
assign (resid 16 and name H3' )(resid 16 and name Hi' )
assign (resid 16 and name H3' )(resid 16 and name H2' )
assign (resid 16 and name H4' )(resid 16 and name H1' )
assign (resid 16 and name H4' )(resid 16 and name H2' )
assign (resid 16 and name H4' )(resid 16 and name H3' )
assign (resid 16 and name H5' or resid 16 and name H5")(resid 16 and name H4' )
assign (resid 16 and name H5' or resid 16 and name H5")(resid 16 and name H1' )
assign (resid 16 and name H5'
assign (resid 16 and name H5'
assign (resid 16 and name H8
assign (resid 16 and name H8
assign (resid 16 and name H8
assign (resid 16 and name H8
assign (resid 16 and name H8
assign (resid 17 and name H1'
assign (resid 17 and name H2'
assign (resid 17 and name H3'
assign (resid 17 and name H3'
assign (resid 17 and name H4'
assign (resid 17 and name H4'
assign (resid 17 and name H4'
or resid 16 and name H5")(resid 16 and name H2' )
or resid 16 and name H5")(resid 16 and name H3' )
)(resid 16 and name HI' )
)(resid 16 and name H2' )
)(resid 16 and name H3' )
)(resid 16 and name H4' )
)(resid 16 and name H5' or resid 16 and name H5" )
)(resid 16 and name H2' )
)(resid 17 and name Hi' )
)(resid 17 and name H1' )
)(resid 17 and name H2' )
)(resid 17 and name HI' )
)(resid 17 and name H2' )
)(resid 17 and name H3' )
assign (resid 17 and name H5' or resid 17 and name H5")(resid 17 and name H3' )
assign (resid 17 and name H5' or resid 17 and name H5")(resid 17 and name H4' )
assign (resid 17 and name H8 )(resid 16 and name Hi' )
assign (resid 17 and name H8 )(resid 16 and name H2' )
assign (resid 17 and name H8 )(resid 16 and name H3' )
assign (resid 17 and name H8 )(resid 16 and name H8 )
assign (resid 17 and name H8 )(resid 17 and name H1' )
assign (resid 17 and name H8 )(resid 17 and name H2' )
assign (resid 17 and name H8 )(resid 17 and name H3' )
assign (resid 17 and name H8 )(resid 17 and name H4' )
2.40
2.90
2.40
2.90
3.40
2.40
2.90
3.90
3.90
3.40
3.40
2.90
3.40
3.40
3.90
3.40
2.40
2.90
2.40
2.90
2.90
2.40
3.90
2.90
3.40
2.40
2.90
3.40
2.90
3.40
2.90
3.40
0.60
1.10
0.60
1.10
1.60
0.60
1.10
2.10
2.10
1.60
1.60
1.10
1.60
1.60
2.10
1.60
0.60
1.10
0.60
1.10
1.10
0.60
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1.10
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0.60
1.10
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1.60
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0.60
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0.60
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1.60
1.10
1.60
1.60
1.10
1.60
0.60
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0.60
1.10
1.10
0.60
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1.10
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assign (resid 17 and name H8 )(resid 17 and name H5' or resid 17 and name H5")
assign (resid 18 and name H 1' )(resid 17 and name H2' )
assign (resid 18 and name H2' )(resid 18 and name H' )
assign (resid 18 and name H3' )(resid 18 and name H1' )
assign (resid 18 and name H4' )(resid 18 and name HI' )
assign (resid 18 and name H4' )(resid 18 and name H3' )
assign (resid 18 and name H5' or resid 18 and name H5" )(resid 17 and name H2' )
assign (resid 18 and name H5' or resid 18 and name H5" )(resid 18 and name HI' )
assign (resid 18 and name H5' or resid 18 and name H5" )(resid 18 and name H113' )
assign (resid 18 and name H5' or resid 18 and name H5" )(resid 18 and name H4' )
assign (resid 18 and name H41
assign (resid 18 and name H42
assign (resid 18 and name H6
assign (resid 18 and name H6
assign (resid 18 and name H6
assign (resid 18 and name H6
assign (resid 18 and name H6
assign (resid 18 and name H6
assign (resid 18 and name H6
assign (resid 18 and name H6
assign (resid 18 and name H5
assign (resid 18 and name H5
assign (resid 18 and name H5
assign (resid 19 and name H112'
assign (resid 19 and name H113'
assign (resid 19 and name H3'
assign (resid 19 and name H4'
assign (resid 19 and name H42
assign (resid 19 and name H42
assign (resid 19 and name H6
assign (resid 19 and name H6
assign (resid 19 and name H6
assign (resid 19 and name H6
assign (resid 19 and name H6
assign (resid 19 and name H5
assign (resid 19 and name H5
assign (resid 19 and name H5
assign (resid 20 and name H11'
assign (resid 20 and name H2'
assign (resid 20 and name H3'
assign (resid 20 and name H3'
assign (resid 20 and name H113'
assign (resid 20 and name H4'
assign (resid 20 and name H4'
assign (resid 20 and name H4'
)(resid 17 and name H1
)(resid 17 and name H1
)(resid 17 and name H1' )
)(resid 17 and name H2' )
)(resid 17 and name H3' )
)(resid 18 and name Hi' )
)(resid 18 and name H2' )
)(resid 18 and name H3' )
)(resid 18 and name H4' )
)(resid 18 and name H5' o
)(resid 17 and name H2' )
)(resid 17 and name H113' )
)(resid 18 and name H113' )
r resid 18 and name H115" )
)(resid 19 and name H1' )
)(resid 19 and name Hi' )
)(resid 19 and name H2' )
)(resid 19 and name H2' )
)(resid 18 and name H42 )
)(resid 18 and name H5 )
)(resid 18 and name H2' )
)(resid 18 and name H3' )
)(resid 19 and name H1' )
)(resid 19 and name H113' )
)(resid 19 and name H5' or resid 19 and name H5" )
)(resid 18 and name H41 )
)(resid 18 and name H42 )
)(resid 18 and name H5 )
)(resid 19 and name H112' )
)(resid 20 and name H111' )
)(resid 19 and name H112' )
)(resid 20 and name HI' )
)(resid 20 and name H2' )
)(resid 20 and name Hi' )
)(resid 20 and name H2' )
)(resid 20 and name H3' )
assign (resid 20 and name H5' or resid 20 and name H5")(resid 20 and name H3' )
assign (resid 20 and name H5' or resid 20 and name H5")(resid 20 and name H4' )
assign (resid 20 and name H8 )(resid 19 and name H1' )
assign (resid 20 and name H8 )(resid 19 and name H2' )
assign (resid 20 and name H8 )(resid 19 and name H113' )
assign (resid 20 and name H8 )(resid 19 and name H6 )
3.90 2.10 1.10
3.40
2.40
2.90
2.90
2.40
3.90
3.90
3.40
2.90
3.90
3.90
3.40
2.90
3.40
3.40
3.40
2.40
3.40
3.90
3.65
3.65
3.40
2.40
2.90
2.40
3.40
3.90
3.90
2.40
2.90
3.40
2.90
3.90
3.90
3.90
3.40
3.40
2.40
3.40
2.90
2.40
2.90
2.90
2.40
3.40
2.90
3.40
2.40
2.90
3.40
1.60
0.60
1.10
1.10
0.60
2.10
2.10
1.60
1.10
2.10
2.10
1.60
1.10
1.60
1.60
1.60
0.60
1.60
2.10
1.85
1.85
1.60
0.60
1.10
0.60
1.60
2.10
2.10
0.60
1.10
1.60
1.10
2.10
2.10
2.10
1.60
1.60
0.60
1.60
1.10
0.60
1.10
1.10
0.60
1.60
1.10
1.60
0.60
1.10
1.60
1.60
0.60
1.10
1.10
0.60
1.10
1.10
0.60
0.10
2.10
2.10
1.60
1.10
1.60
1.60
1.60
0.60
1.60
1.10
2.35
1.35
2.60
0.60
1.10
0.60
1.60
2.10
2.10
0.60
1.10
1.60
1.10
1.10
2.10
2.10
2.60
1.60
0.60
1.60
1.10
0.60
1.10
1.10
0.60
1.60
1.10
1.60
0.60
1.10
2.60
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assign (resid 20 and name H8
assign (resid 20 and name H8
assign (resid 20 and name H8
assign (resid 20 and name H8
assign (resid 20 and name H8
assign (resid 20 and name H2
assign (resid 20 and name H2
assign (resid 21 and name H1'
assign (resid 21 and name H1'
assign (resid 21 and name H2'
assign (resid 21 and name H3'
assign (resid 21 and name H3'
assign (resid 21 and name H3'
assign (resid 21 and name H4'
assign (resid 21 and name H4'
assign (resid 21 and name H5' or resid 21
assign (resid 21 and name H5' or resid 21
assign (resid 21 and name H5' or resid 21
assign (resid 21 and name H8 )(resid 20
assign (resid 21 and name H8 )(resid 20
assign (resid 21 and name H8 )(resid 20
assign (resid 21 and name H8 )(resid 20;
assign (resid 21 and name H8 )(resid 20;
assign (resid 21 and name H8 )(resid 21
assign (resid 21 and name H8 )(resid 21
assign (resid 21 and name H8 )(resid 21
assign (resid 21 and name H8 )(resid 21
assign (resid 21 and name H8 )(resid 21
assign (resid 21 and name H1 )(resid 20
assign (resid 22 and name H 1'
assign (resid 22 and name H2'
assign (resid 22 and name H3'
assign (resid 22 and name H3'
assign (resid 22 and name H4'
assign (resid 22 and name H4'
assign (resid 22 and name H4'
assign (resid 22 and name H5'
assign (resid 22 and name H8
assign (resid 22 and name H8
assign (resid 22 and name H8
assign (resid 22 and name H8
assign (resid 22 and name H8
assign (resid 22 and name H8
assign (resid 22 and name H8
assign (resid 22 and name H8
assign (resid 22 and name H2
assign (resid 22 and name H2
assign (resid 22 and name H2
assign (resid 22 and name H2
)(resid 20 and name HI' )
)(resid 20 and name H2' )
)(resid 20 and name H3' )
)(resid 20 and name H4' )
)(resid 20 and name H5' or resid 20 and name H5")
)(resid 20 and name Hi' )
)(resid 20 and name H2' )
)(resid 20 and name H2' )
)(resid 20 and name H2 )
)(resid 21 and name HI' )
)(resid 20 and name H2' )
)(resid 21 and name H' )
)(resid 21 and name H2' )
)(resid 21 and name H' )
)(resid 21 and name H3' )
and name H5")(resid 20 and name H2' )
and name H5")(resid 21 and name H3' )
and name H5")(resid 21 and name H4' )
and name H1' )
and name H2' )
and name H3' )
and name H8 )
and name H2 )
and name H1' )
and name H2' )
and name H3' )
and name H4' )
and name H5' or resid 21 and name H5")
and name H2 )
)(resid 21 and name H2' )
)(resid 22 and name HI' )
)(resid 22 and name Hi' )
)(resid 22 and name H2' )
)(resid 22 and name Hi' )
)(resid 22 and name H2' )
)(resid 22 and name H3' )
or resid 22 and name H5")(resid 22 and name H3' )
)(resid 21 and name H1' )
)(resid 21 and name H2' )
)(resid 21 and name H3' )
)(resid 21 and name H8 )
)(resid 22 and name Hi' )
)(resid 22 and name H2' )
)(resid 22 and name H3' )
)(resid 22 and name H4' )
)(resid 21 and name HI )
)(resid 21 and name H22 )
)(resid 22 and name H1' )
)(resid 22 and name H2' )
3.40
3.40
2.90
3.40
3.90
3.40
3.40
3.40
2.90
2.40
3.40
3.40
2.40
2.90
2.40
1.60
1.60
1.10
1.60
2.10
1.60
1.60
1.60
1.10
0.60
1.60
1.60
0.60
1.10
0.60
1.60
1.60
1.10
1.60
1.10
1.60
1.60
1.60
1.10
0.60
1.60
1.60
0.60
1.10
0.60
3.90 2.10 1.10
3.90 2.10 1.10
2.90 1.10 0.10
3.40
2.40
2.90
3.40
3.40
3.40
3.40
2.40
3.40
3.90
3.90
3.40
2.40
2.90
2.40
2.90
2.90
2.40
3.90
3.40
2.40
3.40
3.40
3.40
3.40
2.90
3.40
3.40
3.90
3.40
3.90
1.60
0.60
1.10
1.60
1.60
1.60
1.60
0.60
1.60
2.10
2.10
1.60
0.60
1.10
0.60
1.10
1.10
0.60
2.10
1.60
0.60
1.60
1.60
1.60
1.60
1.10
1.60
1.60
2.10
1.60
2.10
1.60
0.60
1.10
2.60
1.60
1.60
1.60
0.60
1.60
1.10
2.10
1.60
0.60
1.10
0.60
1.10
1.10
0.60
1.10
1.60
0.60
1.60
2.60
1.60
1.60
1.10
1.60
1.60
2.10
1.60
2.10
! INTERNUCLEOTIDE NOES TO U23
assign (resid 23 and name H5' or resid 23 and name H5")(resid 22 and name H2' ) 2.90 1.10 2.10
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assign (resid 23 and name HI' )(resid 26 and name H2' or resid 26 and name H3' )
assign (resid 23 and name H1' )(resid 26 and name H4')
assign (resid 23 and name H1' )(resid 26 and name H5' or resid 26 and name H5")
assign (resid 23 and name HI' )(resid 26 and name H8 )
assign (resid 23 and name H4' )(resid 26 and name H5' or resid 26 and name H5")
assign (resid 23 and name H4' )(resid 26 and name H8 )
! INTRANUCLEOTIDE NOES TO U23
assign (resid 23 and name H2' )(resid 23 and name HI' )
assign (resid 23 and name H3' )(resid 23 and name Hi' )
assign (resid 23 and name H3' )(resid 23 and name H2' )
assign (resid 23 and name H3' )(resid 23 and name H5' or resid 23 and name H5")
assign (resid 23 and name H4' )(resid 23 and name H1' )
assign (resid 23 and name H4' )(resid 23 and name H2' )
assign (resid 23 and name H4' )(resid 23 and name H3' )
assign (resid 23 and name H5' or resid 23 and name H5")(resid 23 and name H1' )
assign (resid 23 and name H5' or resid 23 and name H5")(resid 23 and name H4' )
assign (resid 23 and name H6 )(resid 23 and name Hi' )
assign (resid 23 and name H6 )(resid 23 and name H2' )
assign (resid 23 and name H6 )(resid 23 and name H3' )
assign (resid 23 and name H6 )(resid 23 and name H4' )
assign (resid 23 and name H5 )(resid 23 and name H2' )
!internucleotide NOEs to U25
assign (resid 25 and name H3'
assign (resid 25 and name H1'
! intranucleotide NOEs to U25
assign (resid 25 and name H2'
assign (resid 25 and name H3'
assign (resid 25 and name H3'
assign (resid 25 and name H4'
assign (resid 25 and name H4'
assign (resid 25 and name H4'
assign (resid 25 and name H5'
assign (resid 25 and name H5'
assign (resid 25 and name H6
assign (resid 25 and name H6
assign (resid 25 and name H6
assign (resid 25 and name H6
assign (resid 25 and name H6
assign (resid 25 and name H5
assign (resid 26 and name H1'
assign (resid 26 and name H2'
assign (resid 26 and name H4'
assign (resid 26 and name H4'
)(resid 23 and name H4' )
)(resid 42 and name Hi' )
2.90 1.10 1.10
3.40 1.60 1.60
)(resid 25 and name H1' )
)(resid 25 and name H1' )
)(resid 25 and name H2' )
)(resid 25 and name H1' )
)(resid 25 and name H2' )
)(resid 25 and name H3' )
or resid 25 and name H5")(resid 25 and name H3' )
or resid 25 and name H5")(resid 25 and name H4' )
)(resid 25 and name H1' )
)(resid 25 and name H2' )
)(resid 25 and name H3' )
)(resid 25 and name H4' )
)(resid 25 and name H5' or resid 25 and name H5")
)(resid 25 and name H2' )
)(resid 22 and name H2 )
or resid 26 and name H3' )(resid 26 and name H1' )
)(resid 26 and name HI' )
)(resid 26 and name H2' or resid 26 and name H3' )
2.40
2.90
2.40
2.40
3.40
2.40
3.40
2.90
2.90
2.40
2.90
3.40
0.60
1.10
0.60
0.60
1.60
0.60
1.60
1.10
1.10
0.60
1.10
1.60
0.60
1.10
0.60
1.60
1.60
0.60
1.60
0.10
1.10
0.60
2.10
1.60
3.65 1.85 1.35
3.65 1.85 2.35
3.40
2.50
2.40
3.40
1.60
0.70
0.60
1.60
1.60
0.50
1.60
1.60
assign (resid 26 and name H5' or resid 26 and name H5")(resid 26 and name HI' ) 3.90 2.10 1.10
assign (resid 26 and name H5' or resid 26 and name H5")(resid 26 and name H2' or resid 26 and name H3' )
3.90 2.10 2.10
assign (resid 26 and name H5' or resid 26 and name H5")(resid 26 and name H4' ) 2.90 1.10 0.10
assign (resid 26 and name H8 )(resid 22 and name H2' ) 3.65 1.85 1.85
assign (resid 26 and name H8 )(resid 22 and name H2 ) 3.40 1.60 1.60
assign (resid 26 and name H8 )(resid 26 and name Hi' ) 3.40 1.60 1.60
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2.90
3.40
2.90
2.90
3.40
3.40
2.40
3.40
2.40
3.40
2.40
2.90
2.40
3.65
2.65
2.90
2.90
2.90
2.90
3.65
1.10
1.60
1.10
1.10
1.60
1.60
0.60
1.60
0.60
1.60
0.60
1.10
0.60
1.85
0.85
1.10
1.10
1.10
1.10
1.85
1.10
1.60
1.10
1.10
1.60
1.60
0.60
1.60
0.60
1.60
1.60
1.10
0.60
1.35
0.35
1.10
1.10
2.10
2.10
2.35
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assign (resid 26 and name H8
assign (resid 26 and name H8
assign (resid 26 and name H8
assign (resid 26 and name H1
assign (resid 27 and name H1'
assign (resid 27 and name H1'
assign (resid 27 and name H1'
assign (resid 27 and name H2'
assign (resid 27 and name H3'
assign (resid 27 and name H3'
assign (resid 27 and name H3'
assign (resid 27 and name H4'
assign (resid 27 and name H4'
assign (resid 27 and name H4'
)(resid 26 and name H2' or resid 26 and name H3' )
)(resid 26 and name H4' )
)(resid 26 and name H5' or resid 26 and name H5")
)(resid 22 and name H2 )
)(resid 26 and name H2' or resid 26 and name H3' )
)(resid 26 and name H22 )
)(resid 26 and name H21 )
)(resid 27 and name H1' )
)(resid 26 and name H2' or resid 26 and name H3' )
)(resid 27 and name HI' )
)(resid 27 and name H2' )
)(resid 27 and name Hi' )
)(resid 27 and name H2' )
)(resid 27 and name H3' )
assign (resid 27 and name H5' or resid 27 and name H5" )(resid 26 and name H2' or resid
assign (resid 27 and name H5' or resid 27 and name H5" )(resid 27 and name H3' )
assign (resid 27 and name H5'
assign (resid 27 and name H8
assign (resid 27 and name H8
assign (resid 27 and name H8
assign (resid 27 and name H8
assign (resid 27 and name H8
assign (resid 27 and name H8
assign (resid 27 and name H8
assign (resid 27 and name H8
assign (resid 27 and name H2
or resid 27 and name H5" )(resid 27 and name H4' )
)(resid 26 and name H1' )
)(resid 26 and name H2' or resid 26 and name H3' )
)(resid 26 and name H8 )
)(resid 27 and name H1' )
)(resid 27 and name H2' )
)(resid 27 and name H3' )
)(resid 27 and name H4' )
)(resid 27 and name H5' or resid 27 and name H5" )
)(resid 26 and name H1 )
assign (resid 27 and name H61 or resid 27 and name H62)(resid 26 and name H1 )
3.90 2.10
3.40 1.60
3.90 2.10
3.40 1.60
3.90
3.90
3.90
2.40
3.90
2.90
2.40
2.90
3.40
2.40
26 and
4.40
3.90
2.90
3.40
3.90
3.40
3.40
3.40
2.90
3.40
3.90
3.90
3.90
2.10
2.10
2.10
0.60
2.10
1.10
0.60
1.10
1.60
0.60
name
2.60
2.10
1.10
1.60
2.10
1.60
1.60
1.60
1.10
1.60
2.10
2.10
2.10
1.10
1.60
2.10
1.60
2.10
2.10
2.10
0.60
2.10
1.10
0.60
1.10
1.60
0.60
H3'Y)
2.60
1.10
0.10
1.60
2.10
2.60
1.60
1.60
1.10
1.60
1.10
2.10
2.10
assign (resid 28 and name H1'
assign (resid 28 and name H1'
assign (resid 28 and name H2'
assign (resid 28 and name H3'
assign (resid 28 and name H3'
assign (resid 28 and name H3'
assign (resid 28 and name H4'
assign (resid 28 and name H4'
assign (resid 28 and name H4'
)(resid 27 and name H2' )
)(resid 27 and name H2 )
)(resid 28 and name HI' )
)(resid 27 and name H2' )
)(resid 28 and name HI' )
)(resid 28 and name H2' )
)(resid 28 and name HI' )
)(resid 28 and name H2' )
)(resid 28 and name H3' )
assign (resid 28 and name H5' or resid 28 and name H5"
assign (resid 28 and name H5' or resid 28 and name H5"
assign (resid 28 and name H5' or resid 28 and name H5"
assign (resid 28 and name H8
assign (resid 28 and name H8
assign (resid 28 and name H8
assign (resid 28 and name H8
assign (resid 28 and name H8
assign (resid 28 and name H8
assign (resid 28 and name H8
assign (resid 28 and name H8
assign (resid 28 and name H8
assign (resid 28 and name H1
assign (resid 28 and name H1
)(resid 27 and name H2' )
)(resid 28 and name H3' )
)(resid 28 and name H4' )
)(resid 27 and name H1' )
)(resid 27 and name H2' )
)(resid 27 and name HY3' )
)(resid 27 and name H8 )
)(resid 28 and name Hi' )
)(resid 28 and name H2' )
)(resid 28 and name H3' )
)(resid 28 and name H4' )
)(resid 28 and name H5' or resid 28 and name H5" )
)(resid 27 and name H2 )
)(resid 27 and name H61 or resid 27 and name H62)
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3.40
2.90
2.40
3.40
3.40
2.40
2.90
2.90
2.40
3.90
3.40
2.90
2.90
2.40
2.90
3.40
3.40
3.40
2.90
3.40
3.65
3.90
3.90
1.60
1.10
0.60
1.60
1.60
0.60
1.10
1.10
0.60
2.10
1.60
1.10
1.10
0.60
1.10
1.60
1.60
1.60
1.10
1.60
1.85
2.10
2.10
1.60
1.10
0.60
1.60
1.60
0.60
1.10
1.10
0.60
1.10
0.60
0.10
2.10
0.60
1.10
2.60
1.60
1.60
1.10
1.60
1.35
2.10
2.10
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assign (resid 29 and name H1'
assign (resid 29 and name H2'
assign (resid 29 and name H3'
assign (resid 29 and name H3'
assign (resid 29 and name H4'
assign (resid 29 and name H4'
assign (resid 29 and name H41
assign (resid 29 and name H42
assign (resid 29 and name H6
assign (resid 29 and name H6
assign (resid 29 and name H6
assign (resid 29 and name H6
assign (resid 29 and name H6
assign (resid 29 and name H6
assign (resid 29 and name H6
assign (resid 29 and name H6
assign (resid 29 and name H6
assign (resid 29 and name H5
assign (resid 29 and name H5
assign (resid 29 and name H5
assign (resid 29 and name H5
assign (resid 29 and name H5
!TAR LOOP
assign (resid 30 and name H1'
assign (resid 30 and name H2'
assign (resid 30 and name H3'
assign (resid 30 and name H3'
assign (resid 30 and name H4'
assign (resid 30 and name H4'
assign (resid 30 and name H4'
assign (resid 30 and name H4'
)(resid 28 and name H2'
)(resid 29 and name H1'
)(resid 29 and name H1'
)(resid 29 and name H112'
)(resid 29 and name H1'
)(resid 29 and name H2'
)(resid 28 and name H1
)(resid 28 and name H1
)(resid 28 and name H111'
)(resid 28 and name H2'
)(resid 28 and name H3'
)(resid 28 and name H8
)(resid 29 and name Hi1'
)(resid 29 and name H112'
)(resid 29 and name H113'
)(resid 29 and name H4'
)(resid 29 and name H5'
)(resid 28 and name H2'
)(resid 28 and name H3'
)(resid 28 and name H8
)(resid 28 and name H1
)(resid 29 and name H113'
resid 29 and name H5" )
) (resid 29 and name H112')
)(resid 30 and name HI' )
)(resid 30 and name HI' )
)(resid 30 and name H112' )
)(resid 29 and name H2' )
)(resid 30 and name Hi' )
)(resid 30 and name H2' )
)(resid 30 and name H113' )
assign (resid 30 and name H5' or resid 30 and name H5" )(resid 30 and name H3' )
assign (resid 30 and name H115' or resid 30 and name H5" )(resid 30 and name H4' )
assign (resid 30 and name H6
assign (resid 30 and name H6
assign (resid 30 and name H6
assign (resid 30 and name H6
assign (resid 30 and name H6
assign (resid 30 and name H6
assign (resid 30 and name H6
assign (resid 30 and name H5
assign (resid 30 and name H5
assign (resid 30 and name H5
assign (resid 31 and name H2'
assign (resid 31 and name H3'
assign (resid 31 and name H4'
assign (resid 31 and name H4'
assign (resid 31 and name H4'
)(resid 29 and name H111' )
)(resid 29 and name H2' )
)(resid 29 and name H6 )
)(resid 30 and name H111' )
)(resid 30 and name H112' )
)(resid 30 and name H3' )
)(resid 30 and name H4' )
)(resid 29 and name H41 )
)(resid 29 and name H42 )
)(resid 29 and name H5 )
)(resid 31 and name H 1' )
)(resid 31 and name H11' )
)(resid 31 and name H 1' )
)(resid 31 and name H2' )
)(resid 31 and name H3' )
assign (resid 31 and name H5' or resid 31
assign (resid 31 and name H5' or resid 31
assign (resid 31 and name H5' or resid 31
assign (resid 31 and name H5' or resid 31
and name H5" )(resid 30 and name H2' )
and name H5" )(resid 31 and name H12' )
and name H5" )(resid 31 and name H3' )
and name H5" )(resid 31 and name H4' )
3.40
2.40
2.90
2.40
2.90
2.90
3.90
3.90
3.40
2.40
3.40
3.40
3.40
3.40
3.40
3.40
3.90
3.90
3.65
3.65
3.90
3.40
2.40
2.40
3.40
2.40
2.90
2.90
3.40
2.40
1.60
0.60
1.10
0.60
1.10
1.10
2.10
2.10
1.60
0.60
1.60
1.60
1.60
1.60
1.60
1.60
2.10
2.10
1.85
1.85
2.10
1.60
0.60
0.60
1.60
0.60
1.10
1.10
1.60
0.60
1.60
0.60
1.10
0.60
1.10
1.10
2.10
2.10
1.60
0.60
1.60
2.60
1.60
1.60
1.60
1.60
1.10
2.10
1.35
2.35
2.10
2.60
2.60
0.60
1.60
0.60
2.10
1.10
1.60
0.60
3.90 2.10 1.10
3.40 1.60 0.60
3.40
2.40
3.90
3.40
2.40
3.40
3.40
3.90
3.90
3.65
2.40
3.40
2.90
3.40
2.40
3.90
3.90
3.90
2.90
1.60
0.60
2.10
1.60
0.60
1.60
1.60
2.10
2.10
1.85
0.60
1.60
1.10
1.60
0.60
2.10
2.10
2.10
1.10
1.60
0.60
2.10
1.60
1.60
1.60
2.60
2.10
2.10
2.35
0.60
1.60
1.10
1.60
0.60
2.10
2.10
2.10
1.10
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assign (resid 31 and name H6
assign (resid 31 and name H6
assign (resid 31 and name H6
assign (resid 31 and name H6
assign (resid 31 and name H6
assign (resid 31 and name H6
)(resid 30 and name H2' )
)(resid 30 and name H4' )
)(resid 31 and name H1' )
)(resid 31 and name H3' )
)(resid 31 and name H4' )
)(resid 31 and name H5' or resid 31 and name H5" )
assign (resid 32 and name H2' )(resid 32 and name HI' )
assign (resid 32 and name H3' )(resid 32 and name HI' )
assign (resid 32 and name H3' )(resid 32 and name H2' )
assign (resid 32 and name H4' )(resid 32 and name Hi' )
assign (resid 32 and name H4' )(resid 32 and name H2' )
assign (resid 32 and name H4' )(resid 32 and name H3' )
assign (resid 32 and name H5' or resid 32 and name H5" )(resid 31 and name H2' )
assign (resid 32 and name H5' or resid 32 and name H5" )(resid 32 and name H1' )
assign (resid 32 and name H5' or resid 32 and name H5" )(resid 32 and name H2' )
assign (resid 32 and name H5' or resid 32 and name H5" )(resid 32 and name H3' )
assign (resid 32 and name H5' or resid 32 and name H5" )(resid 32 and name H4' )
assign (resid 32 and name H8 )(resid 32 and name HI' )
assign (resid 32 and name H8 )(resid 32 and name H2' )
assign (resid 32 and name H8 )(resid 32 and name HY3' )
assign (resid 32 and name H8 )(resid 32 and name H4' )
assign (resid 32 and name H8 )(resid 32 and name H5' or resid 32 and name H5" )
assign (resid 33 and name H2' )(resid 33 and name HI' )
assign (resid 33 and name H3' )(resid 33 and name HI' )
assign (resid 33 and name H3' )(resid 33 and name H2' )
assign (resid 33 and name H4' )(resid 33 and name H2' )
assign (resid 33 and name H4' )(resid 33 and name HY3' )
assign (resid 33 and name H5' or resid 33 and name H5" )(resid 33 and name HI' )
assign (resid 33 and name H5' or resid 33 and name H5" )(resid 33 and name H2' )
assign (resid 33 and name H5' or resid 33 and name H5" )(resid 33 and name H3' )
assign (resid 33 and name H5' or resid 33 and name H5" )(resid 33 and name H4' )
assign (resid 33 and name H8 )(resid 32 and name Hi' )
assign (resid 33 and name H8 )(resid 33 and name H1' )
assign (resid 33 and name H8 )(resid 33 and name H2' )
assign (resid 33 and name H8 )(resid 33 and name H3' )
assign (resid 33 and name H8 )(resid 33 and name H4' )
assign (resid 34 and name H2' )(resid 34 and name HI' )
assign (resid 34 and name H3' )(resid 34 and name HI' )
assign (resid 34 and name H3' )(resid 34 and name H2' )
assign (resid 34 and name H4' )(resid 34 and name HI' )
assign (resid 34 and name H4' )(resid 34 and name HY3' )
assign (resid 34 and name H5' or resid 34 and name H5" )(resid 34 and name Hi' )
assign (resid 34 and name H5' or resid 34 and name H5" )(resid 34 and name H3' )
assign (resid 34 and name H5' or resid 34 and name H5" )(resid 34 and name H4' )
assign (resid 34 and name H8 )(resid 34 and name H1' )
assign (resid 34 and name H8 )(resid 34 and name H2' )
assign (resid 34 and name H8 )(resid 34 and name H3' )
assign (resid 34 and name H8 )(resid 34 and name H5' or resid 34 and name H5" )
assign (resid 35 and name H2' )(resid 35 and name HI' )
assign (resid 35 and name H3' )(resid 35 and name Hi' )
2.40 0.60 0.60
3.40 1.60 1.60
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3.40
3.40
2.90
2.90
2.90
2.90
2.40
3.40
2.40
2.90
3.40
2.40
3.90
3.90
3.90
3.40
2.90
2.90
2.90
3.40
3.40
3.90
2.40
3.40
2.90
3.40
2.40
3.90
3.90
3.40
2.90
2.90
3.40
2.90
3.40
2.90
2.40
2.90
2.90
2.90
2.40
3.90
3.90
2.90
2.90
2.40
3.40
3.90
1.60
1.60
1.10
1.10
1.10
1.10
0.60
1.60
0.60
1.10
1.60
0.60
2.10
2.10
2.10
1.60
1.10
1.10
1.10
1.60
1.60
2.10
0.60
1.60
1.10
1.60
0.60
2.10
2.10
1.60
1.10
1.10
1.60
1.10
1.60
1.10
0.60
1.10
1.10
1.10
0.60
2.10
2.10
1.10
1.10
0.60
1.60
2.10
1.60
1.60
1.10
2.10
2.10
2.10
0.60
1.60
0.60
1.10
1.60
0.60
2.10
2.10
2.10
1.60
1.10
1.10
1.10
1.60
1.60
2.10
0.60
1.60
1.10
1.60
0.60
1.10
1.10
1.60
0.10
1.10
1.60
1.10
1.60
2.10
0.60
1.10
0.10
1.10
0.60
1.10
1.10
0.10
1.10
0.60
1.60
2.10
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assign (resid 35 and name H4' )(resid 35 and name HI' )
assign (resid 35 and name H4' )(resid 35 and name H2' )
assign (resid 35 and name H4' )(resid 35 and name H3' )
assign (resid 35 and name H5' or resid 35 and name H5" )(resid 34 and name H3' )
assign (resid 35 and name H5' or resid 35 and name H5" )(resid 35 and name Hi' )
assign (resid 35 and name H5' or resid 35 and name H5" )(resid 35 and name H2' )
assign (resid 35 and name H5' or resid 35 and name H5" )(resid 35 and name H3' )
assign (resid 35 and name H5' or resid 35 and name H5" )(resid 35 and name H4' )
assign (resid 35 and name H8
assign (resid 35 and name H8
assign (resid 35 and name H8
assign (resid 35 and name H8
assign (resid 35 and name H8
assign (resid 35 and name H8
! UPPER STEM
assign (resid 36 and name H1'
assign (resid 36 and name H2'
assign (resid 36 and name H3'
assign (resid 36 and name H3'
assign (resid 36 and name H4'
assign (resid 36 and name H4'
assign (resid 36 and name H4'
)(resid 34 and name H3' )
)(resid 35 and name H1' )
)(resid 35 and name H2' )
)(resid 35 and name H3' )
)(resid 35 and name H4' )
)(resid 35 and name H5' or resid 35 and name H5" )
)(resid 34 and name HI' )
)(resid 36 and name HI' )
)(resid 36 and name HI' )
)(resid 36 and name H2' )
)(resid 36 and name Hi' )
)(resid 36 and name H2' )
)(resid 36 and name H3' )
assign (resid 36 and name H5' or resid 36 and name H5" )(resid 36 and name H3' )
assign (resid 36 and name H5' or resid 36 and name H5" )(resid 36 and name H4' )
assign (resid 36 and name H8
assign (resid 36 and name H8
assign (resid 36 and name H8
assign (resid 36 and name H8
assign (resid 36 and name H8
assign (resid 36 and name H8
assign (resid 36 and name H8
assign (resid 36 and name H8
assign (resid 36 and name H8
assign (resid 36 and name H8
assign (resid 36 and name H1
assign (resid 36 and name H1
assign (resid 36 and name H1
assign (resid 36 and name H1
assign (resid 36 and name H1
assign (resid 36 and name H1
assign (resid 37 and name H1'
assign (resid 37 and name H2'
assign (resid 37 and name H3'
assign (resid 37 and name H4'
assign (resid 37 and name H41
assign (resid 37 and name H42
assign (resid 37 and name H41
assign (resid 37 and name H41
assign (resid 37 and name H42
assign (resid 37 and name H42
assign (resid 37 and name H6
assign (resid 37 and name H6
)(resid 34 and name H1' )
)(resid 35 and name H2' )
)(resid 35 and name H3' )
)(resid 34 and name H8 )
)(resid 35 and name H8 )
)(resid 36 and name Hi' )
)(resid 36 and name H2' )
)(resid 36 and name H3' )
)(resid 36 and name H4' )
)(resid 36 and name H5' or resid 36 and name H5" )
)(resid 28 and name Hi )
)(resid 29 and name H41 )
)(resid 29 and name H42 )
)(resid 29 and name H5 )
)(resid 30 and name HI' )
)(resid 37 and name HI' )
)(resid 36 and name H2' )
)(resid 37 and name HI' )
)(resid 37 and name HI' )
)(resid 37 and name HI' )
)(resid 27 and name H61 or resid 27 and name H62)
)(resid 27 and name H61 or resid 27 and name H62)
)(resid 28 and name H1 )
)(resid 36 and name H1 )
)(resid 28 and name H1 )
)(resid 36 and name Hi )
)(resid 36 and name H1' )
)(resid 36 and name H2' )
2.90
2.90
2.40
3.90
3.90
3.90
3.90
2.90
3.40
3.40
2.90
2.90
3.40
3.90
3.40
2.40
3.40
2.40
3.40
3.40
2.40
1.10
1.10
0.60
2.10
2.10
2.10
2.10
1.10
1.60
1.60
1.10
1.10
1.60
2.10
1.60
0.60
1.60
0.60
1.60
1.60
0.60
1.10
1.10
0.60
2.10
2.10
2.10
2.10
1.10
1.60
1.60
2.10
2.10
1.60
1.10
1.60
0.60
1.60
0.60
1.60
1.60
0.60
3.90 2.10 1.10
2.90 1.10 0.10
3.40
3.40
3.40
3.40
3.40
3.40
3.40
3.40
3.40
3.90
3.40
3.90
2.90
3.90
3.40
3.40
3.40
2.40
2.90
2.90
3.90
3.90
3.90
3.90
2.90
3.90
2.90
2.40
1.60
1.60
1.60
1.60
1.60
1.60
1.60
1.60
1.60
2.10
1.60
2.10
1.10
2.10
1.60
1.60
1.60
0.60
1.10
1.10
2.10
2.10
1.10
2.10
1.10
2.10
1.10
0.60
2.60
2.60
2.60
2.60
2.60
1.60
1.60
1.60
1.60
1.10
1.60
2.10
1.10
2.10
2.60
2.60
1.60
0.60
1.10
1.10
2.10
2.10
2.10
2.10
1.10
2.10
2.10
0.60
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assign (resid 37 and name H6
assign (resid 37 and name H6
assign (resid 37 and name H6
assign (resid 37 and name H6
assign (resid 37 and name H6
assign (resid 37 and name H5
assign (resid 37 and name H5
assign (resid 37 and name H5
assign (resid 37 and name H5
assign (resid 37 and name H5
assign (resid 38 and name HI'
assign (resid 38 and name H1'
assign (resid 38 and name H2'
assign (resid 38 and name H3'
assign (resid 38 and name H3'
assign (resid 38 and name H4'
assign (resid 38 and name H4'
assign (resid 38 and name H5'
assign (resid 38 and name H3
assign (resid 38 and name H3
assign (resid 38 and name H3
assign (resid 38 and name H3
assign (resid 38 and name H3
assign (resid 38 and name H3
assign (resid 38 and name H3
assign (resid 38 and name H6
assign (resid 38 and name H6
assign (resid 38 and name H6
assign (resid 38 and name H6
assign (resid 38 and name H6
assign (resid 38 and name H6
assign (resid 38 and name H6
assign (resid 38 and name H6
assign (resid 38 and name H6
assign (resid 38 and name H5
assign (resid 38 and name H5
assign (resid 38 and name H5
assign (resid 38 and name H5
assign (resid 38 and name H5
assign (resid 38 and name H5
assign (resid 39 and name H1'
assign (resid 39 and name H1'
assign (resid 39 and name H1'
assign (resid 39 and name H2'
assign (resid 39 and name H2'
assign (resid 39 and name H2'
assign (resid 39 and name H3'
assign (resid 39 and name H3'
assign (resid 39 and name H3'
assign (resid 39 and name H4'
assign (resid 39 and name H4'
assign (resid 39 and name H4'
)(resid 36 and name H3'
)(resid 36 and name H8
)(resid 37 and name H1'
)(resid 37 and name H2'
)(resid 37 and name H4'
)(resid 28 and name H1
)(resid 36 and name H2'
)(resid 36 and name H3'
)(resid 36 and name H8
)(resid 36 and name Hi
)(resid 27 and name H2 )
)(resid 37 and name H2' )
)(resid 38 and name HI' )
)(resid 38 and name HI' )
)(resid 38 and name H2' )
)(resid 38 and name Hi' )
)(resid 38 and name H2' )
or resid 38 and name H5" )(resid 38 and name H3' )
)(resid 26 and name H1 )
)(resid 28 and name H1 )
)(resid 27 and name H2 )
)(resid 27 and name H61 or resid 27 and name H62 )
)(resid 37 and name H41 )
)(resid 37 and name H42 )
)(resid 38 and name HI' )
)(resid 37 and name H1' )
)(resid 37 and name H2' )
)(resid 37 and name H3' )
)(resid 37 and name H6 )
)(resid 37 and name H5 )
)(resid 38 and name H1' )
)(resid 38 and name H2' )
)(resid 38 and name H3' )
)(resid 38 and name H4' )
)(resid 37 and name H2' )
)(resid 37 and name H3' )
)(resid 37 and name H5 )
)(resid 37 and name H6 )
)(resid 38 and name Hi' )
)(resid 38 and name H3 )
)(resid 27 and name H2 )
)(resid 38 and name H2' )
)(resid 38 and name H3 )
)(resid 26 and name H22 )
)(resid 26 and name H21 )
)(resid 39 and name HI' )
)(resid 38 and name H2' )
)(resid 39 and name Hi' )
)(resid 39 and name H2' )
)(resid 38 and name H2' )
)(resid 39 and name H1' )
)(resid 39 and name H2' )
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3.40
3.40
3.40
3.40
3.40
3.90
3.65
3.65
3.65
3.65
1.60
1.60
1.60
1.60
1.60
2.10
1.85
1.85
1.85
1.85
2.10
1.60
0.60
1.60
0.60
1.10
1.60
1.60
1.60
1.60
0.60
1.10
2.10
2.10
1.60
1.10
0.60
1.10
1.60
1.60
1.10
1.60
0.60
1.60
2.10
1.60
1.85
1.85
1.85
1.60
0.60
1.60
1.60
0.60
0.60
0.60
1.60
1.60
0.60
1.60
1.10
1.60
1.60
2.60
1.60
1.60
1.60
2.10
2.35
1.35
2.35
2.35
2.10
1.60
0.60
1.60
0.60
1.10
1.60
0.60
1.60
1.60
0.60
1.10
2.10
2.10
1.60
2.10
0.60
1.10
2.60
2.60
1.10
1.60
0.60
1.60
2.10
1.60
2.35
2.35
2.35
2.60
0.60
1.60
2.60
3.60
3.60
0.60
1.60
1.60
0.60
1.60
1.10
1.60
3.90
3.40
2.40
3.40
2.40
2.90
3.40
3.40
3.40
3.40
2.40
2.90
3.90
3.90
3.40
2.90
2.40
2.90
3.40
3.40
2.90
3.40
2.40
3.40
3.90
3.40
3.65
3.65
3.65
3.40
2.40
3.40
3.40
2.40
2.40
2.40
3.40
3.40
2.40
3.40
2.90
3.40
assign (resid 39 and name H4' )(resid 39 and name H3' )
assign (resid 39 and name H5' or resid 39 and name H5" )(resid 38 and name H2' )
assign (resid 39 and name H5' or resid 39 and name H5" )(resid 39 and name HI' )
assign (resid 39 and name H5' or resid 39 and name H5" )(resid 39 and name H3' )
assign (resid 39 and name H5' or resid 39 and name H5" )(resid 39 and name H4' )
assign (resid 39 and name H41 )(resid 26 and name H1 )
assign (resid 39 and name H42 )(resid 26 and name HI )
assign (resid 39 and name H42 )(resid 26 and name H22 )
assign (resid 39 and name H41 )(resid 27 and name H61 or resid 27 and name H62)
assign (resid 39 and name H42 )(resid 27 and name H61 or resid 27 and name H62)
assign (resid 39 and name H42 )(resid 38 and name H5 )
assign (resid 39 and name H41 )(resid 38 and name H5 )
assign (resid 39 and name H41 )(resid 38 and name H3 )
assign (resid 39 and name H42 )(resid 38 and name H3 )
assign (resid 39 and name H6 )(resid 38 and name HI' )
assign (resid 39 and name H6 )(resid 38 and name H2' )
assign (resid 39 and name H6 )(resid 38 and name H3' )
assign (resid 39 and name H6 )(resid 38 and name H6 )
assign (resid 39 and name H6 )(resid 39 and name HI' )
assign (resid 39 and name H6 )(resid 39 and name H2' )
assign (resid 39 and name H6 )(resid 39 and name H3' )
assign (resid 39 and name H6 )(resid 39 and name H4' )
assign (resid 39 and name H6 )(resid 39 and name H5' or resid 39 and name H5" )
assign (resid 39 and name H5 )(resid 27 and name H61 or resid 27 and name H62)
assign (resid 39 and name H5 )(resid 38 and name H2' )
assign (resid 39 and name H5 )(resid 38 and name H3 )
assign (resid 39 and name H5 )(resid 38 and name H6 )
assign (resid 39 and name H5 )(resid 38 and name H5 )
assign (resid 39 and name H5 )(resid 39 and name Hi' )
! LOWER STEM
assign (resid 40 and name Hi' )(resid 26 and name H22 )
assign (resid 40 and name HI' )(resid 26 and name H21 )
assign (resid 40 and name Hi' )(resid 39 and name H2' )
assign (resid 40 and name HI' )(resid 39 and name H3' )
assign (resid 40 and name H2' )(resid 26 and name H22 )
assign (resid 40 and name H2' )(resid 26 and name H21 )
assign (resid 40 and name H2' )(resid 40 and name H1' )
assign (resid 40 and name H3' )(resid 39 and name H2' )
assign (resid 40 and name H3' )(resid 40 and name Hi' )
assign (resid 40 and name H3' )(resid 40 and name H2' )
assign (resid 40 and name H4' )(resid 40 and name HI' )
assign (resid 40 and name H4' )(resid 40 and name H2' )
assign (resid 40 and name H5' or resid 40 and name H5" )(resid 39 and name H2' )
assign (resid 40 and name H5' or resid 40 and name H5" )(resid 40 and name H3' )
assign (resid 40 and name H3 )(resid 21 and name Hi )
assign (resid 40 and name H3 )(resid 22 and name H2 )
assign (resid 40 and name H3 )(resid 26 and name H1 )
assign (resid 40 and name H3 )(resid 39 and name H5 )
assign (resid 40 and name H3 )(resid 39 and name H42 )
assign (resid 40 and name H6 )(resid 39 and name Hi' )
assign (resid 40 and name H6 )(resid 39 and name H2' )
assign (resid 40 and name H6 )(resid 39 and name H3' )
assign (resid 40 and name H6 )(resid 39 and name H6 )
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2.90
3.90
3.90
3.90
3.90
3.90
2.90
3.90
3.90
3.90
3.90
3.90
3.90
3.90
3.40
2.40
3.40
3.40
3.40
3.40
2.90
3.40
3.90
4.40
3.65
3.90
3.65
3.65
3.65
3.90
3.90
3.40
3.40
2.40
2.40
2.40
3.40
2.90
2.40
2.90
2.90
3.90
3.90
3.40
2.90
3.40
2.90
3.90
3.40
2.40
2.90
3.40
1.10
2.10
2.10
2.10
2.10
2.10
1.10
2.10
2.10
2.10
2.10
2.10
2.10
2.10
1.60
0.60
1.60
1.60
1.60
1.60
1.10
1.60
2.10
2.60
1.85
2.10
1.85
1.85
1.85
2.10
2.10
1.60
1.60
0.60
0.60
0.60
1.60
1.10
0.60
1.10
1.10
2.10
2.10
1.60
1.10
1.60
1.10
2.10
1.60
0.60
1.10
1.60
1.10
1.10
1.10
1.10
1.10
2.10
1.10
2.10
2.10
2.10
2.10
2.10
2.10
2.10
1.60
0.60
1.60
2.60
1.60
1.60
1.10
1.60
0.10
1.60
2.35
2.10
2.35
2.35
2.35
2.10
2.10
1.60
1.60
3.60
3.60
0.60
1.60
1.10
0.60
1.10
1.10
1.10
1.10
1.60
1.10
1.60
2.10
2.10
1.60
0.60
1.10
2.60
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assign (resid 40 and name H6
assign (resid 40 and name H6
assign (resid 40 and name H6
assign (resid 40 and name H6
assign (resid 40 and name H5
assign (resid 40 and name H5
assign (resid 40 and name H5
assign (resid 40 and name H5
assign (resid 40 and name H5
assign (resid 40 and name H5
assign (resid 41 and name H1'
assign (resid 41 and name Hi'
assign (resid 41 and name H2'
assign (resid 41 and name H3'
assign (resid 41 and name H3'
assign (resid 41 and name H3'
assign (resid 41 and name H41
assign (resid 41 and name H42
assign (resid 41 and name H42
assign (resid 41 and name H42
assign (resid 41 and name H41
assign (resid 41 and name H42
assign (resid 41 and name H6
assign (resid 41 and name H6
assign (resid 41 and name H6
assign (resid 41 and name H6
assign (resid 41 and name H6
assign (resid 41 and name H6
assign (resid 41 and name H6
assign (resid 41 and name H6
assign (resid 41 and name H6
assign (resid 41 and name H5
assign (resid 41 and name H5
assign (resid 41 and name H5
assign (resid 41 and name H5
assign (resid 41 and name H5
assign (resid 41 and name H5
assign (resid 41 and name H5
assign (resid 42 and name H1'
assign (resid 42 and name H1'
assign (resid 42 and name H2'
assign (resid 42 and name H3'
assign (resid 42 and name H3'
assign (resid 42 and name H3'
assign (resid 42 and name H4'
assign (resid 42 and name H4'
assign (resid 42 and name H5'
assign (resid 42 and name H5'
assign (resid 42 and name H3
assign (resid 42 and name H3
assign (resid 42 and name H3
assign (resid 42 and name H3
)(resid 40 and name H1' )
)(resid 40 and name H2' )
)(resid 40 and name H3' )
)(resid 40 and name H4' )
)(resid 39 and name H2' )
)(resid 39 and name H3' )
)(resid 39 and name H5 )
)(resid 39 and name H6 )
)(resid 40 and name HI' )
)(resid 40 and name H3' )
)(resid 22 and name H2 )
)(resid 40 and name H2' )
)(resid 41 and name H 1' )
)(resid 40 and name H2' )
)(resid 41 and name Hi' )
)(resid 41 and name H2' )
)(resid 21 and name H1 )
)(resid 21 and name H1 )
)(resid 21 and name H22
)(resid 40 and name H3 )
)(resid 40 and name H5 )
)(resid 40 and name H5 )
)(resid 40 and name Hi' )
)(resid 40 and name H2' )
)(resid 40 and name H3' )
)(resid 40 and name H6 )
)(resid 41 and name H1' )
)(resid 41 and name H2' )
)(resid 41 and name H3' )
)(resid 41 and name H4' )
)(resid 41 and name H5' or
)(resid 21 and name H1 )
)(resid 40 and name H3 )
)(resid 40 and name H2' )
)(resid 40 and name H3' )
)(resid 40 and name H6 )
)(resid 40 and name H3 )
)(resid 40 and name H5 )
resid 41 and name H5" )
)(resid 21 and name H22 )
)(resid 21 and name H21 )
)(resid 42 and name H1' )
)(resid 41 and name H2' )
)(resid 42 and name Hi' )
)(resid 42 and name H2' )
)(resid 42 and name H1' )
)(resid 42 and name H3' )
or resid 42 and name H5" )(resid 41 and name H2' )
or resid 42 and name H5" )(resid 42 and name H3' )
)(resid 19 and name H42 )
)(resid 20 and name H2 )
)(resid 21 and name H1 )
)(resid 41 and name H42 )
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3.40
3.40
2.90
3.40
3.40
3.15
3.65
3.65
3.65
3.65
2.90
3.40
2.40
3.40
2.90
2.40
3.90
2.90
3.90
3.90
2.90
3.90
3.40
2.40
2.90
3.40
3.40
3.40
2.90
3.40
3.90
3.65
3.65
3.65
3.65
3.65
3.65
3.65
3.90
3.90
2.40
3.40
3.40
2.40
2.90
2.40
3.90
3.40
3.90
2.90
3.40
3.90
1.60
1.60
1.10
1.60
1.60
1.35
1.85
1.85
1.85
1.85
1.10
1.60
0.60
1.60
1.10
0.60
2.10
1.10
2.10
2.10
1.10
2.10
1.60
0.60
1.10
1.60
1.60
1.60
1.10
1.60
2.10
1.85
1.85
1.85
1.85
1.85
1.85
1.85
2.10
2.10
0.60
1.60
1.60
0.60
1.10
0.60
2.10
1.60
2.10
1.10
1.60
2.10
1.60
1.60
1.10
1.60
2.60
1.85
2.35
2.35
2.35
2.35
1.10
1.60
0.60
1.60
1.10
0.60
2.10
1.10
2.10
2.10
1.10
2.10
1.60
0.60
1.10
2.60
1.60
1.60
1.10
1.60
1.10
2.35
2.35
2.35
2.35
2.35
2.35
2.35
2.10
2.10
0.60
1.60
1.60
0.60
1.10
0.60
1.10
1.60
2.10
1.10
1.60
2.10
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assign (resid 42 and name H3
assign (resid 42 and name H6
assign (resid 42 and name H6
assign (resid 42 and name H6
assign (resid 42 and name H6
assign (resid 42 and name H6
assign (resid 42 and name H5
assign (resid 42 and name H5
assign (resid 42 and name H5
assign (resid 42 and name H5
assign (resid 42 and name H5
assign (resid 42 and name H5
assign (resid 42 and name H5
assign (resid 42 and name H5
)(resid 42 and name H1' )
)(resid 41 and name HI' )
)(resid 41 and name H2' )
)(resid 42 and name H1' )
)(resid 42 and name H2' )
)(resid 42 and name H3' )
)(resid 21 and name H1 )
)(resid 41 and name H2' )
)(resid 41 and name H3' )
)(resid 41 and name H41 )
)(resid 41 and name H42 )
)(resid 41 and name H5 )
)(resid 42 and name H3' )
)(resid 42 and name H3 )
assign (resid 43 and name H1' )(resid 20 and name H2 )
assign (resid 43 and name H1' )(resid 42 and name H2' )
assign (resid 43 and name H2' )(resid 43 and name Hi' )
assign (resid 43 and name H3' )(resid 43 and name HI' )
assign (resid 43 and name H3' )(resid 43 and name H2' )
assign (resid 43 and name H4' )(resid 43 and name Hi' )
assign (resid 43 and name H4' )(resid 43 and name H2' )
assign (resid 43 and name H4' )(resid 43 and name H3' )
assign (resid 43 and name H5' or resid 43 and name H5" )(resid 43 and name H3' )
assign (resid 43 and name H5' or resid 43 and name H5" )(resid 43 and name H4' )
assign (resid 43 and name H8 )(resid 42 and name Hi' )
assign (resid 43 and name H8 )(resid 42 and name H2' )
assign (resid 43 and name H8 )(resid 42 and name H3' )
assign (resid 43 and name H8 )(resid 42 and name H6 )
assign (resid 43 and name H8 )(resid 43 and name HI' )
assign (resid 43 and name H8 )(resid 43 and name H2' )
assign (resid 43 and name H8 )(resid 43 and name H3' )
assign (resid 43 and name H8 )(resid 43 and name H4' )
assign (resid 43 and name H8 )(resid 43 and name H5' or resid 43 and name H5" )
assign (resid 43 and name H1 )(resid 18 and name H41 )
assign (resid 43 and name H1 )(resid 18 and name H42 )
assign (resid 43 and name H1 )(resid 19 and name H42 )
assign (resid 43 and name H1 )(resid 44 and name HI' )
assign (resid 43 and name H1 )(resid 19 and name H5 )
assign (resid 43 and name H1 )(resid 20 and name H2 )
assign (resid 43 and name H1 )(resid 42 and name H3 )
assign (resid 43 and name H22 )(resid 20 and name H1' )
assign (resid 43 and name H21 )(resid 20 and name HI' )
assign (resid 43 and name H22 )(resid 44 and name H1' )
assign (resid 43 and name H21 )(resid 44 and name H1' )
assign (resid 44 and name H1' )(resid 43 and name H2' )
assign (resid 44 and name H2' )(resid 44 and name H1' )
assign (resid 44 and name H3' )(resid 44 and name HI' )
assign (resid 44 and name H4' )(resid 44 and name HI' )
assign (resid 44 and name H4' )(resid 44 and name H3' )
assign (resid 44 and name H5' or resid 44 and name H5" )(resid 43 and name H2' )
assign (resid 44 and name H5' or resid 44 and name H5" )(resid 43 and name H3' )
assign (resid 44 and name H5' or resid 44 and name H5" )(resid 44 and name HI' )
3.40
3.40
2.90
3.40
2.90
2.90
3.65
3.65
3.65
3.90
3.90
3.65
3.65
3.90
2.90
3.40
2.40
2.90
2.40
2.90
2.90
2.40
3.90
2.90
3.40
2.40
2.90
3.40
2.90
3.40
2.90
3.40
3.90
3.90
2.90
3.90
3.90
3.90
3.90
3.40
3.90
3.90
3.90
3.90
2.90
2.40
2.90
3.40
2.40
3.90
3.90
3.90
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1.60
1.60
1.10
1.60
1.10
1.10
1.85
1.85
1.85
2.10
2.10
1.85
1.85
2.10
1.10
1.60
0.60
1.10
0.60
1.10
1.10
0.60
2.10
1.10
1.60
0.60
1.10
1.60
1.10
1.60
1.10
1.60
2.10
2.10
1.10
2.10
2.10
2.10
2.10
1.60
2.10
2.10
2.10
2.10
1.10
0.60
1.10
1.60
0.60
2.10
2.10
2.10
1.60
1.60
1.10
1.60
2.10
1.10
2.35
2.35
1.35
2.10
2.10
2.35
2.35
2.10
1.10
1.60
0.60
1.10
0.60
1.10
1.10
0.60
1.10
0.10
1.60
0.60
1.10
2.60
1.10
1.60
1.10
1.60
1.10
2.10
1.10
2.10
2.10
2.10
2.10
1.60
2.10
2.10
2.10
2.10
1.10
0.60
1.10
1.60
0.60
1.10
1.10
1.10
Appendix B Molecular Modeling Details
assign (resid 44 and name H5' or resid 44 and name H5" )(resid 44 and name H3' )
assign (resid 44 and name H5' or resid 44 and name H5" )(resid 44 and name H4' )
assign (resid 44 and name H8
assign (resid 44 and name H8
assign (resid 44 and name H8
assign (resid 44 and name H8
assign (resid 44 and name H8
assign (resid 44 and name H8
assign (resid 44 and name H8
assign (resid 44 and name H8
assign (resid 44 and name H8
assign (resid 44 and name H1
assign (resid 44 and name H1
assign (resid 44 and name H1
assign (resid 44 and name Hi
assign (resid 44 and name Hi
assign (resid 44 and name H1
assign (resid 44 and name Hi
assign (resid 45 and name H1'
assign (resid 45 and name H2'
assign (resid 45 and name H3'
assign (resid 45 and name H3'
assign (resid 45 and name H4'
assign (resid 45 and name H4'
assign (resid 45 and name H4'
)(resid 43 and name H1' )
)(resid 43 and name H2' )
)(resid 43 and name H3' )
)(resid 43 and name H8 )
)(resid 44 and name H1' )
)(resid 44 and name H2' )
)(resid 44 and name H3' )
)(resid 44 and name H4' )
)(resid 44 and name H5' or resid 44 and name H5" )
)(resid 17 and name H1 )
)(resid 18 and name H41 )
)(resid 18 and name H42 )
)(resid 18 and name H5 )
)(resid 19 and name H42 )
)(resid 19 and name H5 )
)(resid 43 and name H1 )
)(resid 44 and name H2'
)(resid 45 and name H1'
)(resid 45 and name H1'
)(resid 45 and name H2'
)(resid 45 and name H1'
)(resid 45 and name H2'
)(resid 45 and name H3'
assign (resid 45 and name H5' or resid 45 and name H5" )(resid 45 and name H3' )
assign (resid 45 and name H5' or resid 45 and name H5" )(resid 45 and name H4' )
assign (resid 45 and name H41
assign (resid 45 and name H42
assign (resid 45 and name H42
assign (resid 45 and name H42
assign (resid 45 and name H42
assign (resid 45 and name H6
assign (resid 45 and name H6
assign (resid 45 and name H6
assign (resid 45 and name H6
assign (resid 45 and name H6
assign (resid 45 and name H6
assign (resid 45 and name H6
assign (resid 45 and name H6
assign (resid 45 and name H6
assign (resid 45 and name H5
assign (resid 45 and name H5
assign (resid 45 and name H5
assign (resid 45 and name H5
assign (resid 45 and name H5
assign (resid 45 and name H5
assign (resid 45 and name H5
assign (resid 46 and name H 1'
assign (resid 46 and name H2'
assign (resid 46 and name H3'
assign (resid 46 and name H3'
)(resid 17 and name H1 )
)(resid 17 and name H1 )
)(resid 18 and name H42 )
)(resid 18 and name H5 )
)(resid 44 and name H1 )
)(resid 44 and name HI' )
)(resid 44 and name H2' )
)(resid 44 and name H3' )
)(resid 44 and name H8 )
)(resid 45 and name H1' )
)(resid 45 and name H2' )
)(resid 45 and name H3' )
)(resid 45 and name H4' )
)(resid 45 and name H5' or resid 45 and name H5" )
)(resid 17 and name H1 )
)(resid 18 and name H42 )
)(resid 44 and name H2' )
)(resid 44 and name H3' )
)(resid 44 and name H8 )
)(resid 44 and name H1 )
)(resid 45 and name H3' )
)(resid 45 and name H2' )
)(resid 46 and name HI' )
)(resid 45 and name H2' )
)(resid 46 and name HI' )
3.40 1.60 0.60
2.90 1.10 0.10
3.40
2.40
2.90
3.40
2.90
3.40
2.90
3.40
3.90
2.90
3.40
2.90
3.90
3.90
3.90
3.40
3.40
2.40
2.90
2.40
2.90
2.90
2.40
1.60
0.60
1.10
1.60
1.10
1.60
1.10
1.60
2.10
1.10
1.60
1.10
2.10
2.10
2.10
1.60
1.60
0.60
1.10
0.60
1.10
1.10
0.60
1.60
0.60
1.10
2.60
1.10
1.60
1.10
1.60
1.10
1.10
2.60
1.10
2.10
2.10
2.10
1.60
1.60
0.60
1.10
0.60
1.10
1.10
0.60
3.90 2.10 1.10
3.40 1.60 0.60
3.90
2.90
3.90
3.90
3.90
3.40
2.40
2.90
3.40
2.90
3.40
2.90
3.40
3.90
3.90
3.90
3.65
3.65
3.65
3.90
3.65
3.40
2.40
3.40
2.90
2.10
1.10
2.10
2.10
2.10
1.60
0.60
1.10
1.60
1.10
1.60
1.10
1.60
2.10
2.10
2.10
1.85
1.85
1.85
2.10
1.85
1.60
0.60
1.60
1.10
2.10
1.10
2.10
2.10
2.10
1.60
0.60
1.10
2.60
1.10
1.60
1.10
1.60
1.10
2.10
2.10
2.35
2.35
2.35
2.10
2.35
1.60
0.60
1.60
1.10
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assign (resid 46 and name H3' )(resid 46 and name H2' )
assign (resid 46 and name H4' )(resid 45 and name H2' )
assign (resid 46 and name H4' )(resid 46 and name H1' )
assign (resid 46 and name H4' )(resid 46 and name H2' )
assign (resid 46 and name H4' )(resid 46 and name H3' )
assign (resid 46 and name H5' or resid 46 and name H5" )(resid 45 and name H2' )
assign (resid 46 and name H5' or resid 46 and name H5" )(resid 45 and name H3' )
assign (resid 46 and name H5' or resid 46 and name H5" )(resid 46 and name H3' )
assign (resid 46 and name H5' or resid 46 and name H5" )(resid 46 and name H4' )
assign (resid 46 and name H6
assign (resid 46 and name H6
assign (resid 46 and name H6
assign (resid 46 and name H6
assign (resid 46 and name H6
assign (resid 46 and name H6
assign (resid 46 and name H6
assign (resid 46 and name H5
assign (resid 46 and name H5
assign (resid 46 and name H5
assign (resid 46 and name H5
)(resid 45 and name H2'
)(resid 45 and name H3'
)(resid 46 and name H1'
)(resid 46 and name H2'
)(resid 46 and name H3'
)(resid 46 and name H4'
)(resid 46 and name H5'
)(resid 17 and name H1
)(resid 45 and name H2'
)(resid 45 and name H3'
)(resid 45 and name H5
)or resid 46 and name
or resid 46 and name H5")
)
)
assign (resid 46 and name H42 )(resid 16 and name H1 )
2.40
3.40
2.90
2.90
2.40
3.90
3.90
3.90
3.40
2.40
2.90
3.40
3.40
2.90
2.90
3.90
3.90
3.65
3.65
3.65
3.65
0.60
1.60
1.10
1.10
0.60
2.10
2.10
2.10
1.60
0.60
1.10
1.60
1.60
1.10
1.10
2.10
2.10
1.85
1.85
1.85
2.35
0.60
1.60
1.10
1.10
0.60
1.10
1.10
1.10
0.60
0.60
1.10
1.60
1.60
1.10
1.10
1.10
2.10
2.35
2.35
2.35
2.35
! INTERMOLECULAR ARGININAMIDE NOES
assign (resid 47 and name HC1 )(resid 38 and name H5 )
assign (resid 47 and name HC2 )(resid 38 and name H5 )
assign (resid 47 and name HB1 or resid 47 and name HB2 )(resid 27 and name H61 or
H61)
assign (resid 47 and name HB 1 or resid 47 and name HB2
assign (resid 47 and name HB 1 or resid 47 and name HB2
assign (resid 47 and name HG1
assign (resid 47 and name HG1
assign (resid 47 and name HG 1
assign (resid 47 and name HD1
assign (resid 47 and name HD 1
assign (resid 47 and name HD1
assign (resid 47 and name HD1
assign (resid 47 and name HE
assign (resid 47 and name HE
assign (resid 47 and name HE
assign (resid 47 and name HE
assign (resid 47 and name HE
or resid 47 and name HG2
or resid 47 and name HG2
or resid 47 and name HG2
or resid 47 and name HD2
or resid 47 and name HD2
or resid 47 and name HD2
or resid 47 and name HD2
)(resid 22 and name H2' )
)(resid 22 and name H3' )
)(resid 22 and name H8 )
)(resid 23 and name H6 )
)(resid 23 and name H5 )
re
)(resid 39 and name H41 )
)(resid 39 and name H42 )
)(resid 22 and name H8 )
)(resid 23 and name H5 )
)(resid 23 and name H6 )
)(resid 22 and name H8 )
)(resid 23 and name H5 )
)(resid 39 and name H41 )
)(resid 39 and name H42 )
assign (resid 47 and name HH11 or resid 47 and name HH12 or resid 47 and name HH21
name HH22)(resid 22 and name H8)
assign (resid 47 and name HH11 or resid 47 and name HH12 or resid 47 and name HH21
name HH22)(resid 26 and name H8)
set echo = on end
set message = on end
Torsion Restraints:
These are the sugar pucker restraints used for the structure determination.
restraints
dihedral
3.40 1.60 2.60
3.40 1.60 2.60
sid 27 and name
3.90 2.10 2.10
3.90 2.10 2.10
3.40 1.60 2.60
3.40 1.60 1.60
2.90 1.10 1.10
3.90 2.10 2.10
3.40 1.60 1.60
2.90 1.10 1.10
3.40 1.60 2.60
3.40 1.60 2.60
3.90 2.10 2.10
3.90 2.10 1.10
3.90 2.10 2.10
3.90 2.10 2.10
3.90 2.10 2.10
or resid 47 and
2.50 0.70 2.50
or resid 47 and
2.50 0.70 2.50
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reset
!c2'endo puckers
assign (resid 23 and name Cl')(resid 23 and name C2')(resid 23 and name C3')
(resid 23 and name C4') 1.0 -40.0 5.0 2
assign (resid 23 and name C3')(resid 23 and name C4')(resid 23 and name 04')
(resid 23 and name Cl') 1.0 0.0 5.0 2
assign (resid 25 and name Cl')(resid 25 and name C2')(resid 25 and name C3')
(resid 25 and name C4') 1.0 -40.0 5.0 2
assign (resid 25 and name C3')(resid 25 and name C4')(resid 25 and name 04')
(resid 25 and name Cl') 1.0 0.0 5.0 2
assign (resid 30 and name Cl')(resid 30 and name C2')(resid 30 and name C3')
(resid 30 and name C4') 1.0 -40.0 5.0 2
assign (resid 30 and name C3')(resid 30 and name C4')(resid 30 and name 04')
(resid 30 and name C1') 1.0 0.0 5.0 2
assign (resid 31 and name Cl')(resid 31 and name C2')(resid 31 and name C3')
(resid 31 and name C4') 1.0 -40.0 5.0 2
assign (resid 31 and name C3')(resid 31 and name C4')(resid 31 and name 04')
(resid 31 and name C1') 1.0 0.0 5.0 2
assign (resid 32 and name Cl')(resid 32 and name C2')(resid 32 and name C3')
(resid 32 and name C4') 1.0 -40.0 5.0 2
assign (resid 33 and name C3')(resid 33 and name C4')(resid 33 and name 04')
(resid 33 and name Cl') 1.0 0.0 5.0 2
assign (resid 33 and name Cl')(resid 33 and name C2')(resid 33 and name C3')
(resid 33 and name C4') 1.0 -40.0 5.0 2
assign (resid 34 and name Cl')(resid 34 and name C2')(resid 34 and name C3')
(resid 34 and name C4') 1.0 -40.0 5.0 2
assign (resid 34 and name C3')(resid 34 and name C4')(resid 34 and name 04')
(resid 34 and name Cl') 1.0 0.0 5.0 2
!A- helix deltas and nu2 for C3' endo pucker
assign (resid 16 and name C5')(resid 16 and name C4')(resid 16 and name C3')
(resid 16 and name 03') 1.0 82.0 5.0 2
assign (resid 16 and name Cl')(resid 16 and name C2')(resid 16 and name C3')
(resid 16 and name C4') 1.0 38.0 5.0 2
assign (resid 17 and name C5')(resid 17 and name C4')(resid 17 and name C3')
(resid 17 and name 03') 1.0 82.0 5.0 2
assign (resid 17 and name Cl')(resid 17 and name C2')(resid 17 and name C3')
(resid 17 and name C4') 1.0 38.0 5.0 2
assign (resid 18 and name C5')(resid 18 and name C4')(resid 18 and name C3')
(resid 18 and name 03') 1.0 82.0 5.0 2
assign (resid 18 and name Cl')(resid 18 and name C2')(resid 18 and name C3')
(resid 18 and name C4') 1.0 38.0 5.0 2
assign (resid 19 and name C5')(resid 19 and name C5')(resid 19 and name C3')
(resid 19 and name 03') 1.0 82.0 5.0 2
assign (resid 19 and name Cl')(resid 19 and name C2')(resid 19 and name C3')
(resid 19 and name C4') 1.0 38.0 5.0 2
assign (resid 20 and name C5')(resid 20 and name C4')(resid 20 and name C3')
(resid 20 and name 03') 1.0 82.0 5.0 2
assign (resid 20 and name Cl')(resid 20 and name C2')(resid 20 and name C3')
(resid 20 and name C4') 1.0 38.0 5.0 2
assign (resid 21 and name C5')(resid 21 and name C4')(resid 21 and name C3')
(resid 21 and name 03') 1.0 82.0 5.0 2
assign (resid 21 and name Cl')(resid 21 and name C2')(resid 21 and name C3')
(resid 21 and name C4') 1.0 38.0 5.0 2
assign (resid 22 and name C5')(resid 22 and name C4')(resid 22 and name C3')
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(resid 22 and name 03') 1.0 82.0 5.0 2
assign (resid 22 and name Cl')(resid 22 and name C2')(resid 22 and name C3')
(resid 22 and name C4') 1.0 38.0 5.0 2
assign (resid 26 and name C5')(resid 26 and name C4')(resid 26 and name C3')
(resid 26 and name 03') 1.0 82.0 5.0 2
assign (resid 26 and name Cl')(resid 26 and name C2')(resid 26 and name C3')
(resid 26 and name C4') 1.0 38.0 5.0 2
assign (resid 27 and name C5')(resid 27 and name C4')(resid 27 and name C3')
(resid 27 and name 03') 1.0 82.0 5.0 2
assign (resid 27 and name Cl')(resid 27 and name C2')(resid 27 and name C3')
(resid 27 and name C4') 1.0 38.0 5.0 2
assign (resid 28 and name C5')(resid 28 and name C4')(resid 28 and name C3')
(resid 28 and name 03') 1.0 82.0 5.0 2
assign (resid 28 and name Cl')(resid 28 and name C2')(resid 28 and name C3')
(resid 28 and name C4') 1.0 38.0 5.0 2
assign (resid 29 and name C5')(resid 29 and name C4')(resid 29 and name C3')
(resid 29 and name 03') 1.0 82.0 5.0 2
assign (resid 29 and name Cl')(resid 29 and name C2')(resid 29 and name C3')
(resid 29 and name C4') 1.0 38.0 5.0 2
assign (resid 36 and name C5')(resid 36 and name C4')(resid 36 and name C3')
(resid 36 and name 03') 1.0 82.0 5.0 2
assign (resid 36 and name Cl')(resid 36 and name C2')(resid 36 and name C3')
(resid 36 and name C4') 1.0 38.0 5.0 2
assign (resid 37 and name C5')(resid 37 and name C4')(resid 37 and name C3')
(resid 37 and name 03') 1.0 82.0 5.0 2
assign (resid 37 and name Cl')(resid 37 and name C2')(resid 37 and name C3')
(resid 37 and name C4') 1.0 38.0 5.0 2
assign (resid 38 and name C5')(resid 38 and name C4')(resid 38 and name C3')
(resid 38 and name 03') 1.0 82.0 5.0 2
assign (resid 39 and name C5')(resid 39 and name C4')(resid 39 and name C3')
(resid 39 and name 03') 1.0 82.0 5.0 2
assign (resid 39 and name Cl')(resid 39 and name C2')(resid 39 and name C3')
(resid 39 and name C4') 1.0 38.0 5.0 2
assign (resid 40 and name C5')(resid 40 and name C4')(resid 40 and name C3')
(resid 40 and name 03') 1.0 82.0 5.0 2
assign (resid 40 and name Cl')(resid 40 and name C2')(resid 40 and name C3')
(resid 40 and name C4') 1.0 38.0 5.0 2
assign (resid 41 and name C5')(resid 41 and name C4')(resid 41 and name C3')
(resid 41 and name 03') 1.0 82.0 5.0 2
assign (resid 41 and name Cl')(resid 41 and name C2')(resid 41 and name C3')
(resid 41 and name C4') 1.0 38.0 5.0 2
assign (resid 42 and name C5')(resid 42 and name C4')(resid 42 and name C3')
(resid 42 and name 03') 1.0 82.0 5.0 2
assign (resid 42 and name Cl')(resid 42 and name C2')(resid 42 and name C3')
(resid 42 and name C4') 1.0 38.0 5.0 2
assign (resid 43 and name C5')(resid 43 and name C4')(resid 43 and name C3')
(resid 43 and name 03') 1.0 82.0 5.0 2
assign (resid 43 and name Cl')(resid 43 and name C2')(resid 43 and name C3')
(resid 43 and name C4') 1.0 38.0 5.0 2
assign (resid 44 and name C5')(resid 44 and name C4')(resid 44 and name C3')
(resid 44 and name 03') 1.0 82.0 5.0 2
assign (resid 44 and name Cl')(resid 44 and name C2')(resid 44 and name C3')
(resid 44 and name C4') 1.0 38.0 5.0 2
assign (resid 45 and name C5')(resid 45 and name C4')(resid 45 and name C3')
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(resid 45 and name 03') 1.0 82.0 5.0 2
assign (resid 45 and name Cl')(resid 45 and name C2')(resid 45 and name C3')
(resid 45 and name C4') 1.0 38.0 5.0 2
assign (resid 46 and name C5')(resid 46 and name C4')(resid 46 and name C3')
(resid 46 and name 03') 1.0 82.0 5.0 2
assign (resid 46 and name Cl')(resid 46 and name C2')(resid 46 and name C3')
(resid 46 and name C4') 1.0 38.0 5.0 2
Hydrogen Bond Restraints:
These are all the distance restraints used to define
structure determination.
set echo = off end
set message = off end
assign (resid 16 and name 06
assign (resid 16 and name 06
assign (resid 16 and name Hi
assign (resid 16 and name NI
assign (resid 16 and name H22
assign (resid 16 and name N2
assign (resid 17 and name 06
assign (resid 17 and name 06
assign (resid 17 and name H1
assign (resid 17 and name NI
assign (resid 17 and name H22
assign (resid 17 and name N2
assign (resid 18 and name H42
assign (resid 18 and name N4
assign (resid 18 and name N3
assign (resid 18 and name N3
the hydrogen bonding interactions for the
)(resid 46 and name H42 )
)(resid 46 and name N4 )
)(resid 46 and name N3 )
)(resid 46 and name N3 )
)(resid 46 and name 02 )
)(resid 46 and name 02 )
)(resid 45 and name H42 )
)(resid 45 and name N4 )
)(resid 45 and name N3 )
)(resid 45 and name N3 )
)(resid 45 and name 02 )
)(resid 45 and name 02 )
)(resid 44 and name 06 )
)(resid 44 and name 06 )
)(resid 44 and name H1 )
)(resid 44 and name N1 )
1.91
2.91
1.95
2.95
1.86
2.86
1.91
2.91
1.95
2.95
1.86
2.86
1.91
2.91
1.95
2.95
assign (resid 18 and name 02 )(resid 44 and name H22 )
assign (resid 18 and name 02 )(resid 44 and name N2 )
assign (resid 19 and name H42
assign (resid 19 and name N4
assign (resid 19 and name N3
assign (resid 19 and name N3
assign (resid 19 and name 02
assign (resid 19 and name 02
assign (resid 20 and name N1
assign (resid 20 and name N1
assign (resid 20 and name H62
assign (resid 20 and name N6
assign (resid 21 and name 06
assign (resid 21 and name 06
assign (resid 21 and name H1
assign (resid 21 and name NI
assign (resid 21 and name H22
assign (resid 21 and name N2
assign (resid 22 and name N1
assign (resid 22 and name N1
assign (resid 22 and name H62
assign (resid 22 and name N6
assign (resid 26 and name 06
0.20
0.20
0.20
0.20
0.20
0.20
0.20
0.20
0.20
0.20
0.20
0.20
0.20
0.20
0.20
0.20
0.20
0.20
0.20
0.20
0.20
0.20
0.20
0.20
0.20
0.20
0.20
0.20
0.20
0.20
0.20
0.20
1.86 0.20 0.20
2.86 0.20 0.20
)(resid 43 and name 06 )
)(resid 43 and name 06 )
)(resid 43 and name H1 )
)(resid 43 and name NI )
)(resid 43 and name H22 )
)(resid 43 and name N2 )
)(resid 42 and name H3 )
)(resid 42 and name N3 )
)(resid 42 and name 04 )
)(resid 42 and name 04 )
)(resid 41 and name H42 )
)(resid 41 and name N4 )
)(resid 41 and name N3 )
)(resid 41 and name N3 )
)(resid 41 and name 02 )
)(resid 41 and name 02 )
)(resid 40 and name H3 )
)(resid 40 and name N3 )
)(resid 40 and name 04 )
)(resid 40 and name 04 )
)(resid 39 and name H42 )
1.91
2.91
1.95
2.95
1.86
2.86
1.70
2.70
1.95
2.95
1.91
2.91
1.95
2.95
1.86
2.86
1.70
2.70
1.95
2.95
1.91
0.20
0.20
0.20
0.20
0.20
0.20
0.20
0.20
0.20
0.20
0.20
0.20
0.20
0.20
0.20
0.20
0.20
0.20
0.20
0.20
0.20
0.20
0.20
0.20
0.20
0.20
0.20
0.20
0.20
0.20
0.20
0.20
0.20
0.20
0.20
0.20
0.20
0.20
0.20
0.20
0.20
0.20
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assign (resid 26 and name 06 )(resid 39 and name N4
assign (resid 26 and name Hi )(resid 39 and name N3
assign (resid 26 and name N1 )(resid 39 and name N3
assign (resid 26 and name H22 )(resid 39 and name 02
assign (resid 26 and name N2 )(resid 39 and name 02
assign (resid 27 and name N1
assign (resid 27 and name Ni
assign (resid 27 and name H62
assign (resid 27 and name N6
assign (resid 28 and name 06
assign (resid 28 and name 06
assign (resid 28 and name H1
assign (resid 28 and name N1
assign (resid 28 and name H22
assign (resid 28 and name N2
assign (resid 29 and name H42
assign (resid 29 and name N4
assign (resid 29 and name N3
assign (resid 29 and name N3
assign (resid 29 and name 02
assign (resid 29 and name 02
set echo = on end
set message = on end
)(resid 38 and name H3 )
)(resid 38 and name N3 )
)(resid 38 and name 04 )
)(resid 38 and name 04 )
)(resid 37 and name H42 )
)(resid 37 and name N4 )
)(resid 37 and name N3 )
)(resid 37 and name N3 )
)(resid 37 and name 02 )
)(resid 37 and name 02 )
)(resid 36 and name 06 )
)(resid 36 and name 06 )
)(resid 36 and name H1 )
)(resid 36 and name NI )
)(resid 36 and name H22 )
)(resid 36 and name N2 )
Argininamide modeling restraints:
These are the hydrogen bonding and planarity restraints used to restrain the argininamide
binding and base triple interations.
!Argininamide - TAR H-bonding distances restraints
assign (resid 47 and name HH11 )(resid 26 and name 06 ) 1.95 0.25 0.25
assign (resid 47 and name NH1 )(resid 26 and name 06 ) 2.95 0.25 0.25
assign (resid 47 and name HH12 )(resid 26 and name N7 ) 1.95 0.25 0.25
assign (resid 47 and name NH1 )(resid 26 and name N7 ) 2.95 0.25 0.25
!Base triple H-bonding distance restraints
assign (resid 23 and name 04 )(resid 27 and name H61 ) 1.95 0.25 0.25
assign (resid 23 and name 04 )(resid 27 and name N6 ) 2.95 0.25 0.25
assign (resid 23 and name H3 )(resid 27 and name N7 ) 1.95 0.25 0.25
assign (resid 23 and name N3 )(resid 27 and name N7 ) 2.95 0.25 0.25
These are the planar restraints restraining the A27 base and the U23 base to be co-planar.
These restraints are selected with the PLAN flag in the XPLOR scripts.
restraints
planar
group
selection=(
(not( name P or name 01P or name 02P or name 05' or
name C5' or name H5' or name H5" or
name C4' or name H4' or name C3' or name H3' or
name C2' or name H2' or name 02' or name HO2' or
name H1' or name CI' or name 04' or name 03') and
residue 23 )
or (not( name P or name 01P or name 02P or name 05' or
name C5' or name H5' or name H5" or
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2.86
1.70
2.70
1.95
2.95
1.91
2.91
1.95
2.95
1.86
2.86
1.91
2.91
1.95
2.95
1.86
2.86
0.20
0.20
0.20
0.20
0.20
0.20
0.20
0.20
0.20
0.20
0.20
0.20
0.20
0.20
0.20
0.20
0.20
0.20
0.20
0.20
0.20
0.20
0.20
0.20
0.20
0.20
0.20
0.20
0.20
0.20
0.20
0.20
0.20
0.20
0.20
0.20
0.20
0.20
0.20
0.20
0.20
0.20
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name C4' or name H4' or name C3' or name H3' or
name C2' or name H2' or name 02' or name H02' or
name H1' or name Cl' or name 04' or name 03') and
residue 27 )
weight=250.0
end
end
These are the planar restraints that constrain the G26 base and the argininamide guanidium
group to be co-planar.
restraints
planar
group
selection=(
(not( name P or name 01P or name 02P or name 05' or
name C5' or name H5' or name H5" or
name C4' or name H4' or name C3' or name H3' or
name C2' or name H2' or name 02' or name HO2' or
name H1' or name Cl' or name 04' or name 03') and
residue 26 )
or (not( name N or name HN1 or name HN2 or name HN3 or
name CA or name HA or name CB or name HB 1 or
name HB2 or name CG or name HG1 or name HG2 or
name CD or name HD1 or name HD2 or name NE or
name HE or name HC1 or name HC2 or name NC or
name O or name C) and residue 47 )
weight=250.0
end
end
A-form torsion restraints:
These are the backbone torsion restraints which were used in various combinations
as discussed in Chapter 3.
restraints
dihedral
reset
!alfas
assign (resid 16 and name 03')(resid 17 and name P )(resid 17 and name 05')
(resid 17 and name C5') 1.0 -68.0 60.0 2
assign (resid 17 and name 03')(resid 18 and name P(resid 18 and name 05')
(resid 18 and name C5') 1.0 -68.0 60.0 2
assign (resid 18 and name 03')(resid 19 and name P)(resid 19 and name 05')
(resid 19 and name C5') 1.0 -68.0 60.0 2
assign (resid 19 and name 03')(resid 20 and name P)(resid 20 and name 05')
(resid 20 and name C5') 1.0 -68.0 60.0 2
assign (resid 20 and name 03')(resid 21 and name P)(resid 21 and name 05')
(resid 21 and name C5') 1.0 -68.0 60.0 2
assign (resid 26 and name 03')(resid 27 and name P)(resid 27 and name 05')
(resid 27 and name C5') 1.0 -68.0 60.0 2
assign (resid 27 and name 03')(resid 28 and name P)(resid 28 and name 05')
(resid 28 and name C5') 1.0 -68.0 60.0 2
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assign (resid 28 and name 03')(resid 29 and name P)(resid 29 and name 05')
(resid 29 and name C5') 1.0 -68.0 60.0 2
assign (resid 36 and name 03')(resid 37 and name P)(resid 37 and name 05')
(resid 37 and name C5') 1.0 -68.0 60.0 2
assign (resid 37 and name 03')(resid 38 and name P)(resid 38 and name 05')
(resid 38 and name C5') 1.0 -68.0 60.0 2
assign (resid 38 and name 03')(resid 39 and name P)(resid 39 and name 05')
(resid 39 and name C5') 1.0 -68.0 60.0 2
assign (resid 40 and name 03')(resid 41 and name P)(resid 41 and name 05')
(resid 41 and name C5') 1.0 -68.0 60.0 2
assign (resid 41 and name 03')(resid 42 and name P)(resid 42 and name 05')
(resid 42 and name C5') 1.0 -68.0 60.0 2
assign (resid 42 and name 03')(resid 43 and name P)(resid 43 and name OS')
(resid 43 and name C5') 1.0 -68.0 60.0 2
assign (resid 43 and name 03')(resid 44 and name P)(resid 44 and name 05')
(resid 44 and name C5') 1.0 -68.0 60.0 2
assign (resid 44 and name 03')(resid 45 and name P)(resid 45 and name 05')
(resid 45 and name C5') 1.0 -68.0 60.0 2
!beta
assign (resid 17 and name P)(resid 17 and name 0S')(resid 17 and name C5')
(resid 17 and name C4') 1.0 178.0 60.0 2
assign (resid 18 and name P)(resid 18 and name 05')(resid 18 and name C5')
(resid 18 and name C4') 1.0 178.0 60.0 2
assign (resid 19 and name P)(resid 19 and name 05')(resid 19 and name C5')
(resid 19 and name C4') 1.0 178.0 60.0 2
assign (resid 20 and name P)(resid 20 and name 05')(resid 20 and name C5')
(resid 20 and name C4') 1.0 178.0 60.0 2
assign (resid 21 and name P)(resid 21 and name 05')(resid 21 and name C5')
(resid 21 and name C4') 1.0 178.0 60.0 2
assign (resid 28 and name P)(resid 28 and name 05')(resid 28 and name C5')
(resid 28 and name C4') 1.0 178.0 60.0 2
assign (resid 29 and name P)(resid 29 and name 05')(resid 29 and name C5')
(resid 29 and name C4') 1.0 178.0 60.0 2
assign (resid 37 and name P)(resid 37 and name 05')(resid 37 and name C5')
(resid 37 and name C4') 1.0 178.0 60.0 2
assign (resid 38 and name P)(resid 38 and name 05')(resid 38 and name C5')
(resid 38 and name C4') 1.0 178.0 60.0 2
assign (resid 39 and name P)(resid 39 and name 05')(resid 39 and name C5')
(resid 39 and name C4') 1.0 178.0 60.0 2
assign (resid 41 and name P)(resid 41 and name 05')(resid 41 and name C5')
(resid 41 and name C4') 1.0 178.0 60.0 2
assign (resid 42 and name P)(resid 42 and name 05')(resid 42 and name C5')
(resid 42 and name C4') 1.0 178.0 60.0 2
assign (resid 43 and name P)(resid 43 and name 05')(resid 43 and name C5')
(resid 43 and name C4') 1.0 178.0 60.0 2
assign (resid 44 and name P)(resid 44 and name 05')(resid 44 and name C5')
(resid 44 and name C4') 1.0 178.0 60.0 2
assign (resid 45 and name P)(resid 45 and name 05')(resid 45 and name C5')
(resid 45 and name C4') 1.0 178.0 60.0 2
assign (resid 46 and name P)(resid 46 and name 05')(resid 46 and name C5')
(resid 46 and name C4') 1.0 178.0 60.0 2
!gammas
assign (resid 17 and name 05')(resid 17 and name C5')(resid 17 and name C4')
(resid 17 and name C3') 1.0 60.0 30.0 2
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assign (resid 18 and name 05')(resid 18 and name C5')(resid 18 and name C4')
(resid 18 and name C3') 1.0 60.0 30.0 2
assign (resid 19 and name 05')(resid 19 and name C5')(resid 19 and name C4')
(resid 19 and name C3') 1.0 60.0 30.0 2
assign (resid 20 and name 05')(resid 20 and name C5')(resid 20 and name C4')
(resid 20 and name C3') 1.0 60.0 30.0 2
assign (resid 21 and name 05')(resid 21 and name C5')(resid 21 and name C4')
(resid 21 and name C3') 1.0 60.0 30.0 2
assign (resid 28 and name 05')(resid 28 and name C5')(resid 28 and name C4')
(resid 28 and name C3') 1.0 60.0 30.0 2
assign (resid 29 and name 05')(resid 29 and name C5')(resid 29 and name C4')
(resid 29 and name C3') 1.0 60.0 30.0 2
assign (resid 37 and name 05')(resid 37 and name C5')(resid 37 and name C4')
(resid 37 and name C3') 1.0 60.0 30.0 2
assign (resid 38 and name 05')(resid 38 and name C5')(resid 38 and name C4')
(resid 38 and name C3') 1.0 60.0 30.0 2
assign (resid 39 and name 05')(resid 39 and name C5')(resid 39 and name C4')
(resid 39 and name C3') 1.0 60.0 30.0 2
assign (resid 41 and name 05')(resid 41 and name C5')(resid 41 and name C4')
(resid 41 and name C3') 1.0 60.0 30.0 2
assign (resid 42 and name 05')(resid 42 and name C5')(resid 42 and name C4')
(resid 42 and name C3') 1.0 60.0 30.0 2
assign (resid 43 and name 05')(resid 43 and name C5')(resid 43 and name C4')
(resid 43 and name C3') 1.0 60.0 30.0 2
assign (resid 44 and name 05')(resid 44 and name C5')(resid 44 and name C4')
(resid 44 and name C3') 1.0 60.0 30.0 2
assign (resid 45 and name 05')(resid 45 and name C5')(resid 45 and name C4')
(resid 45 and name C3') 1.0 60.0 30.0 2
!epsilon
assign (resid 16 and name C4')(resid 16 and name C3')(resid 16 and name 03')
(resid 17 and name P ) 1.0 -155.0 30.0 2
assign (resid 17 and name C4')(resid 17 and name C3')(resid 17 and name 03')
(resid 18 and name P ) 1.0 -155.0 30.0 2
assign (resid 18 and name C4')(resid 18 and name C3')(resid 18 and name 03')
(resid 19 and name P ) 1.0 -155.0 30.0 2
assign (resid 19 and name C4')(resid 19 and name C3')(resid 19 and name 03')
(resid 20 and name P ) 1.0 -155.0 30.0 2
assign (resid 20 and name C4')(resid 20 and name C3')(resid 20 and name 03')
(resid 21 and name P ) 1.0 -155.0 30.0 2
assign (resid 27 and name C4')(resid 27 and name C3')(resid 27 and name 03')
(resid 28 and name P ) 1.0 -155.0 30.0 2
assign (resid 28 and name C4')(resid 28 and name C3')(resid 28 and name 03')
(resid 29 and name P ) 1.0 -155.0 30.0 2
assign (resid 36 and name C4')(resid 36 and name C3')(resid 36 and name 03')
(resid 37 and name P ) 1.0 -155.0 30.0 2
assign (resid 37 and name C4')(resid 37 and name C3')(resid 37 and name 03')
(resid 38 and name P ) 1.0 -155.0 30.0 2
assign (resid 38 and name C4')(resid 38 and name C3')(resid 38 and name 03')
(resid 39 and name P ) 1.0 -155.0 30.0 2
assign (resid 40 and name C4')(resid 40 and name C3')(resid 40 and name 03')
(resid 41 and name P ) 1.0 -155.0 30.0 2
assign (resid 41 and name C4')(resid 41 and name C3')(resid 41 and name 03')
(resid 42 and name P ) 1.0 -155.0 30.0 2
assign (resid 42 and name C4')(resid 42 and name C3')(resid 42 and name 03')
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(resid 43 and name P ) 1.0 -155.0 30.0 2
assign (resid 43 and name C4')(resid 43 and name C3')(resid 43 and name 03')
(resid 44 and name P ) 1.0 -155.0 30.0 2
assign (resid 44 and name C4')(resid 44 and name C3')(resid 44 and name 03')
(resid 45 and name P ) 1.0 -155.0 30.0 2
assign (resid 45 and name C4')(resid 45 and name C3')(resid 45 and name 03')
(resid 46 and name P ) 1.0 -155.0 30.0 2
!zetas
assign (resid 17 and name C3')(resid 17 and name 03')(resid 18 and name P)
(resid 18 and name 05' ) 1.0 -68.0 60.0 2
assign (resid 18 and name C3')(resid 18 and name 03')(resid 19 and name P)
(resid 19 and name 05' ) 1.0 -68.0 60.0 2
assign (resid 19 and name C3')(resid 19 and name 03')(resid 20 and name P)
(resid 20 and name 05' ) 1.0 -68.0 60.0 2
assign (resid 20 and name C3')(resid 20 and name 03')(resid 21 and name P)
(resid 21 and name 05' ) 1.0 -68.0 60.0 2
assign (resid 28 and name C3')(resid 28 and name 03')(resid 29 and name P)
(resid 29 and name 05' ) 1.0 -68.0 60.0 2
assign (resid 36 and name C3')(resid 36 and name 03')(resid 37 and name P)
(resid 37 and name 05' ) 1.0 -68.0 60.0 2
assign (resid 37 and name C3')(resid 37 and name 03')(resid 38 and name P)
(resid 38 and name 05' ) 1.0 -68.0 60.0 2
assign (resid 38 and name C3')(resid 38 and name 03')(resid 39 and name P)
(resid 39 and name 05' ) 1.0 -68.0 60.0 2
assign (resid 40 and name C3')(resid 40 and name 03')(resid 41 and name P)
(resid 41 and name 05' ) 1.0 -68.0 60.0 2
assign (resid 41 and name C3')(resid 41 and name 03')(resid 42 and name P)
(resid 42 and name 05' ) 1.0 -68.0 60.0 2
assign (resid 42 and name C3')(resid 42 and name 03')(resid 43 and name P)
(resid 43 and name 05' ) 1.0 -68.0 60.0 2
assign (resid 43 and name C3')(resid 43 and name 03')(resid 44 and name P)
(resid 44 and name 05' ) 1.0 -68.0 60.0 2
assign (resid 44 and name C3')(resid 44 and name 03')(resid 45 and name P)
(resid 45 and name 05' ) 1.0 -68.0 60.0 2
assign (resid 45 and name C3')(resid 45 and name 03')(resid 46 and name P)
(resid 46 and name 05' ) 1.0 -68.0 60.0 2
end
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Appendix B.2 XPLOR scripts
XPLOR script 1: random.inp
This script generates random coordinates in a 20 A box and then slowly increases the
various geometric contributions to the energy function with the distance restraints kept high
the whole time. The random seed of XPLOR was found to work not randomly so the
program "gaseed" developed by Christopher Cilley which generates a random was used.
To run the xplor scripts, a .csh file like the following was used:
remarks nmr/random.inp adjusted dihe/cdih flags
remarks The ultimate simulated annealing protocol for NMR structure determination!
remarks The starting structure for this protocol can be completely arbitrary, such as random numbers.
remarks Note: the resulting structures need to be further processed by the dgsa.inp protocol.
remarks Author: Michael Nilges
remarks adapted by jrw 12/95 and asb 3/96
parameter { *Read the parameter file.* }
@TOPPAR:gamma.par
end
parameter
@TOPPAR:parallhdg.pro
end
structure @tar8_gamma.psf end {*Read the structure file.* }
noe
nres=3000 {*Estimate greater than the actual number of NOEs.*}
class all
@tar8final.tbl
end
@tar8dihed2.tbl { *Read dihedral angle restraints.*}
noe {*Parameters for NOE effective energy term.*}
ceiling= 1000
averaging * R-6
potential * soft
scale * 1
sqoffset * 0.0
sqconstant * 1.0
sqexponent * 2
soexponent * 1
asymptote * 2.0 {* Initial value - modified later. * }
rswitch * 1.0
end
restraints dihedral
scale=100.
end
set message=off end
evaluate ($end_count=142) { * Number of structures. * }
evaluate ($init_t = 1000) {* Initial simulated annealing temperature.*}
evaluate ($count = 0 )
{ * copied from run that did well for comparison of new restraints * }
set seed=FOOBAR end
while ($count < $end_count ) loop main
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evaluate ($count=$count+l)
{* Generate a starting structure. * }
vector do (x = (random()-0.5)*20) (all)
vector do (y = (random()-0.5)*20) (all)
vector do (z = (random()-0.5)*20) (all)
vector do (fbeta= 10) (all) {*Friction coefficient for MD heatbath.* }
vector do (mass=100) (all) {*Uniform heavy masses to speed*}
parameter nbonds
atom cutnb 100 tolerance 45 repel=1.2
rexp=2 irexp=2 rcon= 1.0 nbxmod 4
end end
flags exclude * include bonds angle impr vdw noe end
evaluate ($knoe = 1.0)
evaluate ($kbon = 0.0001 ) {* Bonds. * }
evaluate ($kang = 0.0001 ) { * Angles. * }
evaluate ($kimp = 0.0 ) {* Impropers. * }
evaluate ($kvdw = 0.1) {* Vdw. *
constraints
interaction (all) (all)
weights bond $kbon angl $kang impr $kimp vdw $kvdw end
end
{*= - High temperature dynamics. *}
vector do (vx = maxwell($init t)) (all)
vector do (vy = maxwell($initt)) (all)
vector do (vz = maxwell($init_t)) (all)
evaluate ($timestep = 0.04)
evaluate ($nstep = 100)
evaluate ($testframe = 0)
evaluate ($totsteps = 0)
while ($kbon < 0.01) loop stagel
evaluate ($testframe = $testframe + 1)
evaluate ($filename="testframe_"+encode($testframe)+".pdb")
display total steps = $totsteps
write coordinates output =$filename end
evaluate ($kbon = min(0.25, $kbon * 1.25))
evaluate ($kang = $kbon)
evaluate ($kimp = 0)
noe scale * $knoe end
restraints dihed scale 0. end
constraints
interaction (all) (all)
weights bond $kbon angl $kang impr $kimp vdw $kvdw end
end
dynamics verlet
nstep=$nstep timestep=$timestep iasvel=current
tcoupling=true tbath=$init_t nprint=50 iprfrq=0
end
evaluate ($totsteps = $totsteps + $nstep)
end loop stagel
noe scale * 50 end
parameter { * Parameters for the repulsive energy term. * }
nbonds
repel=0.9 { * Initial value for repel - modified later. * }
nbxmod=-3 { * Initial value for nbxmod - modified later. *}
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wmin=0.01
cutnb=4.5 ctonnb=2.99 ctofnb=3.
tolerance=0.5
end
end
evaluate ($kbon=0.01)
evaluate ($kvdw = 0.01)
{* initialize dynamics * }
evaluate ($testframe = $testframe + 1)
evaluate ($filename="testframe_"+encode($testframe)+".pdb")
display total steps = $totsteps
write coordinates output = $filename end
constraints
interaction (all) (all)
weights bond $kbon angl $kbon impr $kbon vdw $kvdw elec 0 end
end
dynamics verlet
nstep=500 timestep=0.003 iasvel=maxwell
firstt=$initt
tcoupling=true
tbath=$init_t nprint=50 iprfrq=0
end
evaluate ($totsteps = $totsteps + 500)
{ * Write out the final structure(s).*}
remarks
remarks overall,bonds,angles,improper,vdw,noe,cdih
remarks energies: $ener, $bond, $angl, $impr, $vdw, $noe, $cdih
{===>} { *Name(s) of the family of initial structures.* }
evaluate ($filename= "t8finalinita_"+encode($count)+".pdb")
display grand total steps = $totsteps
write coordinates output =$filename end
restraints dihed scale 200. end
flags exclude * include bonds angle impr vdw noe cdih dihe end
{ * ramp up covalent terms * }
evaluate ($kvdw = .01)
while ($kbon < 1.0) loop rampcov
evaluate ($testframe = $testframe + 1)
evaluate ($filename="testframe_"+encode($testframe)+".pdb")
remarks total steps = $totsteps
write coordinates output = $filename end
evaluate ($kbon = $kbon* 1.5)
constraints
interaction (all) (all)
weights bond $kbon angl $kbon impr $kbon vdw $kvdw end
end
dynamics verlet
nstep=500 timestep=0.003 iasvel=current
tcoupling=true
tbath=$init_t nprint=50 iprfrq=0
end
evaluate ($totsteps = $totsteps + 500)
end loop rampcov
{* 
- Write out the final structure(s).*}
remarks
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remarks overall,bonds,angles,improper,vdw,dihe,noe,cdih
remarks energies: $ener, $bond, $angl, $impr, $vdw, $dihe, $noe, $cdih
{===>} {*Name(s) of the family of covalent structures.*}
evaluate ($filename="t8finalcova_"+encode($count)+".pdb")
display grand total steps = $totsteps
write coordinates output =$filename end
{* ramp up vdw *}
evaluate ($kbon=1.0)
evaluate ($kvdw=0.01)
while ($kvdw < 1.0) loop rampvdw
evaluate ($testframe = $testframe + 1)
evaluate ($filename="testframe_"+encode($testframe)+".pdb")
display total steps = $totsteps
write coordinates output = $filename end
evaluate ($kvdw = $kvdw* 1.5)
constraints
interaction (all) (all)
weights bond $kbon angl $kbon impr $kbon vdw $kvdw elec 0 end
end
dynamics verlet
nstep=500 timestep=0.003 iasvel=current
tcoupling=true
tbath=$init_t nprint=50 iprfrq=0
end
evaluate ($totsteps = $totsteps + 500)
end loop rampvdw
print threshold=0.5 noe
evaluate ($rms_noe=$result)
evaluate ($violations_noe=$violations)
print threshold=2. cdih
evaluate ($rmscdih=$result)
evaluate ($violations_cdih=$violations)
print thres=0.05 bonds
evaluate ($rms_bonds=$result)
print thres=3. angles
evaluate ($rms_angles=$result)
print thres=5. impropers
evaluate ($rms_impropers=$result)
print thres=5. dihedrals
evaluate ($rms_dihedrals=$result)
{ * ---- Write out the final structure(s).* }
remarks
remarks overall,bonds,angles,improper,vdw,dihe,noe,cdih
remarks energies: $ener, $bond, $angl, $impr, $vdw, $dihe, $noe, $cdih
{===> } {*Name(s) of the family of final structures.* }
evaluate ($filename="randonly 12_"+encode($count)+".pdb")
display grand total steps = $totsteps
write coordinates output =$filename end
end loop main
stop
212
Appendix B Molecular Modeling Details
XPLOR script 2: refine.inp
This script is run after the initial random.inp coordinates script. It cools the structures to
400 K through three 10 ps stops at 1000, 600, and 400 K. This protocol is modeled after
the work of Jucker and Pardi (Jucker & Pardi, 1995).
remarks file refine.inp -- Gentle simulated annealing refinement for NMR structure determination
remarks based on Pardi annealing protocol from Biochemistry on CUUG loop.
{1>1
evaluate ($init_t = 1000)
{->}
evaluate ($second_t = 600)
{ >}
evaluate ($third t = 400)
{=>}
evaluate ($cool_steps = 10000)
parameter
{=>}
@TOPPAR:gamma.par
end
parameter
(=>}
@ TOPPAR:parallhdg.pro
end
{====>} structure
noe
{[=>}
nres=3000
class all
@tar8final.tbl
@tar8dist.tbl
end
@tar8dihed2.tbl
noe
ceiling=1000
averaging * R-6
potential * square
scale * 100
sqoffset * 0.0
sqconstant * 1.
sqexponent * 2
soexponent * 1
asymptote * 2.0
rswitch * 1.0
{*SA temperature, in K.* }
{ *Total number of SA steps.* I
{ *Read the parameter file.* }
{ *Read the parameter file.*}
@tar8_gamma.psf end { *Read the structure file. *}
{ *Estimate greater than the actual number of NOEs. *}
{ *Read NOE distance ranges.* }
{ *Read dihedral angle restraints. *}
{ *Parameters for NOE effective energy term.* }
{* Initial value - modified later. *}
end
parameter
nbonds
repel=0.9
rexp=2 irexp=2 rcon=1.
nbxmod=-2
wmin=0.01
cutnb=4.5 ctonnb=2.99 ctofnb=3.
tolerance=0.5
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{ * scale of 1000 = full value based on nucleotide tests * }
end
set seed=FOOBAR end
evaluate ($end_count=41) {*Loop through a family of 41 structures.* }
evaluate ($count = 0)
while ($count < $end_count) loop main
evaluate ($count=$count+1)
====> } { *Filename(s) for embedded coordinates.* }
evaluate ($filename="final_"+encode($count)+".pdb")
coor @ @$filename
flags exclude * include bond angl impr vdw noe cdih dihe end
{* in nucl. tests impr too high led to collapse of bases * }
constraints
interaction (all) (all)
weights impr 0.5 end
end
*
minimize powell nstep= 100 nprint=25 end
*
vector do ( fbeta=,100. ) ( all ) {*
dynamics verlet
nstep=$cool_steps timestep=0.001
iasvel=maxwell firsttemperature=$init_t
tbath=$init_t tcoup=true
nprint=250 iprfrq=2500
end
minimize powell nstep= 700 nprint=25 end
ic
vector do ( fbeta=100. ) ( all ) {* C
dynamics verlet
nstep=$cool_steps timestep=0.001
iasvel=maxwell firsttemperature=$second
tbath=$second_t tcoup=true
nprint=250 iprfrq=2500
end
{ *
minimize powell nstep= 700 nprint=25 end
(
Intial minimization.*
Constant temperature SA.* }
Coupling to heat bath. * }
700 step minimization.*
600 K dynamics *}
)upling to heat bath. * }
_t
700 step minimization.* }
400 K dynamics * }
vector do ( fbeta=100. ) ( all ) {* Coupling to heat bath. *}
dynamics verlet
nstep=$cool_steps timestep=0.001
iasvel=maxwell firsttemperature=$third_t
tbath=$third_t tcoup=true
nprint=250 iprfrq=2500
end
Final minimization.* }
Write out the final structure(s).*}
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end
end
restraints dihedral
scale=5.
minimize powell nstep= 1000 nprint=25 end
{* 
print threshold=0.2 noe
evaluate ($rms_noe=$result)
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evaluate ($violations_noe=$violations)
print threshold=5. cdih
evaluate ($rms_cdih=$result)
evaluate ($violations_cdih=$violations)
print thres=0.05 bonds
evaluate ($rms_bonds=$result)
print thres=5. angles
evaluate ($rms_angles=$result)
print thres=5. impropers
evaluate ($rms_impropers=$result)
print thres=5. dihedrals
evaluate ($rms_dihedrals=$result)
remarks
remarks overall,bonds,angles,improper,vdw,dihedrals,noe,cdih
remarks energies: $ener, $bond, $angl, $impr, $vdw, $dihe, $noe, $cdih
remarks
remarks bonds,angles,impropers,noe,cdih
remarks rms-d: $rmsbonds,$rms_angles,$rms_impropers,$rms_noe,$rms_cdih
remarks
remarks noe, cdih
remarks violations.: $violations_noe, $violations_cdih
remarks
{ ====> } { *Name(s) of the family of final structures.* }
evaluate ($filename="refine_"+encode($count)+".pdb")
write coordinates output =$filename end
end loop main
stop
XPLOR script 3: repelno.inp
This script slowly cools the structures to 10K using the quartic non-bonding terms.
remarks file nmr/refinelow.inp -- Gentle simulated annealing refinement
remarks for NMR structure determination
evaluate ($zero_t = 500)
evaluate ($init_t = 300) {*SA temperature, in K.*}
evaluate ($second_t = 150)
evaluate ($third_t = 50)
evaluate ($fourth_t = 10)
evaluate ($cool_steps = 2000 ) { *Total number of SA steps.*
parameter { *Read the parameter file.* }
@TOPPAR:gamma.par
end
parameter {*Read the parameter file.* }
@TOPPAR:parallhdg.pro
end
{====>} structure @tar8_gamma.psf end { *Read the structure file.* }
noe
nres=3000
class all
@tar8final.tbl
@tar8dist.tbl
end
@tar8dihed2.tbl
{*Estimate greater than the actual number of NOEs.* }
{*Read NOE distance ranges.*}
{ *Read dihedral angle restraints.* }
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noe { *Parameters for NOE effective energy term.*}
ceiling=1000
averaging * R-6
potential * square
scale * 50
sqoffset * 0.0
sqconstant * 1.
sqexponent * 2
soexponent * 1
asymptote * 2.0 { * Initial value - modified later. * }
rswitch * 1.0
end
{ * lower repel radius 4/5/96 * }
parameter
nbonds
repel=0.9
rexp=2 irexp=2 rcon=1.
nbxmod=-5
wmin=0.01
cutnb=4.5 ctonnb=2.99 ctofnb=3.
tolerance=0.5
end
end
restraints dihedral { * scale is 1000 = full value base on nt. tests
scale=20.
end
vector do (mass=100) (all)
set seed=FOOBAR end
evaluate ($end_count= 27) { *Loop through a family of 7 structur
evaluate ($count = 0 )
while ($count < $end_count ) loop main
evaluate ($count=$count+l)
====> } { *Filename(s) for embedded coordinates.* }
evaluate ($filename="refine_"+encode($count)+".pdb")
coor @ @$filename
flags exclude * include bond angl impr vdw noe cdih end
{ * in nucl. tests impr too high led to collapse of bases * }
constraints
interaction (all) (all)
weights impr 0.5 end
end
vector do (fbeta= 10) (all) {* Coupling to
dynamics verlet
nstep=$cool_steps timestep=0.001
iasvel=maxwell firsttemperature=$zero_t
tbath=$zero_t tcoup=true
nprint=250 iprfrq=2500
end
I*
vector do (fbeta= 10) (all) { * Coupling t
dynamics verlet
nstep=$cool_steps timestep=0.001
iasvel=maxwell firsttemperature=$init_t
tbath=$init_t tcoup=true
heat bath. *}
Constant temperature SA.* }
o heat bath. *}
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* I
es.* }
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nprint=250 iprfrq=2500
end
{* 100 Kdynamics *
vector do (fbeta= 10) (all) {* Coupling to heat bath. *}
dynamics verlet
nstep=$cool_steps timestep=0.001
iasvel=maxwell firsttemperature=$second_t
tbath=$second_t tcoup=true
nprint=250 iprfrq=2500
end
{* 50 K dynamics *}
vector do (fbeta= 10) (all)
dynamics verlet
nstep=$cool_steps timestep=0.001
iasvel=maxwell firsttemperature=$third_t
tbath=$third_t tcoup=true
nprint=250 iprfrq=2500
end
vector do (fbeta=10) (all) {* Coupling to heat bath. *}
dynamics verlet
nstep=$cool_steps timestep=0.001
iasvel=maxwell firsttemperature=$fourth_t
tbath=$fourth_t tcoup=true
nprint=250 iprfrq=2500
Final minimization.* }
minimize powell nstep= 1000 nprint=25 end
{, ----------- Write out the final structure(s).* }
print threshold=0.2 noe
evaluate ($rms_noe=$result)
evaluate ($violations_noe=$violations)
print threshold=5. cdih
evaluate ($rms_cdih=$result)
evaluate ($violations_cdih=$violations)
print thres=0.05 bonds
evaluate ($rms_bonds=$result)
print thres=5. angles
evaluate ($rms_angles=$result)
print thres=5. impropers
evaluate ($rms_impropers=$result)
print thres=5. dihedrals
evaluate ($rms_dihedrals=$result)
remarks
remarks overall,bonds,angles,improper,vdw,dihedrals,noe,cdih
remarks energies: $ener, $bond, $angl, $impr, $vdw, $dihe, $noe, $cdih
remarks
remarks bonds,angles,impropers,noe,cdih
remarks rms-d: $rms_bonds,$rms_angles,$rms_impropers,$rms_noe,$rms_cdih
remarks
remarks noe, cdih
remarks violations.: $violations_noe, $violations_cdih
remarks
{===>} { *Name(s) of the family of final structures.* }
evaluate ($filename="repelno l_"+encode($count)+".pdb")
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write coordinates output =$filename end
end loop main
stop
XPLOR script 4: ljno.inp
This is the last XPLOR script which cools the structure to 10 K with Lennard-Jones force
field turned on. Otherwise, it is the same protocol as repelno.inp.
remarks file ljno.inp
remarks no dihe force field to allow structures a chance to fix themselves
evaluate ($initt = 300) {*SA temperature, in K.*}
evaluate ($second_t = 150)
evaluate ($third_t = 50)
evaluate ($fourth_t = 10)
evaluate ($cool_steps = 2000 ) {*Total number of SA steps.*}
parameter {*Read the parameter file.* }
@TOPPAR:gamma.par
end
parameter
@ TOPPAR:parallhdg.pro
end
{====> } structure
noe
nres=3000
class all
{1>}
@tar8final.tbl
@tar8dist.tbl
end
@tar8dihed2.tbl
noe
ceiling= 1000
averaging * R-6
potential * square
scale * 50
sqoffset * 0.0
sqconstant * 1.
sqexponent * 2
soexponent * 1
asymptote * 2.0
rswitch * 1.0
end
parameter
@tar8_gamma.psf end
{ *Read the parameter file.* }
{*Read the structure file.* }
{ *Estimate greater than the actual number of NOEs.*}
{*Read NOE distance ranges.*}
{*Read dihedral angle restraints.* }
{*Parameters for NOE effective energy term.*}
{* Initial value - modified later. * }
nbonds
tolerance=0.5
cutnb=11.5 ctonnb=9.5 ctofnb= 10.5 tolerance=0.5 rdie vswitch switch
nbxmod=-5
end
end
restraints dihedral
scale= 1000.
end
{* scale is 1000 = full value base on nt. tests *
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vector do (mass=100) (all)
set seed=FOOBAR end
evaluate ($end_count= 27) {*Loop
evaluate ($count =0)
while ($count < $end_count ) loop main
through a family of 7 structures.* }
evaluate ($count=$count+1)
====>} { *Filename(s) for embedded coordinates.* }
evaluate ($filename="repelnol_"+encode($count)+".pdb")
coor @ @$filename
flags exclude * include bond angl impr vdw noe cdih end
{ * in nucl. tests impr too high led to collapse of bases * }
constraints
interaction (all) (all)
weights impr 0.5 end
end
I*
vector do (fbeta= 10) (all) { * Coupling to heat bath. *}
Constant temperature SA.* }
dynamics verlet
nstep=$cool_steps timestep=0.001
iasvel=maxwell firsttemperature=$init_t
tbath=$init_t tcoup=true
nprint=250 iprfrq=2500
end
vector do (fbeta= 10) (all) {* Coupling to heat bath. * }
dynamics verlet
nstep=$cool_steps timestep=0.001
iasvel=maxwell firsttemperature=$second_t
tbath=$second_t tcoup=true
nprint=250 iprfrq=2500
end
(*
vector do (fbeta= 10) (all)
dynamics verlet
nstep=$cool_steps timestep=0.001
iasvel=maxwell firsttemperature=$third_t
tbath=$third_t tcoup=true
nprint=250 iprfrq=2500
end
{*
vector do (fbeta=10) (all) {* Coupling
dynamics verlet
nstep=$cool_steps timestep=0.001
iasvel=maxwell firsttemperature=$fourth_t
tbath=$fourtht tcoup=true
nprint=250 iprfrq=2500
end
{ *
minimize powell nstep= 1000 nprint=25 end{ * -- _
print threshold=0.1 noe
evaluate ($rms_noe=$result)
evaluate ($violations noe=$violations)
100 K dynamics *}
50 K dynamics *}
10 K dynamics * }
to heat bath. *
Final minimization.*)
Write out the final structure(s).* }
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print threshold=2. cdih
evaluate ($rms_cdih=$result)
evaluate ($violations_cdih=$violations)
remarks
remarks overall,bonds,angles,improper,vdw, noe,cdih
remarks energies: $ener, $bond, $angl, $impr, $vdw, $noe, $cdih
remarks
remarks bonds, angles,impropers, noe, cdih
remarks
remarks noe, cdih
remarks violations.: $violations_noe, $violations_cdih
remarks
{====>} { *Name(s) of the family of final structures.*}
evaluate ($filename="ljno_"+encode($count)+".pdb")
write coordinates output =$filename end
end loop main
stop
Appendix B.3 PERL scripts
This appendix presents a suite of programs run by one master C shell script to
analyze any set of RNA XPLOR .pdb files describing a RNA structure. A C shell script is
used to run all the PERL programs mostly because PERL3 does not support
multidimensional arrays straightforwardly. However, PERL5 does, and these programs
probably could be upgraded, but despite their length, they work just fine.
Torsion.csh:
This is the master .csh script: torsion.csh that calls in some PERL scripts. The output
includes a file called table which lists each nucleotide's average torsion with the standard
deviation. All that needs to be adjusted is the numer of total structures the "to" variable
and the "nuc_min" and "nuc_max" variables which are the nucleotide numbering.
#!/bin/csh
set n= 1
set to=20
set nuc_min= 16
set nuc_max=46
set out=final
# this loop runs the xplor file torsion_core.inp that actually measures the torsions
# then the PERL script cleantor.pl deals with the date and spits out the all the torsions by structure into
# final.tor files
while ( $n <= $to)
sed -e "s/FOOBAR/$out$n.pdb/" torsion_core.inp > torsion.inp2
xplor < torsion.inp2 > tor_$n.log
cat tor_$n.log I cleantor.pl > $out$n.tor
my tabtor tot_$n.tor
@ n = $n + 1
end
#reset n to 1
set n=1
#this loop takes the xplor output and places sorts by
while ( $n <= $to )
cat tor_$n.log I tornuc.pl > struct_$n.tor
my tabtor tot_$n.tor
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@ n= $n+ 1
end
set i=$nuc_min
set imax=$nuc_max
# this loop takes the struct.tor files and makes files sorted by nucleotide
while ($i <= $imax )
grep " $i " struct*.tor > nuc_$i.tor
@ i = $i + 1
end
# reset i
set n=$nucmin
# this loop takes the nucleotide sorted torsion files and calculates the average and standard deviation over all
# the structures by nucleotide position and makes a neat table in a file called table.
header.pl
sed -e "s/FOO/$to/" table.pl > table.pl2
chmod +x *.p12
while ( $n <= $nuc_max)
echo this is file number $n
cat nuc_$n.tor I table.pl2
@ n =$n + 1
end
Header.pl
#!/usr/local/bin/perl
open(output ,"> table");
print output "residue alfa beta gamma delta epsilon zeta \n";
print output " 292 178 60 88 205 292 \n";
Table.pl
This PERL script takes input from the nuc.tor files and outputs a file called table which lists
the average torsion ± the standard deviation at each position.
#!/usr/local/bin/perl
open(output ,">> table");
#total structures are adjusted by the tormaster.csh script
$total_structures = FOO;
$alfa_total = 0;
$beta_total = 0;
$gamma_total = 0;
$epsilon_total = 0;
$zeta_total = 0;
$delta_total=0;
$i=0; $j=0;
while ($i < $total_structures) {
@alfal [$i]=($j);
$i = $i + 1; }
$i=O; $j=0;
while ($i < $total_structures) {
@betal [$i]=($j);
$i = $i + 1; }
$i=0; $j=0;
while ($i < $total_structures) {
@gammal [$i]=($j);
221
Appendix B Molecular Modeling Details
$i=$i+ 1; }
$i=0; $j=O;
while ($i < $total_structures) {
@epsilon 1 [$i]=($j);
$i = $i + 1; }
$i=0; $j=O;
while ($i < $total_structures) {
@zetal [$i]=($j);
$i = $i + 1; }
$i=0; $j=O;
while ( $i < $total_structures) {
@deltal [$i]=($j);
$i = $i + 1; }
$count=O;
$i=0;
while(<>) {
($file, $residue, $alfa, $beta, $gamma, $delta, $epsilon, $zeta) = split(As+/,$_);
if ( $alfa < 0 ) {
$alfal[$i] = $alfa + 360; }
else {
$alfal[$i] = $alfa; }
if ($beta < 0 ) {
$betal [$i] = $beta + 360; }
else {
$betal[$i] = $beta; }
if ($gamma < 0 ) {
$gammal[$i] = $gamma + 360; }
else {
$gammal[$i] = $gamma; }
if ($epsilon < 0 ) {
$epsilonl[$i] = $epsilon + 360;
else {
$epsilonl[$i] = $epsilon; }
if ( $zeta < 0 ) {
$zetal[$i] = $zeta + 360; }
else {
$zetal[$i] = $zeta; }
if ( $delta < 0 ) {
$deltal [$i] = $delta + 360; }
else {
$deltal [$i]=$delta; }
$i= $i+1;
$count= $count + 1;
#end of while loop }
$i=0;
while ( $i < $total_structures) {
$alfa_total = $alfal [$i] + $alfa_total;
$beta_total = $betal [$i] + $beta_total;
$gamma_total = $gammal [$i] + $gamma_total;
$epsilon_total = $epsilonl [$i] + $epsilon_total;
$zeta_total = $zetal [$i] + $zeta_total;
$delta_total = $deltal [$i] + $delta_total;
$i =$i +1; }
$alfa_avg= $alfa_total / $total_structures;
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$beta_avg = $beta_total / $total_structures;
$gamma_avg = $gamma_total / $total_structures;
$epsilon_avg = $epsilon_total / $total_structures;
$zeta_avg = $zeta_total / $total_structures;
$delta_avg = $delta_total / $total_structures;
printf output "%4d %s ", $residue, $name;
$angle_count=l;
&standard_dev($alfa_avg, $angle_count, @alfal);
$angle_count=2;
&standard_dev($beta_avg, $angle_count, @betal);
$anglecount = 3;
&standard_dev($gamma_avg, $angle_count, @gammal);
$angle_count=4;
&standard_dev($delta_avg, $angle_count, @deltal);
$angle_count=5;
&standard_dev($epsilon_avg, $angle_count, @epsilonl);
$angle_count=6;
&standard_dev($zeta_avg, $angle_count, @zetal);
printf output "\n";
#this function calculates the standard deviation
sub standard_dev {
local($avg, $angle_name, @angle)= @_;
$sum=O;
$diff=O;
$diffa=O;
$stnd=O;
#print "this is the average angle: $avg \n";
$i=0;
#print "this is angle_res:$angle_name \n";
if ( $angle_name == 1) {
$name = alfa; I
if ($angle_name == 2) {
$name = beta; }
if ($angle_name == 3 ) {
$name = gamma; }
if ($angle_name == 4) {
$name = delta; }
if ($angle_name == 5 ) {
$name = epsilon; }
if ($angle_name == 6 ) {
$name = zeta; }
if ($angle[$i] < $avg) {
$diff = $angle[$i] - $avg; }
if ( $angle[$i] > $avg ) {
$diff=($avg - $angle[$i]); }
$diffa = $diff * $diff;
$sum = $diffa + $sum;
$i++; }
$stnd = sqrt($sum)/$total_structures;
# this section makes for pretty ouput of the table
if ( $stnd > 10 ) {
if ($avg < 100 && $avg > 10) {
printf output " %-4.2f ± %-4.2f ", $avg, $stnd;
}
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else { printf output " %-4.2f ± %-4.2f ", $avg, $stnd; } }
else {
if ( $avg == 0) {
printf output " %-4.2f ± %-4.2f ", $avg, $stnd; I
else {
if ($avg < 100 && $avg > 10) {
printf output " %-4.2f + %-4.2f ", $avg, $stnd; }
if ($avg < 10 ) {
printf output " %-4.2f ± %-4.2f ", $avg, $stnd; I
if ($avg > 100 ) {
printf output " %-4.2f ± %-4.2f ", $avg, $stnd; I
# end of stnd dev function
}
Energy.pl:
This script calculates the average value for all the energy terms used in structure
calculations. Unfortunately, this was written before I figured out object oriented PERL
programming, so it is a bit verbose. The energies line is greped from the .pdb files and
then sent to the PERL script.
grep energies ljfinal*.pdb > foo
cat foo I energy.pl
#!/usr/local/bin/perl
open(output, "> total_energy");
$total_structures=20;
$i=0; $j=O;
while ($i < $total_structures) {
@bond_energy[$i]=($j);
$i = $i + 1; }
$i=0; $j=O;
while ($i < $total_structures) {
@cdih_array[$i]=($j);
$i = $i + 1; }
$i=0; $j=O;
while ($i < $total_structures) {
@bond_array[$i]=($j);
$i = $i + 1; }
$i=0; $j=O;
while ($i < $total_structures) {
@bond_improper[$i]=($j);
$i = $i + 1;
$i=0; $j=O;
while ($i < $total_structures) {
@angle_array[$i]=($j);
$i = $i + 1; }
$i=0; $j=O;
while ($i < $total_structures) {
@vdw_array[$i]=($j);
$i = $i + 1; }
$i=0; $j=O;
while ($i <$total_structures) {
@diff_from_mean[$i]=($j);
$i = $i + 1;
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$energy=O;
$avg_energy--0;
$count=O;
$noe=0;
$cdih=0;
$avg_noe=O;
$avg_cdih=O;
$noe_high = 0;
$noe_low = 100;
$noe_high=O;
$noe_low=100;
$energy_low=O;
$energy_high=-500;
$j=0;
while(<>) {
if( As*energies:\s*(\S*)\s*(\S*)\s*(\S*)\s*(\S*)\s*(\S*)\s*(\S*)\s*(\S*)\s*/) {
#print "$2\n";
$count++;
$energy = $1 + $energy;
if($1 > $energy_high) {
$energy_high = $1; }
if($1 < $energy_low) {
$energy_low = $1; }
$noe = $6 + $noe;
$cdih= $7 + $cdih;
$bond = $2 + $bond;
$angle = $3 + $angle;
$improper = $4 + $improper;
$vdw = $5 + $vdw;
$cdih_array[$j] = $7;
$bondarray[$j] = $2;
$angle_array[$j] = $3;
$improperarray[$j] = $4;
$vdw_array[$j] = $5;
$energy_array[$j] = $1;
$j++;
if($6 > $noe_high) {
$noe_high=$6; }
if($6 < $noe_low) {
$noelow=$6; }
if($7 > cdih_high) {
$cdih_high = $7; }
if($7 < $cdih_low) {
$cdihlow = $7; }
#end of if
}
#end of while input loop
}
print "this is count $count\n";
$avg_energy = $energy / $count;
$avg_noe = $noe / $count;
$avg_cdih = $cdih / $count;
$avgbond = $bond / $count;
$avg_angle = $angle / $count;
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$avg_improper = $improper/$count;
$avg_vdw = $vdw/$count;
#calculate standard deviation
$test=O;
$i=0;
while ($i < $count) {
$test = $avg_energy - $energy_array[$i];
if( $test > 0 ) {
$diff_from_mean[$i]= $test; }
if( $test < 0 ) {
$diff from mean[$i]= 0 - $test; }
$square = $difffrommean[$i] * $diff_frommean[$i];
$sum_stnd_energy = $sumstndenergy + $square;
$i = $i + 1; }
$i=0;
while ($i < $count) {
$test = $avg_bond - $bond_array[$i];
if( $test > 0 ) {
$difffrom_mean[$i]= $test; }
if( $test < 0 ) {
$diff_from_mean[$i]= 0 - $test; }
$square = $difffrom_mean[$i] * $diff frommean[$i];
$sum_stnd_bond = $sum_stnd_bond + $square;
$i = $i + 1; }
$i=0;
while ($i < $count) {
$test = $avg_angle - $angle_array[$i];
if( $test > 0 ) {
$difffrom_mean[$i]= $test; }
if( $test < 0 ) {
$difffrom_mean[$i]= 0 - $test; }
$square = $difffrom_mean[$i] * $difffrommean[$i];
$sum_stnd_angle = $sum_stnd_angle + $square;
$i = $i + 1;}
$i=0;
while ($i < $count) {
$test = $avg_improper - $improperarray[$i];
if( $test > 0 ) {
$diff_from_mean[$i]= $test; }
if( $test < 0 ) {
$difffrom mean[$i]= 0 - $test;
#print "this is diff from-mean $diff_from_mean[$i] \n";
$square = $difffrom_mean[$i] * $diff_frommean[$i];
$sumstndimproper = $sum_stndimproper + $square;
$i = $i + 1; }
$i=0;
while ($i < $count) {
$test = $avgvdw - $vdw_array[$i];
if( $test > 0 ) {
$diff frommean[$i]= $test; I
if( $test < 0 ) {
$difffrom_mean[$i]= 0 - $test; }
$square = $diff_frommean[$i] * $difffrommean[$i];
$sum_stnd_vdw = $sum_stnd_vdw + $square;
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$i = $i + 1; }
$i=0;
while ($i < $count) {
$test = $avg_cdih - $cdih_array[$i];
if( $test > 0 ) {
$diff_from_mean[$i]= $test; }
if( $test < 0 ) {
$difffrommean[$i]= 0 - $test;
#print "this is r $r \n"; }
$square = $diff frommean[$i] * $difffrommean[$i];
$sum_stnd_cdih = $sum_stnd_cdih + $square;
$i = $i + 1; }
$stand_dev_cdih = sqrt($sum_stnd_cdih/)$total_structures;
$stand_dev_bond = sqrt($sum_stnd_bond)/ $total_structures;
$stand_dev_angle = sqrt($sum_stnd_angle)/ $total_structures;
$stand_dev_improper = sqrt($sum_stnd_improper)/ $total_structures;
$stand_dev_vdw = sqrt($sum_stnd_vdw)/ $total_structures;
$stand_dev_energy = sqrt($sum_stnd_energy)/ $totalstructures;
print "this is the average total energy: $avg_energy \n";
print "This is the standard deviation of the total energy: $stand_dev_energy \n";
print "this is the average noe violation energy $avg_noe \n";
print "the total energy ranges from $energy_low to $energy_high \n";
print "the noe violation energy ranges from $noe_low to $noe_high \n";
print "this is the average cdih violation energy $avg_cdih \n";
print "the cdih violation energy ranges from $cdih_low to $cdih_high \n";
print "the standard deviation of the cdih violation energy is $stand_dev_cdih \n";
print " this is the average bond energy: $avg_bond \n";
print "the standard deviation of the bond violation energy is $stand_dev_bond \n";
print " This is the average angle energy: $avg_angle \n";
print " This is the standard deviation for the ANGLE energy $stand_dev_angle \n";
print " this is the average improper energy: $avg_improper \n";
print "This is the standard deviation for the improper energy: $stand_dev_improper \n";
print " This is the average non-bonding energy: $avg_vdw \n";
print "This is the standard deviation for the non-bonding energy: $stand_dev_vdw \n";
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Appendix C: The Williamson WWW Home Page and NMR
Database: HTML and cgi-bin Scripts
This Appendix presents some of the HTML and cgi-bin scripts that were part of the
Williamson Lab home page at MIT. Only the main home page HTML is given as most of
the information will be out of date and can be found on-line anyway. In addition to the
home page, a crude NMR database was written to keep track of all the NMR experiments
that are run in the lab. The database uses slightly different scripts and HTML depending on
the dimension of the NMR experiment (2D, 3D, or 4D). These cgi-bin scripts are written
in PERL3 and call in the standard cgi-lib.pl script which does a lot of the hard work of
dealing with the data from the HTML form pages. A representative set of the form page,
and PERL scripts is given for 4D data. A similiar set of files are used to deal with 2D and
3D NMR data.
Williamson Lab Home Page:
<HTML>
<HEAD>
<base href="http://volvox.mit.edu/home_us.html">
<TITLE>Williamson Lab: for internal use only</TITLE>
</HEAD>
<body bgcolor="000000" vlink="ff0000" link="88BBff' text="FFFFFF">
<table><tr><th>
<a href =links/figs/hiv2_tar.gif><img src="links/figs/hiv2_tar.gif' height=233 width=140
alt = Structure of HIV-2 TAR RNA binding Argininamide.></a></th>
<th><font size =21>
Williamson <a name="Group">Group<p></a></font></th>
<th><a href =figs/webpagel.gif> <img src="figs/webpagel.gif'" height=233 width=194
alt = Structure of HIV RRE RNA and rev peptide Complex.></a></tr>
<tr><td><strong><center>Structure of HIV-2 TAR RNA binding Argininamide.</center></strong></td>
<td><strong><center>Structure of HIV RRE RNA - rev peptide Complex.
</center></strong></td></tr></table><blockquote>
The Williamson Lab is in the Dept. of Chemistry at MIT. We are interested in the fascinating molecule,
RNA. Our research focuses on understanding RNA's interactions with ligands, especially proteins, and on
how really large RNA molecules fold into complex structures. At this site, we have made available some
<a href="links/coords.html">pdb files</a> of the NMR models that have been developed in the lab.
</blockquote><font size=10><table border=7>
<tr><td align=center><strong><a href="links/members.html">Lab Personnel </a></strong> </td>
<td align=center><strong><a href="links/coords.html">NMR Models & Coordinates</a> </strong></td>
</tr><tr><td align=center><strong><a href="links/linkframe.html">Useful Links</a> </strong></td>
<td align=center><strong><a href="links/publications.html">Publications & Abstracts</a>
</strong></td></tr><tr>
<td align=center><strong><a href="http://www.wi.mit.edu/news/bioweek.html" target= "new">Biology
Week</a></strong> </td>
<td align=center><strong><a href="/usage/">Usage statistics for this server.</a>
</strong> </td></tr><tr>
<td align=center><strong><A HREF = figs/view.gif>A Lovely View of Boston from the
Lab</a></strong></td>
<td align=center><strong><A HREF = "http://www.document.com/cam/now.html" target ="new">
Current WeatherCam View from Downtown Boston </A></strong></td></tr>
<tr><td align=center><strong><a href="links/new.html">What's New</a></strong></td>
<td align=center><strong><a href="labonly/lab.html">Williamson Lab Stuff</a></strong></td></tr>
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<tr>
<td align=center><strong><a href="links/chairs.html">Williamson Lab Chair Museum</a></strong></td>
<td align=center><strong><a href="links/funke_today.html">Daily Funke Factoid</a></strong></td></tr>
<tr><td align=center><strong><a href="links/tenure.html">The Tenure Bash! </a></strong></td></tr>
</table></font><p>
<img src="/cgi-bin/Count.cgi?df=sample.dat" align=absmiddle> people have visited this page since May 1,
1997!<br>
Any comments and/or questions about these pages or the Lab are welcome!<br>
</BODY></HTML>
4d_nmr.html:
This is the form page for entering the NMR data to the NMR database.
<HTML>
<HEAD>
<base href="http://volvox.mit.edu/labonly/NMR/4d_nmr.html">
<TITLE>4D NMR FORM</TITLE></HEAD>
<body vlink="ff0000" link="88BBff' text="000000" bgcolor=-"#BFDFFF">
<font size=10><center>
You are entering information for a 4-D experiment! <br>
If this is not correct you can go back to the main NMR page by clicking here!
<A HREF="nmr_master.html"><IMG SRC="../../links/figs/back.gif" ALIGN="left" ALT="[Go
Back]"></A> </center>
<br clear="all"></font>
<FORM METHOD="POST" ACTION="http://volvox.mit.edu/cgi-bin/4D_magnetsort.pl">
<HR><center>
<h3>Enter all information carefully to ensure accuracy!! </h3>
<h3> DO NOT use any commas in any of the text boxes!! The program will not work properly! </h3>
</center><HR><table cellspacing= 10><tr><td align=center><font size=2>
Enter your name (choose a user name and use this for all entries!) </td>
<td align=left><INPUT TYPE="text" NAME="name" SIZE="20"> </font></td></tr>
<td align=center><font size=2> Login id</td>
<td align=left><INPUT TYPE="text" NAME="login" SIZE="20"> </font></td></tr>
<td align=center><font size=2>
Name of the sample e.g. tfr24-TAR8 </td>
<td align=left><INPUT TYPE="text" NAME="sample_name" SIZE="30"> </font></td></tr></table>
Please indicate the type of sample.<br>
<font size=2>
<INPUT type="radio" name="sample_label" value="peptide/protein only" > peptide/protein only
<INPUT type="radio" name="sample_label" value="RNA only" > RNA only
<INPUT type="radio" name="sample_label" value="peptide/protein-RNA complex" > peptide/protein-RNA
complex
<INPUT type="radio" name="sample_label" value="RNA_ligand complex" > RNA-ligand complex
<INPUT type="radio" name="sample_label" value="nucleotide" > nucleotide
<INPUT type="radio" name="sample_label" value="other test sample" > other test samples
<INPUT type="radio" name="sample_label" value="other" > other </font>
<P><table cellspacing=10>
<td align=center><font size=2>
Please indicate labeling pattern of sample. </font> </td>
<td align=left>
<SELECT name="label">
<OPTION>all molecules unlabeled
<OPTION>13C RNA
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<OPTION>15N RNA
<OPTION>13C/15N RNA
<OPTION>13C/2H RNA
<OPTION>15N peptide or protein
<OPTION>15N/13C peptide or protein
<OPTION>2H random RNA
<OPTION>2H selective RNA
<OPTION>2H random peptide or protein
<OPTION>2H/13C/15N protein
<OPTION>2H/15N protein
<OPTION>2H protein
<OPTION>13C RNA in complex
<OPTION>15N RNA in complex
<OPTION>13C/15N RNA in complex
<OPTION>15N peptide or protein in complex
<OPTION>15N/13C peptide or protein in complex
<OPTION>2H random RNA in complex
<OPTION>2H selective RNA in complex
<OPTION>2H random peptide or protein in complex
<OPTION>2H/13C/15N protein in complex
<OPTION>2H/15N protein in complex
<OPTION>2H protein in complex </select></P></td></tr>
<tr><td align=center><font size=2>
Please indicate the concentration of the sample e.g. 1 mM </font> </td>
<td align=left><INPUT TYPE="text" NAME="concentration" SIZE="20"> </td></tr>
<td align=center> <font size=2>
Please indicate the approximate concentration of salt and what kind of salt e.g. 50mM NaCl </font> </td>
<td align=left><INPUT TYPE="text" NAME="salt" SIZE="20"> </td></tr>
<tr><td align=center> <font size=2> Which Magnet did you use? </font> </td>
<td align =left>
<SELECT name="magnet">
<OPTION>None
<OPTION>Didinium Varian 600
<OPTION>Bitter Lab 500
<OPTION>Bitter Lab 591
<OPTION>Bitter Lab 750
<OPTION>Wagner Varian 750
<OPTION>Other </SELECT></td></tr>
<tr><td align=center> <font size=2>When did you start on the magnet? </font> </td>
<td align =left>
<SELECT name="date">
<OPTION>January
<OPTION>February
<OPTION>March
<OPTION>April
<OPTION>May
<OPTION>June
<OPTION>July
<OPTION>August
<OPTION>September
<OPTION>October
<OPTION>November
<OPTION>December </SELECT>
<SELECT name="number">
<OPTION>1
<OPTION>2
<OPTION>3
<OPTION>4
<OPTION>5
<OPTION>6
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<OPTION>7
<OPTION>8
<OPTION>9
<OPTION>10
<OPTION>11
<OPTION>12
<OPTION>13
<OPTION>14
<OPTION>15
<OPTION>16
<OPTION>17
<OPTION>18
<OPTION>19
<OPTION>20
<OPTION>21
<OPTION>22
<OPTION>23
<OPTION>24
<OPTION>25
<OPTION>26
<OPTION>27
<OPTION>28
<OPTION>29
<OPTION>30
<OPTION>31 </SELECT>
<SELECT name="year">
<OPTION>1997
<OPTION>1998
<OPTION> 1999<OPTION> 1997
<OPTION>1998
<OPTION> 1999</SELECT></td></tr>
<tr><td align=center> <font size=2>When did you finish on the magnet? </td>
<td align=left><SELECT name="date_fin">
<OPTION>January
<OPTION>February
<OPTION>March
<OPTION>April
<OPTION>May
<OPTION>June
<OPTION>July
<OPTION>August
<OPTION>September
<OPTION>October
<OPTION>November
<OPTION>December </SELECT>
<SELECT name="number_fin">
<OPTION>1
<OPTION>2
<OPTION>3
<OPTION>4
<OPTION>5
<OPTION>6
<OPTION>7
<OPTION>8
<OPTION>9
<OPTION>10
<OPTION> 1
<OPTION>12
<OPTION>13
<OPTION>14
<OPTION>15
<OPTION>16
<OPTION>17
<OPTION>18
<OPTION>19
<OPTION>20
<OPTION>21
<OPTION>22
<OPTION>23
<OPTION>24
<OPTION>25
<OPTION>26
<OPTION>27
<OPTION>28
<OPTION>29
<OPTION>30
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<OPTION>31
</SELECT><SELECT name="yearfin">
<OPTION>1997
<OPTION>1998
<OPTION>1999 </SELECT></td></tr>
<tr><td align=center> <font size=2>Please enter the probe you used:</font></td>
<td align=left>
<SELECT name="probe">
<OPTION> None
<OPTION> Didinium HCN Z-grad
<OPTION> Didinium HCP Z-grad
<OPTION> Bitter 500 HCN Z-grad
<OPTION> Bitter 750 H only Z-grad
<OPTION> Bitter 750 HX Z-grad
<OPTION> Wagner 750 HCN Z-grad
</SELECT></td></tr></table>
<hr><h3>Enter the experiment information requested you ran and whether they were considered
successful or not. (Note: default is successful ... ever the optimist!) </h3>
<table cellspacing=10><tr><td align=center> <font size=2>
Please Choose from the list of standard Experiments (If you choose other, enter the name in the textarea
below): </font></td>
<td align=left>
<SELECT name="stndexpt">
<OPTION> 1H-13C HMQC-NOESY-HMQC
<OPTION> OTHER
</SELECT></td> </tr>
<tr><td align=center> <font size=2>
If you entered OTHER, please give a name for your experiment. Otherwise you can
just leave this blank. (once you create a name, please use this name for all entries)
</td><td align=left><INPUT TYPE="text" NAME="nonstndexpt" SIZE="25"> </td></tr>
<tr><td align=center> <font size=2>
Please enter the name of the Varian pulse sequence name (seqfil) or Bitter Lab macro to run this experiment.
</font></td><td align=left>
<INPUT TYPE="text" NAME="macro" SIZE="30"></td></tr>
<tr><td align=center> <font size=2>Did your experiment work to your satisfaction? </Font></td>
<td align=left><INPUT type="radio" name= "success" value="successful" checked> successful
<INPUT type="radio" name="success" value="not_successful"> not successful<br></td></tr>
</table><HR><center><h4>
Experimental Parameters: </h4>
Enter all pulse lengths in microseconds!<br> </center>
<table cellspacing=10>
<tr><td align=center> <font size=2> Please enter the temperature at which you ran the experiment.
</font></td>
<td align=left><INPUT TYPE="text" NAME="temperature" SIZE="5"> </td></tr>
<tr><td align=center> <font size=2>Sweep Width for acquistion dimemsion (sw in Varian):
</font></td><td align=left><INPUT type="text" name="sw_t4" size="8"> </td></tr>
<tr><td align=center> <font size=2>Number of REAL points in acquisition dimension (np/2 in Varian):
</font></td><td align=left><INPUT type="text" name="pts_t4" size="8"> </td></tr>
<tr><td align=center> <font size=2>Enter the nucleus detected in the acquisition dimension.
</font></td><td align=left>
<select name="hetnuct4">
<option> none
<option> proton
<option> carbon
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<option> nitrogen
<option> phosphorous
</select> </td></tr>
<tr><td align=center> <font size=2>Sweep Width for first indirect dim. (swl in Varian):
</font></td><td align=left><INPUT type="text" name="sw_t3" size="8"></td></tr>
<tr><td align=center> <font size=2>Number of REAL points in first indirect dim. (ni in Varian):
</font></td><td align=left><INPUT type="text" name="pts_t3" size="8"></td></tr>
<tr><td align=center> <font size=2>Enter the nucleus acquired in the first indirect dimension.
</font></td><td align=left>
<select name="hetnuc_t3">
<option> none
<option> proton
<option> carbon
<option> nitrogen
<option> phosphorous
</select> </td></tr>
<tr><td align=center> <font size=2>Sweep Width for second indirect dim.(sw2 in Varian):
</font></td><td align=left><INPUT type="text" name="sw_t2" size="8"> </td></tr>
<tr><td align=center> <font size=2>Number of REAL points in second indirect dim. (ni2 in Varian):
</font></td><td align=left><INPUT type="text" name="pts_t2" size="8"> </td></tr>
<tr><td align=center> <font size=2>Enter the nucleus acquired in the second indirect dimension.
</font></td><td align=left>
<select name="hetnuc_t3">
<option> none
<option> proton
<option> carbon
<option> nitrogen
<option> phosphorous
</select> </td></tr>
<tr><td align=center> <font size=2>Sweep Width for third indirect dim.(sw2 in Varian):
<font></td><td align=left><INPUT type="text" name="sw_tl" size="8"> <td></tr>
<tr><td align=center> <font size=2>Number of REAL points in second indirect dim. (ni2 in Varian):
</font></td><td align=left><INPUT type="text" name="pts_tl" size="8"> </td></tr>
<tr><td align=center> <font size=2>Enter the nucleus acquired in the second indirect dimension.
</font></td><td align=left>
<select name="hetnuc_tl">
<option> none
<option> proton
<option> carbon
<option> nitrogen
<option> phosphorous
</select> </td></tr>
<tr><td align=center> <font size=2>Proton 90 pulse length:
</font></td><td align=left> <INPUT type="text" name="H_length" size="8"> </td></tr>
<tr><td align=center> <font size=2>Proton 90 pulse power level (typically tpwr in Varian):
</font></td><td align=left><INPUT type="text" name="H_power" size="8"> </td><tr>
<tr><td align=center> <font size=2>Enter the recycle delay in seconds (dl in Varian / RD in Bitter Lab):
</font></td><td align=left><INPUT type="text" name="recycle" size="8"> </td></tr></table>
<hr><center> <h4> Heteronuclei information </h4></center>
<table cellspacing=10>
<tr><td align=center> <font size=2>
Did you use Carbon? <select name="hetnuc_carbon">
<option> no
<option> yes
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</select> </font></td></tr>
<tr> <td align=center><font size=2>
Did you use Nitrogen? <select name="hetnuc_nitrogen">
<option> no
<option> yes
</select> </font></td></tr>
<tr> <td align=center><font size=2>
Did you use Phosphorus? <select name="hetnuc_phosphor">
<option> no
<option> yes
</select> </font></td></tr>
<tr><td align=center> <font size=4>
What transmitter offsets did you use? (List additional offsets in comments)</td></tr></table>
<center><table cellspacing=1><tr><td align=left>Offset in Hz according in "magnet units"</td>
<td align=center>Offset in approximate ppm </td></tr>
<tr><td align=center> <font size=2> Proton (tof in Varian):
</font></td><td align=left><INPUT type="text" name="H_xmit" size="8"> </td>
<td align=left><INPUT type="text" name="H_ppm" size="8"></td></tr>
<tr><td align=center> <font size=2>
Carbon:</font></td><td align=left><INPUT type="text" name="C_xmit" size="8"> </td>
<td align=left><INPUT type="text" name="C_ppm" size="8"></td></tr>
<tr><td align=center> <font size=2>
Nitrogen: </font></td><td align=left><INPUT type="text" name="N_xmit" size="8"> </td>
<td align=left><INPUT type="text" name="N_ppm" size="8"></td></tr>
<tr><td align=center> <font size=2>
Phosphor: </font></td><td align=left><INPUT type="text" name="P_xmit" size="8"> </td>
<td align=left><INPUT type="text" name="Pppm" size="8"></td></tr>
<tr><td align=right> <font size=2>
Did you use deuterium decoupling? (Note: default is no.)</font></td>
<td align=left><INPUT type="radio" name="deut_dec" value="yes"> yes
<INPUT type="radio" name="deut_dec" value="no" checked> no </td></tr></table>
<center>If you used deuterium decoupling, please enter the parameters you used below.
<TEXTAREA NAME="deut_comments" ROWS="3" COLS="60"></TEXTAREA><p>
Enter all pulse lengths in microseconds !<br></center>
<table cellspacing=10><tr><td align=center> <font size=2>
Carbon 90 pulse length:</font></td>
<td align=left><INPUT type="text" name="carb_length" size="8"> </td></tr>
<tr><td align=center> <font size=2>
Carbon 90 pulse power level:</font></td><td align=left>
<INPUT type="text" name="carb_power" size="8"> </td></tr>
<tr><td align=center> <font size=2>
Carbon decoupling pulse length:</font></td>
<td align=left><INPUT type="text" name="Cdec_length" size="8"> </td></tr>
<tr><td align=center> <font size=2>
Carbon decoupling power level:</font></td>
<td align=left><INPUT type="text" name="Cdec_power" size="8"> </td></tr>
<tr><td align=center> <font size=2>
Nitrogen 90 pulse length:</font></td>
<td align=left><INPUT type="text" name="nit_length" size="8"> </td></tr>
<tr><td align=center> <font size=2>
Nitrogen 90 pulse power level:</font></td>
<td align=left><INPUT type="text" name="nitpower" size="8"> </td></tr>
<tr><td align=center> <font size=2>
Nitrogen decoupling pulse length:</font></td>
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<td align=left><INPUT type="text" name="Ndec_length" size="8"> </td></tr>
<tr><td align=center> <font size=2>
Nitrogen decoupling power level:</font></td>
<td align=left><INPUT type="text" name="Ndec_power" size="8"> </td></tr>
<tr><td align=center> <font size=2>
Phosphor 90 pulse length:</font></td>
<td align=left><INPUT type="text" name="phos_length" size="8"> <br>
<tr><td align=center> <font size=2>
Phosphor 90 pulse power level:</font></td>
<td align=left><INPUT type="text" name="phos_power" size="8"> <br>
<tr><td align=center> <font size=2>
Phosphor decoupling pulse length:</font></td>
<td align=left><INPUT type="text" name="Pdec_length" size="8"> </td></tr>
<tr><td align=center> <font size=2>
Phosphor decoupling power level:</font></td>
<td align=left><INPUT type="text" name="Pdec_power" size="8"> </td></tr></table>
<HR><h4> Comments Sections </h4>
<strong><table cellspacing=l><tr><td align=center font=2>
Check here if the comments below include an important general concern! !(Note:default is No)</td>
<td align=left>
<INPUT TYPE="checkbox" name="import_comments" value="yes"> Important general comments included
</td> </tr></table></strong>
<table cellspacing=10> <tr><td align=center font=3><strong>
DO NOT USE ANY COLONS IN THE COMMENTS BOXES!! </strong>
</td></tr></table><br>
Comments regarding any computer problems including hangups, tuning hangups, reboots, and networking.
<TEXTAREA NAME="computer_problems" ROWS="3" COLS="60"></TEXTAREA>
<br clear=-"all"><br>
Comments. Please indicate why you believe your experiment did not work:<BR>
<TEXTAREA NAME="comments" ROWS="3" COLS="60"></TEXTAREA>
<br clear="all"><br>
Comments. For the future, please enter all other important parameters required
to make this pulse sequence work eg. shaped pulse parameters, mix times, other
transmitter frequencies etc.
<TEXTAREA NAME="parameters" ROWS="6" COLS="60"></TEXTAREA>
<h3>Is all the information correct? Once the submit button is clicked,
there is no going back!! </h3>
<h3> Did you use any commas?? If so, please go back and delete them!! </h3>
<P><INPUT TYPE=submit value="Submit the Form"> <INPUT TYPE=reset>
</center></FORM></body></html>
4D_magnetsort.pl:
This script takes the input from the form page, 4d_nmr.html, and first checks to ensure that
all the critical fields have been entered before writing the data to temporary files. The script
then sends the data back to the browser for the user to check a final time, before the data is
officially submitted to the database.
#!/usr/local/bin/perl
#4d NMR perl script to deal with 4D data from the 4d_nmr.html form page
require ("/usr/people/brodsky/cgi-bin/cgi-lib.pl");
&ReadParse;
#handling the heteronuclear options
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@hetnuc = split( "\0", $in {'hetnuc'} );
print "Content-type:text/html\n\n";
print "<html> \n";
print "<title>4D NMR response Page</title> \n";
#check to see if all input has been entered.
if ($in{'stndexpt'} eq "OTHER") {
if( $in{'nonstndexpt'} eq "") {
print "<hl> \n";
print "You did not enter a name for your non-standard experiment ... Please go back and
resubmit the form!!";
print "</hl>";
exit(0); } }
if ($in{'magnet'} eq "None") {
print "<hl> \n";
print "You did not enter which magnet you used ... Please go back and resubmit the form!!";
print "</hl>";
exit(0); }
if ($in{'macro'} eq "") {
print "<hl> \n";
print "You did not enter a macro or pulse sequence ... Please go back and resubmit the form!!";
print "</hl>";
exit(0); I
if ($in{'name'} eq "") {
print "<hl> \n";
print "You did not enter your name ... Please go back and resubmit the form!!";
print "</hl>";
exit(0); I
if ($in{'login'} eq "") {
print "<hl> \n";
print "You did not enter your e-mail address ... Please go back and resubmit the form!!";
print "</hl>";
exit(0); }
if ($in{'salt'} eq "") {
print "<hl> \n";
print "You did not enter the salt concentration ... Please go back and resubmit the form!!";
print "</hl>";
exit(0); }
if ($in{'concentration'} eq "") {
print "<hl> \n";
print "You did not enter the concentration of your sample ... Please go back and resubmit the
form!! ";
print "</hl>";
exit(0); I
if ($in{'sample_name'} eq "") {
print "<hl> \n";
print "You did not enter the type of sample you used ... Please go back and resubmit the form!!";
print "</hl>";
exit(0); }
if ($in {'temperature'} == "\0") {
print "<hl> \n";
print "You did not enter a temperature ... Please go back and resubmit the form!!";
print "</hl>";
exit(0); I
if ($in{'probe'} eq "None") {
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print "<hl> \n";
print "You did not enter any probe information ... Please go back and resubmit the form! !";
print "</hl>";
exit(O); }
if($in{'hetnuc_t3'} eq "none") {
print "<hl> \n";
print "You did not enter a nucleus in the acquisition dimension... Please go back and resubmit the
form!! \n";
print "</hl> ";
exit(0); }
if ($in{'sw_t4'} == "\0") {
print "<hl> \n";
print "You did not enter any sweep width in the acquisition dim. ... Please go back and resubmit
the form!!";
print "</hl>";
exit(0); }
if ($in{'pts_t4'} == "\0") {
print "<hl> \n";
print "You did not enter any points in the acquisition dim. ... Please go back and resubmit the
form!!";
print "</hl>";
exit(0); }
if($in{ 'hetnuc_t3'} eq "none") {
print "<hl> \n";
print "You did not enter a nucleus in the first indirect dimension... Please go back and resubmit the
form!! \n";
print "</hl> ";
exit(0); }
if ($in{'sw_t3'} == "\0") I
print "<hl> \n";
print "You did not enter any sweep width in the first indirect dim. ... Please go back and resubmit
the form!!";
print "</hl>";
exit(0); }
if ($in{'pts_t3'} == "\0") {
print "<hl> \n";
print "You did not enter any points in the first indirect dim. ... Please go back and resubmit the
form! !";
print "</hl>";
exit(0); }
if($in{'hetnuc_t2'} eq "none") {
print "<hl> \n";
print "You did not enter a nucleus in the second indirect dimension... Please go back and resubmit
the form!! \n";
print "</hl> ";
exit(0); }
if ($in{'sw_t2'} == "\0") {
print "<hl> \n";
print "You did not enter a sweep width in the second indirect dim.... Please go back and resubmit
the form!!";
print "</hl>";
exit(0); }
if ($in{'pts_t2'} == "\0") {
print "<hl> \n";
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print "You did not enter any points in the second indirect dim. ... Please go back and resubmit the
form!!";
print "</hl>";
exit(0); }
if($in{'hetnuc_tl'} eq "none") {
print "<hl> \n";
print "You did not enter a nucleus in the third indirect dimension... Please go back and resubmit
the form!! \n";
print "</hl> ";
exit(0); }
if ($in{'sw_tl'} == "\0") {
print "<hl> \n";
print "You did not enter a sweep width in the third indirect dim. ... Please go back and resubmit
the form!!";
print "</hl>";
exit(0); }
if ($in{'pts_tl'} == "\0") {
print "<hl> \n";
print "You did not enter any points in the third indirect dim. ... Please go back and resubmit the
form!! ";
print "</hl>";
exit(0); }
if ($in{ 'H_ength' == "\0") {
print "<hl> \n";
print "You did not enter a 90 proton pulse length ... Please go back and resubmit the form!!";
print "</hl>";
exit(0); I
if ($in{'H_power'} == "\0") {
print "<hl> \n";
print "You did not enter a 90 proton power level ... Please go back and resubmit the form!!";
print "</hl>";
exit(0); }
if( $in{'het_nuc'} eq "carbon") {
if ($in{'C_xmit'} == "\0") {
print "<hl> \n";
print "You used carbon and did not enter a carbon transmitter offset ... Please go back and
resubmit the form!!";
print "</hl>";
exit(0); }
if ($in{'carb_length'} == "\0") {
print "<hl> \n";
print "You used carbon and did not enter a carbon 90 pulse length ... Please go back and
resubmit the form!!";
print "</hl>";
exit(0); }
if ($in {'carb_power'} == "\0") {
print "<hl> \n";
print "You used carbon and did not enter a carbon 90 pulse power level. Please go back
and resubmit the form! !";
print "</hl>";
exit(0); } }
if( $in{'het_nuc'} eq "nitrogen") {
if ($in{'N_xmit'} == "\0") {
print "<hl> \n";
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print "You used nitrogen and did not enter a nitrogen transmitter offset ... Please go back
and resubmit the form!!";
print "</hl>";
exit(0); }
if ($in{'nit_length'} == "\0") {
print "<hl> \n";
print "You used nitrogen and did not enter a nitrogen 90 pulse length ... Please go back
and resubmit the form!! </hl>";
exit(0); }
if ($in{'nitpower') == "\0") {
print "<hl> \n";
print "You used nitrogen and did not enter a nitrogen 90 pulse power level. Please go
back and resubmit the form!! </hl>";
exit(0); } }
if( $in{'het_nuc'} eq "phosphor") {
if ($in{'C_xmit'} == "\0") {
print "<hl> \n";
print "You used phosphor and did not enter a phosphor transmitter offset ... Please go
back and resubmit the form!! </hl>";
exit(0); }
if ($in{'phos_length'} == "\0") {
print "<hl> \n";
print "You used phosphor and did not enter a phosphor 90 pulse length ... Please go back
and resubmit the form!! </hl>";
exit(0); }
if ($in{'phos_power') == "\0") { print "<hl> \n";
print "You used phosphor and did not enter a phosphor 90 pulse power level. Please go
back and resubmit the form!! </hl>";
exit(0); } }
print <<END_OF_MESSAGE;
<hl>Thank you $in{'name'} for filling out the 4D parameter form!</hl>
END_OF_MESSAGE
printf "4D EXPT <br> \n";
printf "USER: $in{'name'} <br> \n";
printf "Magnet: $in{'magnet'} <br> \n";
printf "Start Date: $in{'date') $in{ 'number'),$in {'year'). <br> \n";
printf "Finish Date: $in{'datefin') $in{'numberfin'} ,$in{'yearfin'} <br> \n";
if($in{'stndexpt'} ne OTHER) {
printf "4D Experiment: $in{'stndexpt'} <br> \n"; }
else { printf "4D Experiment: $in{'nonstndexpt'} <br> \n"; }
printf "Macro/Pulse Sequence: $in{'macro'} <br> \n";
printf "Probe: $in{'probe'} <br> \n";
printf "Sample: $in{'sample_name' } <br> \n";
printf "Type of Sample: $in{'sample_label'} <br> \n";
printf "Concentration of Sample: $in{'concentration') <br> \n";
printf "Labelling Pattern: $in{ 'label') <br> \n";
printf "Salt Concentration: $in{'salt') <br> \n";
printf "Temperature: $in{'temperature') <br> \n";
if($in{'success'} eq "successful") {
printf "Success: YES <br> \n"; }
else { printf "Success: NO <br> \n"; }
printf "Proton 90: $in{'H_length'}) <br> \n";
printf "Proton 90 power: $in{'H_power' <br> \n";
printf "Recycle Delay: $in{'recycle') <br> \n";
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printf "Acquisition detected $in{'hetnuc_t3'} with ";
printf "SW(t4): $in{'sw_t4'} \nPTS(t3):$in{'pts_t4'} <br> \n";
printf "First Indirect dimension detected $in{'hetnuc_t3'} with ";
printf "SW(t3): $in{'sw_t3'} \nPTS(t3):$in{'pts_t3'} <br> \n";
printf "Second indirect dimension detected $in{'hetnuc_t2'} with ";
printf "SW(t2): $in{'sw_t2'1 \nPTS(tl):$in{'pts_t2'1 <br> \n";
printf "Third indirect dimension detected $in{'hetnuc_tl'} with ";
printf "SW(tl): $in{'sw_tl' \nPTS(tl):$in{'pts_tl' <br> \n";
printf "PROTON_XMIT: $in{'H_xmit'} which is at $in{'H_ppm'} ppm <br> \n";
if ( $in{'deutdec'} eq "no") { printf "Deuterium Decoupling: NO <br> \n";
else { printf "Deuterium Decoupling: YES <br> \n";
printf "Deuterium Decoupling Parameters: \n $in{'deut_comments') <br> \n"; }
if($in{ 'hetnuc_carbon'} eq "yes") {
printf "Heteronucleus: CARBON <br> \n";
printf "CARBON_XMIT: $in{'C_xmit'} which is at $in{'C_ppm'} ppm<br> \n";
printf "CARBON 90: $in{'carb_length' <br>\nCARBON 90 POWER:
$in {'carbpower'} <br> \n";
printf "CARBON DECOUPLING 90: $in{'Cdec_length'} <br>\nCARBON DEC 90
POWER: $in {'Cdec_power'} <br> \n"; }
if($in{'hetnuc_nitrogen'} eq "yes") {
printf "Heteronucleus: NITROGEN <br> \n";
printf "NITROGEN_XMIT: $in{'N_xmit'} which is at $in{'N_ppm' ppm<br> \n";
printf "NITROGEN 90:$in{'nit_length'} <br> \nNITROGEN 90
POWER:$in {'nitpower'} <br> \n";
printf "NITROGEN DECOUPLING 90:$in{'Ndec_length'} <br> \nNITROGEN DEC
90 POWER:$in {'Ndec_power'} <br> \n"; }
if($in{ 'hetnuc_phosphor'} eq "yes") {
printf "Heteronucleus: PHOSPHOR <br> \n";
printf "PHOSPHOR_XMIT:$in{ 'P_xmit' } which is at $in{'P_ppm' ppm<br> \n";
printf "PHOSPHOR 90:$in{ 'phos_length'} <br>\nPHOSPHOR 90
POWER:$in{ 'phos_power'} <br> \n";
printf "PHOSPHOR DECOUPLING 90:$in{'Pdec_length'} <br>\nPHOSPHOR DEC
90 POWER:$in {'Pdec_power'} <br> \n"; }
if ($in{'import_comments'} eq "yes" ) {
printf "<strong> You have a critical GENERAL concern in the comments below </strong <br> \n";
}
printf "COMPUTER COMMENTS: $in{ 'computerproblems' }<br> \n";
printf "SUCCESS COMMENTS: $in{'comments'} <br> \n";
printf "PARAMETER COMMENTS: $in{'parameters') <br> \n";
printf "<h3> Is this information correct? <br> \n";
printf "If this information is correct click the submit button, if not return to the form page using the
netscape back button and correct the wrong information! </h3> \n";
printf "<strong>Any problems or questions please contact Alex. Bugs/problems will not be fixed if not
reported! ThankYou! </strong> \n";
printf "<a href=mailto:brodsky@mit.edu>brodsky@mit.edu</a> \n";
printf "<form ACTION=http://volvox.mit.edu/cgi-bin/4D_submit.pl> \n";
print <<END_OF_MESSAGE;
<input type="radio" name="tmpfile" value="$in{ 'name' }_tmpfile" checked> <br>
END_OF_MESSAGE
printf '<P><INPUT TYPE=submit value="FINAL Submit to the Database">';
printf " \n </FORM> \n </html> \n";
#to write to temporary data file to read if data is actually submitted to database
open(DATAFILE, "> /usr/ns-home/docs/labonly/NMR/$in{ 'name' }_tmpfile");
flock (DATAFILE, 2);
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#printf DATAFILE "4D EXPT \n";
printf DATAFILE "USER: $in{'name'},";
printf DATAFILE "$in{ 'login' },";
printf DATAFILE "Magnet: $in{'magnet'}, ";
printf DATAFILE "Start Date: $in{'date'} $in{'number'} $in{'year'}, ";
printf DATAFILE "Finish Date: $in{'datefin'} $in{'numberfin' $in{ 'year_fin' i,";
printf DATAFILE "Probe: $in{ 'probe'},";
if($in{'stndexpt'} ne OTHER) {
printf DATAFILE "4D Experiment: $in{'stndexpt'},";
else { printf DATAFILE "4D Experiment: $in{'nonstndexpt'},"; }
printf DATAFILE "Macro/Pulse Sequence: $in{'macro' ,";
printf DATAFILE "Probe: $in {'probe'},";
printf DATAFILE "Sample: $in {'sample_name' },";
printf DATAFILE "Type of Sample: $in{'sample_label'},";
printf DATAFILE "Concentration of Sample: $in{'concentration' ,";
printf DATAFILE "Labelling Pattern: $in{'label'},";
printf DATAFILE "Salt Concentration: $in{'salt'},";
printf DATAFILE "Temperature: $in {'temperature'},";
if($in{'success'} eq "successful") { printf DATAFILE "Success: YES,"; }
else { printf DATAFILE "Success: NO,"; }
printf DATAFILE "Proton 90: $in{'Hlength'},";
printf DATAFILE "Proton 90 power: $in{'H_power' ,";
printf DATAFILE "Recycle Delay:$in {'recycle'},";
printf DATAFILE "$in{ 'hetnuc_t4' },";
printf DATAFILE "SW(t3):$in {'sw_t4'},PTS(t3):$in {'pts_t4' ,";
printf DATAFILE "$in{'hetnuc_t3'},";
printf DATAFILE "SW(t3):$in {'sw_t3' },PTS(t3):$in {'pts_t3' ,";
printf DATAFILE "$in {'hetnuc_t2'},";
printf DATAFILE "SW(t2): $in {'sw_t2'} ,PTS(t2):$in{ 'pts_t2' ,";
printf DATAFILE "$in{ 'hetnuc_t l' },";
printf DATAFILE "SW(tl): $in{'sw_tl',PTS(tl):$in{'pts_tl' ,";
printf DATAFILE "PROTON_XMIT:$in {'H_xmit' },$in{ 'H_ppm'},";
if ( $in{'deut_dec'} eq "no") {
printf DATAFILE "Deuterium Decoupling: NO,";
#printf DATAFILE "Deuterium Decoupling Parameters: None,";
else { printf DATAFILE "Deuterium Decoupling: YES,";
#printf DATAFILE "Deuterium Decoupling Parameters: $in{'deut_comments' },";
if($in{'hetnuc_carbon'} eq "yes") {
printf DATAFILE "Carbon,"; }
else { printf DATAFILE "No,"; }
if($in{ 'hetnuc_nitrogen' eq "yes") {
printf DATAFILE "Nitrogen,"; }
else { printf DATAFILE "No,"; }
if($in{'hetnuc_phosphor'} eq "yes") { printf DATAFILE "Phosphor,";
else { printf DATAFILE "No,"; I
printf DATAFILE "CARBON_XMIT: $in {'C_xmit' },$in{'C_ppm' },";
printf DATAFILE "CARBON 90: $in{'carb_length'}, CARBON 90 POWER:
$in{ 'carb_power' },";
printf DATAFILE "CARBON DECOUPLING 90: $in{'Cdec_length'}, CARBON DEC
90 POWER: $in {'Cdec_power'},";
printf DATAFILE "NITROGEN_XMIT: $in{ 'N_xmit' },$in {'N_ppm' },";
printf DATAFILE "NITROGEN 90:$in{'nit_length'}, NITROGEN 90
POWER:$in{ 'nit_power') },";
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printf DATAFILE "NITROGEN DECOUPLING 90:$in{'Ndec_length'}, NITROGEN
DEC 90 POWER:$in {'Ndec_power'},";
printf DATAFILE "PHOSPHOR_XMIT:$in{ 'P_xmit' },$in{ 'P_ppm' },";
printf DATAFILE "PHOSPHOR 90:$in{ 'phos_length' }, PHOSPHOR 90
POWER:$in{ 'phos_power'),";
printf DATAFILE "PHOSPHOR DECOUPLING 90:$in{ 'Pdec_length'}, PHOSPHOR
DEC 90 POWER:$in{ 'Pdec_power' },";
if ($in{'import_comments'} eq "yes" ) { printf DATAFILE "yes,"; }
else { printf DATAFILE "no,"; }
flock (DATAFILE, 8);
close DATAFILE;
open(DATAFILE, "> /usr/ns-home/docs/labonly/NMR/$in {'name' _tmpfilecom");
flock (DATAFILE, 2);
printf DATAFILE "COMPUTER COMMENTS:$in {'computer_problems' }";
flock (DATAFILE, 8);
close DATAFILE;
open(DATAFILE, "> /usr/ns-home/docs/labonly/NMR/$in {'name' _tmpfilecom 1");
flock (DATAFILE, 2);
printf DATAFILE "SUCCESS COMMENTS:$in{ 'comments')";
flock (DATAFILE, 8);
close DATAFILE;
open(DATAFILE, "> /usr/ns-home/docs/labonly/NMR/$in {'name' }_tmpfilecom2");
flock (DATAFILE, 2);
printf DATAFILE "PARAMETER COMMENTS: $in {'parameters')";
flock (DATAFILE, 8);
close DATAFILE;
open(DATAFILE, "> /usr/ns-home/docs/labonly/NMR/$in{'name'}_tmpfilecom3");
flock (DATAFILE, 2);
printf DATAFILE "Deuterium Decoupling Parameters:$in {'deut_comments')";
flock (DATAFILE, 8);
close DATAFILE;
#RECORD_ITEM
4D_submit.pl: This script reads the temporary file and writes the data to the different files for permanent
record. The data is sorted by the dimension of the experiment, by the magnet it was run on, and to a master
list of all experiments. Other sorting by type of experiment like NOESY or through-bond can be added.
Also, the script send mail to the user and to Jamie for the user's records.
#!/usr/local/bin/perl
#4d NMR perl script to deal with 4D data from the 4D_response.html form page for FINAL
#submission to the database
require ("/usr/people/brodsky/cgi-bin/cgi-lib.pl");
&ReadParse;
print <<END_OF_MESSAGE;
<title>4D NMR Submission Response</title>
<hl> Thank you for submitting your data to the Williamson Lab NMR database </hl>
<h3>
<a href=http://volvox.mit.edu/labonly/NMR/nmr_master.html>Return to the main NMR page</a> </h3>
END_OF_MESSAGE
#read the temp file to get the information enterer by the user
open (input,"/usr/ns-home/docs/labonly/NMR/$in{ 'tmpfile' ");
while(<input>) {
($user, $login, $magnet, $start, $finish, $probe, $exptname, $macro, $probe, $sample, $type, $conc,
$label, $salt, $temperature, $success, $proton_90, $proton_power, $recycle,$hetnuc_t4, $sw_t4,$pts_t4,
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$hetnuc_t3,$sw_t3, $ptst3, $hetnuc_t2,
$sw_t2, $ptst2, $hetnuc_tl, $sw_tl, $ptstl, $proton_xmit, $proton_ppm,$deut_no,
$hetcarbon,$hetnit,$het_phos,$carbonxmit,$carbppm,$carb_90,$carbpower,$carbdec9,
$carb_decpower,
$nitxmit,$nitppm,$nit90,$nit-power,$nitdec9,$nitdecpower,$phosxmit,$phosppm,$phos-O,
$phos_power,$phos_dec90,$phos_decpower,$importconcern) = split(/,/, $_);
} #end of while input
close(input);
$/=""; #enable paragraph mode
$*=1; #enable multi line patterns
open(com,"/usr/ns-home/docs/labonly/NMR/$in { 'tmpfile' }com");
while(<com>) {
($computercomment,$ccom)=split(/:/,$_);
close(com);
open(com 1,"/usr/ns-home/docs/labonly/NMR/$in { 'tmpfile' }com 1");
while(<coml>) {
($success_comments,$scom)=split(/:/,$);
close(coml);
open(com2,"/usr/ns-home/docs/labonly/NMR/$in { 'tmpile' } com2");
while(<com2>) {
($parameter_comments,$pcom)=split(/:/,$_);
close(com2);
open(com3,"/usr/ns-home/docs/labonly/NMR/$in { 'tmpfile' } com3");
while(<com3>) {
($deut_comments,$deutcom)=split(/:/,$3);
close(com3);
#to establish the count of all experiments
open(inputl,total_exptcount);
while (<inputl>) {
($count) = split(As+/,$_);
$count= $count + 1;
#print "<strong>You performed experiment number $count. </strong> ";
close(inputl);
open(output, "> /usr/people/brodsky/cgi-bin/total_exptcount");
flock (output, 2);
printf output "$count";
flock (output, 8);
close(output);
#send mail to the submitter
$mailer-$login;
&write_mail($mailer);
#send mail to Jamie
$mailer=-jrwill;
&write_mail($mailer);
#send mail to Kwaku
$mailer=-kwaku;
&write_mail($mailer);
sub write_mail {
local($mailer) = @_;
#routine to send mail
#to send mail upon submission
open (MAIL, "I /usr/lib/sendmail -oi -n -t" );
print MAIL <<MAIL_MESSAGE;
To:$mailer
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From:NMR database
MAIL_MESSAGE
printf MAIL "4D EXPT \n";
printf MAIL "Experiment number: $count \n";
printf MAIL "$user \n";
printf MAIL "$magnet \n";
printf MAIL "$start \n";
printf MAIL "$finish \n";
printf MAIL "$exptname \n";
printf MAIL "$macro \n";
printf MAIL "$probe \n";
printf MAIL "$sample \n";
printf MAIL "$type \n";
printf MAIL "$conc \n";
printf MAIL "$label \n";
printf MAIL "$salt \n";
printf MAIL "$temperature \n";
printf MAIL "$success\n";
printf MAIL "$recycle \n";
printf MAIL "Acquisition nucleus:$hetnuc_t4 \n";
printf MAIL "$sw_t4 \n";
printf MAIL "$pts_t4 \n";
printf MAIL "First indirect nucleus:$hetnuc_t3 \n";
printf MAIL "$swt3 \n";
printf MAIL "$pts_t3 \n";
printf MAIL "Second indirect nucleus:$hetnuc_t2 \n";
printf MAIL "$sw_t2 \n";
printf MAIL "$pts_t2 \n";
printf MAIL "Third indirect nucleus:$hetnuc_tl \n";
printf MAIL "$sw_tl \n";
printf MAIL "$pts_tl \n";
printf MAIL "$proton_90 \n";
printf MAIL "$proton_power \n";
printf MAIL "$proton_xmit at $proton_ppm ppm \n";
if ( $deut_no eq "Deuterium Decoupling: NO" ) {
printf MAIL "Deuterium Decoupling: NO \n";
else {
printf MAIL "Deuterium Decoupling: YES \n";
printf MAIL "$deut_comments$deutcom \n";
if($het_carbon ne "No") {
printf MAIL "Heteronucleus: CARBON \n";
printf MAIL "$carb_xmit at $carb_ppm ppm\n";
printf MAIL "$carb_90 \n$carb_power \n";
printf MAIL "$carb_dec90\n$carb_decpower \n";
if($het_nit ne "No") {
printf MAIL "Heteronucleus: NITROGEN \n";
printf MAIL "$nit_xmit at $nit_ppm ppm\n";
printf MAIL "$nit_90\n$nitpower \n";
printf MAIL "$nit_dec90\n$nitdecpower \n";
if($het_phos ne "No") {
printf MAIL "Heteronucleus: PHOSPHOR \n";
printf MAIL "$phos_xmit at $phos_ppm ppm\n";
printf MAIL "$phos_90 \n$phos_power \n";
printf MAIL "$phos_dec90\n$phos_decpower \n";
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if ($import_concern eq "yes" ) {
printf MAIL "GENERAL CONCERN LISTED IN COMMENTS \n";
printf MAIL "$computer_comment:$ccom\n";
printf MAIL "$success_comments:$scom \n";
printf MAIL "$parameter_comments:$pcom \n";
close MAIL; I
# determine the index and database file names to write to
# write to files for all 4D experiments tracking
$index="/disks/work0/brodsky/webpages/NMR/4D/all_index4D.html";
$data_file ="/disks/workO/brodsky/webpages/NMR/4D/all_database4D.html";
$data_link ="all_database4D.html";
#call the index subroutine
&writejndex($index,$data_link);
#call subroutine to write to a database file
&write_database($data_file);
#write to files for all experiments
$index="/disks/workO/brodsky/webpages/NMR/all_index.html";
$data_file ="/disks/work0/brodsky/webpages/NMR/all_database.html";
$data_link ="all_database.html";
#call the index subroutine
&write_index($index,$datalink);
#call subroutine to write to a database file
&write_database($data_file);
#write to file if experiment was run on didinium
if( $magnet eq "Magnet: Didinium Varian 600" ) {
$index="/disks/work0/brodsky/webpages/NMR/4D/didiniumindex4D.html";
$datafile ="/disks/work0/brodsky/webpages/NMR/4D/didinium_database4D.html";
$data_link ="didinium_database4D.html";
#call the index subroutine
&write_index($index,$datalink);
#call subroutine to write to a database file
&write_database($datafile); }
elsif ( $magnet eq "Magnet: Bitter Lab 591" ) {
$index="/disks/work0/brodsky/webpages/NMR/4D/bitter59l_index4D.html";
$data_file ="/disks/work0/brodsky/webpages/NMR/4D/bitter591_database4D.html";
$data_link ="bitter59l_database4D.html";
#call the index subroutine
&writeindex($index,$data link);
#call subroutine to write to a database file
&write_database($data_file); I
elsif ( $magnet eq "Magnet: Bitter Lab 750") {
$index="/disks/work0/brodsky/webpages/NMR/4D/bitter750_index4D.html";
$datafile ="/disks/work0/brodsky/webpages/NMR/4D/bitter750_database4D.html";
$data_link ="bitter750_database4D.html";
#call the index subroutine
&writeindex($index,$datalink);
#call subroutine to write to a database file
&write_database($data_file); }
elsif ( $magnet eq "Magnet: Bitter Lab 500") {
$index="/disks/workO/brodsky/webpages/NMR/4D/bitter500_index4D.html";
$datafile ="/disks/work0/brodsky/webpages/NMR/4D/bitter500_database4D.html";
$data_link ="bitter500_database4D.html";
#call the index subroutine
&writeindex($index,$datalink);
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#call subroutine to write to a database file
&write_database($datafile); I
elsif ( $magnet eq "Magnet: Wagner Varian 750") {
$index="/disks/workO/brodsky/webpages/NMR/4D/wagner750_index4D.html";
$data_file ="/disks/workO/brodsky/webpages/NMR/4D/wagner750_database4D.html";
$data_link ="wagner750_database4D.html";
#call the index subroutine
&writeindex($index,$data_link);
#call subroutine to write to a database file
&write_database($data_file); }
elsif ( $magnet eq "Magnet: Other" ) {
$index="/disks/workO/brodsky/webpages/NMR/4D/other_index4D.html";
$datafile ="/disks/work0/brodsky/webpages/NMR/4D/other_database4D.html";
$data_link ="other_database4D.html";
#call the index subroutine
&write_index($index,$data_link);
#call subroutine to write to a database file
&write_database($data_file); }
#subroutine to write an index file
sub write_index { local($index_file,$data_link) = @_;
open(DATAFILE20, ">> $index_file");
flock (DATAFILE20, 2);
#underscores to delimit records
printf DATAFILE20 " <br>\n";
printf DATAFILE20 "<a href=$dataJink#$count> \n";
printf DATAFILE20 "<h3>4D EXPT </h3> \n ";
printf DATAFILE20 "4D EXPT \n";
printf DATAFILE20 "Experiment number: $count \n";
printf DATAFILE20 "$user \n";
printf DATAFILE20 "$magnet \n";
printf DATAFILE20 "$finish \n";
printf DATAFILE20 "$exptname \n";
printf DATAFILE20 " $success \n";
if ($import_concern eq "yes" ) {
printf DATAFILE20 "GENERAL CONCERN LISTED IN COMMENTS <br> \n";
printf DATAFILE20 "</a> \n";
printf DATAFILE <<END_OF_MESSAGE;
<strong><a href="#top_ofpage">Return to the top of this page</a> </strong>
END_OF_MESSAGE
#RECORD_ITEM
flock (DATAFILE20, 8);
close DATAFILE20; }
#subroutine to write a database file that is passed to it.
sub write_database { local($database_file) = @_;
open(DATAFILE, ">> $databasefile");
flock (DATAFILE, 2);
#underscores to delimit records
printf DATAFILE " <br>\n";
printf DATAFILE "<a name = $count > \n";
printf DATAFILE "<h3>4D EXPT </h3>\n";
printf DATAFILE "</a> \n";
printf DATAFILE "Experiment number: $count <br>\n";
printf DATAFILE "$user <br>\n";
printf DATAFILE "$magnet <br>\n";
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printf DATAFILE "$start. <br>\n";
printf DATAFILE "$finish <br>\n";
printf DATAFILE "$expt_name <br>\n";
printf DATAFILE "$macro <br>\n";
printf DATAFILE "$probe <br> \n";
printf DATAFILE "$sample <br> \n";
printf DATAFILE "$type <br> \n";
printf DATAFILE "$conc <br>\n";
printf DATAFILE "$label <br> \n";
printf DATAFILE "$salt <br> \n";
printf DATAFILE "$temperature deg C<br> \n";
printf DATAFILE "$success <br> \n";
printf DATAFILE "$recycle seconds<br> \n";
printf DATAFILE "Acquisition detected $hetnuc_t4 with ";
printf DATAFILE "<br>$sw_t4 \n$pts_t4 <br> \n";
printf DATAFILE "First Indirect dimension detected $hetnuc_t3 with ";
printf DATAFILE "<br>$sw_t3 \n$pts_t3 <br> \n";
printf DATAFILE "Second indirect dimension detected $hetnuc_t2 with ";
printf DATAFILE "<br>$sw_t2 \n$pts_t2 <br> \n";
printf DATAFILE "Third indirect dimension detected $hetnuc_t with ";
printf DATAFILE "<br>$sw_tl \n$pts_t1 <br> \n";
printf DATAFILE "$proton_xmit at $proton_ppm ppm<br> \n";
if ( $deutno eq "Deuterium Decoupling: NO" ) {
printf DATAFILE "Deuterium Decoupling: NO <br>\n"; }
else {
printf DATAFILE "Deuterium Decoupling: YES <br> \n";
printf DATAFILE "$deut_comments:<pre>$deutcom <br>\n"; }
if($het_carbon ne "No") {
printf DATAFILE "Heteronucleus: CARBON <br>\n";
printf DATAFILE "$carb_xmit at $carb_ppm ppm<br> \n";
printf DATAFILE "$carb_90 \n$carb_power <br>\n";
printf DATAFILE "$carb_dec90\n$carb_decpower <br> \n";
if($het_nit ne "No") {
printf DATAFILE "Heteronucleus: NITROGEN <br> \n";
printf DATAFILE "$nit_xmit at $nitppm ppm<br>\n";
printf DATAFILE "$nit_90\n$nit power <br>\n";
printf DATAFILE "$nit_dec90\n$nit_decpower <br> \n";
if($het_phos ne "No") {
printf DATAFILE "Heteronucleus: PHOSPHOR <br> \n";
printf DATAFILE "$phos_xmit at $phos_ppm ppm<br>\n";
printf DATAFILE "$phos_90 \n$phos_power <br>\n";
printf DATAFILE "$phos_dec90\n$phos_decpower <br> \n";
if ($import_concern eq "yes" ) {
printf DATAFILE "GENERAL CONCERN LISTED IN COMMENTS <br> \n";
printf DATAFILE "$computer_comment:$ccom <br>\n";
printf DATAFILE "$success_comments:$scom <br>\n";
printf DATAFILE "$parameter comments:$pcom <br>\n";
printf DATAFILE <<END_OF_MESSAGE;
<strong><a href="#top_of_page">Return to the top of this page</a> <br></strong>
END_OF_MESSAGE
#RECORD_ITEM
flock (DATAFILE, 8);
close DATAFILE; }
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